pathway	n_phen	n_clust	enrich_un_n2	un_n2_erich
NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON	29	11	3	3
chr16q24	25	12	4	2
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP	37	11	3	2
GRATIAS_RETINOBLASTOMA_16Q24	12	6	2	1
GSE45365_CD8A_DC_VS_CD11B_DC_DN	35	13	5	3
GSE28408_LY6G_POS_VS_NEG_DC_UP	61	16	6	5
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	59	17	7	4
KEGG_MELANOGENESIS	57	14	6	4
CHIN_BREAST_CANCER_COPY_NUMBER_DN	32	9	3	2
GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_UP	53	15	6	3
GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_DN	44	8	3	2
GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN	57	18	6	5
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN	117	54	15	10
GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN	56	14	6	3
GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN	40	14	6	5
GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_UP	58	19	7	5
GRADE_COLON_CANCER_UP	66	19	11	5
NUYTTEN_EZH2_TARGETS_DN	63	19	8	5
chr20q11	43	13	4	3
DELACROIX_RARG_BOUND_MEF	64	19	8	5
BCAT_GDS748_DN	32	8	4	2
REACTOME_METABOLISM_OF_PROTEINS	54	16	5	3
CAGGTG_E12_Q6	145	74	22	11
GGGAGGRR_MAZ_Q6	130	61	17	11
TGGAAA_NFAT_Q4_01	134	70	17	9
GGGCGGR_SP1_Q6	127	56	19	11
TTGTTT_FOXO4_01	143	79	18	10
AACTTT_UNKNOWN	136	72	18	10
CTTTGT_LEF1_Q2	126	68	19	8
RYTTCCTG_ETS2_B	92	43	13	7
RNGTGGGC_UNKNOWN	92	40	15	8
GCANCTGNY_MYOD_Q6	101	46	15	10
TTANTCA_UNKNOWN	105	46	14	10
CAGGTA_AREB6_01	97	45	15	7
CAGCTG_AP4_Q5	102	48	13	7
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	98	43	12	7
GGGTGGRR_PAX4_03	96	41	13	9
PILON_KLF1_TARGETS_DN	88	37	14	6
CTGCAGY_UNKNOWN	92	41	11	7
RTAAACA_FREAC2_01	109	54	16	8
PUJANA_BRCA1_PCC_NETWORK	84	30	14	8
CACGTG_MYC_Q2	89	33	13	9
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	75	27	12	8
BLALOCK_ALZHEIMERS_DISEASE_UP	98	43	12	9
GTGCCTT_MIR506	81	33	12	7
DODD_NASOPHARYNGEAL_CARCINOMA_UP	95	44	13	7
SCGGAAGY_ELK1_02	70	21	10	7
DOUGLAS_BMI1_TARGETS_UP	68	24	9	4
TGANTCA_AP1_C	93	41	14	6
TGGNNNNNNKCCAR_UNKNOWN	72	24	11	7
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	76	31	9	6
MARTENS_BOUND_BY_PML_RARA_FUSION	65	20	10	5
SOX9_B1	70	25	12	4
TCCATTKW_UNKNOWN	61	17	8	5
TATAAA_TATA_01	108	51	15	11
MGGAAGTG_GABP_B	77	26	11	7
WTGAAAT_UNKNOWN	91	39	13	6
BENPORATH_ES_WITH_H3K27ME3	113	54	15	9
DANG_BOUND_BY_MYC	81	29	13	7
GATTGGY_NFY_Q6_01	88	32	11	8
chr12q24	51	17	6	3
chr6p21	51	11	3	2
CTCAGGG_MIR125B_MIR125A	62	18	8	5
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP	67	22	8	6
ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY	100	42	15	11
ENK_UV_RESPONSE_KERATINOCYTE_UP	60	18	9	4
NERF_Q2	62	15	7	5
YOSHIMURA_MAPK8_TARGETS_UP	116	48	17	10
POU3F2_02	74	32	9	2
SREBP1_Q6	65	20	9	6
TGACAGNY_MEIS1_01	95	45	13	7
TAATTA_CHX10_01	102	47	14	8
KRIEG_HYPOXIA_NOT_VIA_KDM3A	66	21	7	4
CTTTGA_LEF1_Q2	112	56	15	9
REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE	54	14	8	5
GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	112	54	15	8
MARSON_BOUND_BY_FOXP3_UNSTIMULATED	82	33	13	8
BLALOCK_ALZHEIMERS_DISEASE_DN	93	44	9	6
REACTOME_SIGNALLING_BY_NGF	60	18	9	5
FISCHER_DREAM_TARGETS	72	24	9	5
TGACCTY_ERR1_Q2	97	48	15	7
GTGACGY_E4F1_Q6	71	22	11	7
NRF1_Q6	69	22	11	7
DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	105	48	13	7
MILI_PSEUDOPODIA_CHEMOTAXIS_DN	69	22	11	8
BENPORATH_SOX2_TARGETS	73	26	13	5
CDC5_01	79	33	12	5
TGCCTTA_MIR124A	75	31	12	4
GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_UP	59	15	7	5
TGTTTGY_HNF3_Q6	94	42	13	6
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A	70	27	11	5
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE	62	20	10	4
PAX2_02	80	31	14	7
GCGNNANTTCC_UNKNOWN	55	14	4	2
CHEN_METABOLIC_SYNDROM_NETWORK	75	26	13	6
WTTGKCTG_UNKNOWN	85	37	12	6
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	87	40	12	6
CATTGTYY_SOX9_B1	77	28	12	5
TTGCCAA_MIR182	75	28	12	6
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	62	22	8	3
FIRESTEIN_PROLIFERATION	63	21	10	4
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP	71	25	10	6
GTTTGTT_MIR495	66	21	9	6
TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P	81	32	12	7
CTTTGTA_MIR524	86	37	13	6
PAX4_01	67	25	11	4
FORTSCHEGGER_PHF8_TARGETS_DN	76	24	10	5
ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY	107	43	14	9
GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP	59	16	7	3
TGATTTRY_GFI1_01	84	35	13	6
E2A_Q2	64	21	9	4
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP	79	30	12	6
TCF1P_Q6	66	22	10	6
RORA1_01	61	19	8	4
LMO2COM_02	72	28	13	4
CACCCBINDINGFACTOR_Q6	67	20	9	4
WGTTNNNNNAAA_UNKNOWN	91	43	14	7
ER_Q6	65	18	8	5
BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	66	22	8	4
HOXA4_Q2	66	23	13	5
PUJANA_ATM_PCC_NETWORK	84	33	14	9
BENPORATH_MYC_MAX_TARGETS	70	24	11	6
RODRIGUES_NTN1_TARGETS_DN	51	15	7	2
ACATTCC_MIR1_MIR206	66	23	7	5
CACBINDINGPROTEIN_Q6	61	18	10	5
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_DN	61	19	10	5
PATIL_LIVER_CANCER	69	22	10	5
GATA1_03	74	29	11	6
FOXO4_01	66	22	9	4
TAAWWATAG_RSRFC4_Q2	61	18	6	3
AREB6_04	74	27	12	6
POU6F1_01	80	35	12	5
TGAATGT_MIR181A_MIR181B_MIR181C_MIR181D	86	39	11	6
RCGCANGCGY_NRF1_Q6	70	23	9	7
SENESE_HDAC3_TARGETS_DN	67	22	10	4
GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN	53	12	5	2
BENPORATH_EED_TARGETS	109	49	14	9
WONG_ADULT_TISSUE_STEM_MODULE	89	42	13	5
RGAGGAARY_PU1_Q6	78	29	11	7
GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_DN	53	12	6	3
MARSON_BOUND_BY_FOXP3_STIMULATED	74	29	13	6
P300_01	66	21	12	5
VDR_Q6	65	21	9	5
GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN	53	13	8	3
AP2_Q6_01	66	20	11	6
BROWNE_HCMV_INFECTION_48HR_DN	71	28	11	3
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP	77	31	10	7
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP	58	18	8	2
MYCMAX_03	57	15	7	5
GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_DN	48	13	5	3
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_UP	51	16	8	4
GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_DN	51	12	5	2
SOX5_01	77	30	10	5
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	81	31	13	8
GATA1_04	75	26	12	5
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP	62	19	10	5
TCCCRNNRTGC_UNKNOWN	53	14	7	3
NKX62_Q2	77	28	13	7
TATA_C	77	31	12	6
RGAANNTTC_HSF1_01	67	25	9	4
GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN	54	13	7	2
ATGTACA_MIR493	82	37	12	5
SF1_Q6	62	21	10	5
IK1_01	68	23	10	6
GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN	55	14	10	4
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	66	23	9	6
RFX1_01	63	18	7	4
AREB6_01	69	24	11	5
REACTOME_HEMOSTASIS	73	23	12	8
FOXM1_01	77	30	12	6
GARY_CD5_TARGETS_UP	63	18	10	5
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP	79	30	11	6
KEGG_MAPK_SIGNALING_PATHWAY	66	21	11	4
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN	58	16	8	4
GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP	59	17	10	5
GGATTA_PITX2_Q2	84	37	12	6
PUJANA_CHEK2_PCC_NETWORK	67	22	12	5
GATAAGR_GATA_C	69	27	14	4
GATA_C	64	21	9	2
HNF1_C	66	24	11	5
SMTTTTGT_UNKNOWN	79	36	11	4
PID_VEGFR1_2_PATHWAY	58	16	8	5
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN	57	16	8	2
BENPORATH_NANOG_TARGETS	81	33	13	5
GSE17721_0.5H_VS_8H_LPS_BMDC_UP	51	13	6	3
GATA_Q6	59	16	5	3
GFI1_01	77	30	13	7
AAGCCAT_MIR135A_MIR135B	67	21	9	5
MILI_PSEUDOPODIA_HAPTOTAXIS_DN	69	20	11	7
FREAC3_01	66	21	8	5
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_DN	59	18	11	3
CRX_Q4	70	27	9	5
SRY_02	79	34	11	7
MIKKELSEN_NPC_HCP_WITH_H3K27ME3	81	31	10	7
CHEN_HOXA5_TARGETS_9HR_UP	52	14	6	3
ATGTCAC_MIR489	64	20	11	4
GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN	50	12	6	3
EGR1_01	76	27	12	7
CIZ_01	65	20	8	3
YATTNATC_UNKNOWN	82	35	10	6
TCANNTGAY_SREBP1_01	69	26	14	4
GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN	68	20	10	7
GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN	58	14	7	4
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	59	17	7	6
MARTINEZ_RB1_TARGETS_UP	74	26	12	8
TEF1_Q6	58	18	9	3
MYCMAX_B	66	22	9	4
GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_UP	54	18	9	3
TGCGCANK_UNKNOWN	63	20	8	2
TGGTGCT_MIR29A_MIR29B_MIR29C	73	26	10	6
BROWNE_HCMV_INFECTION_1HR_DN	63	19	9	4
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	67	20	9	5
REACTOME_IMMUNE_SYSTEM	76	28	12	6
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN	78	33	10	4
GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_UP	50	10	5	3
GSE10325_CD4_TCELL_VS_BCELL_UP	60	20	10	3
CEBP_Q2_01	70	28	10	4
GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP	58	17	7	4
NFAT_Q4_01	70	25	10	5
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	57	16	9	3
BASAKI_YBX1_TARGETS_DN	61	20	9	4
HSF1_01	56	14	6	3
TITF1_Q3	66	22	10	6
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	70	24	8	3
CHOP_01	66	23	10	5
GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN	57	18	9	4
SP3_Q3	63	19	9	5
GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP	58	18	9	3
ETS1_B	69	24	11	6
TTCYNRGAA_STAT5B_01	69	25	13	6
GATA1_02	73	26	11	6
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	83	33	13	6
CUI_TCF21_TARGETS_2_DN	94	44	11	8
KOYAMA_SEMA3B_TARGETS_DN	61	21	8	3
GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP	55	15	10	3
MYCMAX_02	65	20	9	6
DELYS_THYROID_CANCER_UP	68	21	9	5
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN	52	14	6	3
HP1SITEFACTOR_Q6	68	23	12	5
GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN	47	9	4	2
LEE_BMP2_TARGETS_UP	82	31	13	7
YTATTTTNR_MEF2_02	89	41	12	7
ZF5_01	60	18	9	5
PID_ENDOTHELIN_PATHWAY	50	13	4	2
PID_LYSOPHOSPHOLIPID_PATHWAY	54	15	6	2
HNF3ALPHA_Q6	66	21	9	4
GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP	56	17	8	4
MZF1_02	68	22	9	4
MARTINEZ_TP53_TARGETS_DN	76	27	11	7
RASHI_RESPONSE_TO_IONIZING_RADIATION_5	50	10	5	3
GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_DN	56	14	8	5
GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP	56	16	8	4
SRF_Q5_01	68	25	11	4
DODD_NASOPHARYNGEAL_CARCINOMA_DN	83	36	11	6
RACCACAR_AML_Q6	65	22	11	5
TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497	84	33	13	7
GCACTTT_MIR175P_MIR20A_MIR106A_MIR106B_MIR20B_MIR519D	83	33	12	8
HFH3_01	69	22	9	4
RREB1_01	65	19	11	7
KEGG_VEGF_SIGNALING_PATHWAY	42	9	3	2
TEF_Q6	70	26	9	4
GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN	59	15	9	5
HNF4_01	67	21	11	6
TTTGCAC_MIR19A_MIR19B	88	40	12	5
JOHNSTONE_PARVB_TARGETS_3_DN	68	22	9	6
GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_UP	65	20	9	4
KIM_WT1_TARGETS_DN	55	17	9	5
MULLIGHAN_MLL_SIGNATURE_2_UP	52	13	7	4
GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_DN	49	13	5	3
GSE17721_0.5H_VS_8H_CPG_BMDC_UP	46	10	6	2
GENTILE_UV_HIGH_DOSE_DN	60	19	8	2
AHR_Q5	60	17	8	7
TTGCACT_MIR130A_MIR301_MIR130B	86	37	13	6
STK33_NOMO_DN	65	21	11	4
TGCCAAR_NF1_Q6	88	40	13	6
GCCATNTTG_YY1_Q6	64	20	9	4
MAZR_01	63	14	7	7
GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	49	11	5	3
STAT6_02	63	19	9	4
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	73	23	10	7
AP4_Q6_01	57	19	7	2
NUYTTEN_EZH2_TARGETS_UP	87	36	13	7
GATA3_01	73	26	12	7
TGACATY_UNKNOWN	98	45	15	7
PEREZ_TP53_TARGETS	76	28	11	7
GTGCAAT_MIR25_MIR32_MIR92_MIR363_MIR367	63	21	7	3
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	55	14	5	4
NMYC_01	67	21	9	6
PDGF_ERK_DN.V1_DN	51	11	7	5
GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_UP	55	13	6	3
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	62	19	9	4
OCT1_03	68	25	10	5
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP	70	24	11	5
OCT1_04	89	41	14	5
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	74	27	8	5
WEI_MYCN_TARGETS_WITH_E_BOX	63	20	7	6
GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN	78	27	11	6
MAX_01	66	20	9	4
GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN	58	17	8	3
SENESE_HDAC3_TARGETS_UP	77	28	12	6
NFAT_Q6	69	25	11	5
GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP	56	16	5	3
GATA1_01	63	20	10	5
AGCACTT_MIR93_MIR302A_MIR302B_MIR302C_MIR302D_MIR372_MIR373_MIR520E_MIR520A_MIR526B_MIR520B_MIR520C_MIR520D	74	25	12	8
STEIN_ESRRA_TARGETS	65	21	11	3
KEGG_AXON_GUIDANCE	59	19	6	2
GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_DN	45	11	6	2
MARTINEZ_RB1_AND_TP53_TARGETS_DN	70	24	12	6
USF_02	55	15	6	3
SPZ1_01	65	24	11	5
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_UP	61	16	9	6
POU1F1_Q6	76	29	11	4
RSRFC4_01	67	21	6	4
GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP	56	16	10	3
GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP	53	13	6	2
GSE6259_DEC205_POS_DC_VS_CD4_TCELL_DN	52	11	6	3
YGCGYRCGC_UNKNOWN	62	16	6	5
ONKEN_UVEAL_MELANOMA_DN	66	22	10	6
GSE12366_NAIVE_VS_MEMORY_BCELL_UP	59	19	10	2
REACTOME_DEVELOPMENTAL_BIOLOGY	78	31	10	7
KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3	77	29	11	5
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	78	31	12	7
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP	64	20	9	3
NABA_MATRISOME	94	40	16	8
NFKB_C	71	22	12	8
GSE17721_LPS_VS_CPG_1H_BMDC_UP	49	9	4	3
MAZ_Q6	58	15	7	5
ISRE_01	75	27	12	7
GATA1_05	66	21	10	4
GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP	54	11	5	3
GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_DN	62	19	7	5
GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_UP	53	16	7	2
BENPORATH_SUZ12_TARGETS	107	49	11	8
OCT1_05	80	34	12	6
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	53	12	5	4
OCT1_02	75	29	10	5
RSRFC4_Q2	64	18	6	5
GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP	55	16	9	4
TST1_01	67	24	11	4
HLF_01	69	26	12	6
CCCNNGGGAR_OLF1_01	65	20	10	5
TGCTGAY_UNKNOWN	75	29	13	6
GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_UP	60	17	9	6
CACTGCC_MIR34A_MIR34C_MIR449	68	23	10	3
MZF1_01	59	19	11	4
E4BP4_01	63	19	8	5
GSE36826_WT_VS_IL1R_KO_SKIN_UP	55	14	6	3
NFKAPPAB65_01	59	17	9	6
VEGF_A_UP.V1_UP	63	17	9	4
GSE3039_NKT_CELL_VS_B1_BCELL_DN	53	13	6	2
GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN	49	12	6	2
GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_UP	54	15	7	3
GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_UP	58	17	9	4
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3	71	27	12	6
AAAGACA_MIR511	62	19	8	5
ACCAAAG_MIR9	87	38	16	7
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP	54	15	6	3
USF_01	57	16	7	4
REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION	52	13	8	4
GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP	55	14	7	3
GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_UP	65	19	8	4
GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_DN	60	18	8	5
GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_UP	51	14	8	2
GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_DN	55	16	8	5
EVI1_04	72	28	12	4
GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP	62	20	8	5
GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_UP	56	16	9	5
GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_UP	63	18	9	4
GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP	62	17	10	7
MULLIGHAN_MLL_SIGNATURE_1_UP	59	16	8	5
PTF1BETA_Q6	77	31	11	4
SP1_Q4_01	63	19	9	6
MYB_Q6	62	22	9	6
LOPEZ_MBD_TARGETS	75	26	12	7
TTF1_Q6	68	19	8	6
GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN	58	17	12	5
ETS_Q4	60	18	8	6
GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_DN	45	9	3	2
MEF2_03	62	18	6	3
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	61	20	9	3
GSE6259_BCELL_VS_CD4_TCELL_UP	54	13	8	3
GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	53	13	5	3
FREAC2_01	74	27	11	6
PARENT_MTOR_SIGNALING_UP	73	24	13	8
MYCMAX_01	62	18	8	5
GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN	58	17	9	3
GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_DN	56	16	6	3
GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP	55	16	9	4
STAT3_02	63	20	10	6
REACTOME_SIGNALING_BY_PDGF	51	13	8	4
SMID_BREAST_CANCER_NORMAL_LIKE_UP	68	26	10	5
GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_DN	53	14	6	3
GSE40655_FOXO1_KO_VS_WT_NTREG_UP	59	17	8	4
YCATTAA_UNKNOWN	88	37	13	6
GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_UP	59	17	8	4
FOXD3_01	72	25	12	6
GSE3982_BASOPHIL_VS_TH1_UP	55	18	9	3
GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_DN	50	11	6	3
GSE3565_DUSP1_VS_WT_SPLENOCYTES_UP	54	17	8	4
GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	54	21	10	3
GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN	61	18	10	5
GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_DN	49	14	8	3
GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_DN	56	13	7	4
MULLIGHAN_NPM1_SIGNATURE_3_UP	64	22	9	5
KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	45	12	7	3
CTTTAAR_UNKNOWN	98	46	15	9
GSE3982_DC_VS_BASOPHIL_UP	53	14	6	3
GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_DN	45	10	5	2
GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN	52	12	6	2
GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN	59	16	9	5
GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_DN	49	13	5	2
AATGTGA_MIR23A_MIR23B	82	34	13	7
GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP	55	13	7	5
GSE17721_CTRL_VS_LPS_1H_BMDC_UP	50	10	5	2
GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP	64	19	10	4
SANSOM_APC_TARGETS_DN	61	16	10	6
NFKB_Q6	67	23	11	6
KEGG_CHEMOKINE_SIGNALING_PATHWAY	58	17	8	4
NKX25_02	64	23	8	3
GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP	55	19	8	3
MYOD_Q6	63	20	10	6
GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_UP	62	19	11	4
AAANWWTGC_UNKNOWN	73	27	9	5
CACTGTG_MIR128A_MIR128B	77	34	11	5
GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_DN	49	14	5	3
GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP	51	12	5	4
GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_DN	51	14	7	3
GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP	51	12	6	3
GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP	55	18	7	2
VDR_Q3	64	20	9	4
ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	101	53	15	7
LEE_BMP2_TARGETS_DN	66	20	8	5
HSF2_01	56	15	6	3
GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN	53	17	10	5
ATATGCA_MIR448	68	25	7	3
ACEVEDO_LIVER_CANCER_UP	63	21	9	4
PAX4_02	78	31	15	7
PID_PDGFRB_PATHWAY	57	17	8	6
KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	51	11	5	3
NUYTTEN_NIPP1_TARGETS_DN	76	28	12	5
GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN	48	13	7	4
GSE29618_BCELL_VS_MONOCYTE_DN	48	16	9	3
OSMAN_BLADDER_CANCER_UP	61	19	11	7
TCF11_01	67	22	7	4
CREL_01	63	20	11	6
KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	55	18	6	3
YWATTWNNRGCT_UNKNOWN	50	13	6	4
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY	54	17	9	4
LIU_PROSTATE_CANCER_UP	49	13	6	3
GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN	58	14	9	5
GSE17721_POLYIC_VS_CPG_6H_BMDC_UP	51	13	5	2
GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN	61	20	12	4
GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_DN	51	13	7	3
MYOD_Q6_01	65	20	12	7
MYB_Q5_01	62	23	9	4
GSE40666_WT_VS_STAT1_KO_CD8_TCELL_DN	64	20	10	5
PU1_Q6	63	21	10	4
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN	65	18	8	4
AP2GAMMA_01	59	17	8	4
GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP	65	18	10	5
GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	55	14	8	3
GSE360_CTRL_VS_T_GONDII_MAC_UP	46	10	4	2
GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP	55	12	6	3
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN	59	17	9	3
AAAYWAACM_HFH4_01	72	28	9	3
ONKEN_UVEAL_MELANOMA_UP	69	23	12	6
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D	74	24	12	6
FOX_Q2	70	24	11	6
GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_UP	54	13	8	3
GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP	56	15	7	5
GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP	59	17	8	6
GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN	50	11	5	2
TGCTTTG_MIR330	72	25	9	5
ACTWSNACTNY_UNKNOWN	47	11	5	2
GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_UP	55	15	9	3
OLF1_01	66	20	9	3
RICKMAN_METASTASIS_DN	48	10	5	3
MYC_UP.V1_DN	47	9	4	2
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP	61	18	8	4
BLUM_RESPONSE_TO_SALIRASIB_UP	49	14	6	3
GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_DN	52	11	6	4
GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN	57	17	9	2
GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_DN	60	18	10	7
IK2_01	72	25	10	7
MIKKELSEN_ES_ICP_WITH_H3K4ME3	68	21	9	6
MEF2_02	71	24	7	5
E2F1_Q3_01	55	13	6	3
GR_Q6	70	26	12	5
ETS2_B	59	19	10	4
GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_UP	48	13	7	3
GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP	49	13	7	4
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN	55	14	7	2
KEGG_DILATED_CARDIOMYOPATHY	54	17	7	3
KUMAR_TARGETS_OF_MLL_AF9_FUSION	60	19	11	6
GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN	43	9	5	2
MIKKELSEN_MCV6_HCP_WITH_H3K27ME3	74	27	9	6
GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_UP	65	23	11	6
GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	47	13	7	2
GSE24210_TCONV_VS_TREG_DN	60	14	8	6
MITSIADES_RESPONSE_TO_APLIDIN_UP	63	21	12	5
GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_DN	55	16	8	5
STAT5B_01	61	20	9	4
GSE39864_WT_VS_GATA3_KO_TREG_DN	57	15	9	7
GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP	50	11	4	3
PEREZ_TP63_TARGETS	68	24	7	3
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	57	15	6	3
GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP	53	13	7	3
WHN_B	64	21	9	5
WANG_MLL_TARGETS	76	27	10	7
EGR2_01	67	21	11	6
GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_UP	52	13	4	2
PAX4_03	59	18	8	5
GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_UP	55	18	7	3
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	55	15	9	3
GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP	53	14	7	2
USF_Q6	64	20	9	4
SRF_Q4	60	18	8	3
chr5q13	44	11	4	0
TGACCTTG_SF1_Q6	63	21	11	5
CTATGCA_MIR153	69	24	8	6
GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP	56	16	7	3
GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_UP	57	13	7	5
GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_UP	56	14	7	3
GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP	57	19	9	3
CEBPB_02	64	20	7	4
GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN	54	13	7	3
OCT1_07	69	25	11	4
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	60	16	8	3
GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_UP	50	13	6	4
GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	51	12	5	3
GSE15215_CD2_POS_VS_NEG_PDC_DN	50	11	6	2
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	65	26	7	4
CTAWWWATA_RSRFC4_Q2	62	18	7	3
CHX10_01	63	23	10	5
MMEF2_Q6	67	21	9	6
E2F1_Q4	58	18	8	5
PIT1_Q6	74	31	9	5
GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP	48	13	7	3
GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN	50	12	5	2
KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_DN	62	17	10	6
GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_UP	56	14	8	3
ACTGTGA_MIR27A_MIR27B	83	36	12	7
MYOGENIN_Q6	60	17	7	4
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	61	17	7	3
GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP	48	10	5	3
BENPORATH_CYCLING_GENES	68	24	12	7
SILIGAN_BOUND_BY_EWS_FLT1_FUSION	48	13	4	2
chr2p23	51	14	7	0
GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_UP	54	16	8	3
GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP	57	16	8	3
GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN	50	13	7	4
GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP	43	9	4	2
GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_UP	61	18	11	6
GRUETZMANN_PANCREATIC_CANCER_DN	58	17	8	4
GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP	58	18	10	4
GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_UP	56	17	11	3
KEGG_PATHWAYS_IN_CANCER	75	25	11	8
CEBPDELTA_Q6	65	23	9	4
ENK_UV_RESPONSE_KERATINOCYTE_DN	65	21	6	3
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN	55	15	6	3
GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN	53	15	8	5
GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_UP	55	14	6	3
GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_UP	52	12	7	3
YTAATTAA_LHX3_01	67	22	8	5
PUJANA_BRCA2_PCC_NETWORK	65	21	11	6
GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP	44	10	5	2
NFY_Q6_01	66	18	7	6
GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_UP	55	14	8	2
GATA4_Q3	68	23	8	4
FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	48	9	4	2
MOOTHA_MITOCHONDRIA	54	15	6	3
KEGG_GNRH_SIGNALING_PATHWAY	48	10	6	3
PID_ANGIOPOIETIN_RECEPTOR_PATHWAY	46	11	7	6
GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP	53	14	7	3
GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN	56	16	9	5
HNF6_Q6	79	34	12	5
TAXCREB_01	46	8	4	3
GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN	63	18	9	5
GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP	64	18	9	5
GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN	68	24	10	5
GSE7852_THYMUS_VS_FAT_TCONV_DN	51	16	10	3
HFH4_01	63	20	10	4
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_DN	56	15	5	5
PID_MTOR_4PATHWAY	45	9	4	2
BRUINS_UVC_RESPONSE_LATE	89	37	12	8
GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP	62	19	10	5
E2F3_UP.V1_DN	48	10	5	2
GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_UP	55	15	8	3
NUYTTEN_NIPP1_TARGETS_UP	64	24	9	5
ACACTAC_MIR1423P	55	14	7	4
GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_UP	47	12	5	2
GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	58	18	7	2
GSE17721_LPS_VS_CPG_0.5H_BMDC_UP	46	9	4	3
NGFIC_01	68	20	10	7
GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN	52	16	6	3
DR4_Q2	64	19	9	7
REACTOME_SIGNALING_BY_ERBB2	54	15	9	4
GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP	58	16	7	3
KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_DN	62	19	9	4
GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_UP	51	11	6	4
GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	53	13	6	3
GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP	62	19	8	6
P53_02	71	29	10	4
REACTOME_SIGNALING_BY_GPCR	78	32	12	6
HOXA9_DN.V1_DN	43	8	3	2
MYB_Q3	64	21	9	4
ESC_V6.5_UP_EARLY.V1_UP	51	13	5	3
GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_DN	49	11	5	3
GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN	51	13	5	3
NFMUE1_Q6	55	14	7	2
GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_UP	48	12	7	3
GSE7852_TREG_VS_TCONV_DN	59	18	9	6
CEBP_C	67	25	9	4
IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR	79	31	9	4
MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3	105	52	13	8
AMEF2_Q6	67	23	8	3
PTEN_DN.V2_DN	51	13	6	3
GRE_C	49	14	6	2
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION	56	16	7	4
GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_DN	46	11	4	2
GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN	53	16	9	5
ELK1_01	56	15	9	5
GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN	55	14	8	4
GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	47	10	5	2
GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN	54	15	6	3
GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP	43	8	4	2
GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_DN	50	16	8	5
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	61	19	6	3
CTACCTC_LET7A_LET7B_LET7C_LET7D_LET7E_LET7F_MIR98_LET7G_LET7I	67	21	10	5
GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	58	15	8	5
GSE27786_BCELL_VS_MONO_MAC_UP	47	11	5	2
GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_UP	61	19	9	5
PR_Q2	67	22	11	4
RTTTNNNYTGGM_UNKNOWN	72	26	11	6
ACTACCT_MIR196A_MIR196B	55	14	8	2
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	63	18	9	4
DBP_Q6	66	25	8	3
GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP	56	16	6	3
GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN	52	14	6	3
GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP	44	13	6	2
GTTRYCATRR_UNKNOWN	46	11	6	2
MEIS1BHOXA9_01	54	16	6	4
SENESE_HDAC1_TARGETS_UP	62	20	10	5
GSE7460_TCONV_VS_TREG_THYMUS_UP	50	14	8	3
OCT1_B	76	33	12	5
AR_Q6	61	21	10	4
CDX2_Q5	71	28	10	3
GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_DN	52	13	6	3
GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP	55	15	6	3
GSE27786_LSK_VS_NEUTROPHIL_UP	53	12	4	4
ACTGAAA_MIR30A3P_MIR30E3P	52	13	6	2
TGTGTGA_MIR377	66	25	11	4
GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_UP	57	21	7	3
JOHNSTONE_PARVB_TARGETS_2_DN	64	22	7	2
GEORGES_TARGETS_OF_MIR192_AND_MIR215	80	33	11	6
GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN	51	13	9	4
PUJANA_XPRSS_INT_NETWORK	41	7	4	2
GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN	49	11	4	3
PIGF_UP.V1_DN	67	18	8	5
PID_MAPK_TRK_PATHWAY	43	7	3	2
RUTELLA_RESPONSE_TO_HGF_UP	64	20	9	4
GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_UP	52	13	5	4
GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	55	13	8	4
GSE17721_LPS_VS_POLYIC_4H_BMDC_DN	47	9	4	3
GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_DN	54	17	6	3
GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN	54	16	9	3
TAL1BETAE47_01	63	20	7	5
EFC_Q6	64	21	11	7
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7	61	19	6	3
ZF5_B	55	15	5	3
STAT5A_04	68	28	8	4
GCTNWTTGK_UNKNOWN	69	24	11	5
IVANOVA_HEMATOPOIESIS_STEM_CELL	59	20	7	2
GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP	52	12	8	2
GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_DN	51	13	6	2
GSE4984_GALECTIN1_VS_LPS_STIM_DC_DN	42	10	6	2
GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN	47	11	6	3
NIKOLSKY_BREAST_CANCER_7P15_AMPLICON	9	4	2	2
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	48	9	5	2
GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_UP	44	9	4	2
GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP	51	15	8	4
GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_DN	51	13	7	4
GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN	57	19	8	4
GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP	56	14	6	3
GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_DN	61	17	9	5
SREBP_Q3	60	17	9	6
BERNARD_PPAPDC1B_TARGETS_DN	44	8	4	2
CAGTATT_MIR200B_MIR200C_MIR429	76	29	9	6
CTTTGCA_MIR527	70	22	9	7
YNGTTNNNATT_UNKNOWN	82	38	9	6
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP	47	11	5	2
GSE27859_DC_VS_CD11C_INT_F480_INT_DC_DN	41	8	3	2
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	42	14	5	2
GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN	47	10	5	2
GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_DN	52	14	6	2
GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_UP	57	18	10	5
GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_DN	51	15	7	4
GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_UP	50	16	7	3
HEN1_01	67	22	8	5
GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN	48	9	3	2
SRF_C	54	12	5	3
GSE360_DC_VS_MAC_UP	55	19	10	4
GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN	42	11	6	2
GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN	50	14	9	4
GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN	51	13	5	3
GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_DN	43	8	3	3
GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP	48	12	7	4
GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP	54	14	4	2
CP2_02	55	13	5	2
WEI_MIR34A_TARGETS	56	13	6	3
NFKAPPAB_01	62	17	9	6
AML1_Q6	63	21	10	4
AML1_01	63	21	10	4
GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_UP	53	15	7	3
GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_DN	37	11	6	3
GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_UP	50	13	7	4
GSE42724_MEMORY_BCELL_VS_PLASMABLAST_DN	49	10	3	2
GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP	53	14	6	3
GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN	47	12	5	3
MANALO_HYPOXIA_UP	57	20	6	3
HOELZEL_NF1_TARGETS_DN	51	14	4	2
MIKKELSEN_MEF_HCP_WITH_H3K27ME3	79	35	8	3
GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_DN	54	14	5	2
GSE11924_TFH_VS_TH2_CD4_TCELL_DN	47	12	4	3
GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_UP	49	9	4	2
PRC2_EZH2_UP.V1_DN	61	18	10	4
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	63	23	10	3
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	74	30	10	4
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN	64	21	10	4
ONDER_CDH1_TARGETS_2_DN	68	25	11	4
GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_DN	58	17	6	2
GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP	52	15	7	2
GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP	47	11	6	2
GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_DN	53	11	4	3
DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	79	33	11	6
CATTTCA_MIR203	66	29	10	4
LXR_DR4_Q3	47	11	5	2
GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_UP	42	10	6	2
GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP	51	15	8	2
GSE34515_CD16_POS_MONOCYTE_VS_DC_DN	58	14	6	3
GSE11924_TH1_VS_TH2_CD4_TCELL_UP	51	11	7	3
NKX22_01	57	18	7	3
GSE4748_CTRL_VS_LPS_STIM_DC_3H_DN	45	14	7	3
FREAC7_01	68	21	10	6
REACTOME_SIGNALLING_TO_ERKS	41	7	3	2
NRF2_01	55	12	7	3
PEA3_Q6	64	20	11	6
CHICAS_RB1_TARGETS_CONFLUENT	82	34	11	4
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN	47	9	3	2
GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP	48	12	7	4
GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_UP	60	19	7	4
OSF2_Q6	66	21	10	5
GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP	62	20	11	4
P53_DN.V1_UP	55	17	5	2
TIEN_INTESTINE_PROBIOTICS_24HR_UP	58	18	8	5
GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_DN	53	13	6	3
BHAT_ESR1_TARGETS_VIA_AKT1_UP	57	17	9	3
AACATTC_MIR4093P	63	21	8	3
GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_UP	53	16	8	3
TAL1BETAITF2_01	65	22	9	4
GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN	51	16	9	5
GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_UP	56	17	10	4
AP2_Q3	65	21	9	5
GCM_Q2	59	18	9	5
AFP1_Q6	67	26	9	4
GSE12366_GC_VS_MEMORY_BCELL_DN	52	13	6	2
GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_UP	49	11	4	2
GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP	54	14	6	2
GSE22886_DC_VS_MONOCYTE_DN	51	9	5	3
GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN	58	17	8	4
GSE17721_LPS_VS_POLYIC_16H_BMDC_DN	55	16	7	5
FEVR_CTNNB1_TARGETS_UP	65	21	10	7
GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN	51	15	7	3
GRUETZMANN_PANCREATIC_CANCER_UP	57	18	10	5
PPAR_DR1_Q2	63	20	10	4
TATA_01	59	14	8	5
IKEDA_MIR1_TARGETS_UP	47	10	3	1
KEGG_ACUTE_MYELOID_LEUKEMIA	47	10	6	4
TCTGATA_MIR361	55	16	7	3
GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN	55	15	9	5
SP1_Q2_01	66	19	8	6
GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN	55	14	8	4
GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_UP	51	14	6	2
GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_UP	49	11	6	3
GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_UP	48	13	6	3
GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_UP	57	15	9	6
CART1_01	73	26	8	5
GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP	54	18	7	3
GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_DN	53	16	7	3
MARTENS_TRETINOIN_RESPONSE_DN	59	15	6	3
GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_DN	56	15	6	4
GCTTGAA_MIR498	53	13	5	2
REACTOME_G_ALPHA_S_SIGNALLING_EVENTS	51	13	6	2
GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_DN	51	12	7	2
GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP	51	12	6	3
STAT5A_01	63	24	9	3
GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP	59	17	8	6
GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_UP	54	16	10	2
GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_DN	47	12	4	3
GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN	57	15	9	5
GSE17721_0.5H_VS_12H_POLYIC_BMDC_DN	51	11	6	3
GSE13411_NAIVE_VS_MEMORY_BCELL_DN	54	13	5	3
GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_UP	57	15	6	4
GSE29618_BCELL_VS_MDC_DN	51	13	7	3
TATTATA_MIR374	70	29	9	3
GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_UP	54	13	8	2
LI_AMPLIFIED_IN_LUNG_CANCER	51	11	7	3
PID_MET_PATHWAY	51	14	7	3
ELVIDGE_HIF1A_TARGETS_DN	47	11	3	2
EVI1_02	47	13	6	2
CP2_01	62	20	11	6
BRN2_01	76	33	13	3
GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_UP	58	17	9	5
GSE19198_1H_VS_6H_IL21_TREATED_TCELL_DN	56	14	8	4
GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_DN	47	10	5	3
GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP	57	14	7	3
GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN	52	12	4	2
REACTOME_PLC_BETA_MEDIATED_EVENTS	45	10	5	2
chr16p11	48	12	6	4
GATA6_01	71	26	12	4
OCT1_Q5_01	75	35	10	4
GSE27786_LIN_NEG_VS_CD4_TCELL_DN	51	12	6	2
GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_UP	62	20	10	4
GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN	54	15	7	4
GATA2_01	59	19	11	4
GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP	56	20	9	3
GSE17721_POLYIC_VS_CPG_12H_BMDC_UP	48	10	4	2
GSE360_DC_VS_MAC_T_GONDII_DN	50	12	5	3
RRAGTTGT_UNKNOWN	70	26	9	5
ICSBP_Q6	76	27	11	7
GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_UP	49	14	8	3
PID_P75_NTR_PATHWAY	46	12	7	5
GSE16385_MONOCYTE_VS_MACROPHAGE_DN	47	13	3	2
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_DN	59	14	8	5
GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_DN	56	16	9	3
GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP	55	17	8	5
GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_UP	57	17	9	5
WEST_ADRENOCORTICAL_TUMOR_UP	55	14	7	4
MATSUDA_NATURAL_KILLER_DIFFERENTIATION	74	27	13	7
YOSHIMURA_MAPK8_TARGETS_DN	64	20	8	5
OCT_Q6	73	31	10	5
TFIIA_Q6	48	13	5	2
DOANE_RESPONSE_TO_ANDROGEN_DN	61	18	9	5
KEGG_GAP_JUNCTION	50	13	5	4
MASSARWEH_TAMOXIFEN_RESISTANCE_UP	73	26	12	5
KATSANOU_ELAVL1_TARGETS_UP	47	9	4	2
GSE27786_BCELL_VS_NKTCELL_DN	45	9	4	2
GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN	60	18	10	5
GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN	53	13	6	4
AP2ALPHA_01	63	20	11	4
GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_DN	52	13	6	3
GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	69	23	10	7
LIAO_METASTASIS	74	28	12	4
MCCABE_BOUND_BY_HOXC6	59	17	8	3
SCHLOSSER_SERUM_RESPONSE_DN	72	24	11	6
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	54	17	6	4
NKX61_01	75	28	11	6
PID_CXCR3_PATHWAY	42	7	3	2
PID_RET_PATHWAY	37	9	5	2
LU_EZH2_TARGETS_DN	57	17	6	4
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12	56	14	8	3
GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_UP	44	8	4	2
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	48	10	4	2
GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_UP	59	17	12	7
GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP	48	13	6	2
SASSON_RESPONSE_TO_GONADOTROPHINS_DN	45	10	4	4
REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	60	17	11	5
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP	38	12	5	3
PID_S1P_S1P2_PATHWAY	39	6	3	2
FEVR_CTNNB1_TARGETS_DN	59	18	8	2
GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP	48	12	6	3
GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP	59	17	8	3
GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN	53	12	6	2
GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP	46	12	5	3
GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	58	16	8	4
GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_UP	51	12	4	3
GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_DN	49	12	7	3
GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN	52	15	8	3
GSE40273_GATA1_KO_VS_WT_TREG_DN	52	17	8	4
GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_DN	55	15	8	5
GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN	48	15	8	2
HNF4_Q6	62	21	9	7
ERR1_Q2	59	19	9	5
GGGYGTGNY_UNKNOWN	72	25	11	6
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP	74	30	10	4
BIOCARTA_MAPK_PATHWAY	52	12	7	3
PID_TRKR_PATHWAY	49	13	6	4
ACACTCC_MIR122A	52	16	4	2
PID_RB_1PATHWAY	54	14	11	5
GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP	54	14	8	2
GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN	43	14	8	2
GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP	45	9	3	2
AACTGGA_MIR145	65	23	11	5
AP4_01	70	23	11	7
GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_UP	48	14	8	4
HEB_Q6	65	21	10	4
GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_DN	54	15	5	2
NCX_01	65	22	11	5
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	46	12	6	4
ATTCTTT_MIR186	66	24	9	5
GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP	53	15	7	5
GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP	54	15	7	4
GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP	50	14	7	4
GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	60	18	7	4
GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN	50	12	5	3
NFE2_01	52	15	7	4
RUTELLA_RESPONSE_TO_HGF_DN	60	20	10	4
MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3	79	32	12	6
STAT4_01	74	27	10	5
GSE22886_NAIVE_BCELL_VS_DC_UP	55	17	8	3
GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_DN	58	18	7	3
GSE17721_POLYIC_VS_CPG_4H_BMDC_UP	51	11	6	4
GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_UP	50	16	9	5
GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_DN	48	14	7	3
GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_UP	39	7	4	2
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP	67	22	9	7
MEF2_Q6_01	71	27	9	4
NF1_Q6	63	22	12	6
PAX8_B	53	12	6	4
KIM_WT1_TARGETS_12HR_UP	54	19	11	4
GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP	59	18	11	2
HNF1_Q6	72	25	12	6
MAF_Q6	66	22	10	4
YATGNWAAT_OCT_C	74	32	9	6
SP1_Q6_01	58	16	8	6
GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	49	13	7	3
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_UP	53	15	7	4
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4	61	21	10	4
STAT6_01	67	22	10	8
BURTON_ADIPOGENESIS_5	46	13	9	5
GSE3982_EOSINOPHIL_VS_BCELL_DN	47	12	5	3
RACTNNRTTTNC_UNKNOWN	55	14	7	4
GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_DN	53	13	6	3
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN	74	34	11	5
GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_DN	50	11	6	3
TAAYNRNNTCC_UNKNOWN	52	16	7	3
ELVIDGE_HYPOXIA_UP	53	14	4	3
GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP	46	11	4	2
GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_UP	52	12	5	3
GSE2585_CTEC_VS_MTEC_THYMUS_UP	50	10	4	3
GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN	53	16	7	3
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	62	22	10	4
EGR_Q6	63	17	9	5
DANG_REGULATED_BY_MYC_DN	58	19	10	5
GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_DN	47	11	3	2
GSE29618_MONOCYTE_VS_MDC_DN	49	12	5	3
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_UP	51	14	8	3
GSE27786_CD4_TCELL_VS_MONO_MAC_UP	46	12	8	2
SP1_01	59	16	8	2
CDP_02	70	28	9	5
E47_01	58	18	11	5
AP1_Q6_01	52	15	5	2
BIOCARTA_ECM_PATHWAY	33	6	3	1
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	59	18	8	4
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D	66	20	11	6
GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_DN	48	13	8	3
GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN	51	16	11	5
GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP	54	15	6	3
GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN	58	19	8	3
GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_UP	53	16	9	4
GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_DN	49	12	6	3
HMGIY_Q6	70	24	13	5
GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN	47	11	6	3
E2F1DP1_01	52	14	6	3
GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_UP	55	16	6	2
E2F1DP2_01	52	14	6	3
REACTOME_OPIOID_SIGNALLING	49	13	8	2
GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_UP	53	14	6	3
GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP	51	11	6	3
KEGG_FOCAL_ADHESION	48	13	4	3
GSE27786_LIN_NEG_VS_BCELL_DN	52	13	6	3
OCT1_Q6	77	32	13	5
GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN	46	14	6	3
E2F_02	52	14	6	3
E2F4DP2_01	52	14	6	3
GSE4590_SMALL_VS_LARGE_PRE_BCELL_UP	51	15	8	4
GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_DN	51	12	7	3
RODWELL_AGING_KIDNEY_UP	56	17	8	3
CETS1P54_01	55	12	7	4
GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN	55	16	8	5
GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN	49	14	6	3
GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	50	15	8	3
GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_UP	45	7	4	2
GSE2706_R848_VS_LPS_8H_STIM_DC_DN	40	13	6	3
TTAYRTAA_E4BP4_01	66	19	10	5
AP4_Q6	57	16	7	4
GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_UP	51	13	8	3
GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_UP	49	14	8	3
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	56	13	6	5
GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP	53	16	10	3
GSE339_CD4POS_VS_CD4CD8DN_DC_UP	57	15	8	6
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN	58	18	8	3
REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE	44	7	4	2
S8_01	62	22	9	3
AP2_Q6	68	22	11	5
GAGCCTG_MIR484	48	9	4	3
GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_UP	53	12	7	5
GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN	52	14	7	3
REACTOME_INNATE_IMMUNE_SYSTEM	61	21	10	5
WCAANNNYCAG_UNKNOWN	57	17	8	4
E2F4DP1_01	54	14	6	3
GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_UP	61	18	10	5
DOANE_RESPONSE_TO_ANDROGEN_UP	56	13	7	3
GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP	48	13	5	4
GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_UP	51	15	8	3
GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP	54	14	8	2
GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	57	17	10	5
GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_UP	50	13	8	6
IL2_UP.V1_DN	60	16	7	4
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	53	13	6	3
KEGG_INSULIN_SIGNALING_PATHWAY	47	10	4	2
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN	43	12	3	2
FOXO4_02	71	25	9	5
GSE17721_CTRL_VS_LPS_8H_BMDC_UP	50	15	9	3
GSE11864_UNTREATED_VS_CSF1_IN_MAC_UP	55	16	9	4
GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_UP	49	16	9	3
GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_UP	50	11	4	3
GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_UP	56	14	10	6
GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_DN	57	17	9	4
E12_Q6	60	18	8	5
CREB_Q2	54	15	6	5
GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_DN	47	9	4	2
LIM_MAMMARY_STEM_CELL_UP	71	32	11	2
GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_DN	47	12	6	3
GSE13229_IMM_VS_MATURE_NKCELL_DN	47	13	5	3
GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP	57	15	9	4
WEST_ADRENOCORTICAL_TUMOR_DN	69	25	11	6
GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_DN	48	16	8	4
GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_DN	48	12	5	3
PID_REG_GR_PATHWAY	48	12	8	3
GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP	47	12	4	2
GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP	52	16	8	3
GSE11386_NAIVE_VS_MEMORY_BCELL_UP	46	9	5	2
GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_DN	50	14	5	3
GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_DN	45	10	5	2
GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP	45	11	7	3
SYATTGTG_UNKNOWN	61	17	5	4
PID_CXCR4_PATHWAY	50	14	7	6
TERAO_AOX4_TARGETS_HG_UP	35	11	6	3
GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_UP	55	14	9	5
GSE27786_LSK_VS_NKTCELL_UP	53	12	6	4
GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN	37	8	3	2
GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_DN	48	14	8	4
GSE27786_NKTCELL_VS_MONO_MAC_UP	38	9	5	2
GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP	56	14	6	3
GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN	56	14	8	3
GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_DN	57	17	8	3
GSE4142_PLASMA_CELL_VS_GC_BCELL_UP	48	9	3	2
GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP	47	12	6	3
GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_UP	51	15	7	3
GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_UP	53	15	9	4
GSE17721_0.5H_VS_24H_LPS_BMDC_DN	46	10	5	2
AHRARNT_01	57	16	9	4
GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	48	17	11	4
GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_DN	51	13	6	3
COREBINDINGFACTOR_Q6	69	28	13	5
CEBP_01	78	32	11	6
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR	52	14	8	3
KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	48	11	5	2
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP	60	19	9	5
SMID_BREAST_CANCER_BASAL_UP	67	24	10	5
PID_PI3KCI_PATHWAY	47	13	6	3
AGCATTA_MIR155	59	19	9	3
GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_DN	57	15	8	6
LINSLEY_MIR16_TARGETS	55	16	8	2
GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_UP	55	16	9	6
GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	57	15	10	4
GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP	56	17	6	3
GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP	58	15	7	2
GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_UP	44	14	6	3
GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_DN	48	12	3	2
GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN	34	7	3	2
KOYAMA_SEMA3B_TARGETS_UP	57	16	8	3
PID_S1P_S1P4_PATHWAY	47	8	4	3
REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY	40	7	4	2
LI_ADIPOGENESIS_BY_ACTIVATED_PPARG	22	8	4	3
ZHANG_ADIPOGENESIS_BY_BMP7	37	7	4	2
BENPORATH_ES_1	59	17	7	3
GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP	50	11	5	2
FOXJ2_01	70	27	11	4
REACTOME_SIGNALING_BY_EGFR_IN_CANCER	51	15	9	3
LFA1_Q6	63	18	9	5
GRYDER_PAX3FOXO1_TOP_ENHANCERS	80	33	13	5
GGAMTNNNNNTCCY_UNKNOWN	53	14	8	3
GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN	50	11	5	3
YY1_01	69	19	8	6
GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_UP	51	11	6	3
GSE18893_TCONV_VS_TREG_2H_CULTURE_UP	58	17	8	2
GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_UP	52	13	8	2
GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	59	17	10	4
GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_DN	54	13	7	3
GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_UP	46	9	4	2
ARNT_02	56	14	7	4
GSE3982_BCELL_VS_TH1_UP	46	14	8	2
E4F1_Q6	63	20	9	3
GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN	50	11	4	2
DOUGLAS_BMI1_TARGETS_DN	55	14	7	4
GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN	52	10	4	3
GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN	51	12	5	4
GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_UP	47	9	3	2
LEE_CALORIE_RESTRICTION_NEOCORTEX_UP	53	13	8	5
WEIGEL_OXIDATIVE_STRESS_RESPONSE	41	8	4	3
GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN	49	11	5	2
GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_UP	53	15	9	3
GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_DN	41	10	4	2
GSE360_DC_VS_MAC_L_MAJOR_UP	50	17	11	3
GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN	51	14	7	4
DELACROIX_RAR_BOUND_ES	63	21	9	5
HAND1E47_01	65	22	9	5
GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_UP	48	11	4	2
GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_DN	51	11	5	3
GSE7852_LN_VS_FAT_TCONV_UP	53	11	4	4
GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN	55	16	6	2
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_DN	49	11	6	3
GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_DN	52	11	7	4
GSE17721_POLYIC_VS_CPG_24H_BMDC_UP	50	15	9	2
GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_DN	45	12	4	2
GSE43955_1H_VS_20H_ACT_CD4_TCELL_UP	46	14	6	2
HALLMARK_GLYCOLYSIS	45	12	5	3
GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_DN	58	14	7	5
GSE27786_CD4_TCELL_VS_NEUTROPHIL_DN	47	15	10	3
GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN	58	19	8	6
GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP	52	12	5	3
ROVERSI_GLIOMA_COPY_NUMBER_UP	45	21	9	4
GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_UP	55	15	7	4
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN	51	12	6	3
GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN	52	13	7	2
BIOCARTA_NFAT_PATHWAY	50	12	6	3
GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_DN	60	18	9	4
OCT1_06	73	27	9	5
MARTINEZ_RB1_AND_TP53_TARGETS_UP	77	28	10	8
MARTINEZ_TP53_TARGETS_UP	74	27	11	6
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29	19	7	3	2
GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_DN	46	11	6	2
DARWICHE_PAPILLOMA_RISK_LOW_DN	49	13	6	4
TNCATNTCCYR_UNKNOWN	49	11	5	3
BASAKI_YBX1_TARGETS_UP	49	10	5	3
STK33_DN	63	18	8	5
CEBPB_01	64	24	10	5
GABRIELY_MIR21_TARGETS	65	24	6	2
SP1_Q6	63	21	10	6
ATF3_Q6	54	13	4	3
GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_DN	55	16	8	3
GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_DN	51	11	6	3
GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_UP	50	15	6	3
GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN	50	12	7	3
GSE6875_WT_VS_FOXP3_KO_TREG_DN	50	12	6	3
GSE3039_NKT_CELL_VS_B1_BCELL_UP	54	17	9	3
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN	51	13	7	2
GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP	50	13	6	3
GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN	58	18	8	2
GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP	48	13	8	4
GSE360_CTRL_VS_L_MAJOR_DC_UP	58	14	8	7
CYCLIN_D1_UP.V1_DN	59	16	8	4
GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP	50	12	6	3
GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_UP	53	14	8	3
GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP	52	13	5	2
GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP	50	11	5	2
GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN	47	10	5	2
EGR3_01	53	11	6	3
GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP	47	10	3	2
GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_UP	53	15	6	5
GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_DN	48	10	5	3
GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN	46	10	5	2
GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP	44	9	4	3
GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_DN	49	14	7	4
GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP	33	9	4	3
SANSOM_APC_MYC_TARGETS	52	13	6	2
AAGCACA_MIR218	81	37	11	4
GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_UP	61	18	7	4
HALLMARK_E2F_TARGETS	50	10	4	2
GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_DN	59	17	9	5
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP	51	11	4	2
GSE23695_CD57_POS_VS_NEG_NK_CELL_DN	52	13	6	2
GSE360_CTRL_VS_L_MAJOR_DC_DN	58	19	10	3
GSE27786_LIN_NEG_VS_NKCELL_DN	45	12	6	2
PID_IGF1_PATHWAY	40	9	3	2
REACTOME_SIGNALING_BY_SCF_KIT	46	12	7	3
GSE17721_4H_VS_24H_POLYIC_BMDC_UP	44	9	5	3
GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_DN	46	11	6	3
GSE3982_MAC_VS_BCELL_UP	54	16	6	3
REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS	65	22	10	4
GSE36078_WT_VS_IL1R_KO_LUNG_DC_DN	58	13	7	5
GSE3982_EOSINOPHIL_VS_BASOPHIL_DN	39	13	6	2
MIKKELSEN_NPC_ICP_WITH_H3K4ME3	72	27	10	3
GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_DN	45	12	6	2
GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN	54	13	7	6
GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP	58	17	8	5
GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN	55	15	8	4
GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN	52	11	6	4
GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_UP	54	15	8	3
PID_ERBB1_DOWNSTREAM_PATHWAY	48	11	5	3
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	37	9	5	2
HIF1_Q5	69	21	8	5
HNF1_01	59	19	7	3
ELF1_Q6	60	20	11	5
FOXJ2_02	76	30	13	4
LYF1_01	65	22	11	4
GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_DN	47	10	4	2
GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP	58	17	9	6
GSE24292_WT_VS_PPARG_KO_MACROPHAGE_DN	59	18	6	3
GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_DN	53	16	8	3
GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN	54	13	7	3
GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP	56	20	11	3
GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP	54	15	8	3
GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_UP	46	11	7	4
GSE24210_IL35_TREATED_VS_RESTING_TREG_UP	48	16	9	2
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN	54	12	6	3
GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_UP	57	18	9	2
GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_UP	60	19	11	4
GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_UP	56	16	7	3
GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_UP	55	13	5	4
GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP	54	13	5	2
GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_DN	58	16	8	4
GSE14350_IL2RB_KO_VS_WT_TEFF_DN	57	17	8	3
NKX3A_01	67	22	9	5
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS	75	27	12	7
JOHNSTONE_PARVB_TARGETS_3_UP	65	20	9	7
REACTOME_ACTIVATED_TLR4_SIGNALLING	48	11	5	3
GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_DN	51	14	10	4
GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN	49	12	6	3
GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP	56	16	7	5
GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP	49	13	5	2
GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	66	22	12	5
GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_DN	54	14	6	2
GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_UP	49	10	4	2
GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	47	11	6	4
GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_UP	59	20	9	5
GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN	45	11	4	2
GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN	53	14	5	2
GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_UP	49	14	5	2
GSE22886_DC_VS_MONOCYTE_UP	52	12	7	3
GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP	49	13	6	4
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	44	10	4	3
GSE11924_TFH_VS_TH2_CD4_TCELL_UP	50	10	5	2
GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_UP	50	11	5	2
GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_UP	51	14	8	4
HAN_SATB1_TARGETS_DN	55	19	7	3
STAT_01	68	22	13	7
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	54	14	6	4
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	59	17	8	4
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP	55	16	7	6
GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP	55	12	5	3
STAT5A_03	70	26	12	6
GSE22886_NAIVE_CD8_TCELL_VS_DC_DN	54	12	6	5
GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN	49	15	4	2
GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_DN	55	13	8	4
GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP	48	13	7	3
GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP	55	14	7	3
GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_UP	47	11	5	3
GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN	52	16	8	3
GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_DN	49	13	7	3
GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_UP	60	19	9	5
GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN	58	17	7	3
GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP	50	12	6	2
TBK1.DF_UP	51	13	7	3
GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_UP	44	12	6	2
GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP	54	17	8	4
GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_DN	50	12	7	2
GSE17580_TREG_VS_TEFF_UP	54	15	8	2
GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_UP	59	23	9	5
SGCGSSAAA_E2F1DP2_01	43	9	3	2
CCAGGGG_MIR331	57	17	9	7
TACTTGA_MIR26A_MIR26B	76	29	9	5
KEGG_ENDOMETRIAL_CANCER	53	15	8	4
PID_IL2_1PATHWAY	42	15	6	4
TTGCWCAAY_CEBPB_02	41	11	5	2
REACTOME_NEURONAL_SYSTEM	66	25	9	5
MUELLER_PLURINET	54	16	8	2
GSE3982_BCELL_VS_TH1_DN	53	13	7	3
GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP	55	17	8	3
GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_DN	52	13	7	5
MOHANKUMAR_HOXA1_TARGETS_UP	62	21	8	4
GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP	62	19	8	4
GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_UP	51	14	7	4
TGCACTG_MIR148A_MIR152_MIR148B	61	20	7	5
RIGGI_EWING_SARCOMA_PROGENITOR_UP	84	38	10	5
HFH1_01	75	30	8	4
TBP_01	62	16	8	5
IRF1_01	66	21	10	6
CREBP1_Q2	58	16	7	5
WANG_TUMOR_INVASIVENESS_UP	63	17	9	3
GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_UP	51	11	6	2
GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_DN	50	12	4	3
GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_UP	55	14	6	3
GSE43955_10H_VS_30H_ACT_CD4_TCELL_DN	57	15	6	4
GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP	46	11	6	3
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_UP	43	9	4	3
GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_DN	56	18	8	2
GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_UP	47	10	3	2
GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_DN	56	17	8	4
GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_UP	51	15	7	4
BOCHKIS_FOXA2_TARGETS	64	22	12	4
RELA_DN.V1_DN	50	12	6	3
REACTOME_SIGNALING_BY_INSULIN_RECEPTOR	45	9	5	3
GGGCATT_MIR365	55	14	4	3
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP	52	12	7	4
MARTINEZ_RESPONSE_TO_TRABECTEDIN	56	18	8	2
ASTIER_INTEGRIN_SIGNALING	43	7	4	2
GENTILE_UV_HIGH_DOSE_UP	40	6	3	2
chr9p22	29	11	6	2
GSE17721_CTRL_VS_CPG_4H_BMDC_DN	47	15	4	4
GSE3982_DC_VS_TH2_UP	48	13	6	2
GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_UP	59	17	7	4
GSE42724_MEMORY_BCELL_VS_PLASMABLAST_UP	57	21	9	3
GSE19198_1H_VS_24H_IL21_TREATED_TCELL_UP	45	12	4	3
GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	62	22	10	3
PID_EPHA_FWDPATHWAY	35	9	3	2
GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP	51	13	7	3
CHICAS_RB1_TARGETS_GROWING	58	17	4	3
GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_DN	37	9	3	2
PAX3_B	52	15	8	3
GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_DN	50	12	8	3
GSE3039_B2_VS_B1_BCELL_DN	46	10	5	2
GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP	52	12	6	4
GSE2826_WT_VS_BTK_KO_BCELL_DN	60	18	10	4
GSE24142_DN2_VS_DN3_THYMOCYTE_UP	43	8	3	2
WGGAATGY_TEF1_Q6	67	21	10	6
GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP	67	20	11	7
GSE40273_EOS_KO_VS_WT_TREG_DN	59	17	7	2
REACTOME_CELL_CYCLE_MITOTIC	55	12	7	5
GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	51	17	7	4
GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_DN	54	14	6	4
SCHLOSSER_SERUM_RESPONSE_UP	60	17	10	4
GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP	55	16	10	3
GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP	52	17	8	4
LEF1_Q2	65	20	11	6
GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN	49	10	4	3
GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_DN	46	9	5	2
GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_DN	58	16	8	6
GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN	47	12	6	2
REACTOME_SIGNALING_BY_FGFR	52	13	6	3
SMID_BREAST_CANCER_BASAL_DN	79	34	12	5
AAAGGGA_MIR204_MIR211	71	25	8	6
GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP	42	7	3	2
RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	53	13	5	3
BIDUS_METASTASIS_UP	45	12	5	3
GCAAAAA_MIR129	74	34	9	4
GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP	50	16	8	3
GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_DN	60	21	11	6
GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN	53	17	7	4
GSE3982_MAC_VS_BASOPHIL_UP	47	12	6	2
LEE_TARGETS_OF_PTCH1_AND_SUFU_DN	51	17	9	3
REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM	56	18	8	4
GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	42	10	4	2
GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_UP	52	12	6	3
GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP	44	15	8	3
GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	60	19	10	5
GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN	58	19	12	6
GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_DN	48	11	5	3
GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN	53	15	6	2
REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE	36	8	4	1
GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_DN	57	15	8	3
GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_DN	50	15	7	3
GSE7852_LN_VS_THYMUS_TREG_UP	49	16	5	3
LHX3_01	69	27	11	5
FOXO1_01	66	23	10	3
BILD_E2F3_ONCOGENIC_SIGNATURE	56	16	7	6
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	47	12	6	4
GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_UP	46	11	6	3
GSE6674_UNSTIM_VS_CPG_STIM_BCELL_UP	50	14	8	4
GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN	53	14	6	3
GSE13522_WT_VS_IFNAR_KO_SKIN_DN	53	15	8	4
GSE14415_INDUCED_TREG_VS_TCONV_DN	48	12	6	3
GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_UP	49	8	5	3
GSE13306_TREG_VS_TCONV_SPLEEN_DN	50	12	7	4
PXR_Q2	64	21	9	5
GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	37	9	6	2
GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP	41	10	5	3
GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_DN	50	15	8	2
GSE17721_CTRL_VS_CPG_8H_BMDC_DN	55	15	7	3
CEBPGAMMA_Q6	71	28	10	5
YAGI_AML_WITH_11Q23_REARRANGED	65	22	8	4
PID_ANTHRAX_PATHWAY	25	6	2	1
BIOCARTA_HCMV_PATHWAY	34	10	6	3
REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB	29	7	4	2
REACTOME_ERK_MAPK_TARGETS	44	8	5	3
HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	34	8	5	2
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP	54	15	6	2
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN	58	16	5	5
GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_DN	40	9	4	2
GSE11057_CD4_CENT_MEM_VS_PBMC_DN	45	10	4	2
GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN	50	15	9	3
GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_DN	56	14	5	4
GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_UP	50	12	5	3
GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP	54	15	7	3
GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP	52	13	8	5
GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_DN	43	10	4	2
GSE3039_CD4_TCELL_VS_NKT_CELL_DN	50	11	4	3
GSE40685_NAIVE_CD4_TCELL_VS_TREG_UP	45	9	3	2
WANG_SMARCE1_TARGETS_DN	56	16	6	4
TGIF_01	62	20	8	4
PEREZ_TP53_AND_TP63_TARGETS	60	18	7	3
GSE39556_CD8A_DC_VS_NK_CELL_UP	53	16	5	2
HALLMARK_MYOGENESIS	56	15	8	2
GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_DN	53	14	7	3
WANG_LSD1_TARGETS_DN	45	10	3	2
PID_FCER1_PATHWAY	39	10	5	2
PKCA_DN.V1_UP	43	13	8	3
GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_UP	44	8	4	2
CTCTGGA_MIR520A_MIR525	62	18	9	5
GSE21670_STAT3_KO_VS_WT_CD4_TCELL_UP	41	9	4	3
ELVIDGE_HYPOXIA_BY_DMOG_UP	42	13	3	2
AR_Q2	54	15	8	5
WANG_SMARCE1_TARGETS_UP	59	26	8	5
TAL1ALPHAE47_01	63	20	8	3
SRF_Q6	62	17	8	5
GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_DN	55	15	7	4
GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_DN	54	14	5	2
GSE3982_MAC_VS_TH1_UP	24	7	2	2
DELASERNA_MYOD_TARGETS_UP	50	10	6	3
GRADE_COLON_AND_RECTAL_CANCER_DN	47	14	6	3
GOZGIT_ESR1_TARGETS_DN	96	46	12	6
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_DN	32	11	5	2
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	47	13	7	2
GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN	49	9	3	2
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_DN	41	12	5	2
PENG_LEUCINE_DEPRIVATION_UP	45	10	6	4
GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN	51	16	7	3
SHEPARD_BMYB_MORPHOLINO_UP	48	12	5	3
USF_Q6_01	58	19	6	5
GSE20715_0H_VS_6H_OZONE_LUNG_DN	47	14	8	5
GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP	50	14	7	2
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	69	23	11	5
CCGNMNNTNACG_UNKNOWN	44	13	6	3
AMIT_EGF_RESPONSE_120_HELA	51	11	7	4
PID_SHP2_PATHWAY	51	14	6	4
MASSARWEH_TAMOXIFEN_RESISTANCE_DN	67	24	6	4
GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP	52	13	7	2
GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP	50	11	6	3
EVI1_05	60	20	7	2
GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP	49	12	5	2
GSE360_DC_VS_MAC_DN	40	10	5	3
GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN	54	12	8	3
GACTGTT_MIR212_MIR132	58	16	8	3
GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_UP	43	10	5	2
GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_DN	52	13	6	3
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	34	11	4	3
PAX6_01	51	16	7	2
BIOCARTA_MET_PATHWAY	35	10	5	3
GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP	54	15	6	5
GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN	52	16	9	6
GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP	53	15	8	4
E2F1_Q4_01	57	17	8	4
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP	35	12	6	3
GSE18893_TCONV_VS_TREG_24H_CULTURE_DN	59	25	10	3
PID_NETRIN_PATHWAY	42	9	5	3
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	65	22	10	5
REACTOME_REGULATION_OF_SIGNALING_BY_CBL	11	5	2	1
ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF	73	27	11	6
GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP	51	15	5	5
GSE14000_UNSTIM_VS_16H_LPS_DC_UP	51	13	5	3
GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_UP	46	12	6	2
GSE17721_LPS_VS_CPG_24H_BMDC_UP	47	11	3	2
GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN	39	10	4	3
GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_DN	50	12	5	3
GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN	48	12	5	3
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_UP	56	14	6	6
GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_DN	48	10	2	2
REACTOME_GPCR_DOWNSTREAM_SIGNALING	73	29	12	6
USF_C	61	17	11	4
REACTOME_SIGNALING_BY_NOTCH	56	12	7	5
GSE2706_2H_VS_8H_R848_STIM_DC_UP	38	8	4	2
PKCA_DN.V1_DN	55	14	8	3
GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP	44	9	4	2
GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_DN	56	15	8	4
GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	45	9	4	2
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN	47	9	3	2
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN	99	47	12	6
GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_UP	44	14	6	2
GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP	49	10	5	2
GSE22033_WT_VS_PPARG_KO_MEF_UP	49	12	5	3
GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_DN	52	12	5	2
GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP	40	6	3	2
E2F1_Q6	53	14	6	3
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN	66	22	12	5
GCACCTT_MIR18A_MIR18B	55	14	3	2
GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_DN	48	12	5	4
KIM_ALL_DISORDERS_DURATION_CORR_DN	48	11	5	2
KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION	49	10	5	2
FIGUEROA_AML_METHYLATION_CLUSTER_1_DN	31	7	3	2
chr16p12	41	9	2	1
GSE34006_WT_VS_A2AR_KO_TREG_DN	58	15	7	4
PLASARI_TGFB1_TARGETS_10HR_UP	61	19	10	5
GSE17721_LPS_VS_CPG_8H_BMDC_DN	44	10	6	4
GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP	47	11	5	2
GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_DN	48	9	4	2
GSE7852_TREG_VS_TCONV_FAT_DN	48	15	6	3
GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_UP	53	17	9	5
KCCGNSWTTT_UNKNOWN	47	11	4	3
CDP_01	38	13	5	2
BAELDE_DIABETIC_NEPHROPATHY_DN	61	23	8	4
HSIAO_HOUSEKEEPING_GENES	51	10	5	4
REACTOME_TRIF_MEDIATED_TLR3_SIGNALING	47	13	8	3
CAIRO_HEPATOBLASTOMA_CLASSES_UP	55	15	5	2
GRESHOCK_CANCER_COPY_NUMBER_UP	77	31	13	7
NABA_MATRISOME_ASSOCIATED	78	32	13	6
IRF1_Q6	67	25	11	5
MCBRYAN_PUBERTAL_BREAST_3_4WK_UP	54	15	7	2
GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_DN	44	15	8	3
GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN	54	18	8	2
GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_UP	54	14	7	5
GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN	47	12	7	2
GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_DN	55	13	7	3
GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN	58	16	9	3
GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_DN	47	10	5	3
SASSON_RESPONSE_TO_FORSKOLIN_DN	47	11	5	4
CREB_Q4	52	14	6	4
ACTAYRNNNCCCR_UNKNOWN	59	18	9	4
GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_UP	43	12	5	3
GSE17721_0.5H_VS_12H_LPS_BMDC_UP	50	13	7	3
GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP	59	17	9	4
GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN	58	17	6	4
GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP	46	12	5	2
GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_DN	54	21	11	5
GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	52	13	8	2
GSE17721_0.5H_VS_12H_POLYIC_BMDC_UP	51	16	7	3
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN	45	11	4	2
GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_UP	44	10	4	2
GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN	49	12	6	3
GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_DN	44	10	5	2
GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	48	11	3	3
GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP	43	14	7	3
HTF_01	46	10	7	2
KEGG_COLORECTAL_CANCER	52	13	7	3
REACTOME_SEMAPHORIN_INTERACTIONS	41	13	8	4
SENESE_HDAC1_AND_HDAC2_TARGETS_UP	54	14	6	5
REACTOME_IL_3_5_AND_GM_CSF_SIGNALING	27	9	5	3
PARK_APL_PATHOGENESIS_DN	36	9	5	2
BIOCARTA_INTEGRIN_PATHWAY	33	7	3	1
MELLMAN_TUT1_TARGETS_DN	36	10	5	3
AAAYRNCTG_UNKNOWN	70	24	8	6
GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP	60	15	7	4
GABP_B	43	9	3	2
REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE	47	9	5	3
GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_UP	56	19	10	5
CROONQUIST_IL6_DEPRIVATION_DN	42	8	4	3
GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN	42	13	7	2
GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP	50	14	6	4
GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN	55	12	8	4
GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_UP	55	15	8	3
GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_UP	42	8	4	2
GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_DN	45	14	7	3
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA	42	10	4	2
CREBP1_01	62	18	9	5
E2F3_UP.V1_UP	48	10	4	2
GSE14026_TH1_VS_TH17_UP	44	9	5	3
GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_DN	43	9	5	2
REACTOME_SIGNALING_BY_FGFR_IN_DISEASE	50	11	5	3
E2F_Q3_01	60	19	9	5
GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_DN	49	10	6	2
TGCACTT_MIR519C_MIR519B_MIR519A	75	32	10	5
GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_UP	55	13	6	4
GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_UP	55	20	9	4
GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP	59	16	8	5
GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_UP	47	8	4	3
GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN	45	10	4	2
GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP	54	14	8	2
GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN	59	16	7	4
GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN	51	14	9	2
LIN_NPAS4_TARGETS_DN	36	6	3	1
REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE	45	11	7	2
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION	47	11	7	3
ATTACAT_MIR3803P	55	19	7	3
GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP	63	19	9	6
GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_UP	54	14	6	3
GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN	47	11	7	3
GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN	49	11	6	2
GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP	52	10	5	3
GSE36095_WT_VS_HDAC9_KO_TREG_UP	50	13	5	4
ST_B_CELL_ANTIGEN_RECEPTOR	38	12	5	3
GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN	48	10	4	2
REACTOME_DNA_REPLICATION	47	8	5	4
MSX1_01	66	23	9	5
GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_DN	54	16	8	5
GSE7509_DC_VS_MONOCYTE_DN	47	14	6	3
GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_DN	49	14	6	2
GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP	57	18	10	4
GENTILE_UV_RESPONSE_CLUSTER_D8	31	9	4	2
GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_UP	51	13	6	3
ESC_J1_UP_EARLY.V1_UP	40	12	7	2
GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_DN	52	10	4	3
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	55	16	6	3
CTGAGCC_MIR24	60	16	7	4
BOYLAN_MULTIPLE_MYELOMA_C_D_UP	46	9	5	3
MENSE_HYPOXIA_UP	52	15	8	4
GSE7831_1H_VS_4H_CPG_STIM_PDC_UP	51	17	9	2
LI_WILMS_TUMOR	39	9	4	5
GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_DN	52	12	6	2
GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_UP	54	11	4	2
REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION	45	9	5	5
GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_UP	47	10	4	2
GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP	50	14	6	4
GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_DN	48	12	6	3
GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN	53	14	7	2
GSE17721_LPS_VS_POLYIC_8H_BMDC_DN	57	17	10	4
GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_DN	46	12	4	2
BURTON_ADIPOGENESIS_6	49	12	5	3
SREBP1_02	49	9	3	2
chr15q25	27	11	6	5
GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP	50	10	5	3
GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_DN	61	17	6	4
GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN	39	11	5	2
GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN	52	14	8	4
GCATTTG_MIR105	61	21	9	3
HNF3_Q6	63	19	10	4
GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_UP	58	17	10	6
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_UP	53	15	9	4
GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_DN	50	12	5	3
GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN	54	15	6	4
REACTOME_ADAPTIVE_IMMUNE_SYSTEM	61	20	10	5
PLASARI_TGFB1_TARGETS_10HR_DN	65	24	7	5
PODAR_RESPONSE_TO_ADAPHOSTIN_UP	41	8	3	2
GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_DN	45	14	7	3
GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN	48	12	5	2
GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_DN	49	11	5	2
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN	55	16	7	2
GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_DN	38	6	3	2
GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN	55	13	5	6
GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN	56	13	7	6
GSE12366_GC_VS_NAIVE_BCELL_DN	48	12	6	2
CEBP_Q2	66	24	9	5
GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN	52	13	7	3
GSE14308_TH2_VS_NATURAL_TREG_UP	50	12	4	3
GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_UP	49	9	5	2
PENG_RAPAMYCIN_RESPONSE_UP	51	14	6	2
GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_UP	48	11	5	3
GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_DN	51	17	7	2
BOYLAN_MULTIPLE_MYELOMA_C_UP	25	6	2	1
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN	46	12	7	3
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP	51	13	6	3
KEGG_LONG_TERM_DEPRESSION	53	12	5	4
GSE17721_LPS_VS_POLYIC_2H_BMDC_DN	48	11	5	2
GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_UP	41	10	5	2
GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_UP	42	7	3	2
GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_DN	48	14	6	3
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	46	12	6	3
GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_DN	48	12	8	4
GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_DN	44	14	6	3
GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_DN	45	9	4	2
GSE39022_LN_VS_SPLEEN_DC_DN	56	20	10	6
GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_DN	45	10	4	2
GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_UP	51	14	8	3
GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP	46	11	6	2
GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_UP	50	9	4	3
GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP	43	10	5	2
GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP	54	16	8	4
GSE27786_BCELL_VS_CD4_TCELL_UP	56	16	8	6
TTGGAGA_MIR5155P_MIR519E	48	13	7	3
PDGF_UP.V1_UP	49	13	6	5
GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_UP	56	15	8	4
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	50	12	4	2
GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN	47	10	5	3
GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN	52	12	7	4
GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN	54	16	8	5
PRC2_EED_UP.V1_UP	53	13	6	3
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP	56	18	9	4
GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_UP	52	12	6	3
CAHOY_NEURONAL	52	14	6	3
REACTOME_TOLL_RECEPTOR_CASCADES	55	16	9	3
STAT1_03	59	17	10	3
NFKB_Q6_01	65	22	11	5
GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_DN	50	12	6	3
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_UP	66	22	12	8
GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_UP	45	10	7	3
GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	44	11	5	3
GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_UP	53	13	8	3
GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	51	10	6	3
GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN	47	10	5	3
GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_DN	43	9	4	3
GSE17721_LPS_VS_CPG_6H_BMDC_DN	50	11	5	2
GSE2128_C57BL6_VS_NOD_THYMOCYTE_UP	43	7	4	2
GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_UP	48	9	4	2
GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN	43	11	5	2
GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN	53	15	8	4
GSE27786_LIN_NEG_VS_NEUTROPHIL_DN	47	8	3	2
GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_DN	52	16	7	3
GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_UP	43	7	3	2
BROWNE_HCMV_INFECTION_24HR_DN	48	18	7	3
PDGF_ERK_DN.V1_UP	57	18	6	4
GTACTGT_MIR101	69	23	8	7
STK33_SKM_DN	58	18	8	2
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	50	15	6	2
CCAWNWWNNNGGC_UNKNOWN	46	9	5	3
PID_LYMPH_ANGIOGENESIS_PATHWAY	26	7	3	2
PID_S1P_S1P1_PATHWAY	32	7	3	1
DELACROIX_RAR_TARGETS_UP	38	8	4	1
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_DN	58	19	9	5
GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN	45	10	4	2
GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP	48	11	5	2
GSE22886_TCELL_VS_BCELL_NAIVE_DN	49	14	6	2
GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_DN	50	14	6	3
GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_DN	49	11	4	3
GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_UP	47	11	4	3
KEGG_SPLICEOSOME	40	6	3	2
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP	45	9	4	2
GSE3982_NKCELL_VS_TH2_UP	48	15	7	4
HALLMARK_XENOBIOTIC_METABOLISM	68	19	9	4
KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM	20	8	4	2
GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_DN	43	11	6	2
GGCAGTG_MIR3243P	45	10	5	4
GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN	50	13	6	2
GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN	57	16	9	4
TCTCTCC_MIR185	58	19	9	4
GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_UP	53	10	4	2
GSE4142_PLASMA_CELL_VS_GC_BCELL_DN	44	10	3	2
GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_DN	51	16	7	4
GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN	41	11	6	2
GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP	54	14	7	4
HNF4_01_B	66	20	10	6
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR	57	15	6	3
GSE3982_EOSINOPHIL_VS_TH1_DN	51	16	9	3
GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP	55	16	8	4
GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_UP	49	12	6	4
GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN	53	13	6	3
GSE24726_WT_VS_E2_22_KO_PDC_DAY4_POST_DELETION_DN	56	16	8	4
GSE17721_LPS_VS_CPG_6H_BMDC_UP	55	15	6	3
GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN	43	9	3	3
GSE30083_SP1_VS_SP3_THYMOCYTE_UP	46	11	5	3
MTOR_UP.N4.V1_UP	61	18	9	4
GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_DN	47	12	7	3
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP	45	10	4	2
GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_DN	58	19	8	4
KIM_ALL_DISORDERS_CALB1_CORR_UP	63	23	8	5
GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_UP	49	14	8	4
GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN	50	13	6	3
GSE4142_GC_BCELL_VS_MEMORY_BCELL_UP	55	14	7	3
GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_UP	56	15	7	5
MARTINEZ_RB1_TARGETS_DN	69	23	10	7
REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	47	10	5	3
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN	41	8	4	2
CAGCACT_MIR5123P	52	17	7	3
VECCHI_GASTRIC_CANCER_EARLY_UP	61	18	8	4
YKACATTT_UNKNOWN	69	25	8	3
GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN	54	15	9	2
GSE17721_CTRL_VS_POLYIC_1H_BMDC_UP	47	11	6	3
GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP	49	12	6	4
GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_UP	61	19	10	5
GSE20715_0H_VS_48H_OZONE_LUNG_UP	59	17	10	3
GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_DN	59	16	8	5
GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_DN	40	8	3	2
GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN	50	17	7	3
GSE17721_0.5H_VS_24H_POLYIC_BMDC_UP	47	10	5	2
GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	46	12	5	2
GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN	51	12	5	3
GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_DN	57	17	8	5
GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_DN	53	16	8	3
GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_DN	51	16	9	4
GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_DN	53	15	5	3
GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_DN	44	13	7	3
KYNG_DNA_DAMAGE_UP	58	19	7	5
CEBP_Q3	69	25	9	4
PAX2_01	43	10	3	2
FREAC4_01	54	20	11	5
GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_UP	41	10	5	2
RAAGNYNNCTTY_UNKNOWN	57	20	7	2
MIKKELSEN_IPS_LCP_WITH_H3K4ME3	42	8	4	2
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN	43	13	7	5
KEGG_OOCYTE_MEIOSIS	51	11	6	3
GSE3982_NEUTROPHIL_VS_NKCELL_DN	46	12	5	4
GSE31082_DN_VS_DP_THYMOCYTE_DN	51	12	4	2
GSE3982_EOSINOPHIL_VS_BASOPHIL_UP	54	15	5	2
GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	56	13	7	4
GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_DN	50	16	7	3
GSE17721_CTRL_VS_LPS_24H_BMDC_UP	57	14	6	5
GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP	52	13	5	4
GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP	51	10	6	4
GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN	56	14	6	2
GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_DN	50	12	5	3
GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN	47	13	6	2
GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_UP	47	12	6	3
MEISSNER_NPC_HCP_WITH_H3K4ME2	75	29	11	5
GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_UP	52	13	5	3
ENK_UV_RESPONSE_EPIDERMIS_DN	69	27	12	6
TTTTGAG_MIR373	69	26	12	3
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	51	12	4	2
PID_PRL_SIGNALING_EVENTS_PATHWAY	41	9	5	3
SREBP1_01	48	11	7	4
GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN	38	7	3	2
KEGG_PURINE_METABOLISM	50	13	5	3
GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN	44	11	4	3
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN	52	13	6	2
GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_DN	53	14	9	4
GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_DN	56	14	9	4
GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_UP	39	9	5	2
GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP	50	11	6	2
HALLMARK_APICAL_JUNCTION	50	15	8	2
GSE3982_MAST_CELL_VS_TH1_UP	47	10	4	3
CEBPA_01	66	24	9	5
GSE26669_CD4_VS_CD8_TCELL_IN_MLR_DN	56	15	6	3
GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN	46	12	4	2
GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN	45	11	5	2
GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_DN	48	13	8	4
GSE13306_TREG_VS_TCONV_DN	49	14	8	2
GSE29949_MICROGLIA_VS_DC_BRAIN_UP	48	17	8	4
GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_DN	42	17	9	4
GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_UP	52	12	5	3
GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP	73	24	10	5
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP	72	26	9	6
PID_TCPTP_PATHWAY	26	8	4	2
REACTOME_GLUCOSE_METABOLISM	30	7	4	3
chr12q23	41	12	3	2
GSE2706_UNSTIM_VS_8H_LPS_DC_UP	44	14	7	2
GSE360_CTRL_VS_L_MAJOR_MAC_DN	52	12	5	3
GSE17721_LPS_VS_CPG_8H_BMDC_UP	50	12	3	2
GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_UP	57	17	10	3
FOXO3_01	67	26	11	4
GSE360_CTRL_VS_T_GONDII_MAC_DN	48	11	5	3
GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_UP	58	19	10	3
CAGNYGKNAAA_UNKNOWN	49	12	6	2
GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP	46	10	5	3
GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN	48	12	6	4
GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN	41	9	3	2
GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	53	17	8	5
GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_DN	57	17	7	6
GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	50	10	4	2
GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_DN	42	8	3	2
GSE17721_12H_VS_24H_PAM3CSK4_BMDC_UP	48	12	6	4
GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_DN	44	9	4	3
GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_UP	49	11	3	3
GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN	44	10	3	4
GSE28237_EARLY_VS_LATE_GC_BCELL_UP	59	17	7	5
GSE6259_DEC205_POS_DC_VS_CD4_TCELL_UP	44	9	4	2
OSMAN_BLADDER_CANCER_DN	52	11	6	2
GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_DN	45	11	4	2
REACTOME_SIGNALING_BY_ILS	35	11	5	3
GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_DN	43	10	6	2
GSE14308_TH17_VS_INDUCED_TREG_UP	48	11	6	3
GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_DN	45	10	5	2
GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_UP	50	13	7	2
YYCATTCAWW_UNKNOWN	59	18	6	2
GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN	55	18	8	4
GSE17721_POLYIC_VS_CPG_2H_BMDC_UP	47	11	5	2
GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_UP	58	12	8	4
GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP	53	12	5	3
GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_DN	53	16	8	3
GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN	44	10	5	2
GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_UP	41	11	4	3
GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_UP	51	11	6	3
GSE32901_NAIVE_VS_TH1_CD4_TCELL_DN	49	10	4	2
TCATCTC_MIR143	56	14	6	4
GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	49	11	4	2
GOZGIT_ESR1_TARGETS_UP	45	14	8	4
BERENJENO_TRANSFORMED_BY_RHOA_UP	57	16	6	3
NABA_CORE_MATRISOME	58	21	9	3
REACTOME_CELL_CYCLE	59	16	8	5
MARSON_FOXP3_TARGETS_STIMULATED_DN	41	9	4	0
KIM_ALL_DISORDERS_DURATION_CORR_UP	33	7	3	2
GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN	52	16	8	4
GSE7852_TREG_VS_TCONV_THYMUS_DN	47	13	7	3
GSE22886_IL2_VS_IL15_STIM_NKCELL_UP	51	13	4	2
AGCYRWTTC_UNKNOWN	48	11	3	2
GSE3982_CTRL_VS_LPS_48H_DC_DN	52	12	5	3
GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_UP	48	12	4	3
GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN	50	11	4	2
GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN	59	18	9	5
GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP	52	13	6	2
GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_UP	36	14	4	2
GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_UP	55	14	6	3
GSE43955_1H_VS_10H_ACT_CD4_TCELL_DN	63	19	12	5
GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_DN	50	14	6	2
GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP	55	16	9	3
GSE17721_0.5H_VS_4H_POLYIC_BMDC_DN	40	11	6	2
AMUNDSON_RESPONSE_TO_ARSENITE	49	13	5	4
GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_UP	44	14	8	4
VERRECCHIA_EARLY_RESPONSE_TO_TGFB1	34	10	4	5
BIOCARTA_HDAC_PATHWAY	37	8	4	2
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP	24	8	3	2
CCCAGAG_MIR326	57	16	8	4
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_UP	51	13	6	3
GSE20366_TREG_VS_TCONV_UP	54	16	7	4
GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP	33	9	4	3
GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	57	18	10	4
GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN	53	16	6	3
ZHANG_TLX_TARGETS_60HR_UP	59	21	11	6
GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN	49	11	6	3
GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP	46	13	7	2
RAF_UP.V1_UP	41	11	3	2
GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_UP	48	11	4	2
GSE14308_TH17_VS_NATURAL_TREG_DN	54	13	8	3
GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP	59	20	9	6
GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_DN	53	17	8	4
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	63	23	11	4
ZIC1_01	61	20	10	6
BACH1_01	55	18	8	4
ACTGCAG_MIR173P	57	18	8	4
E47_02	67	24	9	4
REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	44	11	6	3
PBX1_01	75	28	9	6
GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP	45	11	3	3
REACTOME_MITOTIC_M_M_G1_PHASES	45	7	4	4
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	46	10	4	2
GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_UP	49	12	8	3
GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_UP	52	14	6	3
GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_UP	44	15	6	2
GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN	57	18	8	3
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_DN	48	16	7	3
GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_UP	46	11	6	3
GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_DN	50	12	6	4
GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP	57	15	8	5
GSE17721_0.5H_VS_12H_LPS_BMDC_DN	42	10	5	3
GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN	47	12	6	3
GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_UP	52	15	9	4
GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP	55	14	6	5
GSE29618_PDC_VS_MDC_DN	48	12	6	3
ARNT_01	56	15	7	4
PID_AR_TF_PATHWAY	41	12	7	3
PRAMOONJAGO_SOX4_TARGETS_UP	41	9	4	2
RHODES_UNDIFFERENTIATED_CANCER	35	6	3	2
PID_INSULIN_PATHWAY	32	9	5	3
GAGCTGG_MIR337	59	18	7	3
GSE6259_DEC205_POS_DC_VS_CD8_TCELL_DN	51	13	8	5
GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_UP	45	12	5	3
GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP	45	13	7	4
RB_P130_DN.V1_UP	45	13	7	3
GSE17721_POLYIC_VS_CPG_1H_BMDC_UP	54	13	7	4
GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_UP	53	15	7	2
GSE38304_MYC_NEG_VS_POS_GC_BCELL_DN	51	15	7	4
GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN	53	15	6	3
GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP	55	15	7	5
GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP	58	16	8	6
GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN	56	15	9	4
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_UP	60	20	9	5
RUAN_RESPONSE_TO_TNF_DN	36	10	4	2
ER_Q6_01	69	24	8	5
TTCYRGAA_UNKNOWN	56	16	7	4
CHICAS_RB1_TARGETS_SENESCENT	58	17	7	3
GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP	47	9	3	2
REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	32	9	4	2
CACGTTT_MIR302A	36	6	3	1
BIOCARTA_RACCYCD_PATHWAY	45	8	6	3
REACTOME_SIGNALLING_TO_RAS	32	7	3	2
PID_RXR_VDR_PATHWAY	45	12	8	3
GSE21379_TFH_VS_NON_TFH_CD4_TCELL_DN	48	15	8	3
ATACCTC_MIR202	57	21	7	3
GSE3982_EOSINOPHIL_VS_DC_DN	48	12	5	3
GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN	55	18	9	3
GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP	55	13	7	3
RP58_01	57	20	7	4
GSE11924_TFH_VS_TH17_CD4_TCELL_UP	57	15	8	5
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN	43	9	4	2
P53_DECAMER_Q2	58	18	8	3
YAGI_AML_WITH_INV_16_TRANSLOCATION	67	20	11	6
PID_AVB3_INTEGRIN_PATHWAY	45	11	4	2
GSE23568_ID3_KO_VS_WT_CD8_TCELL_DN	65	20	8	5
ENK_UV_RESPONSE_EPIDERMIS_UP	58	17	9	4
GSE17721_12H_VS_24H_CPG_BMDC_UP	41	11	5	3
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_UP	50	16	6	3
GSE12366_GC_VS_NAIVE_BCELL_UP	42	9	3	2
GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_DN	50	15	9	4
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_DN	50	15	5	3
GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_UP	54	14	6	4
GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_UP	52	13	5	2
GSE7852_LN_VS_FAT_TREG_DN	54	16	7	4
GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP	54	14	8	6
LIU_VMYB_TARGETS_UP	41	10	4	2
GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_DN	41	10	4	3
NKX25_01	57	17	7	6
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	36	10	5	3
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP	67	22	10	5
GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_UP	52	12	6	4
LBP1_Q6	61	16	8	5
GSE17721_12H_VS_24H_LPS_BMDC_UP	55	15	9	4
GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP	50	13	4	3
TIEN_INTESTINE_PROBIOTICS_24HR_DN	40	8	4	2
GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN	66	21	10	7
GSE2585_CTEC_VS_THYMIC_DC_DN	51	11	5	2
GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN	54	15	8	2
GSE17721_CTRL_VS_LPS_4H_BMDC_UP	57	17	7	4
GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP	46	13	6	3
GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_DN	51	17	9	2
GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_UP	47	12	5	3
GSE15659_TREG_VS_TCONV_UP	50	13	8	2
GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_DN	43	11	4	2
ACACTGG_MIR199A_MIR199B	50	13	6	2
TGTATGA_MIR4853P	62	21	6	3
KEGG_CHRONIC_MYELOID_LEUKEMIA	51	17	10	4
WU_HBX_TARGETS_3_DN	43	6	4	2
REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY	39	7	4	2
PITX2_Q2	66	25	12	5
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	48	14	7	5
GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_UP	44	11	5	2
GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_DN	49	11	5	3
CHANDRAN_METASTASIS_UP	54	13	6	3
GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN	48	11	4	5
GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP	62	20	8	4
GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN	50	14	5	4
PID_CD8_TCR_PATHWAY	13	11	5	2
ELVIDGE_HYPOXIA_BY_DMOG_DN	44	8	3	2
PID_PTP1B_PATHWAY	35	12	6	2
ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	41	13	6	2
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_DN	49	11	5	2
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_DN	51	10	4	2
GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_DN	39	14	9	3
GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_UP	48	11	5	3
GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_DN	50	13	6	2
REACTOME_CA_DEPENDENT_EVENTS	36	8	4	2
BIOCARTA_CXCR4_PATHWAY	28	7	4	1
KEGG_PRION_DISEASES	22	5	2	2
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	22	11	7	5
REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES	42	7	4	3
chr5q12	22	6	3	1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN	48	15	5	2
GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP	54	15	5	3
GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN	59	19	8	4
GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP	53	16	7	5
GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN	42	9	3	2
GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP	43	12	6	3
GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_UP	59	17	9	4
GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_DN	45	15	7	5
GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP	42	13	5	2
KOBAYASHI_EGFR_SIGNALING_24HR_UP	39	8	3	2
GCTCTTG_MIR335	49	10	5	2
GSE17721_CTRL_VS_LPS_2H_BMDC_UP	43	8	4	2
GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_DN	48	9	5	3
GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_UP	37	11	4	2
GSE34515_CD16_NEG_VS_POS_MONOCYTE_DN	41	11	6	2
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP	53	15	7	5
GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_DN	57	19	8	3
GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_UP	54	15	7	5
GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_DN	50	17	10	4
GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_UP	45	11	4	2
GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_UP	60	18	11	5
GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN	47	11	4	2
GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_UP	48	12	6	3
CAIRO_HEPATOBLASTOMA_UP	62	20	7	4
TFIII_Q6	61	18	10	6
GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN	44	9	4	2
SENESE_HDAC1_TARGETS_DN	59	15	6	4
HNF4ALPHA_Q6	63	19	7	4
PID_KIT_PATHWAY	42	15	8	3
EVI1_03	40	12	5	3
GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN	48	12	5	2
TIEN_INTESTINE_PROBIOTICS_6HR_DN	42	13	5	2
GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_UP	39	8	4	2
GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN	46	12	7	4
RPS14_DN.V1_DN	45	10	4	3
ZHENG_BOUND_BY_FOXP3	79	33	13	7
GSE339_CD4POS_VS_CD8POS_DC_UP	54	17	8	5
TEL2_Q6	52	14	8	6
PAX4_04	73	28	7	4
GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP	49	11	5	2
KEGG_ECM_RECEPTOR_INTERACTION	28	8	2	2
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	28	7	3	2
AREB6_03	66	22	11	7
MEISSNER_BRAIN_HCP_WITH_H3K27ME3	58	17	7	5
CUI_TCF21_TARGETS_2_UP	58	17	5	3
GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN	45	10	5	3
GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_DN	57	16	9	5
GSE17721_0.5H_VS_4H_POLYIC_BMDC_UP	47	12	6	2
GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP	49	16	8	2
GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_DN	43	7	4	2
GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP	46	10	5	2
GSE27786_BCELL_VS_ERYTHROBLAST_UP	47	10	6	2
REACTOME_DAG_AND_IP3_SIGNALING	37	9	4	2
SIG_CD40PATHWAYMAP	35	10	4	2
HAN_SATB1_TARGETS_UP	68	23	8	3
GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_DN	51	17	7	3
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	52	18	9	3
AP3_Q6	66	23	10	4
AP1_Q2	57	17	10	4
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B	61	22	9	4
DAZARD_RESPONSE_TO_UV_NHEK_DN	66	25	10	4
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2	50	13	7	3
CYCLIN_D1_UP.V1_UP	49	12	7	3
GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_DN	45	12	6	3
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_UP	35	13	7	3
GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_DN	48	10	4	3
GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_UP	41	12	5	3
GSE30083_SP3_VS_SP4_THYMOCYTE_DN	52	15	6	4
OCT1_01	70	28	10	4
YAMAZAKI_TCEB3_TARGETS_DN	59	19	8	4
GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_UP	58	15	7	3
ATGTTAA_MIR302C	54	22	6	3
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP	58	18	7	3
GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_UP	41	8	3	2
GSE25087_TREG_VS_TCONV_ADULT_UP	54	18	7	4
GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN	50	12	5	2
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_UP	53	13	8	3
GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_DN	50	14	5	4
GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_UP	41	11	3	2
PRC2_EED_UP.V1_DN	58	15	9	3
GSE25123_WT_VS_PPARG_KO_MACROPHAGE_UP	51	16	9	4
BIOCARTA_NUCLEARRS_PATHWAY	24	7	4	3
BIOCARTA_BCELLSURVIVAL_PATHWAY	32	7	4	1
REACTOME_MRNA_SPLICING	33	7	3	2
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM	65	21	11	5
HUTTMANN_B_CLL_POOR_SURVIVAL_UP	49	17	8	2
REACTOME_AXON_GUIDANCE	60	20	8	4
HALLMARK_COAGULATION	44	18	10	6
GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_DN	40	17	8	3
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	23	6	2	1
YY1_02	53	12	5	3
chr4q21	21	12	5	0
GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_UP	63	18	8	4
TTANWNANTGGM_UNKNOWN	45	13	6	3
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_UP	45	10	4	2
REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	36	10	4	2
BIOCARTA_CREB_PATHWAY	30	8	3	2
GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP	56	16	7	3
PID_HDAC_CLASSII_PATHWAY	35	7	4	3
PID_S1P_S1P3_PATHWAY	44	8	3	2
BIOCARTA_EDG1_PATHWAY	40	8	5	2
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_UP	54	13	6	3
WANG_RESPONSE_TO_ANDROGEN_UP	31	8	5	1
GSE1566_WT_VS_EZH2_KO_LN_TCELL_UP	44	7	3	2
GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP	53	13	5	3
GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP	48	12	6	3
GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_UP	50	16	9	3
GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_DN	53	15	7	4
GSE34515_CD16_NEG_MONOCYTE_VS_DC_DN	53	14	6	2
GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP	46	15	8	4
GOLDRATH_ANTIGEN_RESPONSE	51	15	8	3
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	62	27	12	4
AML_Q6	68	24	10	6
STAT1_02	46	13	8	3
GSE45837_WT_VS_GFI1_KO_PDC_UP	55	15	6	3
GSE22589_HEALTHY_VS_HIV_INFECTED_DC_UP	44	10	5	2
GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN	50	17	7	3
GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	54	16	7	2
GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_DN	45	16	9	4
GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_DN	53	13	6	2
GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_UP	55	18	9	3
GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP	53	14	7	2
GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_UP	54	13	7	4
GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP	47	13	7	3
GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_UP	52	16	9	2
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP	50	11	5	3
AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G	50	14	7	3
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN	37	17	8	3
GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN	53	15	7	3
MITSIADES_RESPONSE_TO_APLIDIN_DN	56	17	7	4
SANSOM_APC_TARGETS	54	18	7	2
NABA_ECM_REGULATORS	45	14	6	3
AGGAGTG_MIR483	29	9	3	2
BIOCARTA_PPARA_PATHWAY	34	11	6	3
GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_DN	41	10	4	2
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_DN	54	19	10	4
GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_DN	45	10	5	3
GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_DN	50	14	5	2
GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_UP	51	12	5	3
RIZKI_TUMOR_INVASIVENESS_3D_DN	50	12	5	2
GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP	55	14	7	3
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN	46	9	5	3
HALLMARK_UV_RESPONSE_DN	59	23	8	2
GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP	49	15	8	5
ELVIDGE_HYPOXIA_DN	47	9	4	2
STEIN_ESRRA_TARGETS_DN	34	13	7	2
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	40	12	5	2
AP1_Q4	51	13	8	4
GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_DN	48	11	6	2
GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_UP	45	10	4	2
GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN	44	8	4	2
GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_DN	57	16	6	2
GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP	53	13	8	3
GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_DN	48	11	6	4
GSE2706_UNSTIM_VS_2H_R848_DC_DN	50	15	8	4
MURAKAMI_UV_RESPONSE_6HR_UP	34	10	4	3
CCTGAGT_MIR510	44	9	4	3
GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_UP	43	9	5	4
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN	41	12	6	2
GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP	53	14	5	2
ZHU_CMV_ALL_DN	57	16	6	3
BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	49	16	10	3
JAATINEN_HEMATOPOIETIC_STEM_CELL_UP	71	29	9	5
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN	60	18	8	3
TAKAO_RESPONSE_TO_UVB_RADIATION_UP	43	8	4	3
GTACAGG_MIR486	48	14	6	2
GATGKMRGCG_UNKNOWN	33	11	6	1
GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_DN	48	9	5	3
GSE25087_TREG_VS_TCONV_ADULT_DN	51	17	8	2
GSE27786_BCELL_VS_ERYTHROBLAST_DN	40	8	4	2
GSE7852_LN_VS_FAT_TREG_UP	38	8	4	2
RAPA_EARLY_UP.V1_DN	53	13	5	3
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_UP	42	9	4	2
GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	52	17	10	3
GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_DN	47	11	6	3
GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN	50	12	5	2
GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN	35	10	4	3
IL15_UP.V1_UP	57	13	7	4
ATGTTTC_MIR494	52	14	4	2
GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP	49	11	5	3
GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_DN	50	13	6	3
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	63	22	10	5
E2F_Q4_01	58	19	9	5
KRAS.600.LUNG.BREAST_UP.V1_DN	54	19	9	3
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	70	19	10	8
GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP	41	7	3	2
GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_DN	47	11	5	3
GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_DN	42	11	4	2
REACTOME_SIGNAL_ATTENUATION	26	6	3	2
REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	29	8	3	1
REACTOME_CRMPS_IN_SEMA3A_SIGNALING	20	5	2	1
chr13q31	16	7	1	1
BIOCARTA_AKAP13_PATHWAY	39	9	5	3
GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP	57	18	7	2
GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN	54	14	6	2
GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN	56	17	8	3
GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN	50	17	10	5
GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN	47	12	4	2
GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_UP	55	14	7	3
GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN	45	9	5	2
HALLMARK_ADIPOGENESIS	52	17	7	3
GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_UP	62	20	10	5
GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP	52	13	6	3
GSE3982_NKCELL_VS_TH1_UP	57	16	7	4
GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_DN	47	9	4	3
GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN	38	12	5	2
KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	40	10	4	2
RB_P107_DN.V1_UP	46	9	3	2
CATRRAGC_UNKNOWN	46	10	6	2
LIU_SOX4_TARGETS_UP	39	11	6	4
RORA2_01	56	17	6	2
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3	24	11	5	3
CCACACA_MIR147	46	11	4	2
E2F_01	37	9	4	2
GTGTCAA_MIR514	46	11	4	3
GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_DN	51	16	9	4
GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN	56	16	8	5
REACTOME_METABOLISM_OF_CARBOHYDRATES	45	13	5	3
GSE14308_TH17_VS_INDUCED_TREG_DN	50	10	5	2
GSE13493_DP_VS_CD8POS_THYMOCYTE_DN	52	14	6	2
GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN	50	13	6	3
GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN	56	17	8	3
NAKAMURA_METASTASIS_MODEL_UP	44	8	3	2
GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP	57	15	5	2
BILANGES_SERUM_SENSITIVE_VIA_TSC2	37	6	3	2
GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP	46	10	4	3
GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_UP	40	11	7	3
GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_UP	36	7	4	2
HALLMARK_MYC_TARGETS_V1	44	10	5	2
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	33	7	3	2
UDAYAKUMAR_MED1_TARGETS_DN	50	19	10	3
GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_DN	37	9	4	2
GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_DN	55	17	10	4
GU_PDEF_TARGETS_DN	44	10	4	3
GSE31622_WT_VS_KLF3_KO_BCELL_DN	50	12	5	3
E2F_03	55	16	8	4
GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_UP	48	14	6	4
CYCLIN_D1_KE_.V1_UP	65	20	14	6
AKT_UP_MTOR_DN.V1_DN	33	10	3	2
SMAD4_Q6	62	20	10	4
ATF2_UP.V1_UP	52	14	6	3
GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_UP	53	13	7	4
GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	44	13	7	3
GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	48	14	8	3
HADDAD_B_LYMPHOCYTE_PROGENITOR	64	22	8	3
KIM_GASTRIC_CANCER_CHEMOSENSITIVITY	52	12	7	3
POU3F2_01	54	16	7	3
HIF1_Q3	61	17	9	4
ACAGGGT_MIR10A_MIR10B	45	16	5	2
ONDER_CDH1_TARGETS_1_UP	49	13	6	4
GSE22886_CD4_TCELL_VS_BCELL_NAIVE_UP	51	14	8	3
GSE15659_RESTING_VS_ACTIVATED_TREG_DN	28	11	5	4
GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_UP	49	16	8	4
GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_UP	55	16	6	4
ATF2_S_UP.V1_UP	49	14	7	3
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_UP	49	12	6	2
GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN	49	16	6	3
JNK_DN.V1_UP	39	13	5	3
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_DN	42	11	6	3
GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	50	16	10	5
GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_UP	47	14	7	3
GSE34515_CD16_NEG_VS_POS_MONOCYTE_UP	57	16	7	5
GSE45365_NK_CELL_VS_CD8A_DC_DN	50	13	6	3
GSE27786_NKCELL_VS_ERYTHROBLAST_UP	44	10	6	3
GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP	52	10	4	2
GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	43	9	4	2
GSE22886_NAIVE_CD8_TCELL_VS_DC_UP	51	17	8	2
GSE3982_MAC_VS_NKCELL_DN	52	14	6	4
GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN	49	12	5	3
GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP	44	10	5	2
STTTCRNTTT_IRF_Q6	60	22	11	4
ACATATC_MIR190	54	15	9	5
CTCAAGA_MIR526B	56	17	8	4
KEGG_NON_SMALL_CELL_LUNG_CANCER	47	11	6	3
E2F_Q4	53	13	6	3
GSE14308_TH2_VS_TH17_DN	52	15	8	3
GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_DN	47	14	8	3
GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_UP	54	17	6	3
GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_UP	53	13	6	3
GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN	55	13	7	4
GSE17721_CTRL_VS_POLYIC_2H_BMDC_UP	45	10	6	3
GSE3982_MAST_CELL_VS_TH1_DN	54	13	4	2
GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP	48	12	6	3
GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_DN	56	15	7	5
GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP	47	12	6	4
BILD_MYC_ONCOGENIC_SIGNATURE	46	9	5	2
GSE15330_WT_VS_IKAROS_KO_HSC_DN	38	6	2	2
CYCLIN_D1_KE_.V1_DN	59	17	8	6
GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP	52	15	6	2
GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_UP	46	10	5	2
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	43	13	6	2
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP	50	14	7	3
GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_UP	38	8	4	1
AMUNDSON_GENOTOXIC_SIGNATURE	43	8	4	2
ZID_01	53	15	5	2
ST_ERK1_ERK2_MAPK_PATHWAY	46	10	6	4
PID_AR_NONGENOMIC_PATHWAY	43	8	5	2
chr15q24	39	11	6	4
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN	39	8	4	1
GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_UP	49	13	7	3
GSE3982_CTRL_VS_LPS_4H_MAC_UP	50	12	5	3
GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_DN	53	13	6	2
GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN	48	10	3	2
GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP	53	14	7	3
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP	55	18	10	3
GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_DN	60	17	11	7
GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP	51	15	5	2
GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_DN	60	18	10	5
GSE2826_XID_VS_BTK_KO_BCELL_DN	49	12	7	4
GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_UP	51	16	8	3
GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP	44	10	6	2
GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	49	13	6	3
GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP	50	13	7	4
GSE17721_4_VS_24H_CPG_BMDC_DN	53	14	8	3
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_DN	47	12	7	3
GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_DN	56	18	9	2
GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP	55	14	6	5
GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP	36	8	3	2
GSE11924_TFH_VS_TH17_CD4_TCELL_DN	41	8	4	2
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN	54	16	7	5
GSE45365_NK_CELL_VS_BCELL_DN	46	14	5	3
BROWNE_HCMV_INFECTION_24HR_UP	49	13	7	3
ATGCTGC_MIR103_MIR107	67	24	10	6
CACCAGC_MIR138	64	19	10	3
PID_MYC_REPRESS_PATHWAY	42	10	6	3
RNTCANNRNNYNATTW_UNKNOWN	39	9	3	2
BROWNE_HCMV_INFECTION_20HR_DN	57	19	8	2
SANA_TNF_SIGNALING_DN	45	12	3	2
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN	30	6	3	1
YAGUE_PRETUMOR_DRUG_RESISTANCE_DN	29	6	2	2
PID_SYNDECAN_3_PATHWAY	36	7	4	2
PID_LPA4_PATHWAY	44	8	4	3
GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	68	19	9	7
GSE27786_LSK_VS_NEUTROPHIL_DN	54	15	7	2
GSE3982_EOSINOPHIL_VS_MAC_UP	41	9	4	2
GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_UP	43	11	3	3
GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_DN	37	10	6	2
GSE3982_EOSINOPHIL_VS_TH2_DN	55	16	8	5
GSE8515_CTRL_VS_IL1_4H_STIM_MAC_UP	52	13	7	7
GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP	53	19	10	4
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	60	19	9	3
GSE27859_DC_VS_CD11C_INT_F480_INT_DC_UP	54	17	9	2
GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP	50	11	4	2
GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	53	16	8	4
GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	45	9	5	3
GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_UP	52	14	6	3
GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_UP	57	17	8	4
SMAD3_Q6	57	18	8	4
REACTOME_MRNA_PROCESSING	42	8	3	2
GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN	59	16	8	4
GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_UP	52	13	6	4
GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN	49	12	4	2
GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP	52	15	7	4
GSE11924_TH1_VS_TH2_CD4_TCELL_DN	48	17	9	3
GSE7852_THYMUS_VS_FAT_TCONV_UP	57	17	10	4
GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_DN	41	17	9	4
GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN	39	13	7	2
GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_UP	54	16	8	4
GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN	56	19	8	5
GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_UP	38	12	5	4
GSE6875_TCONV_VS_FOXP3_KO_TREG_UP	53	16	8	4
GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_UP	55	16	6	3
GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_DN	36	10	4	2
GSE27786_LSK_VS_LIN_NEG_CELL_UP	50	14	5	2
GSE27786_LIN_NEG_VS_CD8_TCELL_UP	48	10	3	2
GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_DN	40	13	6	3
GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN	49	11	4	2
GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP	45	13	6	3
GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN	43	11	4	3
GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP	54	15	6	3
GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_UP	46	12	5	3
GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_UP	58	16	8	2
RAO_BOUND_BY_SALL4_ISOFORM_A	57	19	7	4
YAATNRNNNYNATT_UNKNOWN	56	15	6	3
BIOCARTA_AGR_PATHWAY	42	8	3	2
ZUCCHI_METASTASIS_DN	24	10	5	2
WILCOX_RESPONSE_TO_PROGESTERONE_DN	51	16	7	2
GGCKCATGS_UNKNOWN	46	13	6	2
PID_FAS_PATHWAY	32	7	3	1
BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	44	10	3	2
VALK_AML_WITH_CEBPA	32	10	7	2
ZHAN_EARLY_DIFFERENTIATION_GENES_DN	43	12	7	3
PID_FAK_PATHWAY	30	10	5	3
NUTT_GBM_VS_AO_GLIOMA_DN	41	8	4	2
REACTOME_GABA_B_RECEPTOR_ACTIVATION	44	9	4	2
GSE6269_FLU_VS_E_COLI_INF_PBMC_UP	43	10	4	2
GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP	51	13	7	3
GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP	42	9	5	2
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_DN	56	15	7	4
GSE28130_ACTIVATED_VS_INDUCEED_TREG_UP	47	14	9	4
GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_UP	56	17	9	4
GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN	46	10	7	3
GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_UP	49	17	9	5
GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_DN	46	10	5	3
GSE3982_BCELL_VS_TH2_UP	34	9	3	2
GSE17721_LPS_VS_POLYIC_8H_BMDC_UP	48	12	4	2
GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP	45	14	6	4
GSE39022_LN_VS_SPLEEN_DC_UP	50	13	8	4
GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP	52	16	8	2
GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_DN	47	11	6	2
GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_DN	42	10	4	3
GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_DN	52	14	7	4
GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP	38	12	6	2
GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_UP	48	9	4	3
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_UP	42	15	6	3
GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP	45	12	7	3
GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN	51	14	8	3
GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_DN	42	11	3	2
GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN	54	17	8	3
GSE19825_CD24LOW_VS_IL2RA_HIGH_DAY3_EFF_CD8_TCELL_UP	49	14	7	3
GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_DN	48	14	7	2
GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_UP	52	15	7	4
GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP	48	10	3	2
GSE17721_CTRL_VS_LPS_6H_BMDC_UP	57	16	6	2
IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR	60	18	10	6
HALLMARK_ANDROGEN_RESPONSE	46	9	6	2
WANG_HCP_PROSTATE_CANCER	41	9	5	2
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1	57	16	8	4
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP	61	22	11	4
PR_01	53	15	7	4
STAT5A_02	55	16	7	2
T3R_Q6	63	18	7	6
CAGCTTT_MIR320	65	23	7	4
GSE4142_NAIVE_VS_MEMORY_BCELL_UP	39	12	5	2
GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP	44	11	5	4
GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN	48	10	6	2
GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP	55	14	6	4
GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN	53	10	4	3
GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_DN	49	10	3	2
GSE30083_SP1_VS_SP4_THYMOCYTE_UP	47	12	6	3
KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_DN	57	16	8	4
ROME_INSULIN_TARGETS_IN_MUSCLE_DN	49	14	6	2
E2F1_UP.V1_DN	57	17	10	4
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN	49	11	6	2
GSE40273_EOS_KO_VS_WT_TREG_UP	48	10	5	2
GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN	48	11	5	4
HUTTMANN_B_CLL_POOR_SURVIVAL_DN	54	15	6	5
GTGTGAG_MIR342	45	11	6	3
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP	47	10	4	3
GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_DN	47	9	4	3
SENESE_HDAC1_AND_HDAC2_TARGETS_DN	59	16	8	5
PAX_Q6	67	23	10	6
GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN	58	16	7	5
GSE14308_TH2_VS_INDUCED_TREG_DN	53	13	7	4
GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN	40	12	7	3
GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_UP	53	17	8	3
GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_UP	60	19	10	2
HUANG_GATA2_TARGETS_UP	41	11	4	2
GSE557_CIITA_KO_VS_I_AB_KO_DC_UP	45	15	10	4
GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN	52	17	7	4
GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_UP	57	15	6	4
GSE360_L_DONOVANI_VS_T_GONDII_DC_DN	49	11	4	3
GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_DN	55	15	9	5
GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_DN	49	12	5	3
GSE3982_MAST_CELL_VS_MAC_DN	53	18	7	2
GSE2585_THYMIC_DC_VS_MTEC_UP	48	10	6	2
GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP	50	14	8	3
GSE3982_BCELL_VS_NKCELL_DN	54	16	9	4
GSE22886_IGA_VS_IGM_MEMORY_BCELL_UP	51	15	7	3
LTE2_UP.V1_DN	55	15	5	2
GSE17721_POLYIC_VS_CPG_6H_BMDC_DN	48	11	5	4
GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_DN	50	12	7	2
HALLMARK_HYPOXIA	45	11	4	2
GSE13411_NAIVE_VS_MEMORY_BCELL_UP	56	19	8	4
GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_DN	56	14	6	3
KEGG_CALCIUM_SIGNALING_PATHWAY	51	14	8	5
HALLMARK_MTORC1_SIGNALING	47	12	5	2
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_DN	44	12	4	2
GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	45	11	5	2
GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP	42	10	5	2
GSE21379_WT_VS_SAP_KO_CD4_TCELL_DN	42	12	5	3
GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP	42	8	4	2
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_DN	46	12	5	4
CCTGCTG_MIR214	61	18	9	5
VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1	43	11	6	2
BILBAN_B_CLL_LPL_DN	31	9	5	2
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	58	17	6	3
REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING	48	13	6	4
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2	57	16	7	4
KAYO_AGING_MUSCLE_UP	61	17	10	4
REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN	39	6	3	2
chr15q23	22	9	3	2
MATZUK_IMPLANTATION_AND_UTERINE	37	10	5	3
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN	10	6	2	1
NIKOLSKY_BREAST_CANCER_7P22_AMPLICON	31	8	4	3
HUI_MAPK14_TARGETS_UP	27	7	3	2
chr11q11	45	10	6	3
GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_DN	53	12	7	4
GSE2826_WT_VS_XID_BCELL_UP	47	13	6	3
GSE17721_CTRL_VS_POLYIC_8H_BMDC_DN	50	12	4	3
GSE17721_0.5H_VS_4H_CPG_BMDC_UP	44	8	4	2
GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	42	10	5	2
GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP	38	8	4	2
GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN	56	14	6	5
GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_UP	43	14	6	2
GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP	49	15	7	4
GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP	42	10	5	3
REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	53	18	9	5
GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP	50	14	9	4
GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_DN	47	15	6	3
GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP	46	10	4	2
GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_DN	43	13	6	4
GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP	46	11	6	3
GSE7219_WT_VS_NIK_NFKB2_KO_DC_UP	48	13	8	3
GSE17721_LPS_VS_POLYIC_6H_BMDC_DN	51	11	6	2
GSE14350_IL2RB_KO_VS_WT_TEFF_UP	56	17	9	3
GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN	49	13	5	2
GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_DN	39	9	4	2
GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	53	15	8	3
GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_DN	47	11	5	3
PID_BCR_5PATHWAY	40	11	5	2
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP	49	11	4	2
GGCNRNWCTTYS_UNKNOWN	36	8	4	2
TGAYRTCA_ATF3_Q6	63	21	10	4
REACTOME_TRANSLATION	36	7	4	2
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP	55	16	7	2
FOXO1_02	57	23	9	4
MYOD_01	60	21	10	3
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN	66	25	9	2
GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP	59	20	8	4
GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_DN	48	14	5	3
GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN	50	13	7	2
GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_UP	49	12	7	3
GSE3982_DC_VS_MAC_LPS_STIM_DN	55	14	7	4
GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN	42	12	4	2
GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_UP	52	13	8	4
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_UP	49	9	5	2
GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_UP	58	18	8	5
GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_UP	54	13	5	3
GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP	46	15	8	3
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP	45	15	9	5
GSE27786_LIN_NEG_VS_CD8_TCELL_DN	57	17	9	4
GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN	45	14	7	3
GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_UP	49	15	7	3
GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN	64	17	8	6
GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_UP	49	14	8	4
GSE27786_CD4_TCELL_VS_NKTCELL_UP	52	13	9	3
GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_DN	37	11	5	3
GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP	53	15	7	3
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_UP	60	18	10	4
GSE25087_FETAL_VS_ADULT_TCONV_UP	53	16	9	3
GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN	48	15	7	3
GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_DN	48	12	6	3
GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN	53	10	5	2
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_UP	55	14	7	4
GSE14308_TH1_VS_INDUCED_TREG_UP	46	12	6	3
GSE12505_WT_VS_E2_2_HET_PDC_DN	44	9	5	4
P53_DN.V2_DN	48	12	5	4
GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_UP	46	12	6	4
AREB6_02	62	19	9	5
BACH2_01	53	16	7	5
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	69	22	11	4
REACTOME_IL_2_SIGNALING	37	9	6	3
GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_DN	51	15	6	3
GSE17721_POLYIC_VS_CPG_4H_BMDC_DN	47	11	5	3
GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN	53	18	9	3
GSE17721_CTRL_VS_POLYIC_1H_BMDC_DN	53	14	6	2
GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN	55	14	7	5
GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_UP	59	19	9	4
GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN	48	11	4	4
ROME_INSULIN_TARGETS_IN_MUSCLE_UP	63	20	9	4
GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN	41	7	3	2
PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY	42	8	4	2
GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN	44	8	4	2
PID_GMCSF_PATHWAY	35	11	4	2
HOLLMANN_APOPTOSIS_VIA_CD40_UP	56	17	7	3
GSE17721_CTRL_VS_POLYIC_12H_BMDC_DN	54	13	7	3
MYAATNNNNNNNGGC_UNKNOWN	49	12	4	3
GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP	41	15	5	2
GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN	42	15	7	3
GSE27786_NKCELL_VS_NKTCELL_UP	52	14	7	5
ROESSLER_LIVER_CANCER_METASTASIS_UP	48	10	6	3
GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN	53	13	6	3
REACTOME_PI3K_AKT_ACTIVATION	41	11	5	3
AACTGAC_MIR223	49	13	6	2
GSE27786_CD4_TCELL_VS_MONO_MAC_DN	47	11	5	4
ATCMNTCCGY_UNKNOWN	39	10	3	2
GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	53	15	7	5
REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS	37	9	4	2
GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN	48	16	6	2
AGTCTTA_MIR499	45	12	5	2
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF	53	19	8	4
ALFANO_MYC_TARGETS	62	18	13	6
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN	69	29	10	5
HAMAI_APOPTOSIS_VIA_TRAIL_DN	48	9	5	3
GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	47	12	6	3
GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN	45	11	5	4
GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP	59	21	10	5
GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP	48	14	6	3
GSE27786_NEUTROPHIL_VS_MONO_MAC_DN	48	10	4	2
GR_01	55	21	9	4
GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN	49	13	7	4
GSE3982_EOSINOPHIL_VS_MAST_CELL_UP	39	14	6	3
GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_DN	47	10	4	2
GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN	56	16	9	4
GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN	59	17	9	6
GSE19198_1H_VS_24H_IL21_TREATED_TCELL_DN	53	18	10	4
GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP	51	11	6	3
GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_DN	53	12	7	3
GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_DN	51	15	7	5
GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP	41	9	4	3
GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP	48	14	7	3
GSE12366_NAIVE_VS_MEMORY_BCELL_DN	47	12	5	4
GSE3982_MAST_CELL_VS_NKCELL_DN	48	14	6	2
GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP	48	15	8	4
IRF7_01	68	24	10	4
RFX1_02	52	13	6	3
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	58	17	8	4
LI_INDUCED_T_TO_NATURAL_KILLER_DN	46	15	7	3
GGTGTGT_MIR329	47	12	4	2
EN1_01	57	20	8	5
MCCLUNG_CREB1_TARGETS_UP	46	11	4	2
GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	46	12	5	2
GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP	48	11	6	3
GSE14415_NATURAL_TREG_VS_TCONV_UP	55	19	10	4
GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_UP	45	13	5	2
GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_DN	52	21	13	5
GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_UP	43	10	5	2
GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_DN	48	12	4	3
GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP	60	15	6	6
GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_DN	49	15	8	3
GSE17721_0.5H_VS_24H_POLYIC_BMDC_DN	47	12	6	2
HALLMARK_G2M_CHECKPOINT	51	13	6	3
GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN	57	19	9	5
GSE27786_BCELL_VS_CD8_TCELL_UP	51	12	7	3
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_DN	50	13	8	3
GSE18893_TCONV_VS_TREG_24H_CULTURE_UP	42	12	8	3
GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_UP	54	16	9	3
GSE11057_PBMC_VS_MEM_CD4_TCELL_UP	44	11	4	2
GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	42	11	6	3
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	34	6	3	2
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_UP	50	10	4	3
GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_UP	57	18	10	4
OCT_C	69	27	10	5
KEGG_RENAL_CELL_CARCINOMA	39	11	5	3
GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_UP	46	9	3	2
KASLER_HDAC7_TARGETS_1_UP	57	18	9	4
GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_DN	49	11	6	2
ZHENG_GLIOBLASTOMA_PLASTICITY_UP	50	13	4	2
MANALO_HYPOXIA_DN	43	8	4	2
GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_UP	59	21	10	2
GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_UP	42	10	5	2
GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_DN	51	13	7	5
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	69	23	11	5
VERNOCHET_ADIPOGENESIS	19	7	3	1
GENTILE_UV_LOW_DOSE_UP	37	6	3	2
LAMB_CCND1_TARGETS	38	11	7	3
BIOCARTA_ACH_PATHWAY	36	9	5	3
BIOCARTA_NKCELLS_PATHWAY	26	5	3	1
BIOCARTA_ERK5_PATHWAY	32	6	4	0
BIOCARTA_PTEN_PATHWAY	35	8	4	2
NADLER_OBESITY_DN	48	11	5	3
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	47	9	3	1
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION	52	15	9	5
GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_UP	48	12	6	3
GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_UP	46	11	5	2
LABBE_TGFB1_TARGETS_UP	56	14	7	5
GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_DN	44	15	7	3
GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP	46	9	3	2
GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP	53	13	8	4
GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	46	11	6	3
GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_UP	47	10	5	2
GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_UP	44	13	8	2
GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_DN	49	13	6	3
GSE20715_0H_VS_6H_OZONE_LUNG_UP	56	13	5	4
GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP	59	20	9	4
GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_DN	43	9	3	2
CTACTGT_MIR199A	68	28	12	4
GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP	50	12	5	2
GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN	50	16	7	3
GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_DN	51	13	5	3
GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	56	21	9	3
GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_UP	61	20	10	7
GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_UP	51	12	5	2
GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_DN	46	13	5	2
GSE17721_0.5H_VS_8H_POLYIC_BMDC_DN	50	12	4	2
MOOTHA_HUMAN_MITODB_6_2002	54	16	8	2
LEF1_Q6	63	19	9	4
GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	55	20	8	3
GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN	61	17	8	5
GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP	51	12	5	4
GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP	53	10	4	3
GNCF_01	56	18	11	5
GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP	61	17	8	5
GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_UP	52	14	7	3
GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_DN	52	13	7	6
REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE	32	6	4	2
GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_UP	47	16	7	4
YAGI_AML_FAB_MARKERS	56	16	6	2
GSE20715_0H_VS_24H_OZONE_LUNG_UP	59	20	11	3
GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_DN	47	18	12	6
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP	57	17	8	4
GSE27786_CD8_TCELL_VS_NKTCELL_DN	47	10	4	3
GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP	37	7	4	3
GARY_CD5_TARGETS_DN	58	17	9	5
GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_UP	52	15	5	3
GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_UP	42	11	5	2
LEIN_MIDBRAIN_MARKERS	54	14	5	4
GSE20715_0H_VS_24H_OZONE_LUNG_DN	45	9	4	2
CGTSACG_PAX3_B	47	10	4	2
BROWNE_HCMV_INFECTION_14HR_UP	41	12	4	2
GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN	51	14	6	3
GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_DN	50	17	8	3
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP	47	10	3	3
ESC_V6.5_UP_LATE.V1_UP	58	17	7	5
GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_DN	46	8	4	3
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN	42	9	4	2
TCCAGAT_MIR5165P	47	8	4	2
SMID_BREAST_CANCER_ERBB2_DN	19	6	2	1
REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION	17	5	3	2
chr3p11	19	8	3	0
IPF1_Q4	70	25	9	4
GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN	60	16	9	4
GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_DN	57	16	8	6
GSE7852_THYMUS_VS_FAT_TREG_DN	52	18	10	4
GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN	55	16	8	2
GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN	41	13	6	3
GSE43955_10H_VS_60H_ACT_CD4_TCELL_DN	56	16	8	4
GSE17721_LPS_VS_CPG_4H_BMDC_UP	52	15	5	2
GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP	50	13	6	4
GSE3982_NEUTROPHIL_VS_BASOPHIL_DN	43	13	6	3
GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_DN	35	8	4	2
GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_UP	53	9	4	4
GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN	51	15	8	3
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN	53	14	6	2
GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN	47	11	5	2
GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP	49	10	6	4
GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP	51	13	6	3
GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN	45	14	7	3
MULLIGHAN_NPM1_SIGNATURE_3_DN	43	11	5	3
GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_DN	55	15	7	4
LIU_CMYB_TARGETS_UP	45	11	4	2
TBK1.DF_DN	54	14	7	3
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	42	11	6	2
REACTOME_AQUAPORIN_MEDIATED_TRANSPORT	35	9	4	2
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN	43	8	3	2
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	31	6	3	2
RIZ_ERYTHROID_DIFFERENTIATION_6HR	43	10	6	4
FXR_Q3	47	13	7	3
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	51	15	6	4
NIELSEN_GIST	37	9	3	2
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP	40	8	3	2
GTTAAAG_MIR302B	49	12	5	2
STEIN_ESRRA_TARGETS_UP	51	12	5	3
GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_DN	52	13	7	3
GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_UP	52	14	7	3
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	54	14	5	5
GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_DN	48	14	6	3
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN	56	21	8	2
GSE30083_SP1_VS_SP2_THYMOCYTE_DN	45	13	4	2
LIU_SOX4_TARGETS_DN	51	14	5	3
GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_UP	56	16	8	4
GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_UP	54	19	8	4
GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP	44	12	7	3
GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_DN	58	16	9	5
GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP	44	13	7	2
GSE43955_1H_VS_20H_ACT_CD4_TCELL_DN	43	9	3	2
GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	51	17	8	4
GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN	52	17	10	4
GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_UP	50	14	4	3
GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_UP	39	9	4	2
GSE17721_LPS_VS_POLYIC_24H_BMDC_DN	50	15	8	6
GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_DN	50	10	4	2
GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_UP	53	11	6	4
GSE15659_TREG_VS_TCONV_DN	43	10	3	2
GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_UP	46	12	4	2
TAGCTTT_MIR9	64	23	7	5
THUM_SYSTOLIC_HEART_FAILURE_DN	52	17	6	2
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN	70	26	9	5
GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN	59	22	9	5
GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP	47	9	4	2
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_UP	55	14	8	5
GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN	54	13	7	3
GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN	52	14	7	2
GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN	45	16	8	4
GSE14350_TREG_VS_TEFF_UP	38	8	3	2
GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	51	16	8	3
GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP	52	13	6	2
GSE34515_CD16_NEG_MONOCYTE_VS_DC_UP	50	12	7	4
RIZKI_TUMOR_INVASIVENESS_3D_UP	56	14	6	4
GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_UP	52	14	6	4
GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_DN	44	12	7	4
GSE13306_TREG_VS_TCONV_UP	52	17	7	3
GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN	51	15	7	3
GSE7852_LN_VS_FAT_TCONV_DN	47	14	9	3
GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_UP	53	12	7	4
GSE20366_EX_VIVO_VS_DEC205_CONVERSION_DN	51	19	11	3
GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP	50	21	9	4
GSE3982_MAST_CELL_VS_BCELL_UP	50	14	8	4
GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	47	10	6	4
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	49	13	6	2
REACTOME_ARMS_MEDIATED_ACTIVATION	14	6	2	2
KAPOSI_LIVER_CANCER_MET_UP	31	6	3	2
PID_SMAD2_3PATHWAY	38	7	4	2
STEGER_ADIPOGENESIS_UP	15	7	2	1
REACTOME_TIE2_SIGNALING	11	7	3	0
GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	44	8	4	2
GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN	52	12	5	3
GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_DN	43	9	3	2
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP	54	14	4	3
TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA	37	11	3	2
YAMASHITA_LIVER_CANCER_STEM_CELL_DN	48	13	5	4
PID_MYC_ACTIV_PATHWAY	44	12	7	2
REACTOME_G_ALPHA1213_SIGNALLING_EVENTS	46	13	6	2
GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN	48	14	8	3
GSE3982_CTRL_VS_LPS_4H_MAC_DN	55	19	9	4
CREB_Q4_01	48	12	6	2
GENTILE_UV_RESPONSE_CLUSTER_D2	47	11	5	2
LU_EZH2_TARGETS_UP	41	11	6	2
GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP	41	13	5	3
TIEN_INTESTINE_PROBIOTICS_6HR_UP	40	8	4	2
GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_DN	46	11	4	3
GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP	51	17	7	2
GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN	56	25	9	4
GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN	55	21	11	4
GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP	44	10	6	2
GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP	55	13	6	5
AMIT_EGF_RESPONSE_120_MCF10A	22	5	2	1
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN	47	17	10	4
LENAOUR_DENDRITIC_CELL_MATURATION_UP	29	14	7	2
CTIP_DN.V1_DN	32	8	3	1
GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_UP	46	13	6	3
PHONG_TNF_RESPONSE_NOT_VIA_P38	57	19	10	5
GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_DN	44	11	4	2
WNT_UP.V1_UP	47	10	5	2
LEE_LIVER_CANCER_SURVIVAL_UP	55	14	7	6
GSE42724_NAIVE_VS_B1_BCELL_DN	38	7	3	2
HALLMARK_UV_RESPONSE_UP	52	11	6	3
LU_AGING_BRAIN_DN	45	11	5	2
GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_UP	44	12	5	4
GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	60	21	12	5
GSE29618_MONOCYTE_VS_PDC_UP	50	16	8	3
LEE_RECENT_THYMIC_EMIGRANT	59	19	9	4
GSE11924_TFH_VS_TH1_CD4_TCELL_UP	54	13	6	4
REACTOME_GENERIC_TRANSCRIPTION_PATHWAY	52	14	7	3
GSE34515_CD16_POS_MONOCYTE_VS_DC_UP	58	16	8	2
GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN	54	18	8	6
REACTOME_METABOLISM_OF_RNA	43	8	5	3
GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN	56	16	8	5
GSE17721_CTRL_VS_CPG_12H_BMDC_DN	49	15	9	2
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP	50	14	7	4
AP4_Q5	66	21	11	4
GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	48	15	7	2
ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN	56	15	6	3
TTTGTAG_MIR520D	66	26	10	3
AATGGAG_MIR136	41	11	4	2
MEISSNER_NPC_HCP_WITH_H3K27ME3	46	13	7	3
LXR_Q3	41	11	4	2
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	41	11	4	2
GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_DN	45	11	3	2
KATSANOU_ELAVL1_TARGETS_DN	38	11	5	2
GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP	48	13	7	3
CHANDRAN_METASTASIS_DN	66	21	10	4
LEE_NEURAL_CREST_STEM_CELL_UP	42	11	4	2
GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_UP	47	12	5	3
GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_DN	52	14	7	3
GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP	45	13	8	3
GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	44	13	6	4
GSE17721_12H_VS_24H_LPS_BMDC_DN	41	8	3	2
GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP	39	8	3	2
MIKKELSEN_MEF_LCP_WITH_H3K4ME3	32	6	2	2
GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_UP	51	12	6	3
GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN	57	17	9	5
GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP	56	23	7	4
GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_UP	44	13	6	3
GSE3039_NKT_CELL_VS_B2_BCELL_UP	49	12	6	3
GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_UP	50	11	6	3
GSE16266_CTRL_VS_LPS_STIM_MEF_UP	47	16	10	5
GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_UP	51	15	9	6
LUI_THYROID_CANCER_CLUSTER_1	23	8	4	2
BIOCARTA_BIOPEPTIDES_PATHWAY	24	9	4	2
chr2p24	28	7	3	0
PID_THROMBIN_PAR1_PATHWAY	43	11	5	4
MORI_IMMATURE_B_LYMPHOCYTE_UP	45	10	4	2
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS	51	11	4	3
GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP	54	16	8	3
GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN	52	14	7	5
GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP	41	13	5	3
GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP	48	14	6	3
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	50	13	8	3
GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_DN	44	11	5	3
GSE7460_TCONV_VS_TREG_THYMUS_DN	59	20	9	4
DARWICHE_PAPILLOMA_RISK_HIGH_DN	49	12	5	4
GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN	55	13	7	2
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	47	12	5	2
RATTENBACHER_BOUND_BY_CELF1	68	23	12	4
REACTOME_MITOTIC_PROMETAPHASE	39	6	3	3
AAGGGAT_MIR188	52	11	4	2
PID_P38_MK2_PATHWAY	25	5	3	1
REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION	38	13	7	4
chr5q11	17	7	3	0
PID_ECADHERIN_KERATINOCYTE_PATHWAY	30	10	4	2
REACTOME_NEPHRIN_INTERACTIONS	15	11	5	2
REACTOME_G_PROTEIN_ACTIVATION	34	7	3	1
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP	20	6	3	1
GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP	60	20	12	7
E2F1_Q6_01	56	15	6	3
WIERENGA_STAT5A_TARGETS_UP	53	16	8	4
GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_DN	48	16	6	3
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_DN	48	13	6	2
GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_DN	39	9	4	2
GSE11386_NAIVE_VS_MEMORY_BCELL_DN	56	17	6	3
BROWNE_HCMV_INFECTION_6HR_DN	47	15	6	5
REACTOME_METABOLISM_OF_MRNA	43	9	5	3
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	48	11	4	3
GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_DN	48	10	6	2
GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_UP	55	14	7	4
GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_UP	25	10	5	3
MARKEY_RB1_CHRONIC_LOF_UP	52	21	10	5
GSE21063_WT_VS_NFATC1_KO_BCELL_DN	48	12	6	3
GSE17721_0.5H_VS_24H_CPG_BMDC_DN	43	12	5	2
SANA_RESPONSE_TO_IFNG_DN	48	10	4	2
QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR	40	10	4	1
PID_EPHB_FWD_PATHWAY	32	9	4	2
PID_ERBB4_PATHWAY	41	10	3	2
YTTCCNNNGGAMR_UNKNOWN	38	15	8	6
REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS	41	11	4	2
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	13	5	2	1
DASU_IL6_SIGNALING_UP	30	7	3	2
BIOCARTA_TCR_PATHWAY	27	9	6	3
GSE25087_FETAL_VS_ADULT_TCONV_DN	45	15	7	2
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	50	14	6	4
GSE14415_ACT_VS_CTRL_NATURAL_TREG_DN	51	13	6	3
GSE45365_WT_VS_IFNAR_KO_CD11B_DC_UP	55	15	9	4
GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP	48	10	4	2
GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_UP	49	13	7	3
TGFB_UP.V1_UP	60	22	10	5
GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_UP	50	12	6	3
GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP	53	13	4	5
GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_UP	53	15	6	2
GSE17721_POLYIC_VS_CPG_1H_BMDC_DN	49	13	6	5
REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	36	8	3	2
ATF6_01	41	9	5	2
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	45	8	4	2
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_DN	49	12	7	2
GSE6259_DEC205_POS_DC_VS_CD8_TCELL_UP	51	14	6	2
GCNP_SHH_UP_EARLY.V1_DN	45	10	5	2
GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_DN	49	13	6	4
GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_UP	43	8	4	2
GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_UP	47	10	4	2
GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_UP	43	13	6	2
SRC_UP.V1_DN	47	11	5	3
COATES_MACROPHAGE_M1_VS_M2_UP	37	9	4	3
TCTGGAC_MIR198	51	15	7	3
CAGGGTC_MIR504	49	14	7	2
GSE40273_XBP1_KO_VS_WT_TREG_DN	47	13	5	3
GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP	45	12	7	3
GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_UP	44	10	4	3
GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN	44	13	6	2
GTGCCAA_MIR96	64	24	10	7
SIG_BCR_SIGNALING_PATHWAY	39	11	4	2
IL21_UP.V1_DN	46	11	5	2
GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_DN	45	11	5	2
JIANG_AGING_CEREBRAL_CORTEX_DN	25	7	3	2
GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_UP	43	8	4	2
GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_UP	46	11	5	2
GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_DN	54	13	6	5
REACTOME_HIV_INFECTION	42	8	4	2
PID_ERBB2_ERBB3_PATHWAY	37	7	3	2
GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_UP	41	13	5	4
REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	37	10	5	3
GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_UP	45	7	4	2
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	34	9	4	2
GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP	55	15	8	3
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP	61	20	10	4
BIOCARTA_MAL_PATHWAY	32	7	3	3
GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_DN	42	14	5	2
REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS	22	6	2	2
chr11p11	25	16	9	4
GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP	50	14	7	4
GR_Q6_01	59	19	9	5
LIU_PROSTATE_CANCER_DN	74	29	12	5
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	59	18	6	3
ZERBINI_RESPONSE_TO_SULINDAC_UP	8	4	1	1
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	44	13	7	3
CCCNNNNNNAAGWT_UNKNOWN	42	10	5	2
GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP	43	12	6	2
GSE2706_UNSTIM_VS_2H_R848_DC_UP	35	9	5	2
GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_DN	49	13	6	3
GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	48	12	5	3
GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_UP	47	11	4	2
GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP	57	16	6	5
GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN	37	10	4	3
GSE3565_DUSP1_VS_WT_SPLENOCYTES_DN	49	13	8	3
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_UP	52	13	5	2
GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_DN	40	11	7	3
GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_DN	45	9	4	3
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	53	19	8	4
SMID_BREAST_CANCER_ERBB2_UP	39	10	6	4
PUJANA_BRCA_CENTERED_NETWORK	35	6	3	2
GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN	40	11	3	2
CERVERA_SDHB_TARGETS_1_UP	34	10	4	3
KAUFFMANN_DNA_REPAIR_GENES	51	13	7	4
SRY_01	58	18	6	4
GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_UP	49	12	5	2
CREB_Q2_01	54	15	6	5
HATADA_METHYLATED_IN_LUNG_CANCER_UP	70	28	9	4
ZHANG_TLX_TARGETS_60HR_DN	50	12	3	2
HELLER_HDAC_TARGETS_UP	53	13	7	3
GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_DN	47	14	7	3
GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_UP	41	12	6	4
GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP	51	15	6	2
KEGG_WNT_SIGNALING_PATHWAY	50	16	9	5
GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	43	12	6	3
GSE37301_PRO_BCELL_VS_CD4_TCELL_UP	57	19	9	3
GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_DN	40	9	4	3
GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_UP	40	9	3	2
GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_DN	46	11	4	2
GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN	55	17	8	5
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_DN	52	15	7	3
MCLACHLAN_DENTAL_CARIES_UP	49	17	8	5
HOX13_01	40	9	4	2
KEGG_VIBRIO_CHOLERAE_INFECTION	25	8	4	2
chr7p15	21	9	5	3
REACTOME_TCR_SIGNALING	28	10	6	1
FIGUEROA_AML_METHYLATION_CLUSTER_3_UP	46	12	7	3
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	37	6	3	2
REACTOME_TRANSCRIPTION	37	8	3	2
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	42	7	4	3
chr17q21	76	25	14	7
SAFFORD_T_LYMPHOCYTE_ANERGY	19	7	2	2
KEGG_ADHERENS_JUNCTION	59	18	8	5
SASSON_RESPONSE_TO_FORSKOLIN_UP	43	11	7	4
ACTTTAT_MIR1425P	67	23	8	4
GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP	36	6	3	2
GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP	55	17	8	5
GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_DN	42	10	5	2
GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	45	13	8	5
GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_DN	41	6	3	2
GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP	47	14	7	3
GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP	46	12	5	2
GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_UP	46	13	5	3
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	47	12	5	3
GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_DN	45	15	7	2
DAZARD_UV_RESPONSE_CLUSTER_G6	51	15	6	3
DR1_Q3	61	18	9	3
GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN	50	15	7	2
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_UP	26	13	4	2
GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN	42	9	4	2
GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_UP	38	13	7	3
GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP	47	14	8	5
GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_DN	52	11	6	4
GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN	51	14	6	3
FORTSCHEGGER_PHF8_TARGETS_UP	51	13	5	2
ONDER_CDH1_TARGETS_2_UP	58	24	7	2
NF1_Q6_01	52	15	9	5
SWEET_LUNG_CANCER_KRAS_UP	56	15	8	4
GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN	42	14	7	4
MTOR_UP.V1_DN	55	15	7	2
GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_DN	46	10	3	2
GSE360_CTRL_VS_L_DONOVANI_MAC_UP	53	14	8	4
GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_UP	42	12	7	3
GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_UP	41	7	4	2
BIOCARTA_RAS_PATHWAY	36	10	7	3
GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP	51	13	4	2
GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_DN	46	12	5	3
PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	13	6	2	1
ESC_J1_UP_EARLY.V1_DN	57	17	9	5
GSE6875_TCONV_VS_TREG_DN	47	12	5	3
GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_UP	60	18	8	4
GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_DN	49	14	8	4
GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP	42	14	7	3
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	38	12	8	4
GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN	55	15	5	3
GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN	46	9	4	2
GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN	38	11	6	4
POOLA_INVASIVE_BREAST_CANCER_UP	52	16	7	3
REACTOME_GABA_RECEPTOR_ACTIVATION	41	9	4	2
DAUER_STAT3_TARGETS_UP	38	13	6	3
BENPORATH_PRC2_TARGETS	97	41	13	9
E2F_Q6	51	13	6	3
E2F_Q6_01	50	16	7	4
KAYO_AGING_MUSCLE_DN	35	10	6	3
GERY_CEBP_TARGETS	42	10	5	2
GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_DN	49	15	6	3
GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_UP	41	10	5	3
RASHI_RESPONSE_TO_IONIZING_RADIATION_2	49	13	8	4
GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP	38	10	5	2
GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_DN	44	8	3	2
GSE3982_EOSINOPHIL_VS_MAST_CELL_DN	29	8	3	2
GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_DN	49	13	4	2
GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_UP	45	14	7	2
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN	43	12	5	2
GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN	43	9	3	2
GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_DN	46	12	7	2
GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_DN	40	9	3	2
GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP	50	12	7	5
GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_UP	52	14	8	3
GSE10325_BCELL_VS_MYELOID_UP	54	18	8	2
GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_UP	38	9	4	3
GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_UP	47	9	4	2
TGANNYRGCA_TCF11MAFG_01	54	19	7	5
GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_DN	51	19	10	3
GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_DN	44	8	4	2
GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP	40	8	3	2
STEIN_ESR1_TARGETS	35	9	4	2
GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_UP	34	8	4	2
GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_DN	48	12	7	3
GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_UP	49	10	5	4
GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN	38	11	6	2
GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP	48	9	4	2
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	52	15	7	4
KRAS.BREAST_UP.V1_DN	37	14	5	3
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_DN	41	13	7	3
GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	51	13	4	2
GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_DN	49	10	4	2
GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP	49	11	5	4
AGGGCAG_MIR18A	56	14	7	5
GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP	52	17	9	5
GSE31082_DN_VS_CD4_SP_THYMOCYTE_UP	48	14	9	3
GGGNNTTTCC_NFKB_Q6_01	54	14	9	4
GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP	46	9	4	3
GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_UP	42	9	3	2
chr19q13	24	13	5	3
GGGATGC_MIR3245P	33	11	7	5
STARK_HYPPOCAMPUS_22Q11_DELETION_UP	34	10	4	2
GUILLAUMOND_KLF10_TARGETS_UP	25	8	4	1
KEGG_TYPE_II_DIABETES_MELLITUS	44	12	5	3
GSE27786_LSK_VS_CD8_TCELL_UP	46	11	4	3
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS	58	18	8	3
GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_DN	46	11	5	3
GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN	42	9	4	2
GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_UP	40	8	4	2
GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_UP	51	10	7	4
GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_DN	42	15	8	3
GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN	47	10	5	3
GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_UP	40	12	4	3
GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN	43	12	6	2
GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_DN	53	17	8	3
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN	57	18	9	4
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP	40	14	6	3
GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_UP	34	10	4	2
GSE17721_0.5H_VS_12H_CPG_BMDC_UP	36	7	3	2
GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN	34	11	4	2
GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN	46	13	5	2
GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_UP	50	15	9	4
GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_DN	50	12	7	2
GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	48	15	5	2
GSE3982_EOSINOPHIL_VS_NKCELL_DN	33	10	4	2
GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN	48	13	5	3
MIKKELSEN_IPS_WITH_HCP_H3K27ME3	47	16	9	4
GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_UP	36	13	8	2
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP	42	14	5	5
JIANG_VHL_TARGETS	46	9	6	3
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	43	17	6	2
GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_UP	43	12	5	4
RODWELL_AGING_KIDNEY_NO_BLOOD_UP	44	14	5	2
ATF1_Q6	55	20	9	3
VALK_AML_CLUSTER_1	44	10	4	2
BIOCARTA_TFF_PATHWAY	35	7	4	2
AGTCTAG_MIR151	14	8	3	3
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	25	8	4	2
BIOCARTA_EIF4_PATHWAY	27	6	3	2
chr5q34	20	9	3	0
REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING	29	12	6	2
GSE22886_NAIVE_TCELL_VS_DC_UP	46	13	6	3
GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP	40	10	6	4
GSE17721_CTRL_VS_LPS_24H_BMDC_DN	44	10	4	2
GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN	51	15	8	3
GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN	45	13	7	4
GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP	40	8	4	2
GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_UP	49	10	6	4
GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN	49	13	8	4
GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN	42	14	7	3
GSE36826_WT_VS_IL1R_KO_SKIN_DN	41	7	4	2
GSE3982_NEUTROPHIL_VS_NKCELL_UP	46	14	9	3
GSE31082_DN_VS_CD8_SP_THYMOCYTE_UP	41	10	4	2
GSE6875_WT_VS_FOXP3_KO_TREG_UP	49	16	6	3
GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP	46	9	4	3
GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN	43	17	7	3
GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_DN	42	7	4	3
GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_UP	53	16	7	2
GSE14308_TH1_VS_NATURAL_TREG_DN	49	14	6	4
GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP	33	9	5	3
GSE3982_DC_VS_MAC_UP	41	13	7	3
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN	47	16	7	4
GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP	41	8	3	2
GSE27786_NKCELL_VS_MONO_MAC_UP	38	7	3	2
GSE22886_NAIVE_TCELL_VS_NKCELL_UP	52	12	4	2
GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_DN	44	10	5	2
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_DN	35	10	4	2
GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP	56	17	10	5
GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP	57	16	9	4
GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_DN	43	15	7	3
GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_DN	50	14	6	3
TTTGCAG_MIR518A2	64	19	8	4
HNF4_DR1_Q3	61	20	11	5
PEDRIOLI_MIR31_TARGETS_DN	59	20	10	5
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	47	15	8	3
KEGG_CELL_CYCLE	53	12	8	3
BORCZUK_MALIGNANT_MESOTHELIOMA_UP	45	10	4	3
GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_DN	39	14	8	4
GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_UP	46	14	7	4
GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_UP	55	17	6	4
GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_DN	46	14	6	3
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_UP	46	14	6	3
GSE3982_MAST_CELL_VS_BCELL_DN	45	12	6	2
COLDREN_GEFITINIB_RESISTANCE_DN	48	13	6	3
GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_UP	43	12	8	3
GSE22045_TREG_VS_TCONV_DN	45	13	6	2
PRC1_BMI_UP.V1_DN	55	15	8	3
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_UP	45	11	4	3
GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_DN	49	14	8	3
GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_UP	42	8	4	2
GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN	40	14	6	4
GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP	53	14	7	2
GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_UP	51	14	8	3
HORIUCHI_WTAP_TARGETS_DN	56	15	5	2
REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL	54	17	9	4
GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_UP	45	13	6	2
ACTGTAG_MIR139	51	15	5	2
E2F1_Q3	51	12	5	3
BROWNE_HCMV_INFECTION_20HR_UP	62	21	11	6
KIM_WT1_TARGETS_UP	67	24	9	5
MIKKELSEN_MEF_ICP_WITH_H3K27ME3	54	18	8	3
GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_UP	40	13	5	2
GSE30083_SP1_VS_SP2_THYMOCYTE_UP	44	14	9	5
GSE14308_TH17_VS_NAIVE_CD4_TCELL_DN	52	13	7	3
GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_DN	54	18	11	3
GSE360_CTRL_VS_L_MAJOR_MAC_UP	48	16	12	6
GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_UP	51	16	8	3
GSE360_CTRL_VS_T_GONDII_DC_DN	40	13	5	3
GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_UP	50	18	7	3
GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN	39	10	4	3
OXFORD_RALB_TARGETS_DN	21	6	3	1
GSE27786_NKCELL_VS_ERYTHROBLAST_DN	46	14	7	3
GSE14308_TH1_VS_TH17_DN	60	17	9	4
CGGTGTG_MIR220	24	8	3	1
GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN	53	16	10	3
GSE13547_WT_VS_ZFX_KO_BCELL_UP	52	16	8	5
BROWNE_HCMV_INFECTION_48HR_UP	55	18	9	4
GSE3982_EOSINOPHIL_VS_NEUTROPHIL_DN	48	10	5	2
GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN	54	16	8	3
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15	38	7	3	2
GSE17721_CTRL_VS_CPG_1H_BMDC_UP	55	17	8	2
GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP	46	12	6	2
GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_DN	44	9	5	2
GSE32986_UNSTIM_VS_GMCSF_STIM_DC_UP	51	15	6	3
GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_DN	53	15	9	3
GSE45365_WT_VS_IFNAR_KO_CD8A_DC_UP	36	7	3	2
GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_DN	48	14	7	3
GSE22033_WT_VS_PPARG_KO_MEF_DN	55	15	8	3
chr10q22	39	8	2	2
KEGG_MTOR_SIGNALING_PATHWAY	42	9	4	2
ZHU_CMV_8_HR_DN	49	15	9	4
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	45	9	4	2
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	42	14	7	2
RB_DN.V1_UP	40	7	3	2
GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_UP	57	17	9	3
GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_UP	51	16	8	5
GSE3982_CTRL_VS_LPS_48H_DC_UP	48	13	6	3
GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_DN	53	14	9	3
GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP	52	14	4	3
GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_DN	49	12	6	4
GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_DN	41	7	3	2
WANG_RESPONSE_TO_FORSKOLIN_UP	22	5	2	1
GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP	54	17	10	4
GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN	34	11	4	3
GSE14350_IL2RB_KO_VS_WT_TREG_UP	55	18	8	2
GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_DN	48	10	5	3
GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_UP	56	15	6	3
KIM_WT1_TARGETS_8HR_UP	45	13	6	3
GSE24726_WT_VS_E2_2_KO_PDC_DAY4_POST_DELETION_UP	33	10	3	2
GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP	41	9	4	2
NUMATA_CSF3_SIGNALING_VIA_STAT3	39	12	7	3
MEF2_04	21	10	3	1
GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_UP	40	12	6	2
GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP	48	12	6	4
NAKAMURA_CANCER_MICROENVIRONMENT_UP	38	6	3	2
GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_UP	32	8	3	2
GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_DN	51	11	6	3
REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA	22	10	5	2
GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN	46	10	5	4
GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_UP	46	11	4	2
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP	34	8	3	2
GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN	43	9	4	3
GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN	51	16	8	5
ABE_VEGFA_TARGETS_30MIN	41	10	5	2
GSE17721_CTRL_VS_CPG_8H_BMDC_UP	48	12	6	4
MARKEY_RB1_ACUTE_LOF_UP	52	11	5	3
MTF1_Q4	51	15	8	3
BOUDOUKHA_BOUND_BY_IGF2BP2	39	9	5	4
GSE27786_LSK_VS_MONO_MAC_DN	49	14	5	2
GSE3982_NEUTROPHIL_VS_TH1_DN	52	16	8	4
GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP	51	13	7	5
GSE21379_WT_VS_SAP_KO_CD4_TCELL_UP	46	12	6	2
GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_UP	53	14	5	4
GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP	35	10	3	2
GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_DN	42	11	4	3
GSE3982_MAC_VS_NEUTROPHIL_DN	37	9	4	2
GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_DN	63	21	10	7
PAL_PRMT5_TARGETS_UP	54	16	7	2
GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN	40	9	6	3
GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_UP	45	9	4	3
GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_UP	51	13	6	2
GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_DN	44	11	5	4
GSE29949_MICROGLIA_VS_DC_BRAIN_DN	45	13	6	3
GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP	32	13	7	3
GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP	42	14	7	3
GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN	47	12	6	2
GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_DN	51	15	6	2
GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_DN	49	11	5	3
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP	48	10	4	2
GSE5960_TH1_VS_ANERGIC_TH1_UP	51	14	7	3
GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN	49	13	7	4
GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_UP	57	16	10	4
GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_DN	48	9	5	2
SMID_BREAST_CANCER_LUMINAL_B_DN	61	19	9	4
PID_IL4_2PATHWAY	48	12	7	4
REACTOME_CIRCADIAN_CLOCK	31	11	5	2
GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP	58	16	8	4
NAGASHIMA_NRG1_SIGNALING_UP	51	13	5	4
GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_DN	50	16	8	5
GSE16266_CTRL_VS_LPS_STIM_MEF_DN	52	13	7	2
GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_UP	45	14	6	3
GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_DN	53	15	9	4
GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN	31	9	2	2
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP	55	17	11	3
GSE23695_CD57_POS_VS_NEG_NK_CELL_UP	45	13	8	5
GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP	36	11	5	2
GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_DN	55	14	8	3
GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_DN	49	13	4	2
GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN	38	9	4	2
GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_DN	42	10	5	2
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN	51	10	3	2
GSE27786_CD8_TCELL_VS_ERYTHROBLAST_UP	45	8	4	2
GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_UP	42	9	3	2
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP	51	11	5	3
GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_UP	40	14	8	3
GSE14000_UNSTIM_VS_4H_LPS_DC_UP	49	8	3	2
GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_DN	39	8	3	2
GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_DN	42	11	6	2
GSE10325_CD4_TCELL_VS_BCELL_DN	57	16	7	3
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP	43	10	4	2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	49	18	9	3
BENPORATH_PROLIFERATION	29	8	4	4
GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	45	12	4	2
GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	44	7	3	2
GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_DN	43	14	3	2
ATM_DN.V1_UP	45	14	6	4
SMAD_Q6	53	21	9	4
ZHANG_BREAST_CANCER_PROGENITORS_UP	57	20	6	2
GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN	58	18	8	4
GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP	59	15	7	5
GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP	32	9	5	2
GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	56	15	6	3
GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_DN	46	13	6	3
GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_UP	42	10	5	3
GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN	47	13	6	2
GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_UP	58	17	6	3
GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_UP	56	18	9	3
GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN	49	17	7	3
GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_UP	47	10	6	3
GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP	45	15	8	4
GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_UP	46	12	6	3
GSE10325_BCELL_VS_MYELOID_DN	40	13	6	3
GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_DN	50	16	8	3
GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_DN	47	11	5	3
GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	32	11	4	2
GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_DN	52	12	4	3
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_DN	42	9	4	2
GSE14308_INDUCED_VS_NATURAL_TREG_UP	45	7	4	3
GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN	44	12	5	3
GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_UP	41	11	6	3
GSE13493_DP_VS_CD8POS_THYMOCYTE_UP	45	8	3	2
CAGTGTT_MIR141_MIR200A	68	27	12	5
KOBAYASHI_EGFR_SIGNALING_24HR_DN	48	9	3	2
chr1q22	32	8	5	1
BIOCARTA_BAD_PATHWAY	38	7	3	2
RELA_DN.V1_UP	43	10	5	4
REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION	29	10	5	2
REACTOME_MYOGENESIS	28	10	4	2
PID_LIS1_PATHWAY	36	8	5	3
GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_UP	47	13	5	4
BIOCARTA_IGF1R_PATHWAY	31	5	3	2
AGGTGCA_MIR500	51	14	6	2
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	47	10	5	4
GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_DN	39	10	4	3
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_DN	48	18	9	3
GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP	42	11	5	3
GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN	53	16	6	3
GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_DN	34	10	3	2
GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN	45	9	4	2
IL2_UP.V1_UP	54	14	9	6
GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_DN	49	18	9	4
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN	40	9	5	3
GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_UP	51	13	6	2
GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN	43	10	4	3
GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_DN	43	11	5	3
WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	36	10	3	2
GSE6259_CD4_TCELL_VS_CD8_TCELL_UP	53	14	6	2
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP	41	8	4	3
GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	58	18	10	4
GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_UP	40	12	5	2
GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_DN	37	12	5	2
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN	37	11	5	3
GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_UP	53	15	6	2
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP	36	7	4	2
GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN	53	14	6	3
GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_DN	45	12	7	3
GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN	42	9	4	3
GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN	57	15	7	3
GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN	52	13	6	4
GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_UP	51	12	4	3
GSE17721_CTRL_VS_LPS_4H_BMDC_DN	55	16	7	2
GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_UP	35	10	6	4
GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	51	15	7	3
PID_TXA2PATHWAY	36	12	6	2
GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN	42	13	5	2
GSE24574_NAIVE_VS_TCONV_CD4_TCELL_DN	49	14	7	4
GSE8515_IL1_VS_IL6_4H_STIM_MAC_UP	55	15	7	5
GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP	51	13	6	4
TMTCGCGANR_UNKNOWN	48	10	4	2
GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP	46	9	5	2
GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_UP	44	15	8	3
GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP	41	15	9	5
GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_UP	44	10	4	2
GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_UP	51	15	8	4
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_DN	54	14	8	4
SHEPARD_BMYB_MORPHOLINO_DN	44	12	6	3
GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP	56	15	6	4
GSE17721_CTRL_VS_POLYIC_4H_BMDC_UP	47	12	6	3
GSE10325_MYELOID_VS_LUPUS_MYELOID_DN	38	14	6	4
GSE27786_NKCELL_VS_MONO_MAC_DN	49	12	4	2
GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN	45	10	4	3
GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_DN	47	14	7	2
GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP	54	16	8	2
GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_DN	44	16	9	4
GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN	37	12	5	2
KONDO_PROSTATE_CANCER_WITH_H3K27ME3	37	12	6	3
GSE27786_LIN_NEG_VS_MONO_MAC_DN	54	15	5	2
GTCNYYATGR_UNKNOWN	47	16	7	4
REACTOME_SIGNALING_BY_ERBB4	50	11	5	3
AAGCAAT_MIR137	62	27	12	4
ACTGCCT_MIR34B	63	20	6	2
GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP	43	13	7	5
GSE20727_CTRL_VS_H2O2_TREATED_DC_DN	48	10	4	2
GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_DN	31	10	4	3
GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_UP	51	15	9	4
REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE	40	12	7	2
GSE11924_TH2_VS_TH17_CD4_TCELL_UP	59	18	10	2
GTCAGGA_MIR378	38	11	6	2
GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN	49	12	4	3
GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN	49	17	6	2
GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP	53	14	5	3
GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_DN	48	11	5	2
GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_DN	40	11	4	3
GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_DN	50	12	6	2
GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_DN	48	12	6	2
GSE27786_NKTCELL_VS_NEUTROPHIL_UP	51	12	6	3
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	29	8	4	2
CYTAGCAAY_UNKNOWN	41	10	4	2
GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP	39	12	5	2
GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN	48	17	8	3
GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_UP	48	11	7	3
BILBAN_B_CLL_LPL_UP	34	15	9	3
GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_UP	48	13	5	3
GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN	52	13	6	2
GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN	54	15	10	3
GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN	62	16	7	3
GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN	38	13	5	3
GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_UP	43	16	7	4
SMITH_TERT_TARGETS_UP	48	11	5	3
GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN	53	14	8	4
GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_UP	54	14	7	3
PEDRIOLI_MIR31_TARGETS_UP	51	14	6	3
GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN	43	11	3	2
GSE17721_LPS_VS_CPG_12H_BMDC_DN	48	11	4	4
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN	37	13	5	2
GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN	37	10	5	2
GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN	46	13	6	2
MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3	36	9	5	2
GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP	35	10	4	2
GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_UP	49	12	6	4
GSE3982_MAST_CELL_VS_NEUTROPHIL_DN	36	11	5	3
GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN	44	12	6	2
THUM_SYSTOLIC_HEART_FAILURE_UP	49	19	8	4
REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES	55	23	11	4
KEGG_ERBB_SIGNALING_PATHWAY	43	12	5	2
KEGG_SMALL_CELL_LUNG_CANCER	45	11	5	4
AP1_Q6	52	14	5	3
GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_DN	42	12	6	2
GAGACTG_MIR452	48	14	6	4
KEGG_TGF_BETA_SIGNALING_PATHWAY	46	13	6	4
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	43	11	5	3
REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE	24	6	3	3
LU_TUMOR_ANGIOGENESIS_UP	26	5	2	2
BIOCARTA_MCALPAIN_PATHWAY	16	5	2	1
GTAGGCA_MIR189	8	6	2	0
PID_TRAIL_PATHWAY	29	7	4	1
GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_UP	58	18	7	5
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_DN	41	13	6	2
GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_UP	43	8	3	2
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_UP	57	16	9	3
GSE3982_EOSINOPHIL_VS_TH2_UP	42	12	6	2
KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_UP	61	19	11	5
GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_UP	35	12	6	3
GSE17721_CTRL_VS_POLYIC_4H_BMDC_DN	50	12	5	3
GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP	46	8	4	2
GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN	52	17	9	5
GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP	43	12	3	2
GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN	48	19	8	4
GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_DN	54	15	5	4
GSE3982_MAC_VS_TH1_DN	46	7	4	3
GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_DN	53	18	7	3
GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_DN	43	14	5	2
GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_UP	46	11	5	3
GSE6259_33D1_POS_DC_VS_BCELL_DN	46	12	7	4
GSE17721_POLYIC_VS_CPG_16H_BMDC_UP	54	17	9	3
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_DN	50	13	7	3
GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP	50	15	7	4
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	49	14	6	4
GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP	50	15	5	3
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_UP	49	14	7	3
GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_UP	44	13	5	3
GSE17721_CTRL_VS_LPS_6H_BMDC_DN	56	17	6	4
GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_UP	56	14	6	5
GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_UP	49	12	5	3
GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_DN	46	11	5	3
KRAS.DF.V1_DN	52	14	8	5
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN	57	15	4	4
chr4q23	26	9	2	1
REACTOME_INTEGRATION_OF_PROVIRUS	32	6	3	2
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP	14	3	1	1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN	20	6	2	0
OXFORD_RALA_TARGETS_UP	22	4	2	1
CASORELLI_APL_SECONDARY_VS_DE_NOVO_DN	18	5	2	1
REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS	29	7	5	2
RICKMAN_METASTASIS_UP	45	12	7	2
GSE360_L_MAJOR_VS_T_GONDII_MAC_DN	38	10	4	2
RPS14_DN.V1_UP	50	14	6	4
GSE33424_CD161_INT_VS_NEG_CD8_TCELL_DN	42	9	4	3
GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN	54	19	8	3
GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP	45	12	5	2
GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_UP	55	15	8	6
GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP	35	10	5	3
GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP	50	13	6	2
GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_UP	53	17	10	2
GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_DN	43	9	4	2
GSE3982_DC_VS_NEUTROPHIL_UP	50	13	7	3
GSE17721_0.5H_VS_4H_LPS_BMDC_UP	53	15	7	3
GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN	39	10	4	2
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_DN	48	13	7	3
GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_UP	58	19	9	5
GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_DN	43	18	8	2
GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_DN	47	14	6	4
HALLMARK_ESTROGEN_RESPONSE_LATE	48	13	6	2
GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_DN	38	12	6	2
GSE31082_CD4_VS_CD8_SP_THYMOCYTE_DN	51	16	9	3
GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_UP	43	19	9	3
GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP	57	16	7	2
CTGRYYYNATT_UNKNOWN	32	12	6	2
GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_UP	38	9	4	2
TATCTGG_MIR488	45	9	3	2
GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP	37	11	6	2
GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN	47	11	7	3
GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_UP	56	16	8	5
GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	46	13	6	4
GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_DN	48	12	5	3
GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_DN	48	11	4	2
GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP	45	10	4	2
GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_UP	51	15	8	5
GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_DN	57	15	7	4
GSE15767_MED_VS_SCS_MAC_LN_DN	53	16	8	4
GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN	49	11	5	2
GSE15215_CD2_POS_VS_NEG_PDC_UP	56	14	8	4
GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_DN	49	13	7	5
GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN	54	18	8	5
GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP	46	10	6	4
GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_UP	49	16	8	4
BROWNE_HCMV_INFECTION_4HR_DN	55	16	9	4
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN	41	15	7	2
GSE360_CTRL_VS_L_DONOVANI_MAC_DN	41	12	5	4
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_DN	52	12	5	3
GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_DN	52	15	7	4
GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP	49	14	6	3
GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_UP	52	14	6	3
GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP	53	14	5	4
GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN	60	18	10	6
GSE3039_NKT_CELL_VS_B2_BCELL_DN	52	11	4	3
GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP	51	13	6	4
GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP	58	19	11	4
GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN	52	14	9	3
GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_UP	43	12	5	3
GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_UP	49	11	5	3
GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_DN	47	16	8	2
GSE3982_MAST_CELL_VS_DC_DN	50	12	5	2
GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN	50	15	7	5
GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_UP	43	13	6	2
GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_UP	48	19	10	5
GSE2585_THYMIC_MACROPHAGE_VS_MTEC_DN	50	14	7	2
GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_DN	46	13	7	4
GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN	36	13	5	2
GSE16385_MONOCYTE_VS_MACROPHAGE_UP	50	14	9	3
GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_DN	47	12	4	2
GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN	58	21	12	4
GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP	47	14	7	4
GSE40685_NAIVE_CD4_TCELL_VS_TREG_DN	54	15	8	4
GSE10325_CD4_TCELL_VS_MYELOID_DN	53	16	8	3
GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN	45	13	7	3
GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_DN	52	14	8	3
GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_UP	39	13	7	3
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN	49	13	5	3
GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_DN	40	11	3	2
GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP	43	12	6	2
CSR_EARLY_UP.V1_DN	40	9	4	2
GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP	45	10	4	2
WHITFIELD_CELL_CYCLE_M_G1	39	10	4	4
LU_IL4_SIGNALING	44	16	9	3
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP	31	6	3	2
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	39	10	5	3
GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP	39	14	6	5
GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_DN	47	11	6	2
GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_UP	52	17	7	4
GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_DN	48	17	8	4
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	55	13	7	4
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	28	8	3	2
GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_UP	59	17	7	5
GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP	42	9	4	2
GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP	49	17	11	3
GSE6681_DELETED_FOXP3_VS_WT_TREG_DN	39	13	6	2
GSE557_WT_VS_CIITA_KO_DC_DN	53	15	9	2
PID_NFAT_3PATHWAY	34	8	4	2
GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_UP	50	15	6	2
GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN	57	16	8	3
GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP	52	17	8	4
BIOCARTA_PYK2_PATHWAY	35	7	3	2
GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	52	13	5	2
GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP	46	15	8	5
APPEL_IMATINIB_RESPONSE	24	8	3	1
GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_DN	45	11	5	2
IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM	42	9	3	3
chr1q21	39	11	6	1
GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN	54	16	8	3
GSE17721_POLYIC_VS_CPG_2H_BMDC_DN	47	16	7	3
GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_UP	55	15	6	2
GSE2585_CTEC_VS_THYMIC_DC_UP	55	19	8	3
PID_P38_MKK3_6PATHWAY	35	7	3	2
GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_UP	48	15	8	3
GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_DN	51	13	5	2
GSE17721_CTRL_VS_CPG_4H_BMDC_UP	44	11	5	2
GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_UP	51	11	4	4
GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_DN	47	12	4	2
GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP	52	15	6	3
ZAMORA_NOS2_TARGETS_UP	32	6	3	1
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_DN	44	14	8	2
GSE27786_NKCELL_VS_NKTCELL_DN	49	14	7	2
GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_UP	35	12	6	2
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP	48	12	4	2
GSE17721_LPS_VS_POLYIC_1H_BMDC_UP	52	15	8	4
chr1p31	36	9	4	0
GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN	47	11	4	3
GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_UP	41	10	4	3
GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP	46	12	5	2
GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_DN	63	18	9	7
GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	59	15	7	5
IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM	17	5	2	2
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_DN	50	14	6	3
GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_UP	42	11	6	2
GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_DN	38	15	6	3
WHITFIELD_CELL_CYCLE_S	47	11	4	3
GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_DN	49	14	8	2
GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_UP	49	16	8	5
GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_DN	53	17	8	2
GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_UP	54	16	9	2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	43	13	5	3
GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN	46	12	6	4
GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN	61	23	10	5
GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_UP	35	11	4	2
GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_UP	50	16	7	3
GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_DN	46	11	5	2
GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP	43	11	4	5
GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP	47	15	8	3
GSE27786_BCELL_VS_CD8_TCELL_DN	39	8	5	3
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN	50	15	6	4
GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN	59	24	12	3
GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP	52	13	7	4
GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_UP	54	20	11	4
GSE11924_TH2_VS_TH17_CD4_TCELL_DN	62	17	8	5
GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_UP	52	16	8	4
KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP	62	18	8	5
GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	46	11	3	2
GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_DN	42	14	8	3
GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_UP	60	18	8	5
GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	23	10	4	3
JAZAG_TGFB1_SIGNALING_UP	38	7	3	2
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	41	9	4	2
KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3	47	15	6	2
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN	33	10	3	2
GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP	43	13	5	3
VERHAAK_AML_WITH_NPM1_MUTATED_DN	55	17	7	2
GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN	66	21	8	5
GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_DN	59	17	10	4
GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_DN	39	10	4	2
GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	53	14	6	3
GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_UP	62	21	7	2
GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN	48	12	6	4
GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_UP	52	12	4	2
GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN	48	15	6	2
GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP	47	13	6	3
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_UP	39	12	6	3
GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN	40	16	5	2
GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_UP	46	13	5	3
GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_UP	57	20	9	5
GSE17721_LPS_VS_CPG_16H_BMDC_DN	46	11	6	2
GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP	47	10	4	2
DAZARD_RESPONSE_TO_UV_NHEK_UP	38	10	5	3
GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN	36	11	5	3
SCHEIDEREIT_IKK_INTERACTING_PROTEINS	48	14	6	4
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	34	7	3	2
PID_HDAC_CLASSI_PATHWAY	36	11	6	2
AR_03	47	10	5	3
NFE2L2.V2	51	17	6	3
NRSF_01	33	8	3	2
ATF_01	59	20	10	5
HALLMARK_COMPLEMENT	61	20	10	6
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_UP	46	9	5	3
GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN	55	17	6	3
GSE9037_WT_VS_IRAK4_KO_BMDM_UP	49	16	9	3
GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN	56	15	8	5
GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP	52	16	7	3
GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	47	17	10	5
GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_UP	55	17	6	3
GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_UP	54	14	8	5
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP	54	14	8	3
GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP	46	15	7	3
GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	54	15	7	2
CAGCCTC_MIR4855P	49	11	6	3
GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN	45	11	6	3
GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN	48	13	4	2
GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_DN	36	14	7	2
GSE339_CD8POS_VS_CD4CD8DN_DC_DN	57	19	10	6
YTAAYNGCT_UNKNOWN	35	15	5	2
GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_UP	47	13	5	2
GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_DN	28	11	4	3
BIOCARTA_VEGF_PATHWAY	29	8	4	2
PID_BARD1_PATHWAY	38	10	6	3
NABA_PROTEOGLYCANS	19	7	2	2
BIOCARTA_CARM_ER_PATHWAY	37	12	5	2
REACTOME_DOWNSTREAM_TCR_SIGNALING	26	11	7	1
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN	38	10	4	2
ABE_VEGFA_TARGETS_2HR	26	11	6	3
YRCCAKNNGNCGC_UNKNOWN	43	11	4	2
PUJANA_BREAST_CANCER_LIT_INT_NETWORK	52	16	9	6
REACTOME_METABOLISM_OF_NUCLEOTIDES	27	6	3	1
GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN	49	9	3	2
REACTOME_S_PHASE	43	8	6	2
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP	40	11	4	3
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	54	17	6	3
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_DN	57	15	8	4
GSE30971_WBP7_HET_VS_KO_MACROPHAGE_UP	29	12	6	4
GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_UP	62	21	9	3
GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_UP	44	10	4	3
GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP	58	17	9	4
GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_DN	44	18	10	4
PID_TGFBR_PATHWAY	39	10	6	3
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	55	15	7	5
GSE3982_EOSINOPHIL_VS_NEUTROPHIL_UP	42	9	3	2
GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_DN	44	11	5	3
GSE31082_DP_VS_CD4_SP_THYMOCYTE_DN	45	15	8	4
JI_RESPONSE_TO_FSH_UP	36	7	4	3
KEGG_PROSTATE_CANCER	56	16	8	4
GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN	54	14	6	4
GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN	53	15	8	6
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN	29	7	3	2
GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_UP	55	16	6	4
GSE3982_DC_VS_TH1_UP	42	11	4	3
GSE43955_1H_VS_42H_ACT_CD4_TCELL_DN	48	11	5	3
GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_UP	59	19	9	6
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_DN	48	9	5	2
GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN	35	8	3	2
VERHAAK_GLIOBLASTOMA_CLASSICAL	54	15	6	4
GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_UP	46	12	4	3
BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION	41	9	5	1
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP	38	5	3	2
chr3p12	41	11	4	0
REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS	27	6	3	2
REACTOME_IL_7_SIGNALING	16	6	3	0
STARK_BRAIN_22Q11_DELETION	41	11	5	4
REACTOME_RNA_POL_I_PROMOTER_OPENING	30	3	2	1
REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING	21	6	2	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN	26	7	3	1
KOINUMA_COLON_CANCER_MSI_UP	37	7	4	3
REACTOME_ANDROGEN_BIOSYNTHESIS	12	6	3	2
HASINA_NOL7_TARGETS_UP	13	7	1	1
WANG_RESPONSE_TO_FORSKOLIN_DN	18	5	2	1
GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_DN	34	10	3	2
GSE360_CTRL_VS_L_DONOVANI_DC_DN	42	17	8	3
GSE3982_DC_VS_NEUTROPHIL_DN	42	13	5	4
GSE17721_POLYIC_VS_CPG_0.5H_BMDC_UP	55	15	8	3
GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_DN	42	15	6	4
GSE22886_NEUTROPHIL_VS_DC_DN	46	13	8	3
GSE22886_NAIVE_TCELL_VS_DC_DN	51	15	6	4
GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_UP	47	14	6	3
VEGF_A_UP.V1_DN	37	11	4	2
GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_DN	42	15	6	3
GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP	62	18	10	4
GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_DN	40	13	8	3
GSE17721_CTRL_VS_CPG_0.5H_BMDC_UP	48	11	6	4
GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP	50	16	9	4
GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_UP	44	14	8	3
GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_DN	43	9	4	2
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	41	10	4	2
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	55	18	8	2
GSE17721_CTRL_VS_POLYIC_8H_BMDC_UP	47	12	5	3
GSE12366_GC_BCELL_VS_PLASMA_CELL_DN	44	10	4	2
GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_UP	47	10	6	3
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	53	13	6	2
GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_UP	48	15	6	2
GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_UP	46	13	7	3
GSE4590_SMALL_VS_LARGE_PRE_BCELL_DN	48	10	5	4
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	56	16	8	5
GTTATAT_MIR410	52	16	5	3
GSE13887_RESTING_VS_ACT_CD4_TCELL_UP	47	12	7	4
GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_DN	24	11	4	1
WESTON_VEGFA_TARGETS	39	8	4	2
GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_DN	39	9	3	2
GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP	48	15	5	3
GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_UP	46	13	5	3
GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN	38	14	7	4
GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP	43	13	8	3
GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN	44	10	3	2
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP	49	12	6	2
GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP	48	17	10	4
GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_UP	55	18	9	6
GSE24726_WT_VS_E2_2_KO_PDC_UP	56	18	10	4
GSE14308_TH1_VS_TH17_UP	38	12	6	2
GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP	34	12	6	3
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	34	9	4	2
GCGSCMNTTT_UNKNOWN	37	10	5	2
REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION	36	7	3	2
DER_IFN_GAMMA_RESPONSE_UP	32	8	4	2
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	73	30	12	5
KEGG_THYROID_CANCER	45	9	4	2
chr1q31	19	7	2	0
GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN	43	13	6	2
GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN	45	11	5	2
HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	44	12	7	3
GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_DN	46	9	5	2
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP	48	11	5	3
GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN	45	12	5	4
GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_DN	50	13	6	3
GSE22886_NAIVE_BCELL_VS_DC_DN	44	10	5	4
GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_DN	49	15	8	3
GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN	60	20	9	3
GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN	48	11	4	2
GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_UP	38	9	4	2
REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION	49	15	8	4
GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_UP	48	12	6	3
GTGTTGA_MIR505	48	10	6	3
CTGTTAC_MIR194	45	10	6	2
GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN	51	12	4	2
GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN	41	8	3	2
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN	46	13	7	3
GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_DN	33	9	5	2
GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN	43	7	4	2
GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_UP	43	9	4	3
GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_DN	45	12	4	2
GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_DN	42	11	4	3
ELVIDGE_HIF1A_TARGETS_UP	33	7	3	2
GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN	59	17	7	4
GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_DN	50	15	5	2
GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_UP	45	15	8	4
GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP	50	13	6	3
GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN	56	15	9	5
REACTOME_SIGNALING_BY_NOTCH1	35	9	4	3
GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_DN	48	15	7	5
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	42	10	5	3
RYTAAWNNNTGAY_UNKNOWN	47	13	7	4
RAF_UP.V1_DN	60	20	7	3
GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP	39	12	4	3
GSE6259_BCELL_VS_CD8_TCELL_DN	46	13	7	4
SHEN_SMARCA2_TARGETS_UP	56	20	9	3
REACTOME_CELL_CYCLE_CHECKPOINTS	50	11	6	3
VANTVEER_BREAST_CANCER_METASTASIS_DN	38	9	3	1
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN	50	12	4	2
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_UP	35	9	3	2
GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN	38	10	3	2
PILON_KLF1_TARGETS_UP	64	22	8	7
MYC_UP.V1_UP	37	6	3	2
GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	35	8	3	2
GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_UP	34	7	3	2
SERVITJA_LIVER_HNF1A_TARGETS_DN	50	11	6	4
GSE8835_CD4_VS_CD8_TCELL_UP	53	15	7	4
GSE17721_CTRL_VS_CPG_1H_BMDC_DN	54	18	9	3
GSE7852_TREG_VS_TCONV_LN_DN	46	13	6	3
GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	52	18	8	3
GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_UP	45	11	5	2
GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_DN	54	15	9	3
GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_DN	48	13	6	2
GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_UP	47	10	6	2
BERENJENO_TRANSFORMED_BY_RHOA_DN	59	20	11	5
REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING	26	8	4	3
REACTOME_DNA_STRAND_ELONGATION	22	5	2	2
ST_ADRENERGIC	23	10	4	0
PID_RETINOIC_ACID_PATHWAY	39	8	3	2
PID_AVB3_OPN_PATHWAY	40	9	5	4
chr12q21	34	7	3	2
AP1FJ_Q2	45	13	8	3
FOSTER_TOLERANT_MACROPHAGE_UP	37	10	4	2
ROSS_AML_OF_FAB_M7_TYPE	42	10	4	1
GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN	49	13	7	3
YEGNASUBRAMANIAN_PROSTATE_CANCER	47	12	7	2
RYTGCNWTGGNR_UNKNOWN	43	9	3	2
NABA_ECM_GLYCOPROTEINS	54	16	7	3
GSE12505_WT_VS_E2_2_HET_PDC_UP	44	11	7	4
GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_UP	53	14	7	3
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	29	12	4	2
GSE13306_TREG_VS_TCONV_SPLEEN_UP	55	21	8	4
REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS	36	7	4	2
FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN	36	11	5	4
GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN	38	14	6	3
GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_DN	47	10	5	2
PID_TCR_PATHWAY	35	16	9	2
GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_DN	42	12	3	2
GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_DN	57	22	12	5
ARGGGTTAA_UNKNOWN	49	12	5	3
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	54	13	8	3
HFH8_01	65	24	10	4
GSE3982_EOSINOPHIL_VS_BCELL_UP	47	13	4	3
GSE17721_LPS_VS_POLYIC_12H_BMDC_DN	47	13	4	2
CAIRO_HEPATOBLASTOMA_CLASSES_DN	52	21	10	5
E2F_Q3	53	15	6	4
GAVIN_FOXP3_TARGETS_CLUSTER_P3	45	13	8	4
GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_DN	46	15	7	3
GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP	45	12	5	2
GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_DN	45	8	3	2
NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN	31	8	5	2
LIM_MAMMARY_LUMINAL_MATURE_UP	52	11	5	3
MARZEC_IL2_SIGNALING_UP	56	14	9	5
GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_UP	39	9	4	3
SHEN_SMARCA2_TARGETS_DN	53	16	8	3
REACTOME_RAF_MAP_KINASE_CASCADE	34	5	3	2
PID_TCR_JNK_PATHWAY	5	5	1	0
KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP	7	4	3	2
REACTOME_P38MAPK_EVENTS	21	6	3	1
MATHEW_FANCONI_ANEMIA_GENES	24	6	2	2
BIOCARTA_ARENRF2_PATHWAY	10	6	3	2
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	48	15	5	1
BYSTROEM_CORRELATED_WITH_IL5_DN	29	6	3	2
MUNSHI_MULTIPLE_MYELOMA_UP	33	7	3	2
YNTTTNNNANGCARM_UNKNOWN	44	16	7	3
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	22	6	3	1
GSE17721_LPS_VS_POLYIC_0.5H_BMDC_UP	53	16	6	3
GSE21380_NON_TFH_VS_TFH_CD4_TCELL_UP	52	17	9	4
GSE36009_WT_VS_NLRP10_KO_DC_DN	52	19	9	5
WALLACE_PROSTATE_CANCER_RACE_UP	40	14	6	3
GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP	47	11	5	2
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_UP	45	13	6	3
GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_UP	44	9	5	2
GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN	30	8	3	2
GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_DN	42	11	6	2
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	53	16	6	3
PID_NEPHRIN_NEPH1_PATHWAY	22	7	4	2
BIOCARTA_AT1R_PATHWAY	34	7	3	2
MATZUK_SPERMATID_DIFFERENTIATION	43	10	5	2
LUI_THYROID_CANCER_PAX8_PPARG_DN	40	9	5	2
LI_LUNG_CANCER	42	9	5	2
SPIRA_SMOKERS_LUNG_CANCER_UP	15	7	3	2
PID_INTEGRIN_A4B1_PATHWAY	20	6	2	2
REACTOME_SIGNALING_BY_RHO_GTPASES	42	12	6	5
CCTNTMAGA_UNKNOWN	40	7	3	2
REACTOME_CELL_CELL_COMMUNICATION	41	16	5	3
GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN	47	12	6	4
SERVITJA_ISLET_HNF1A_TARGETS_DN	40	8	3	2
AFFAR_YY1_TARGETS_UP	49	14	4	2
CTTGTAT_MIR381	59	21	8	3
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP	45	11	5	3
GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP	61	17	8	6
GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP	58	20	9	3
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	34	9	5	5
GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN	61	18	9	6
LMO2COM_01	67	26	12	6
LIM_MAMMARY_STEM_CELL_DN	50	17	9	5
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP	50	15	8	3
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN	43	13	6	4
GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_DN	44	15	7	2
GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP	40	7	3	2
DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN	49	11	6	3
GSE18281_CORTEX_VS_MEDULLA_THYMUS_UP	45	11	4	1
GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_UP	44	13	6	2
GSE45365_BCELL_VS_CD8_TCELL_DN	46	11	6	3
GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN	38	7	4	2
GSE10325_BCELL_VS_LUPUS_BCELL_UP	48	9	4	2
HALLMARK_CHOLESTEROL_HOMEOSTASIS	45	14	8	4
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN	40	10	3	2
GTGGTGA_MIR197	28	8	3	0
VANHARANTA_UTERINE_FIBROID_DN	34	12	5	2
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL	55	16	5	3
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D	42	13	6	3
NFY_C	63	22	8	5
GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP	55	16	7	3
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_UP	50	18	9	4
WOO_LIVER_CANCER_RECURRENCE_UP	48	10	3	2
MATZUK_SPERMATOZOA	36	12	7	4
GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN	42	10	4	2
GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_DN	40	11	5	2
GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_DN	37	6	3	2
GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP	54	12	7	3
GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_UP	46	11	4	2
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP	44	8	3	2
GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP	56	19	9	5
GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_UP	47	12	6	4
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP	52	21	8	5
GTATTAT_MIR3693P	43	17	7	2
GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP	43	18	10	5
GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP	51	16	9	5
WENG_POR_TARGETS_LIVER_UP	34	7	2	0
FAELT_B_CLL_WITH_VH3_21_UP	39	7	4	2
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN	16	8	3	0
PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY	35	10	5	2
BURTON_ADIPOGENESIS_PEAK_AT_16HR	28	7	3	2
REACTOME_CD28_CO_STIMULATION	34	12	6	3
PID_AMB2_NEUTROPHILS_PATHWAY	59	18	12	7
GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_UP	46	9	5	2
GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_UP	42	12	5	2
GSE13522_WT_VS_IFNG_KO_SKIN_DN	39	10	5	2
NOTCH_DN.V1_UP	35	9	3	2
GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	31	8	3	2
ACCTGTTG_UNKNOWN	45	12	5	3
DARWICHE_SKIN_TUMOR_PROMOTER_DN	55	17	9	4
GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP	38	9	3	2
GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_UP	48	11	6	2
DER_IFN_ALPHA_RESPONSE_UP	30	6	3	2
E2F_Q2	38	13	5	1
GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_UP	46	8	4	2
GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_DN	50	13	4	4
GSE4142_NAIVE_VS_GC_BCELL_DN	38	7	3	2
GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_UP	43	10	4	2
MATZUK_SPERMATOCYTE	40	8	4	3
GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_UP	41	12	7	2
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP	41	13	7	4
LI_DCP2_BOUND_MRNA	34	5	3	2
AAGWWRNYGGC_UNKNOWN	48	12	7	2
GTGACTT_MIR224	53	17	6	4
GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_DN	53	17	8	4
GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN	36	11	5	3
ATACTGT_MIR144	60	24	11	4
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	73	24	9	5
KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	62	20	7	4
GTGGGTGK_UNKNOWN	65	24	9	5
HALLMARK_MITOTIC_SPINDLE	46	14	4	3
CAMP_UP.V1_DN	55	18	8	5
GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_DN	52	12	6	3
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_UP	42	8	3	2
GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN	49	12	6	3
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP	39	13	7	3
GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP	41	10	4	2
GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN	35	8	3	2
GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_DN	45	14	7	3
MIKKELSEN_ES_LCP_WITH_H3K4ME3	49	11	5	3
GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_DN	36	10	5	2
RIZ_ERYTHROID_DIFFERENTIATION	40	12	7	2
NATSUME_RESPONSE_TO_INTERFERON_BETA_UP	49	14	8	6
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	30	10	6	3
GROSS_HYPOXIA_VIA_HIF1A_UP	36	7	3	2
HAMAI_APOPTOSIS_VIA_TRAIL_UP	72	30	10	3
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP	50	16	7	3
GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_DN	50	12	6	4
AMIT_EGF_RESPONSE_480_HELA	36	10	6	3
GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_UP	35	8	4	2
GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP	39	14	6	4
GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP	43	14	6	4
GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_DN	36	8	4	2
GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP	37	9	4	2
GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP	39	12	6	2
IRITANI_MAD1_TARGETS_UP	25	7	4	1
DING_LUNG_CANCER_MUTATED_FREQUENTLY	21	5	3	2
BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1	39	10	5	3
BIOCARTA_CDK5_PATHWAY	31	5	2	2
EVI1_01	34	6	3	2
INAMURA_LUNG_CANCER_SCC_DN	18	7	3	2
REACTOME_ERKS_ARE_INACTIVATED	23	6	3	2
REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE	18	7	2	2
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP	32	5	3	2
chr7p22	34	11	4	1
LEE_CALORIE_RESTRICTION_MUSCLE_UP	33	7	4	2
BIOCARTA_FMLP_PATHWAY	38	7	4	2
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN	27	5	2	2
YANG_BCL3_TARGETS_UP	56	17	6	3
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	40	13	7	3
LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP	41	11	4	3
EPPERT_HSC_R	51	17	6	4
GROSS_HYPOXIA_VIA_HIF1A_DN	44	12	5	3
ZWANG_DOWN_BY_2ND_EGF_PULSE	51	11	4	2
GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_UP	48	16	8	3
GSE37532_WT_VS_PPARG_KO_LN_TCONV_DN	42	9	4	2
GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP	49	13	6	3
GSE27859_MACROPHAGE_VS_DC_DN	44	11	5	5
GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_DN	42	9	3	2
GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN	44	10	6	4
GSE17721_LPS_VS_POLYIC_24H_BMDC_UP	47	9	3	2
GSE43955_10H_VS_60H_ACT_CD4_TCELL_UP	50	12	6	3
GSE14769_40MIN_VS_360MIN_LPS_BMDM_UP	41	6	3	2
GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP	42	9	3	2
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	55	13	5	4
GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_DN	43	10	3	2
GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP	32	10	3	2
GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_UP	47	8	3	2
GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_UP	37	12	6	3
GRABARCZYK_BCL11B_TARGETS_UP	32	8	2	2
GTATGAT_MIR154_MIR487	53	18	6	2
ALCALA_APOPTOSIS	36	8	4	2
CROONQUIST_NRAS_SIGNALING_DN	39	8	4	3
KEGG_GLIOMA	44	11	5	3
GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_DN	42	13	7	2
GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP	45	8	4	3
PPARA_02	44	9	4	2
GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_DN	55	18	8	4
GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_DN	44	10	5	3
GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_DN	35	7	4	3
GSE14308_TH2_VS_NAIVE_CD4_TCELL_UP	42	9	4	2
GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_DN	39	9	4	2
JAK2_DN.V1_UP	45	12	5	3
UEDA_PERIFERAL_CLOCK	45	13	7	3
GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	32	10	4	1
GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN	56	15	6	2
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP	62	21	9	4
VECCHI_GASTRIC_CANCER_EARLY_DN	73	28	7	4
WANG_CISPLATIN_RESPONSE_AND_XPC_DN	41	15	10	3
HOSHIDA_LIVER_CANCER_SUBCLASS_S1	54	19	10	4
ZIC2_01	56	17	7	4
BERNARD_PPAPDC1B_TARGETS_UP	29	7	3	2
PID_NCADHERIN_PATHWAY	48	15	5	3
chr17q12	23	10	6	3
PENG_GLUTAMINE_DEPRIVATION_UP	47	15	7	2
REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION	20	11	5	2
MODY_HIPPOCAMPUS_PRENATAL	41	8	4	2
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	42	11	6	2
IWANAGA_CARCINOGENESIS_BY_KRAS_DN	43	13	5	3
GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP	59	15	10	6
SENESE_HDAC2_TARGETS_UP	45	13	7	4
BRCA1_DN.V1_DN	36	7	3	2
MCAATNNNNNGCG_UNKNOWN	24	8	4	1
VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP	34	8	3	2
TAANNYSGCG_UNKNOWN	35	13	6	4
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	37	12	8	4
GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_DN	43	12	6	3
GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN	39	14	5	2
CAMP_UP.V1_UP	40	9	4	2
GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP	31	14	7	2
GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_UP	52	13	6	4
GTCTTCC_MIR7	56	18	7	2
GSE9960_HEALTHY_VS_SEPSIS_PBMC_UP	44	12	5	2
GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_UP	39	10	5	2
BLUM_RESPONSE_TO_SALIRASIB_DN	50	12	5	3
GSE14000_4H_VS_16H_LPS_DC_DN	46	10	4	2
GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN	52	12	6	3
GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP	54	11	5	2
GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP	45	10	5	3
CDPCR3HD_01	78	29	9	5
MARSON_BOUND_BY_E2F4_UNSTIMULATED	59	16	7	5
GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_UP	45	8	3	2
GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_DN	43	8	4	3
GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP	39	10	4	2
GSE27786_BCELL_VS_CD4_TCELL_DN	44	13	7	4
GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_DN	42	13	5	4
GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN	41	10	5	2
GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_UP	45	11	7	2
SANSOM_APC_TARGETS_REQUIRE_MYC	40	12	6	2
GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_DN	39	11	4	3
GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_DN	41	9	2	2
GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_UP	40	11	5	3
GGGACCA_MIR133A_MIR133B	54	16	9	3
GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_UP	49	11	4	2
SHEPARD_CRUSH_AND_BURN_MUTANT_DN	46	11	4	2
GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_UP	45	12	8	3
MIF1_01	42	11	4	2
GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_DN	42	10	4	2
GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN	50	15	11	4
GGCAGCT_MIR22	53	19	10	4
CMYB_01	57	17	8	5
TGAGATT_MIR216	53	17	7	2
GSE32901_NAIVE_VS_TH1_CD4_TCELL_UP	41	9	4	2
LEE_NEURAL_CREST_STEM_CELL_DN	50	12	4	2
REACTOME_PLATELET_HOMEOSTASIS	37	13	6	5
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	40	14	5	2
GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_DN	47	17	7	2
GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_UP	41	7	3	2
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_DN	47	16	5	2
GSE18148_CBFB_KO_VS_WT_TREG_UP	48	13	5	3
GSE15330_HSC_VS_PRO_BCELL_DN	36	9	5	3
GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_DN	52	13	5	3
GSE14308_TH17_VS_NATURAL_TREG_UP	45	12	5	3
GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN	32	7	3	2
GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_DN	47	13	6	3
KOHOUTEK_CCNT1_TARGETS	37	7	3	2
WANG_TARGETS_OF_MLL_CBP_FUSION_UP	42	10	4	2
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN	32	7	3	1
BIOCARTA_PAR1_PATHWAY	29	9	5	2
GROSS_HYPOXIA_VIA_ELK3_ONLY_DN	28	10	6	2
CRGAARNNNNCGA_UNKNOWN	40	7	3	2
HMX1_01	36	10	4	2
VANTVEER_BREAST_CANCER_BRCA1_DN	31	8	3	2
GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP	50	11	6	3
SANSOM_APC_TARGETS_UP	37	7	3	2
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	45	10	4	3
HELLER_HDAC_TARGETS_DN	52	16	8	2
ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN	27	7	4	3
GERHOLD_RESPONSE_TO_TZD_DN	44	10	4	3
SCHAVOLT_TARGETS_OF_TP53_AND_TP63	22	5	2	1
KEGG_ALPHA_LINOLENIC_ACID_METABOLISM	6	6	3	1
REACTOME_UNWINDING_OF_DNA	11	4	1	0
BIOCARTA_PLCE_PATHWAY	20	9	4	1
VERRECCHIA_RESPONSE_TO_TGFB1_C3	29	6	3	1
REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP	43	9	6	4
KRISHNAN_FURIN_TARGETS_DN	15	5	2	1
WANG_CLIM2_TARGETS_UP	56	14	7	4
GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_DN	32	10	3	2
GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN	44	11	6	2
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_DN	56	17	7	5
GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_DN	50	18	9	3
GSE22886_NAIVE_CD4_TCELL_VS_DC_DN	41	10	5	3
GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_DN	44	10	4	2
GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_UP	49	11	3	2
GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_DN	49	12	5	3
GSE6259_BCELL_VS_CD4_TCELL_DN	36	11	5	2
BROWNE_HCMV_INFECTION_18HR_DN	28	10	3	2
GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_UP	56	16	7	4
ESC_J1_UP_LATE.V1_DN	46	11	3	2
GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN	35	9	4	2
GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	33	11	3	2
GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_UP	45	13	6	5
GSE2585_CD80_HIGH_VS_LOW_MTEC_DN	49	10	6	3
REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	46	13	5	3
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	55	17	9	3
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION	24	11	5	0
MATTIOLI_MGUS_VS_PCL	27	6	2	2
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN	39	9	5	2
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	43	9	4	3
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	39	6	3	2
AGCTCCT_MIR28	50	11	4	3
KEGG_PANCREATIC_CANCER	48	14	9	3
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0	35	9	4	2
TAATAAT_MIR126	71	30	11	4
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP	59	17	8	5
GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_DN	41	10	7	2
GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_UP	44	14	8	3
GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_UP	44	13	7	2
GSE42724_B1_BCELL_VS_PLASMABLAST_UP	49	12	5	3
GSE27786_BCELL_VS_MONO_MAC_DN	47	12	6	2
GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_UP	54	17	7	5
GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP	41	12	5	4
GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_UP	49	12	6	3
GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_DN	48	16	8	3
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN	44	9	3	2
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_UP	52	22	12	4
GSE29618_BCELL_VS_MONOCYTE_UP	52	17	7	3
GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_DN	40	13	5	3
GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_DN	47	15	7	4
GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_DN	21	12	6	2
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_DN	42	11	6	3
GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_DN	43	9	4	2
GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_UP	47	9	6	2
GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN	45	9	4	2
GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN	47	12	6	4
GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_DN	39	10	4	2
GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_UP	46	12	7	2
GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_UP	45	12	4	2
GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_DN	37	10	4	2
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN	36	9	5	3
IRF_Q6	67	25	11	6
MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	63	21	9	4
STK33_UP	46	16	6	3
PID_PI3K_PLC_TRK_PATHWAY	37	12	7	3
RIZ_ERYTHROID_DIFFERENTIATION_12HR	33	9	4	3
CGGAARNGGCNG_UNKNOWN	41	7	3	2
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	19	7	3	1
chr1p34	43	11	4	0
YAGI_AML_WITH_T_9_11_TRANSLOCATION	39	12	5	3
HUMMERICH_SKIN_CANCER_PROGRESSION_DN	48	15	6	3
KEGG_MELANOMA	49	15	6	3
WIERENGA_STAT5A_TARGETS_GROUP1	36	12	7	3
GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_DN	50	17	11	4
GSE17721_LPS_VS_CPG_4H_BMDC_DN	50	13	6	2
VILLANUEVA_LIVER_CANCER_KRT19_UP	45	11	3	2
REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM	49	17	9	4
VERHAAK_AML_WITH_NPM1_MUTATED_UP	41	14	7	2
GSE557_WT_VS_I_AB_KO_DC_DN	43	12	6	2
GSE22886_CD8_VS_CD4_NAIVE_TCELL_DN	36	13	6	3
GSE19512_NAUTRAL_VS_INDUCED_TREG_DN	41	15	7	4
GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP	52	13	6	4
chr19p13	48	12	6	3
GSE27896_HDAC6_KO_VS_WT_TREG_UP	47	18	11	5
GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_UP	46	17	10	5
GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_DN	62	17	10	6
GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_UP	44	14	7	3
GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_UP	50	13	5	3
GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_UP	45	13	4	2
GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN	33	10	4	2
GSE27859_MACROPHAGE_VS_DC_UP	37	13	7	3
GSE27786_CD4_TCELL_VS_NEUTROPHIL_UP	45	11	4	2
GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_DN	39	8	3	2
GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_UP	34	10	5	2
GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_UP	45	12	6	3
FOSTER_KDM1A_TARGETS_DN	53	14	5	5
GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN	42	10	4	2
GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP	52	10	6	2
GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP	50	13	6	2
CREB_Q3	59	16	7	3
ALPHACP1_01	59	18	8	3
GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP	41	18	8	2
GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_UP	35	9	6	2
YAMAZAKI_TCEB3_TARGETS_UP	49	18	9	2
GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_UP	44	16	6	3
GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP	41	8	3	2
GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_DN	41	13	7	3
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	32	9	5	3
GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_UP	27	15	6	6
GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_UP	42	14	8	2
GSE17721_LPS_VS_POLYIC_16H_BMDC_UP	37	12	4	3
GSE17721_LPS_VS_CPG_0.5H_BMDC_DN	46	17	11	3
GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP	45	11	4	3
GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP	42	11	3	2
GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_DN	42	10	6	4
GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN	49	10	4	3
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_DN	38	13	5	2
GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_DN	43	13	7	3
GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_DN	47	11	4	2
GSE42724_MEMORY_VS_B1_BCELL_UP	39	10	4	2
GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_DN	38	14	6	4
GSE17721_0.5H_VS_8H_POLYIC_BMDC_UP	48	16	8	3
GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_UP	41	11	5	3
GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_UP	34	9	4	3
LEI_MYB_TARGETS	46	17	10	3
STK33_NOMO_UP	47	15	6	3
DAIRKEE_TERT_TARGETS_UP	53	15	8	3
MEIS1_01	67	22	9	5
ZWANG_EGF_INTERVAL_UP	28	11	4	2
WIELAND_UP_BY_HBV_INFECTION	12	5	2	2
LINDVALL_IMMORTALIZED_BY_TERT_UP	36	12	4	3
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	30	12	5	3
CAGNWMCNNNGAC_UNKNOWN	36	6	3	2
WALLACE_PROSTATE_CANCER_RACE_DN	31	8	4	3
PID_SMAD2_3NUCLEAR_PATHWAY	45	12	8	4
NELSON_RESPONSE_TO_ANDROGEN_UP	32	10	5	2
WHITFIELD_CELL_CYCLE_LITERATURE	30	7	3	1
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP	43	11	4	2
REACTOME_NETRIN1_SIGNALING	36	14	5	1
chr6q21	20	9	4	2
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN	46	9	4	2
GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP	41	11	5	3
JIANG_AGING_HYPOTHALAMUS_DN	23	9	4	2
GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN	31	7	3	2
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP	44	13	7	4
PID_RHOA_REG_PATHWAY	27	7	3	2
HALLMARK_HEME_METABOLISM	43	9	5	3
CACTTTG_MIR520G_MIR520H	80	33	12	8
GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN	48	15	8	4
PID_ECADHERIN_NASCENT_AJ_PATHWAY	29	8	4	2
GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_DN	35	12	6	2
GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_DN	57	17	9	4
GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_UP	42	15	7	3
KANG_DOXORUBICIN_RESISTANCE_UP	32	7	4	3
GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_UP	50	12	7	2
AMIT_EGF_RESPONSE_480_MCF10A	29	8	2	2
KIM_LIVER_CANCER_POOR_SURVIVAL_DN	25	9	3	3
GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_UP	53	13	7	3
GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN	44	15	9	4
chr10q25	23	8	3	2
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN	52	14	6	2
GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_UP	43	11	4	2
GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP	49	14	8	6
LEF1_UP.V1_DN	45	13	6	2
REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	24	8	4	2
GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN	53	15	9	3
GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP	41	10	5	4
GSE28237_EARLY_VS_LATE_GC_BCELL_DN	49	14	7	5
OXFORD_RALA_OR_RALB_TARGETS_UP	36	9	5	2
GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_UP	35	13	8	2
GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN	48	11	6	3
GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_DN	38	10	4	2
GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_UP	49	16	9	3
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_UP	42	11	4	2
AACWWCAANK_UNKNOWN	52	13	5	3
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	21	7	4	1
SMID_BREAST_CANCER_LUMINAL_A_DN	33	6	2	1
BIOCARTA_AKAPCENTROSOME_PATHWAY	18	8	4	2
TOMLINS_METASTASIS_UP	32	6	3	0
DAZARD_UV_RESPONSE_CLUSTER_G3	8	6	3	0
BIOCARTA_BARR_MAPK_PATHWAY	34	6	3	2
ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL	13	6	3	2
REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE	33	6	3	2
GSE22886_NAIVE_VS_MEMORY_TCELL_UP	38	10	4	2
GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_UP	38	11	4	2
GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_UP	40	12	4	2
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_DN	46	13	8	3
GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_DN	48	9	4	2
GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN	43	10	6	2
GSE22886_TH1_VS_TH2_12H_ACT_UP	49	12	5	2
chr11q13	48	16	8	4
HOSHIDA_LIVER_CANCER_SURVIVAL_UP	32	12	6	2
GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP	51	14	7	3
GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP	53	13	4	3
SASSON_RESPONSE_TO_GONADOTROPHINS_UP	47	12	7	5
GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP	39	9	4	2
GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_UP	38	13	5	4
GSE13229_IMM_VS_INTMATURE_NKCELL_DN	52	11	4	2
GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP	49	13	7	4
GSE17721_4_VS_24H_CPG_BMDC_UP	39	12	7	4
GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_UP	49	10	5	5
GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_UP	47	12	7	2
GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_UP	50	14	8	3
GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_DN	34	9	5	2
GSE17721_LPS_VS_CPG_2H_BMDC_DN	51	13	7	3
GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN	50	14	6	2
GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_DN	54	14	7	5
GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN	44	11	4	3
GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_UP	37	13	5	2
DURAND_STROMA_S_UP	71	26	11	3
KAAB_FAILED_HEART_ATRIUM_DN	30	9	3	2
ODONNELL_TFRC_TARGETS_DN	46	10	3	2
GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_DN	35	8	3	1
AP1_01	59	19	10	5
GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN	44	11	6	2
GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP	52	12	5	3
GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP	38	11	6	3
GSE3982_MAC_VS_BASOPHIL_DN	38	12	7	3
GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_DN	42	13	7	4
GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_UP	37	11	6	2
GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_UP	47	14	8	4
GSE17721_CTRL_VS_LPS_1H_BMDC_DN	38	11	6	3
GSE31082_DP_VS_CD4_SP_THYMOCYTE_UP	51	12	7	4
GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN	52	13	7	2
GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_DN	23	12	4	2
GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_UP	48	10	5	4
GSE45365_CD8A_DC_VS_CD11B_DC_UP	42	12	6	4
GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP	48	13	6	3
GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_UP	44	13	7	3
GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_UP	37	12	5	2
GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_DN	38	11	5	3
GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP	49	13	5	2
GSE1460_DP_VS_CD4_THYMOCYTE_UP	39	11	5	2
GSE17721_12H_VS_24H_POLYIC_BMDC_DN	46	10	6	2
GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN	40	9	4	3
GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_UP	48	15	8	2
GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_UP	45	10	5	2
GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_DN	37	12	6	1
LI_INDUCED_T_TO_NATURAL_KILLER_UP	51	15	7	4
HALLMARK_PANCREAS_BETA_CELLS	30	7	3	2
LEE_AGING_MUSCLE_DN	39	12	7	4
chr15q22	20	7	2	2
CTCTATG_MIR368	47	12	5	3
PID_ER_NONGENOMIC_PATHWAY	46	10	5	2
ST_T_CELL_SIGNAL_TRANSDUCTION	24	10	3	2
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	19	11	6	3
RODRIGUES_THYROID_CARCINOMA_DN	51	15	7	3
UEDA_CENTRAL_CLOCK	39	9	3	2
ATGTAGC_MIR221_MIR222	56	17	7	3
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP	41	9	3	2
KEGG_JAK_STAT_SIGNALING_PATHWAY	48	16	7	4
GSE22886_NEUTROPHIL_VS_MONOCYTE_UP	39	11	4	2
GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_UP	42	9	3	2
GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_UP	39	12	5	3
GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN	56	17	8	2
GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_UP	41	12	5	1
GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_DN	52	11	6	3
GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATEDIN_DC_DN	38	9	4	3
GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_UP	49	16	8	3
GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_UP	25	7	3	2
GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP	40	9	5	2
GSE360_DC_VS_MAC_L_DONOVANI_DN	39	9	3	2
GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_UP	32	10	5	3
GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_DN	28	13	6	3
GSE22886_TCELL_VS_BCELL_NAIVE_UP	39	12	7	2
GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_UP	58	17	8	4
GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP	47	10	4	2
PENG_GLUTAMINE_DEPRIVATION_DN	66	20	10	4
GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	50	18	10	3
GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_UP	44	9	5	2
GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_DN	39	10	5	3
GSE22886_TH1_VS_TH2_12H_ACT_DN	59	16	9	6
HSF_Q6	37	12	6	3
GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN	50	13	7	3
GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_DN	49	11	6	2
GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN	49	12	4	2
GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_UP	36	13	6	2
GSE7852_THYMUS_VS_FAT_TREG_UP	41	12	6	3
GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_DN	38	8	5	2
GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_UP	51	16	8	3
GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	41	12	6	2
GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_UP	42	8	5	3
GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP	32	11	6	3
GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_UP	48	8	4	3
VANTVEER_BREAST_CANCER_ESR1_DN	37	12	6	3
GGCACTT_MIR519E	44	12	6	3
IKEDA_MIR30_TARGETS_UP	48	13	5	4
GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	33	10	5	2
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	49	12	6	3
RODRIGUES_DCC_TARGETS_DN	35	11	4	2
GSE2128_C57BL6_VS_NOD_THYMOCYTE_DN	40	11	6	4
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_DN	51	17	9	2
GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN	42	13	6	4
GROSS_HYPOXIA_VIA_ELK3_UP	49	13	7	3
GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP	53	12	5	4
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP	55	17	12	5
GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_DN	43	12	6	4
GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	40	8	5	2
GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP	47	17	7	2
GSE18893_TCONV_VS_TREG_2H_TNF_STIM_UP	35	14	8	2
GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_UP	39	11	5	3
GSE2706_UNSTIM_VS_8H_R848_DC_UP	41	11	5	3
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS	44	11	5	5
GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_UP	42	11	6	3
PRC2_SUZ12_UP.V1_DN	45	14	6	2
GSE24210_RESTING_TREG_VS_TCONV_DN	44	10	5	2
GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP	49	17	9	4
GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_UP	51	14	7	5
GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN	44	15	7	3
GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN	54	18	10	5
GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_DN	38	10	3	2
GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_UP	44	14	8	2
REACTOME_SYNTHESIS_OF_DNA	37	9	6	2
FALVELLA_SMOKERS_WITH_LUNG_CANCER	49	11	4	2
AP1_Q4_01	55	17	9	5
KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_UP	44	13	5	3
GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN	50	12	7	3
GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN	49	15	6	3
GSE360_L_DONOVANI_VS_L_MAJOR_DC_DN	45	13	8	3
ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS	38	12	5	3
GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN	27	8	4	2
ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN	16	10	3	0
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_UP	40	14	7	2
GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN	49	13	4	2
GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_UP	45	13	6	4
GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_UP	53	13	6	2
ALONSO_METASTASIS_UP	40	14	7	4
GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP	47	15	6	3
GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_DN	47	13	7	4
GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP	50	17	8	4
AUNG_GASTRIC_CANCER	25	4	2	2
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN	43	8	3	2
GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_DN	40	14	8	4
KEGG_ARACHIDONIC_ACID_METABOLISM	26	6	2	2
GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	34	14	6	2
GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_DN	41	11	4	2
GSE25677_MPL_VS_R848_STIM_BCELL_DN	52	19	11	4
GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP	37	11	5	3
GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_DN	44	13	5	2
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_DN	52	17	8	3
GSE3982_MAST_CELL_VS_BASOPHIL_UP	48	11	5	2
GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN	53	15	8	2
GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_DN	41	12	6	2
GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN	53	15	7	3
GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN	44	13	6	2
GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN	44	11	4	2
GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN	41	13	8	3
GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN	49	12	5	3
GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP	50	13	6	3
GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP	47	14	8	2
PID_IFNG_PATHWAY	32	9	5	4
GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	54	18	7	4
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN	19	8	5	2
GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_UP	42	11	6	2
GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_UP	55	14	7	6
GSE3982_NEUTROPHIL_VS_BCELL_DN	38	10	5	2
GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_UP	50	13	5	3
GSE3982_DC_VS_TH1_DN	48	14	6	4
GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_DN	32	12	6	2
GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_UP	34	8	4	2
GSE25087_TREG_VS_TCONV_FETUS_DN	33	9	3	3
GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN	47	12	5	3
GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP	52	15	8	5
GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP	43	11	5	3
GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_UP	44	10	5	2
LEE_AGING_MUSCLE_UP	28	7	3	1
GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UP	43	13	7	2
GERHOLD_ADIPOGENESIS_UP	37	10	4	3
GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	42	11	6	2
UDAYAKUMAR_MED1_TARGETS_UP	33	9	5	3
GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_DN	30	10	3	2
GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	34	10	4	2
TSENG_IRS1_TARGETS_DN	34	8	4	2
GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_UP	43	13	6	3
MOOTHA_PGC	47	16	6	2
ER_Q6_02	53	18	9	7
AP1_Q2_01	46	17	6	3
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN	26	6	2	1
KEGG_CIRCADIAN_RHYTHM_MAMMAL	9	7	2	1
GCGCCTT_MIR525_MIR524	30	5	2	2
BIOCARTA_DREAM_PATHWAY	27	6	3	2
BIOCARTA_CDC42RAC_PATHWAY	32	9	5	2
SINGH_NFE2L2_TARGETS	20	6	2	0
REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION	47	12	6	5
WENG_POR_TARGETS_GLOBAL_UP	21	5	2	1
WANG_RECURRENT_LIVER_CANCER_UP	49	10	6	4
REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION	26	8	4	1
REACTOME_SOS_MEDIATED_SIGNALLING	33	5	3	2
ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE	34	9	5	2
BIOCARTA_TALL1_PATHWAY	27	8	4	3
PID_ARF6_DOWNSTREAM_PATHWAY	38	7	3	2
RODRIGUES_NTN1_TARGETS_UP	47	9	3	1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN	21	6	2	1
RUAN_RESPONSE_TO_TROGLITAZONE_DN	31	6	3	0
FOSTER_TOLERANT_MACROPHAGE_DN	63	24	8	4
MORI_IMMATURE_B_LYMPHOCYTE_DN	41	10	4	2
EIF4E_UP	43	8	4	2
TGTYNNNNNRGCARM_UNKNOWN	22	7	3	2
GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP	54	12	5	4
GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_DN	37	13	4	2
GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATED_IN_DC_UP	40	10	5	3
GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	57	15	7	3
GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_UP	49	11	5	3
GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN	49	15	6	2
GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN	48	16	6	3
GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN	44	10	4	2
GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_UP	41	14	7	3
GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP	37	12	4	2
GSE3982_DC_VS_MAC_LPS_STIM_UP	47	12	7	3
GSE27786_ERYTHROBLAST_VS_MONO_MAC_UP	38	11	5	2
GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN	49	14	8	2
GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_DN	54	18	9	3
GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_UP	47	15	8	3
ATF2_S_UP.V1_DN	46	18	10	5
GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	50	14	7	3
GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP	37	9	3	2
GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_DN	41	11	6	3
GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_UP	47	11	5	2
GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_UP	44	10	5	2
MOHANKUMAR_HOXA1_TARGETS_DN	48	17	7	4
GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP	56	16	6	4
CHANG_CORE_SERUM_RESPONSE_UP	49	11	5	4
GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN	33	8	4	2
GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_DN	47	15	6	4
GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP	47	13	6	2
GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN	49	13	5	3
HEN1_02	61	18	7	5
GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN	42	13	7	2
GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP	50	13	5	3
GSE45365_WT_VS_IFNAR_KO_CD8A_DC_DN	54	14	7	4
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	49	11	5	3
SENESE_HDAC2_TARGETS_DN	55	17	6	3
GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_UP	34	9	3	2
GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_UP	44	13	5	2
GSE17721_CTRL_VS_POLYIC_12H_BMDC_UP	33	8	4	2
GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN	50	14	7	4
GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_UP	58	18	10	5
GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_UP	42	13	8	4
GSE27786_LSK_VS_NKCELL_DN	57	15	8	3
GSE17721_LPS_VS_POLYIC_12H_BMDC_UP	64	17	9	5
HALLMARK_WNT_BETA_CATENIN_SIGNALING	43	11	5	3
GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_DN	53	13	6	3
GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	42	15	5	3
PID_FANCONI_PATHWAY	19	6	2	2
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_UP	45	13	5	4
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_UP	21	11	4	3
KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	35	11	4	2
GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP	47	10	5	2
GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_UP	36	10	5	2
GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP	55	13	6	3
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	41	11	5	4
KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES	51	13	6	4
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1	29	7	3	2
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_UP	36	8	3	2
VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	31	7	3	1
GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_DN	48	14	8	5
GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN	42	13	6	4
GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN	57	20	8	3
GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_DN	49	14	9	4
GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_UP	48	12	4	2
GSE14308_TH2_VS_TH17_UP	51	12	5	2
NATSUME_RESPONSE_TO_INTERFERON_BETA_DN	27	7	4	3
ZHAN_MULTIPLE_MYELOMA_CD2_UP	27	9	3	2
SIRNA_EIF4GI_DN	44	11	5	2
CAHOY_OLIGODENDROCUTIC	33	12	9	2
ZHANG_BREAST_CANCER_PROGENITORS_DN	52	14	9	4
GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_DN	42	10	4	3
PECE_MAMMARY_STEM_CELL_DN	30	9	3	3
GSE14415_ACT_VS_CTRL_NATURAL_TREG_UP	40	8	3	2
GSE29618_BCELL_VS_MDC_UP	63	23	10	3
GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP	35	7	3	2
GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP	51	13	7	2
GSE27786_BCELL_VS_NEUTROPHIL_UP	56	14	8	4
GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN	42	15	8	3
GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP	28	8	2	2
GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_DN	48	17	10	2
GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_DN	57	16	6	3
GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_DN	50	15	6	2
GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_DN	46	10	5	2
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN	43	16	7	4
GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	61	19	8	4
GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_DN	45	13	7	2
ZWANG_EGF_INTERVAL_DN	50	15	8	4
GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	47	10	5	3
ESC_J1_UP_LATE.V1_UP	50	16	7	4
GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_UP	51	16	9	4
TGFB_UP.V1_DN	45	15	9	3
GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN	44	15	6	3
GSE34006_WT_VS_A2AR_KO_TREG_UP	45	13	5	2
GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_DN	44	12	6	4
GSE17721_CTRL_VS_LPS_0.5H_BMDC_DN	56	19	9	2
GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_DN	54	15	7	2
HALLMARK_SPERMATOGENESIS	41	14	7	4
WILCOX_RESPONSE_TO_PROGESTERONE_UP	36	13	5	4
RODWELL_AGING_KIDNEY_DN	42	12	4	2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	33	7	3	2
KAYO_CALORIE_RESTRICTION_MUSCLE_UP	41	12	9	3
GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN	34	12	5	2
KIM_MYC_AMPLIFICATION_TARGETS_UP	38	11	5	2
GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_DN	53	20	9	4
SEIDEN_ONCOGENESIS_BY_MET	25	9	5	2
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	42	10	5	2
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	53	21	5	3
GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN	36	13	7	4
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN	42	9	4	2
GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN	49	17	10	5
GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_DN	45	13	7	3
GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_DN	44	12	6	4
GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_DN	62	19	9	7
GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN	54	17	8	5
GSE14000_UNSTIM_VS_4H_LPS_DC_DN	35	9	4	3
GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_UP	48	15	9	4
GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_UP	44	13	7	4
GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_UP	49	15	9	4
GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_UP	43	15	6	3
GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP	35	15	6	2
GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN	39	9	4	3
GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_DN	60	19	10	5
GSE22935_WT_VS_MYD88_KO_MACROPHAGE_DN	53	13	6	4
GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_UP	30	11	7	2
GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN	50	12	5	5
GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_DN	48	13	7	3
GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_UP	39	11	4	2
GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_UP	42	9	4	2
GSE30083_SP3_VS_SP4_THYMOCYTE_UP	37	12	4	2
GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN	55	17	6	5
SWEET_LUNG_CANCER_KRAS_DN	75	31	13	5
MCCLUNG_DELTA_FOSB_TARGETS_2WK	45	9	3	1
TCTGATC_MIR383	44	9	4	2
NADLER_HYPERGLYCEMIA_AT_OBESITY	18	6	3	2
BIOCARTA_CHREBP2_PATHWAY	22	9	5	2
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN	34	8	3	2
REACTOME_PEPTIDE_CHAIN_ELONGATION	29	5	3	2
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	14	5	2	2
MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED	61	17	8	5
REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING	31	5	3	2
GSE22589_HEALTHY_VS_HIV_INFECTED_DC_DN	59	22	10	5
REACTOME_SHC_MEDIATED_SIGNALLING	31	5	3	2
GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN	53	15	7	4
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP	33	6	2	1
BIOCARTA_LONGEVITY_PATHWAY	40	8	4	2
LEE_INTRATHYMIC_T_PROGENITOR	33	11	6	3
GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_UP	37	10	7	3
GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_DN	41	10	4	2
BIOCARTA_IL7_PATHWAY	21	8	5	0
GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_DN	56	15	7	4
GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_DN	40	12	4	2
GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_DN	44	16	8	3
SA_TRKA_RECEPTOR	13	7	2	1
GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN	49	13	6	2
GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP	52	15	7	2
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN	22	5	2	1
GSE3982_BCELL_VS_NKCELL_UP	54	14	7	3
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN	16	8	4	1
GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_UP	47	15	8	4
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	41	12	5	2
KOBAYASHI_EGFR_SIGNALING_6HR_DN	36	6	3	2
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN	40	8	3	2
REACTOME_FANCONI_ANEMIA_PATHWAY	24	6	2	1
SRC_UP.V1_UP	45	10	6	2
GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_DN	47	12	7	3
GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_DN	50	17	9	5
GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_DN	51	11	5	3
REACTOME_GLUCONEOGENESIS	28	7	3	2
chr11q25	18	7	2	1
GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_DN	52	16	9	3
GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_UP	44	17	9	4
HALLMARK_P53_PATHWAY	48	15	10	4
FERRANDO_HOX11_NEIGHBORS	30	7	4	1
GSE411_WT_VS_SOCS3_KO_MACROPHAGE_UP	47	12	5	3
GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_UP	54	16	7	3
GSE13229_MATURE_VS_INTMATURE_NKCELL_UP	55	17	9	3
SYED_ESTRADIOL_RESPONSE	30	6	3	2
GSE43955_1H_VS_10H_ACT_CD4_TCELL_UP	49	14	7	4
GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_DN	36	12	6	3
GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_DN	44	11	5	2
GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	20	10	4	3
CREB_01	49	13	7	2
FIGUEROA_AML_METHYLATION_CLUSTER_7_UP	36	10	3	3
BORCZUK_MALIGNANT_MESOTHELIOMA_DN	48	9	4	3
REACTOME_REGULATION_OF_INSULIN_SECRETION	46	13	7	4
PID_CMYB_PATHWAY	33	9	4	2
ONDER_CDH1_SIGNALING_VIA_CTNNB1	36	14	6	2
GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_UP	52	15	8	5
GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_UP	37	13	6	2
GSE7852_TREG_VS_TCONV_THYMUS_UP	56	16	7	3
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_DN	43	13	6	2
GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP	41	10	5	3
GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN	40	10	4	2
GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_UP	59	17	11	3
GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_UP	46	20	10	4
GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP	49	17	7	3
GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_UP	45	15	8	4
GSE42724_B1_BCELL_VS_PLASMABLAST_DN	46	9	4	3
GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_DN	47	15	7	4
GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN	39	11	5	2
GSE17721_LPS_VS_POLYIC_4H_BMDC_UP	63	22	8	5
GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN	41	17	8	5
GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_DN	52	13	8	3
GSE27786_LSK_VS_CD4_TCELL_DN	51	15	9	3
GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_UP	50	13	6	2
GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	50	14	9	4
GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_UP	49	15	7	3
GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_DN	51	14	7	4
GSE1566_WT_VS_EZH2_KO_LN_TCELL_DN	45	10	5	3
GSE36009_WT_VS_NLRP10_KO_DC_UP	42	12	7	2
GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN	39	12	6	3
WIERENGA_STAT5A_TARGETS_DN	38	12	5	2
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_DN	46	11	5	2
GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_UP	45	11	7	4
GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_DN	34	13	4	3
GSE27786_CD8_TCELL_VS_NKCELL_DN	50	14	7	5
GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_DN	32	12	5	2
GCCNNNWTAAR_UNKNOWN	53	13	6	4
CREBP1CJUN_01	56	16	7	3
BROWNE_HCMV_INFECTION_8HR_DN	32	11	6	3
GCTGAGT_MIR5125P	28	9	4	2
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN	37	10	6	2
MANTOVANI_VIRAL_GPCR_SIGNALING_DN	21	6	2	1
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN	23	10	5	2
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	31	6	3	2
PID_PS1_PATHWAY	37	9	5	3
GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP	55	16	6	2
GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_UP	37	10	3	2
GSE7509_DC_VS_MONOCYTE_UP	55	17	7	4
GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP	47	14	7	5
HAHTOLA_SEZARY_SYNDROM_UP	33	13	6	4
GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN	52	21	10	5
GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP	53	14	6	2
GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN	44	12	6	2
GSE29618_MONOCYTE_VS_MDC_UP	48	17	9	4
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP	51	16	8	4
GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN	53	18	8	5
YGACNNYACAR_UNKNOWN	42	11	6	3
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	30	8	3	3
GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN	44	14	7	2
GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN	55	14	9	4
REACTOME_HIV_LIFE_CYCLE	32	7	3	2
GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN	49	14	7	5
GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_DN	30	10	5	3
NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER	34	9	3	2
GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP	36	13	6	2
GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_DN	41	11	4	3
HOLLERN_EMT_BREAST_TUMOR_DN	33	10	7	4
GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_UP	49	13	5	2
GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP	46	19	10	5
GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN	55	17	6	3
GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN	57	16	7	3
GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_DN	32	12	7	4
GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_DN	35	10	5	3
TCTATGA_MIR376A_MIR376B	44	15	6	3
GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_DN	45	10	4	2
GSE3982_NKCELL_VS_TH1_DN	49	13	7	4
GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP	39	14	7	3
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	58	15	7	4
RODWELL_AGING_KIDNEY_NO_BLOOD_DN	41	11	3	2
CRX_DN.V1_DN	48	16	9	5
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	40	11	5	4
RAO_BOUND_BY_SALL4_ISOFORM_B	67	21	8	5
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_UP	45	12	7	3
GSE7831_1H_VS_4H_CPG_STIM_PDC_DN	50	16	10	3
GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP	35	12	6	3
GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP	50	10	4	3
GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_DN	45	11	5	3
GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP	45	13	6	2
GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	47	13	6	4
GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP	35	10	5	2
GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN	44	11	6	3
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN	60	19	8	5
GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	37	12	6	2
GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP	43	12	6	3
GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN	42	12	3	2
EGFR_UP.V1_DN	43	14	4	2
GSE25087_TREG_VS_TCONV_FETUS_UP	45	17	9	5
GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_UP	44	14	7	3
GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_UP	37	17	9	4
GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN	51	17	9	6
GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN	48	14	6	3
GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP	55	21	10	4
CHYLA_CBFA2T3_TARGETS_UP	57	20	8	3
PASINI_SUZ12_TARGETS_DN	50	19	5	4
POOLA_INVASIVE_BREAST_CANCER_DN	51	13	5	4
KANG_IMMORTALIZED_BY_TERT_UP	39	12	6	2
GSE6269_FLU_VS_E_COLI_INF_PBMC_DN	33	11	6	3
GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_UP	37	11	5	3
GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP	29	16	7	3
GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_DN	49	11	3	3
GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_UP	34	10	3	2
GSE20366_EX_VIVO_VS_DEC205_CONVERSION_UP	45	12	7	4
GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_UP	41	13	6	2
ISHIDA_E2F_TARGETS	30	7	4	3
GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_DN	37	8	3	2
GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN	44	13	8	4
GSE360_L_MAJOR_VS_T_GONDII_MAC_UP	45	14	8	4
GSE3982_NEUTROPHIL_VS_TH1_UP	64	20	11	7
GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_UP	52	17	8	3
GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN	54	16	9	4
PID_IL6_7_PATHWAY	30	11	5	3
GSE4142_NAIVE_VS_GC_BCELL_UP	51	16	8	4
GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP	41	14	5	3
KEGG_RIBOSOME	33	6	3	2
KEGG_VIRAL_MYOCARDITIS	27	8	4	1
GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_DN	43	11	5	3
BCAT.100_UP.V1_UP	30	8	2	2
GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_UP	35	11	6	3
GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_DN	43	12	5	3
GSE7852_LN_VS_THYMUS_TCONV_DN	55	18	9	5
GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN	33	9	4	2
GSE14308_TH2_VS_NATURAL_TREG_DN	55	15	5	3
GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_UP	53	15	6	4
GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	64	19	10	4
GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	49	15	8	3
TBK1.DN.48HRS_UP	32	11	8	4
GSE22935_WT_VS_MYD88_KO_MACROPHAGE_UP	59	18	8	5
VANTVEER_BREAST_CANCER_METASTASIS_UP	32	7	3	2
GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	51	15	7	3
GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_UP	39	13	6	5
GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_UP	56	20	10	6
GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP	41	14	5	3
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION	53	14	8	3
GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_DN	51	12	6	3
GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_UP	45	15	9	3
REACTOME_SIGNALING_BY_NODAL	26	9	4	1
CGCTGCT_MIR503	39	11	4	3
BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	12	6	3	2
ZHANG_RESPONSE_TO_CANTHARIDIN_UP	42	8	4	2
MAHADEVAN_RESPONSE_TO_MP470_DN	23	5	3	1
BIOCARTA_BARRESTIN_SRC_PATHWAY	27	6	3	2
PID_CIRCADIAN_PATHWAY	9	6	2	1
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	16	6	3	0
BIOCARTA_P53HYPOXIA_PATHWAY	33	8	4	2
WENG_POR_DOSAGE	9	5	2	0
AMIT_SERUM_RESPONSE_20_MCF10A	12	6	2	0
STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA	43	9	4	2
PID_NFKAPPAB_ATYPICAL_PATHWAY	22	8	5	2
YANG_MUC2_TARGETS_DUODENUM_6MO_DN	7	3	1	0
KEGG_LINOLEIC_ACID_METABOLISM	19	10	5	3
REACTOME_ACYL_CHAIN_REMODELLING_OF_PE	5	5	2	0
KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS	8	4	1	0
XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR	8	5	2	0
OUYANG_PROSTATE_CANCER_PROGRESSION_DN	39	10	4	2
VERRECCHIA_RESPONSE_TO_TGFB1_C5	36	9	4	3
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	54	15	7	3
AAGCACT_MIR520F	64	22	10	5
GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_UP	46	12	6	2
GSE6259_BCELL_VS_CD8_TCELL_UP	46	11	4	3
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_DN	51	15	6	3
GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP	51	12	6	5
GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN	49	10	4	2
GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP	51	16	8	3
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_UP	40	14	7	3
GSE17721_LPS_VS_CPG_24H_BMDC_DN	62	22	13	6
GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_UP	45	15	8	3
GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_DN	48	14	7	4
GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP	30	14	5	2
GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	48	15	7	5
GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN	63	19	10	4
MEK_UP.V1_UP	51	15	8	3
GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN	51	18	9	5
GSE27786_LIN_NEG_VS_NKTCELL_DN	54	16	10	4
GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_UP	54	16	6	4
GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_DN	46	16	7	5
GSE14350_TREG_VS_TEFF_DN	53	13	6	4
GSE2706_UNSTIM_VS_8H_LPS_DC_DN	44	15	9	3
chr16p13	42	12	7	3
KMCATNNWGGA_UNKNOWN	51	12	4	3
ACAWYAAAG_UNKNOWN	28	10	4	2
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	52	16	7	4
GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	49	12	4	2
GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN	51	13	7	4
GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_DN	44	12	6	2
GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN	37	8	5	2
GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN	48	10	3	2
GSE3039_B2_VS_B1_BCELL_UP	39	14	8	5
GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_DN	47	12	6	3
GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP	50	17	6	3
GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP	44	17	8	4
GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP	49	16	8	3
GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_DN	48	13	5	3
GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_UP	37	10	5	3
GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_DN	35	7	4	3
ZHANG_TLX_TARGETS_36HR_UP	48	16	9	3
NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP	41	10	4	2
REACTOME_PHOSPHOLIPID_METABOLISM	33	10	4	2
GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN	41	11	3	2
GKCGCNNNNNNNTGAYG_UNKNOWN	40	7	3	2
GGTGAAG_MIR412	45	15	6	3
MORI_LARGE_PRE_BII_LYMPHOCYTE_DN	52	15	7	2
PID_A6B1_A6B4_INTEGRIN_PATHWAY	31	9	4	3
MORI_PLASMA_CELL_UP	26	7	2	2
chr15q21	31	13	3	2
NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON	39	11	5	3
FOURNIER_ACINAR_DEVELOPMENT_LATE_2	40	12	5	3
KIM_MYC_AMPLIFICATION_TARGETS_DN	35	12	7	3
LE_EGR2_TARGETS_UP	33	9	4	2
ZHU_CMV_24_HR_DN	42	14	5	2
GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_DN	44	9	4	2
GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_UP	43	14	7	3
GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN	53	21	11	6
GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN	47	15	8	4
GSE27786_CD4_TCELL_VS_NKTCELL_DN	49	13	6	3
GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN	41	18	7	4
GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_DN	30	13	4	3
GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_DN	50	14	6	3
GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN	42	12	6	3
GSE3982_MAST_CELL_VS_TH2_UP	49	15	7	3
GSE17721_0.5H_VS_4H_LPS_BMDC_DN	56	14	6	4
GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_DN	39	9	4	2
GSE1460_DP_VS_CD4_THYMOCYTE_DN	43	15	6	3
GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_UP	37	12	6	2
GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_DN	46	16	6	3
GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN	45	12	6	3
GSE45365_NK_CELL_VS_CD8_TCELL_DN	43	14	7	3
PAX5_01	50	14	9	3
GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_DN	31	7	3	2
ARP1_01	39	13	5	3
BROCKE_APOPTOSIS_REVERSED_BY_IL6	42	13	7	3
JISON_SICKLE_CELL_DISEASE_DN	46	12	7	4
GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	26	9	3	2
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	55	18	7	3
GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_UP	40	12	6	5
GSE20366_CD103_KLRG1_DP_VS_DN_TREG_DN	45	10	5	3
GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP	51	17	10	4
GSE7460_CD8_TCELL_VS_TREG_ACT_DN	45	11	6	2
GSE360_DC_VS_MAC_L_DONOVANI_UP	41	13	8	2
GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_UP	22	10	4	2
GSE27786_NKTCELL_VS_ERYTHROBLAST_UP	40	7	4	3
GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_DN	45	16	5	3
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN	53	14	5	4
GSE2585_THYMIC_DC_VS_MTEC_DN	45	13	7	4
GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN	38	10	6	3
GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_DN	36	10	3	4
GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_UP	45	12	7	4
GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN	48	14	7	5
GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_UP	52	14	6	2
GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_UP	53	15	6	3
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN	52	14	6	4
REACTOME_G1_S_TRANSITION	38	7	5	3
BENPORATH_ES_CORE_NINE_CORRELATED	39	11	6	3
GAVIN_FOXP3_TARGETS_CLUSTER_P7	32	11	4	2
GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN	37	10	5	2
GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN	37	12	5	5
PID_AJDISS_2PATHWAY	40	12	4	3
CUI_GLUCOSE_DEPRIVATION	10	5	2	2
LINDSTEDT_DENDRITIC_CELL_MATURATION_B	18	9	4	3
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	46	9	4	2
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	55	15	5	2
LIN_MELANOMA_COPY_NUMBER_UP	28	8	3	2
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	19	6	2	2
GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP	42	10	6	3
GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	41	9	4	3
MIKKELSEN_NPC_LCP_WITH_H3K4ME3	17	8	4	2
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	20	6	3	2
LEE_LIVER_CANCER_MYC_TGFA_UP	25	7	3	2
ZHAN_MULTIPLE_MYELOMA_UP	29	7	3	2
ROSS_AML_WITH_CBFB_MYH11_FUSION	32	8	3	2
LEE_LIVER_CANCER_E2F1_UP	26	7	2	2
BIOCARTA_KERATINOCYTE_PATHWAY	28	10	6	3
GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP	44	11	8	2
GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN	36	8	4	2
SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES	24	7	4	2
JISON_SICKLE_CELL_DISEASE_UP	25	12	4	2
BIOCARTA_GATA3_PATHWAY	12	9	5	2
BIOCARTA_NGF_PATHWAY	12	8	4	1
BIOCARTA_TOB1_PATHWAY	23	13	7	2
PID_TOLL_ENDOGENOUS_PATHWAY	16	7	3	1
REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION	26	9	5	1
KANG_DOXORUBICIN_RESISTANCE_DN	19	7	2	0
GESERICK_TERT_TARGETS_DN	19	5	2	2
HAHTOLA_CTCL_CUTANEOUS	21	7	3	2
REACTOME_ACYL_CHAIN_REMODELLING_OF_PC	4	4	1	0
BIOCARTA_UCALPAIN_PATHWAY	19	6	3	1
EVI1_06	17	7	4	2
BIOCARTA_MCM_PATHWAY	20	4	2	1
REACTOME_SHC_RELATED_EVENTS	27	5	3	2
AMIT_DELAYED_EARLY_GENES	8	6	4	1
CTACTAG_MIR325	27	7	3	1
GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_UP	33	10	5	3
GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_DN	55	16	7	5
GSE3982_EOSINOPHIL_VS_NKCELL_UP	48	12	5	3
GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_DN	48	12	6	3
GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN	38	10	5	3
GSE3039_CD4_TCELL_VS_B2_BCELL_UP	54	16	7	3
GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_UP	51	18	7	3
HALLMARK_ESTROGEN_RESPONSE_EARLY	54	17	6	2
WINNEPENNINCKX_MELANOMA_METASTASIS_UP	37	8	3	2
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	39	14	7	2
GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_DN	38	7	3	2
GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP	46	12	6	2
IVANOVA_HEMATOPOIESIS_MATURE_CELL	47	15	6	2
GSE30083_SP2_VS_SP3_THYMOCYTE_UP	39	13	7	4
GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_DN	53	14	8	3
GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_UP	55	18	8	4
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN	50	18	7	3
GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_UP	37	11	5	2
GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_DN	38	16	9	4
GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_UP	40	12	5	4
GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_DN	33	9	4	3
WANG_LMO4_TARGETS_DN	49	12	5	3
MARSON_FOXP3_TARGETS_DN	6	6	2	1
RIZKI_TUMOR_INVASIVENESS_2D_DN	37	7	3	2
PID_CERAMIDE_PATHWAY	33	10	5	2
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	25	9	4	2
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4	44	12	6	3
KANNAN_TP53_TARGETS_UP	29	6	3	2
INGRAM_SHH_TARGETS_DN	25	7	2	2
CCAATNNSNNNGCG_UNKNOWN	24	8	3	3
DAIRKEE_CANCER_PRONE_RESPONSE_BPA	38	7	4	2
GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_DN	55	19	7	3
GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN	43	12	6	5
GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_UP	48	12	4	2
GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_DN	42	10	5	2
GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_UP	33	9	3	2
GSE17721_CTRL_VS_CPG_2H_BMDC_DN	49	15	4	3
GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP	47	15	6	3
GSE42724_NAIVE_VS_MEMORY_BCELL_DN	41	15	7	3
GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_UP	55	19	9	6
GSE7852_TREG_VS_TCONV_FAT_UP	36	9	4	2
GSE7764_NKCELL_VS_SPLENOCYTE_UP	56	18	9	5
GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_DN	39	12	6	3
GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_DN	46	14	9	2
GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP	47	13	7	4
GSE17721_0.5H_VS_4H_CPG_BMDC_DN	54	16	7	3
GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN	51	22	12	3
FXR_IR1_Q6	40	9	4	3
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	42	16	6	2
REACTOME_BIOLOGICAL_OXIDATIONS	47	14	7	4
GSE11818_WT_VS_DICER_KO_TREG_DN	40	16	5	2
LANDIS_ERBB2_BREAST_TUMORS_324_DN	32	9	3	3
GSE30083_SP1_VS_SP4_THYMOCYTE_DN	39	15	7	3
GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_UP	45	16	6	4
GSE11057_CD4_EFF_MEM_VS_PBMC_DN	44	9	4	3
GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_DN	54	17	8	5
GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP	39	12	6	2
GSE7852_TREG_VS_TCONV_LN_UP	50	16	7	3
GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_UP	47	11	5	2
GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_UP	48	10	4	2
GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_DN	41	12	5	3
GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_DN	44	12	7	3
GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_DN	36	10	6	3
SABATES_COLORECTAL_ADENOMA_DN	65	26	5	3
PLASARI_NFIC_TARGETS_BASAL_DN	22	6	2	1
chr4q28	9	9	1	0
ST_WNT_CA2_CYCLIC_GMP_PATHWAY	10	8	3	0
BIOCARTA_IGF1_PATHWAY	34	10	5	3
BIOCARTA_IL12_PATHWAY	25	13	6	2
TGCAAAC_MIR452	55	18	7	5
WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG	6	4	1	1
chr7p13	7	7	1	1
WILLERT_WNT_SIGNALING	24	7	3	1
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP	14	7	2	2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	26	6	2	2
ROPERO_HDAC2_TARGETS	51	12	7	2
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	40	16	7	2
WANG_BARRETTS_ESOPHAGUS_DN	17	10	6	2
YANG_MUC2_TARGETS_DUODENUM_3MO_DN	6	4	2	1
PID_EPHA2_FWD_PATHWAY	26	6	3	1
WANG_LSD1_TARGETS_UP	37	6	3	2
LU_TUMOR_ENDOTHELIAL_MARKERS_UP	17	6	3	2
LEE_LIVER_CANCER_ACOX1_UP	24	6	2	2
BURTON_ADIPOGENESIS_PEAK_AT_2HR	16	5	2	1
REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION	37	7	3	2
PID_CD8_TCR_DOWNSTREAM_PATHWAY	18	11	5	2
TANG_SENESCENCE_TP53_TARGETS_DN	26	8	4	2
GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP	50	15	5	3
GSE17721_LPS_VS_CPG_1H_BMDC_DN	43	14	6	4
ELK1_02	45	12	5	3
GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	36	11	5	3
ACCATTT_MIR522	41	18	7	4
BROWN_MYELOID_CELL_DEVELOPMENT_UP	40	10	6	2
GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP	37	8	4	2
GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN	40	11	4	2
GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN	46	15	6	3
GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	43	18	9	5
KIM_WT1_TARGETS_12HR_DN	40	13	5	2
GSE24210_RESTING_TREG_VS_TCONV_UP	55	15	6	5
GSE39556_CD8A_DC_VS_NK_CELL_DN	39	13	6	3
GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_UP	42	14	7	2
GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN	43	11	5	2
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	46	11	4	3
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN	56	19	8	4
GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_DN	20	9	4	2
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN	56	16	7	3
HALLMARK_UNFOLDED_PROTEIN_RESPONSE	33	9	4	2
PECE_MAMMARY_STEM_CELL_UP	35	9	4	2
GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_UP	53	20	10	5
GSE45365_NK_CELL_VS_CD8_TCELL_UP	45	12	6	2
GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_UP	43	6	3	2
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP	54	16	7	4
GSE45837_WT_VS_GFI1_KO_PDC_DN	43	11	5	2
PID_FOXO_PATHWAY	37	10	5	3
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX	39	15	9	4
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	43	17	6	2
SONG_TARGETS_OF_IE86_CMV_PROTEIN	32	9	4	2
GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_UP	29	9	3	2
PEART_HDAC_PROLIFERATION_CLUSTER_UP	16	7	2	1
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	26	7	4	2
RASHI_RESPONSE_TO_IONIZING_RADIATION_4	27	10	5	2
chr16q12	36	13	5	2
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	48	20	9	4
BIOCARTA_NKT_PATHWAY	18	11	6	3
PID_NFKAPPAB_CANONICAL_PATHWAY	8	7	4	1
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP	10	8	4	1
GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN	40	11	6	2
GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_UP	51	16	8	3
REACTOME_NOD1_2_SIGNALING_PATHWAY	14	8	4	1
NABA_SECRETED_FACTORS	65	25	11	5
GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_UP	49	13	7	2
NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON	40	11	4	3
GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN	49	13	5	2
HNF3B_01	66	27	11	5
chr4q31	35	13	5	0
PID_HEDGEHOG_2PATHWAY	31	7	4	2
LE_SKI_TARGETS_DN	28	6	3	2
GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN	40	13	7	3
SERVITJA_ISLET_HNF1A_TARGETS_UP	51	19	5	4
GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN	53	14	6	2
GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_DN	37	11	5	3
GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP	53	19	9	5
GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN	47	15	6	5
BIOCARTA_G1_PATHWAY	45	13	8	4
MEL18_DN.V1_UP	43	13	7	2
BMI1_DN_MEL18_DN.V1_UP	43	15	6	2
GRADE_COLON_AND_RECTAL_CANCER_UP	54	13	6	4
GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_UP	46	13	7	4
WANG_LMO4_TARGETS_UP	54	14	6	3
GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN	56	18	8	7
E2F1_UP.V1_UP	42	9	4	2
GSE14769_20MIN_VS_360MIN_LPS_BMDM_UP	45	10	3	2
GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_UP	48	8	4	2
GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN	47	16	7	4
XBP1_01	49	12	6	3
KRAS.DF.V1_UP	58	19	9	6
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN	56	20	9	3
GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN	38	8	3	3
GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN	42	14	5	3
AMIT_EGF_RESPONSE_240_MCF10A	28	7	3	2
GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP	48	15	8	2
GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP	50	17	8	4
GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN	50	13	6	4
GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_UP	45	10	5	2
GSE42021_TREG_VS_TCONV_PLN_DN	43	12	4	2
ZHANG_TLX_TARGETS_36HR_DN	31	7	3	2
KEGG_HEDGEHOG_SIGNALING_PATHWAY	41	14	7	4
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	57	21	8	2
BROWNE_HCMV_INFECTION_16HR_UP	47	16	8	3
BIOCARTA_CELLCYCLE_PATHWAY	38	8	4	3
GAZIN_EPIGENETIC_SILENCING_BY_KRAS	26	6	3	2
NFY_Q6	46	17	6	3
GAL_LEUKEMIC_STEM_CELL_DN	34	9	5	2
BIOCARTA_CTCF_PATHWAY	33	9	5	3
GU_PDEF_TARGETS_UP	43	14	6	3
BMI1_DN.V1_UP	42	14	7	3
SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP	25	6	2	2
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	41	15	8	2
CHEBOTAEV_GR_TARGETS_UP	35	12	4	2
GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_DN	41	11	4	2
KONG_E2F3_TARGETS	28	8	4	2
ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP	72	31	11	6
GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN	45	15	9	5
GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN	41	9	4	2
REACTOME_G1_PHASE	35	8	5	4
GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_DN	39	10	4	3
GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN	49	12	6	2
GSE19512_NAUTRAL_VS_INDUCED_TREG_UP	41	17	8	3
BOQUEST_STEM_CELL_UP	55	26	7	2
GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_UP	40	9	5	3
GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_UP	53	14	8	4
GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP	43	16	6	3
GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP	46	16	7	3
GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN	38	14	7	3
GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_UP	47	13	6	3
GSE20715_WT_VS_TLR4_KO_LUNG_DN	38	12	6	3
GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_DN	42	15	9	4
GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_UP	51	15	7	2
GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_DN	48	10	3	2
GSE15330_HSC_VS_PRO_BCELL_UP	33	10	5	3
ATF_B	45	13	7	2
GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP	39	11	5	2
GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_DN	36	11	5	3
GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_DN	46	18	11	5
GSE17721_CTRL_VS_POLYIC_2H_BMDC_DN	45	14	6	2
GSE13306_RA_VS_UNTREATED_TCONV_UP	37	11	6	3
GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_DN	49	17	6	3
GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_DN	36	8	4	2
JIANG_HYPOXIA_NORMAL	43	11	6	4
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_DN	49	12	7	4
GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP	46	10	5	3
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3	28	8	4	2
CAATGCA_MIR33	38	15	5	2
GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_DN	39	10	5	2
GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_UP	45	12	6	2
GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_UP	49	15	8	2
GCAAGAC_MIR431	23	9	4	0
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	30	7	4	3
GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN	48	11	4	3
GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_DN	47	10	3	2
GSE17721_0.5H_VS_8H_CPG_BMDC_DN	38	10	4	2
GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN	46	14	6	2
BIOCARTA_ALK_PATHWAY	46	13	7	4
GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_UP	37	15	7	4
GSE27786_CD4_VS_CD8_TCELL_DN	38	9	4	2
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN	32	7	3	2
KONG_E2F1_TARGETS	27	8	5	3
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE	31	8	2	2
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	54	18	9	4
PID_BMP_PATHWAY	31	9	3	2
chr13q14	34	8	3	2
HOSHIDA_LIVER_CANCER_SUBCLASS_S2	39	10	5	3
GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN	50	14	7	4
GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_DN	54	15	7	5
HALLMARK_IL2_STAT5_SIGNALING	54	17	8	6
GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	38	13	7	4
VERHAAK_GLIOBLASTOMA_MESENCHYMAL	49	17	10	5
CCAWYNNGAAR_UNKNOWN	43	14	6	3
REACTOME_MITOTIC_G1_G1_S_PHASES	41	9	7	4
GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB	35	12	7	2
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN	25	6	3	2
MARKS_ACETYLATED_NON_HISTONE_PROTEINS	36	11	6	3
TURJANSKI_MAPK1_AND_MAPK2_TARGETS	37	9	5	3
KEGG_BASAL_CELL_CARCINOMA	47	14	8	5
HALLMARK_TGF_BETA_SIGNALING	37	10	4	3
CORDENONSI_YAP_CONSERVED_SIGNATURE	34	8	3	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	44	11	5	3
PID_NOTCH_PATHWAY	30	9	6	2
ATF4_Q2	48	16	8	4
MORI_MATURE_B_LYMPHOCYTE_DN	27	9	2	2
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	38	10	5	2
CAGCAGG_MIR370	55	15	7	4
PETROVA_PROX1_TARGETS_DN	27	8	4	2
GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_DN	29	7	3	2
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	34	8	5	3
WYAAANNRNNNGCG_UNKNOWN	32	7	3	2
MURAKAMI_UV_RESPONSE_6HR_DN	32	8	6	3
MARTENS_TRETINOIN_RESPONSE_UP	62	22	12	6
GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP	45	13	4	2
GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP	42	10	3	2
JACKSON_DNMT1_TARGETS_UP	41	12	6	4
GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_UP	41	8	3	2
GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP	36	9	4	2
ATGCACG_MIR517B	26	10	4	3
HE_PTEN_TARGETS_UP	24	6	3	2
REACTOME_ENOS_ACTIVATION_AND_REGULATION	25	8	3	3
chr6p22	15	8	3	2
GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN	31	8	3	2
GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_DN	37	11	4	3
BILANGES_SERUM_SENSITIVE_GENES	36	8	4	3
PID_E2F_PATHWAY	30	8	5	2
CAIRO_LIVER_DEVELOPMENT_UP	42	15	5	2
KEGG_PEROXISOME	24	7	3	2
GENTILE_UV_LOW_DOSE_DN	61	21	6	2
GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_DN	46	12	7	3
GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN	44	12	4	3
KESHELAVA_MULTIPLE_DRUG_RESISTANCE	38	6	4	3
GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP	37	7	3	4
GSE369_IFNG_KO_VS_WT_LIVER_DN	42	10	6	2
PID_P73PATHWAY	37	9	4	2
GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP	52	11	6	3
GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN	34	13	5	2
BIOCARTA_ARF_PATHWAY	29	10	5	3
GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_DN	43	13	6	3
NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON	18	8	3	2
TCGA_GLIOBLASTOMA_COPY_NUMBER_DN	37	10	5	4
VERHAAK_GLIOBLASTOMA_PRONEURAL	50	13	6	2
BURTON_ADIPOGENESIS_2	39	11	5	3
SMID_BREAST_CANCER_LUMINAL_A_UP	33	10	3	2
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	46	10	5	3
GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	32	8	4	3
FRASOR_RESPONSE_TO_ESTRADIOL_DN	40	12	8	5
GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_DN	50	12	6	2
GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_DN	51	13	6	3
GSE45365_NK_CELL_VS_CD8A_DC_UP	37	11	5	2
GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_UP	40	13	7	2
HASLINGER_B_CLL_WITH_13Q14_DELETION	35	10	4	3
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN	9	6	3	0
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	51	17	5	2
GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN	56	15	8	3
GSE25088_WT_VS_STAT6_KO_MACROPHAGE_UP	49	14	8	3
GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_DN	46	9	4	3
GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_UP	43	12	5	2
GSE31082_DN_VS_DP_THYMOCYTE_UP	29	8	3	2
FERNANDEZ_BOUND_BY_MYC	53	18	9	6
GSE27786_LIN_NEG_VS_ERYTHROBLAST_UP	47	8	3	2
GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP	39	15	9	3
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_UP	39	14	8	2
GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	45	15	7	4
GSE3039_CD4_TCELL_VS_B1_BCELL_DN	50	13	7	5
GAVIN_FOXP3_TARGETS_CLUSTER_P6	27	8	4	2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP	60	17	8	3
GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN	45	16	10	5
KEGG_ENDOCYTOSIS	45	16	7	3
RYTGCNNRGNAAC_MIF1_01	33	9	4	2
GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_DN	43	11	5	2
chr8q12	27	8	3	1
ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	23	5	2	2
GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP	34	9	4	2
GSE17721_CTRL_VS_POLYIC_24H_BMDC_UP	36	11	4	2
GSE3982_MAC_VS_TH2_DN	38	11	7	3
GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_UP	41	10	6	2
GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_DN	45	12	7	2
BOYLAN_MULTIPLE_MYELOMA_PCA3_UP	38	11	5	3
GSE27786_CD8_TCELL_VS_NKTCELL_UP	29	9	6	2
GSE6259_33D1_POS_DC_VS_CD4_TCELL_UP	46	13	6	3
GSE28130_ACTIVATED_VS_INDUCEED_TREG_DN	50	16	7	3
GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN	42	15	8	3
GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_UP	42	10	5	3
GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_UP	41	12	4	2
GSE3982_BCELL_VS_TH2_DN	41	11	7	5
RYAAAKNNNNNNTTGW_UNKNOWN	46	16	4	2
GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP	46	15	6	4
GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	42	12	5	2
GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN	38	12	4	2
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP	36	9	5	2
GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_UP	45	10	4	3
REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING	34	7	3	2
GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_UP	37	12	6	2
BIOCARTA_TGFB_PATHWAY	32	10	7	2
GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_DN	35	13	6	4
GSE3982_MAC_VS_NEUTROPHIL_UP	51	13	8	2
GSE3982_DC_VS_TH2_DN	43	15	6	4
CARD_MIR302A_TARGETS	37	13	5	2
GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_UP	36	10	4	3
GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP	43	13	6	3
GSE27786_LSK_VS_LIN_NEG_CELL_DN	33	7	3	2
GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN	40	11	4	2
GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN	37	11	5	4
GSE3982_BASOPHIL_VS_NKCELL_DN	42	11	5	3
ERB2_UP.V1_UP	53	14	6	3
GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN	36	9	3	2
PYEON_HPV_POSITIVE_TUMORS_UP	38	8	4	2
GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_UP	47	18	11	3
GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN	39	12	7	3
GSE13306_RA_VS_UNTREATED_TCONV_DN	43	14	7	2
GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN	42	9	4	2
GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_DN	41	13	6	2
GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN	46	13	7	3
FISCHER_G1_S_CELL_CYCLE	51	15	7	4
GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_UP	44	14	7	3
GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_DN	29	9	3	2
GSE20715_0H_VS_48H_OZONE_LUNG_DN	46	14	6	3
GSE2826_WT_VS_XID_BCELL_DN	40	10	5	3
GSE18148_CBFB_KO_VS_WT_TREG_DN	46	16	8	5
MATZUK_MALE_REPRODUCTION_SERTOLI	27	8	3	2
REACTOME_SIGNALING_BY_BMP	33	9	3	2
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_DN	44	15	7	3
GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_DN	40	13	5	3
GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_DN	45	10	5	3
GSE17721_CTRL_VS_CPG_24H_BMDC_DN	44	13	6	3
GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_DN	32	11	6	2
GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_UP	46	13	6	3
LEF1_UP.V1_UP	39	15	8	3
GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_DN	35	14	5	1
GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP	45	9	5	2
GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN	51	18	9	4
GSE22886_TH1_VS_TH2_48H_ACT_DN	35	12	7	4
GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_UP	35	12	6	3
GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_DN	31	12	6	3
GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN	52	19	9	4
LTE2_UP.V1_UP	32	8	3	3
GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP	53	20	10	3
GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_UP	37	14	9	3
GSE369_IFNG_KO_VS_WT_LIVER_UP	42	13	6	4
GSE3982_NKCELL_VS_TH2_DN	40	11	5	3
GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_DN	45	15	8	4
ZHANG_TLX_TARGETS_DN	24	8	3	2
GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_DN	47	16	7	4
PRC2_EZH2_UP.V1_UP	40	17	8	3
GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP	36	10	5	2
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_DN	50	14	7	4
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN	31	7	2	2
LEE_EARLY_T_LYMPHOCYTE_UP	42	8	3	2
GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_DN	41	13	6	4
GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_DN	58	16	5	5
GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_UP	42	15	6	4
GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP	63	20	9	6
GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP	49	13	6	6
GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP	39	14	7	3
GSE43955_10H_VS_30H_ACT_CD4_TCELL_UP	39	10	5	4
GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN	39	13	7	4
GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP	38	13	8	2
GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN	40	15	4	2
GSE17721_LPS_VS_CPG_2H_BMDC_UP	41	12	4	2
GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_UP	46	17	10	4
GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_UP	52	17	8	4
GSE7460_TCONV_VS_TREG_LN_UP	47	18	8	5
GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_UP	40	11	4	2
GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP	37	11	8	4
LABBE_WNT3A_TARGETS_DN	35	11	4	2
GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN	41	14	8	2
GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_UP	49	15	8	5
GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP	48	13	7	4
GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_DN	47	14	5	3
GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_UP	41	13	7	3
RIZ_ERYTHROID_DIFFERENTIATION_HEMGN	25	8	3	3
GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_DN	38	16	9	3
GGCNKCCATNK_UNKNOWN	43	11	5	3
GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP	53	16	8	5
GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_UP	33	12	5	2
GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_UP	32	11	5	4
GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_UP	39	14	7	3
MCCABE_HOXC6_TARGETS_CANCER_UP	14	9	4	1
GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP	40	13	5	2
GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN	33	12	4	2
HALLMARK_HEDGEHOG_SIGNALING	32	10	4	2
JEPSEN_SMRT_TARGETS	39	13	9	2
GSE30083_SP2_VS_SP3_THYMOCYTE_DN	40	13	7	3
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6	28	9	3	2
JI_METASTASIS_REPRESSED_BY_STK11	11	5	2	0
GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP	51	11	5	3
GSE27434_WT_VS_DNMT1_KO_TREG_DN	45	16	9	4
E2F1DP1RB_01	50	13	5	3
PDGF_UP.V1_DN	41	9	4	3
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP	29	8	4	3
TSAI_RESPONSE_TO_RADIATION_THERAPY	27	8	4	1
VALK_AML_CLUSTER_15	29	12	7	2
PID_GLYPICAN_1PATHWAY	32	7	4	2
ROZANOV_MMP14_TARGETS_SUBSET	12	6	3	1
NAKAMURA_ADIPOGENESIS_LATE_UP	41	12	5	2
NRF2_Q4	39	13	6	2
FISCHER_G2_M_CELL_CYCLE	35	8	3	2
chr4p15	45	9	3	1
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN	37	12	6	3
TGACGTCA_ATF3_Q6	42	13	7	2
NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON	31	10	4	1
GSE2585_CD80_HIGH_VS_LOW_MTEC_UP	40	11	7	2
chr8q21	28	11	4	1
GSE24574_NAIVE_VS_TCONV_CD4_TCELL_UP	50	16	5	3
ERB2_UP.V1_DN	44	12	4	2
GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_DN	35	15	7	2
KIM_MYCN_AMPLIFICATION_TARGETS_DN	35	15	7	3
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP	46	15	6	3
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	22	8	4	2
GSE15330_WT_VS_IKAROS_KO_HSC_UP	44	14	5	3
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	17	8	3	2
GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_DN	43	12	8	3
RODRIGUES_THYROID_CARCINOMA_UP	6	5	2	0
GSE6875_TCONV_VS_TREG_UP	47	17	10	5
GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_UP	39	17	7	3
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP	45	14	6	3
GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN	31	15	9	3
GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_UP	41	12	7	3
KIM_GERMINAL_CENTER_T_HELPER_UP	20	11	6	3
GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_UP	34	12	5	2
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE	18	10	4	2
WENDT_COHESIN_TARGETS_UP	9	7	3	2
GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_DN	43	12	5	2
LI_CYTIDINE_ANALOG_PATHWAY	7	6	3	1
LEI_HOXC8_TARGETS_DN	16	7	4	3
chr4q24	17	8	2	0
COMP1_01	58	21	7	5
GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_UP	36	8	3	2
GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_DN	46	13	7	2
GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_DN	41	15	7	3
BROWNE_HCMV_INFECTION_14HR_DN	62	25	11	6
ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP	45	15	7	3
TERAMOTO_OPN_TARGETS_CLUSTER_8	5	4	1	1
GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN	47	19	10	3
GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_UP	37	9	3	2
GSE27786_CD8_TCELL_VS_NEUTROPHIL_DN	46	16	7	4
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP	43	16	7	3
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16	29	10	5	3
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP	6	5	1	0
GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP	45	11	4	2
VERRECCHIA_RESPONSE_TO_TGFB1_C1	21	6	2	1
GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_UP	40	11	6	4
GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN	45	13	7	3
GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	39	12	6	2
GSE2585_CTEC_VS_THYMIC_MACROPHAGE_UP	36	11	4	2
GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN	43	12	7	3
GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP	48	17	7	4
GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_DN	33	8	3	3
FAC1_01	57	19	10	5
BASSO_HAIRY_CELL_LEUKEMIA_UP	51	19	8	4
GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP	58	19	10	5
chr2q36	24	9	4	0
TOMIDA_METASTASIS_UP	9	8	3	1
CERVERA_SDHB_TARGETS_2	46	16	8	4
BMI1_DN.V1_DN	44	12	4	3
SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN	5	5	1	0
MCCLUNG_CREB1_TARGETS_DN	27	10	5	2
GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN	50	15	9	4
GGCNNMSMYNTTG_UNKNOWN	32	10	4	3
GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_UP	41	12	5	4
HOELZEL_NF1_TARGETS_UP	52	21	6	4
NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP	15	12	3	1
GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_UP	48	22	9	3
CSR_LATE_UP.V1_DN	38	17	6	2
MULLIGHAN_MLL_SIGNATURE_1_DN	46	17	7	2
GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN	29	11	5	2
AGGAAGC_MIR5163P	35	16	4	3
GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	33	14	3	3
chr6p25	9	9	2	0
GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP	36	17	7	3
ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN	60	25	11	4
VANTVEER_BREAST_CANCER_ESR1_UP	51	14	6	3
chr3q26	29	11	4	0
chr6q26	29	16	9	4
GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN	34	10	4	2
GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN	38	12	7	4
GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_UP	49	14	6	3
ACAWNRNSRCGG_UNKNOWN	33	10	4	2
GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP	44	16	9	4
GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	43	15	7	4
GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_UP	44	13	6	4
GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_DN	52	17	8	5
GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_DN	56	16	8	4
GSE360_L_DONOVANI_VS_T_GONDII_DC_UP	45	15	5	3
GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN	39	12	7	2
GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN	36	14	4	2
GSE17580_TREG_VS_TEFF_S_MANSONI_INF_UP	47	19	11	5
GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_UP	31	8	3	2
GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN	42	9	5	2
URS_ADIPOCYTE_DIFFERENTIATION_DN	19	9	6	2
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	65	24	10	4
WWTAAGGC_UNKNOWN	46	13	6	3
GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_UP	36	11	5	3
GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP	46	11	4	2
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN	49	12	7	3
GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN	49	13	7	2
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN	45	13	5	3
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN	29	13	6	3
GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_DN	49	18	9	3
GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP	37	10	4	3
HOLLMANN_APOPTOSIS_VIA_CD40_DN	38	16	9	3
GSE20366_TREG_VS_NAIVE_CD4_TCELL_UP	42	14	8	3
GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP	43	18	8	2
GSE42724_NAIVE_VS_B1_BCELL_UP	45	17	7	4
GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_DN	48	16	7	3
GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_DN	48	14	7	4
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP	43	15	8	3
GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	54	17	7	2
GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_UP	44	17	6	3
GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP	39	15	8	3
GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_DN	52	16	6	4
GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_UP	46	12	5	4
GSE14308_INDUCED_VS_NATURAL_TREG_DN	37	11	7	2
GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP	32	7	4	4
SNF5_DN.V1_UP	44	10	5	2
GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP	44	14	7	4
GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_UP	40	12	7	2
IL21_UP.V1_UP	47	14	7	5
GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP	39	11	7	4
CCCACAT_MIR2993P	29	11	5	3
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION	48	12	6	3
GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN	37	11	6	2
GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_DN	33	10	6	3
GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_DN	30	6	3	2
CTCCAAG_MIR432	33	10	4	3
INGRAM_SHH_TARGETS_UP	53	15	6	3
GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP	45	12	7	2
GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_UP	38	10	3	2
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	39	13	8	6
FARMER_BREAST_CANCER_CLUSTER_5	22	4	2	2
GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP	31	6	2	2
TCF4_Q5	54	24	6	4
GSE3039_CD4_TCELL_VS_B2_BCELL_DN	53	17	10	6
GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_UP	42	16	9	3
GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP	48	17	10	5
REACTOME_GPCR_LIGAND_BINDING	55	21	8	6
GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_UP	45	10	3	2
GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP	37	8	4	2
GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_DN	52	20	9	5
GSE23925_DARK_ZONE_VS_NAIVE_BCELL_UP	44	12	5	2
GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP	45	15	7	3
TAVOR_CEBPA_TARGETS_DN	29	7	4	2
GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP	33	10	4	3
GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_DN	40	15	7	3
GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP	44	15	8	3
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN	49	15	6	3
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN	28	7	3	2
GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_DN	38	14	7	3
GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_UP	42	11	5	2
GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_DN	36	14	10	5
GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_DN	38	13	6	3
GSE27786_LSK_VS_CD8_TCELL_DN	38	9	3	2
GSE17721_POLYIC_VS_CPG_0.5H_BMDC_DN	43	14	6	3
GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_UP	39	12	7	4
SENGUPTA_EBNA1_ANTICORRELATED	55	15	8	3
GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP	43	14	7	3
SUBTIL_PROGESTIN_TARGETS	29	5	2	2
FIRESTEIN_CTNNB1_PATHWAY	32	8	4	2
GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP	60	18	7	5
GSE27786_NKCELL_VS_NEUTROPHIL_UP	39	12	7	3
GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_UP	43	16	7	4
GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_UP	32	11	4	2
GSE21033_1H_VS_24H_POLYIC_STIM_DC_DN	39	14	6	4
GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_DN	42	12	4	3
GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP	34	10	6	4
GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_UP	44	18	8	3
GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_UP	45	14	7	4
ROSS_AML_WITH_AML1_ETO_FUSION	25	6	3	2
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	36	9	3	2
YY1_Q6	44	15	8	5
ACEVEDO_LIVER_CANCER_DN	68	20	11	7
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN	20	7	4	4
HOXA3_01	21	9	6	2
GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP	32	9	4	2
EIF4E_DN	50	13	5	3
GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN	40	13	6	3
GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP	53	18	9	4
GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_DN	39	10	3	3
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_DN	30	8	4	2
YANG_BREAST_CANCER_ESR1_UP	23	8	4	3
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1	34	11	3	2
GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP	52	13	6	3
HUANG_DASATINIB_RESISTANCE_DN	36	8	4	2
GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_DN	42	9	4	2
GACAATC_MIR219	61	20	8	4
GSE25123_WT_VS_PPARG_KO_MACROPHAGE_DN	34	9	4	2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	36	15	7	2
GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN	52	12	5	3
REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE	36	6	4	3
PEART_HDAC_PROLIFERATION_CLUSTER_DN	42	9	5	2
PLASARI_TGFB1_TARGETS_1HR_UP	35	9	3	3
GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_DN	39	12	6	2
REACTOME_MEMBRANE_TRAFFICKING	31	7	3	2
GSE22886_NAIVE_CD4_TCELL_VS_DC_UP	50	17	8	4
GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_DN	44	8	3	2
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN	42	11	4	2
GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_UP	38	12	5	2
GSE22886_NEUTROPHIL_VS_MONOCYTE_DN	35	11	4	3
HELLER_SILENCED_BY_METHYLATION_UP	59	17	9	6
EPPERT_CE_HSC_LSC	28	11	5	2
GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	34	10	4	2
GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_DN	53	14	9	5
GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_DN	43	9	4	3
GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN	43	13	5	2
GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP	52	15	5	3
TAATGTG_MIR323	45	18	8	3
BHATTACHARYA_EMBRYONIC_STEM_CELL	24	7	3	2
BROWNE_HCMV_INFECTION_18HR_UP	49	20	10	6
GAL_LEUKEMIC_STEM_CELL_UP	50	13	5	3
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	42	13	6	4
TONG_INTERACT_WITH_PTTG1	34	5	3	2
GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_UP	41	14	6	4
GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN	42	12	5	2
GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN	42	10	4	2
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP	40	14	8	3
GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN	44	16	9	2
GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP	35	8	5	3
GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP	41	15	6	3
GSE3982_MAST_CELL_VS_TH2_DN	41	8	5	2
GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_DN	46	17	9	4
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_DN	40	12	6	3
HALLMARK_ALLOGRAFT_REJECTION	36	16	7	4
GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP	37	9	3	2
GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN	36	10	5	3
CTCNANGTGNY_UNKNOWN	51	16	9	5
GSE17721_CTRL_VS_LPS_0.5H_BMDC_UP	27	9	3	2
WU_CELL_MIGRATION	36	11	4	3
GSE3982_BASOPHIL_VS_TH1_DN	48	16	9	3
GSE339_CD4POS_VS_CD4CD8DN_DC_DN	35	11	4	3
GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP	43	12	5	2
GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP	50	17	7	2
GCNP_SHH_UP_LATE.V1_UP	32	8	4	2
PBX1_02	45	19	8	3
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN	40	14	6	2
MCCLUNG_COCAINE_REWARD_5D	45	8	3	2
GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN	54	17	8	3
GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_UP	56	19	11	3
GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP	52	12	5	2
GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_UP	44	16	8	4
chr17q22	22	7	3	2
RB_P130_DN.V1_DN	39	9	3	2
GSE17721_CTRL_VS_LPS_12H_BMDC_DN	49	14	6	3
GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP	37	10	4	2
GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_DN	51	15	9	4
GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_DN	42	14	8	2
GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP	51	13	7	3
TCCAGAG_MIR518C	48	16	6	5
GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_DN	46	10	4	2
GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_UP	40	8	3	2
GSE27786_CD8_TCELL_VS_MONO_MAC_UP	38	13	7	3
GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_UP	42	8	3	2
GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_UP	47	15	6	4
GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_UP	44	11	4	2
GSE36009_UNSTIM_VS_LPS_STIM_DC_UP	41	17	10	3
GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_UP	52	18	10	4
GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	39	12	5	4
GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_DN	37	11	5	3
GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_UP	32	10	4	3
LINDGREN_BLADDER_CANCER_CLUSTER_2B	47	17	7	4
GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP	44	15	6	4
GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_DN	43	14	7	3
GSE17721_12H_VS_24H_POLYIC_BMDC_UP	40	10	4	2
REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C	36	6	5	3
STAT_Q6	54	21	11	5
GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_DN	47	11	4	2
GSE27786_NKTCELL_VS_ERYTHROBLAST_DN	38	11	5	3
GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_DN	56	20	10	4
GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP	47	11	5	3
GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP	33	10	5	2
GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	36	12	7	2
GSE22886_CTRL_VS_LPS_24H_DC_UP	42	9	4	3
GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_UP	44	12	6	3
PID_TAP63_PATHWAY	44	9	3	2
PENG_RAPAMYCIN_RESPONSE_DN	49	12	7	3
GSE7852_TREG_VS_TCONV_UP	48	18	8	3
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_DN	41	14	9	3
LANDIS_ERBB2_BREAST_TUMORS_324_UP	32	12	8	4
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_UP	46	12	6	2
FARMER_BREAST_CANCER_CLUSTER_4	15	8	2	2
GSE2706_R848_VS_LPS_8H_STIM_DC_UP	19	10	4	2
KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP	60	17	10	5
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN	33	9	5	2
EGFR_UP.V1_UP	52	18	7	4
FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES	24	6	2	2
GSE7460_TREG_VS_TCONV_ACT_UP	41	15	8	4
SESTO_RESPONSE_TO_UV_C5	46	16	8	3
GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_DN	45	12	5	3
GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_UP	43	13	5	4
GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_DN	32	11	4	2
HUPER_BREAST_BASAL_VS_LUMINAL_DN	32	8	3	2
GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_UP	32	7	4	3
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_UP	45	14	7	5
GSE6875_TCONV_VS_FOXP3_KO_TREG_DN	46	15	6	2
GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP	36	11	7	2
GSE15659_RESTING_VS_ACTIVATED_TREG_UP	44	11	4	2
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2	29	8	3	2
GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP	45	14	5	3
GSE360_DC_VS_MAC_T_GONDII_UP	40	15	7	4
HALLMARK_KRAS_SIGNALING_UP	57	21	8	5
BILD_HRAS_ONCOGENIC_SIGNATURE	40	12	5	4
GSE18893_TCONV_VS_TREG_24H_TNF_STIM_DN	42	11	5	2
GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_DN	31	7	4	2
GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	29	7	3	2
RIGGINS_TAMOXIFEN_RESISTANCE_UP	35	12	7	4
FINETTI_BREAST_CANCERS_KINOME_BLUE	35	9	4	2
GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	34	12	4	2
chr1p36	38	13	7	2
GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN	46	15	9	3
GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_DN	37	9	4	2
REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1	35	6	5	3
IGLESIAS_E2F_TARGETS_UP	35	12	5	3
PASINI_SUZ12_TARGETS_UP	34	12	6	3
GSE9960_HEALTHY_VS_SEPSIS_PBMC_DN	35	11	5	2
GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_DN	32	9	4	2
CLIMENT_BREAST_CANCER_COPY_NUMBER_UP	19	10	4	2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	25	7	3	2
GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_DN	47	11	5	3
BENPORATH_OCT4_TARGETS	62	21	9	3
WNT_SIGNALING	42	13	6	4
GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_UP	41	15	6	3
GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP	37	10	4	2
GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP	28	9	3	2
REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS	38	7	5	3
STAT1_01	28	5	2	2
REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING	28	7	3	2
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	35	10	5	3
GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_UP	38	8	4	2
SMIRNOV_RESPONSE_TO_IR_6HR_UP	44	10	4	2
GSE6259_DEC205_POS_DC_VS_BCELL_DN	29	10	3	2
OZEN_MIR125B1_TARGETS	20	6	2	3
REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION	24	10	5	2
HOQUE_METHYLATED_IN_CANCER	48	14	8	4
MASSARWEH_RESPONSE_TO_ESTRADIOL	28	10	2	2
HALLMARK_APOPTOSIS	46	12	7	3
GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP	36	12	4	2
GSE27786_LSK_VS_MONO_MAC_UP	33	10	4	2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10	29	6	2	2
REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION	30	6	3	2
GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP	40	8	3	2
AFFAR_YY1_TARGETS_DN	51	15	9	4
AAACCAC_MIR140	53	19	8	3
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP	32	8	3	2
GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_UP	35	12	5	2
GSE4984_UNTREATED_VS_LPS_TREATED_DC_DN	39	9	5	3
GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_UP	44	10	4	3
CHUANG_OXIDATIVE_STRESS_RESPONSE_UP	28	5	2	2
REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX	29	6	3	2
BRUINS_UVC_RESPONSE_EARLY_LATE	52	17	8	4
OUILLETTE_CLL_13Q14_DELETION_DN	34	7	3	2
MISSIAGLIA_REGULATED_BY_METHYLATION_UP	42	11	6	3
GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP	39	13	7	2
ONDER_CDH1_TARGETS_1_DN	39	13	8	4
GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN	34	12	5	2
GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP	42	12	5	2
GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP	45	12	5	2
GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP	30	8	3	2
DIRMEIER_LMP1_RESPONSE_EARLY	27	10	5	2
GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN	40	10	6	3
AP2REP_01	55	20	9	3
PRC2_SUZ12_UP.V1_UP	32	9	3	2
GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_DN	40	9	4	2
CHO_NR4A1_TARGETS	9	5	2	0
GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN	33	12	5	3
GSE22886_IL2_VS_IL15_STIM_NKCELL_DN	43	8	4	2
ZEILSTRA_CD44_TARGETS_UP	11	4	2	1
chr17q	24	5	2	2
GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_DN	36	8	5	2
GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_DN	25	10	4	2
GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS	23	6	3	2
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	58	17	8	5
GSE3982_MEMORY_CD4_TCELL_VS_BCELL_DN	30	11	5	2
GSE2706_R848_VS_LPS_2H_STIM_DC_DN	29	8	3	3
TENEDINI_MEGAKARYOCYTE_MARKERS	43	11	4	3
PID_P53_REGULATION_PATHWAY	31	7	3	3
GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_DN	42	15	8	3
GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_UP	40	14	8	3
GSE14415_NATURAL_TREG_VS_TCONV_DN	39	9	3	2
GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_UP	40	11	4	2
GSE13306_TREG_RA_VS_TCONV_RA_DN	42	9	4	3
FARDIN_HYPOXIA_11	35	10	3	3
WILLIAMS_ESR2_TARGETS_UP	23	5	3	2
ATGCTGG_MIR338	44	16	6	4
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	27	9	4	3
GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_UP	50	16	6	3
MIKKELSEN_MCV6_ICP_WITH_H3K27ME3	31	8	4	3
GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP	30	9	3	2
GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN	37	11	6	2
GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_UP	38	12	5	2
GSE29618_PDC_VS_MDC_UP	37	12	6	2
GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN	37	8	3	2
GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_DN	24	8	4	2
GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_UP	29	7	4	3
GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_DN	46	16	9	5
GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_DN	37	12	5	2
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN	56	20	8	5
PID_WNT_SIGNALING_PATHWAY	28	7	3	3
MCBRYAN_PUBERTAL_BREAST_5_6WK_UP	28	10	4	3
THEODOROU_MAMMARY_TUMORIGENESIS	40	14	6	3
CHEBOTAEV_GR_TARGETS_DN	47	19	9	5
REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX	33	7	4	2
GGGNRMNNYCAT_UNKNOWN	33	10	6	2
WESTON_VEGFA_TARGETS_3HR	33	9	4	2
ZIC3_01	59	19	10	6
GSE14308_TH17_VS_NAIVE_CD4_TCELL_UP	43	12	5	3
GSE13306_RA_VS_UNTREATED_TREG_UP	47	12	6	3
GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_UP	48	12	6	3
GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN	49	15	7	3
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP	42	11	5	2
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_UP	49	15	6	3
GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP	48	12	5	2
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	32	11	5	2
GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN	45	13	6	4
GSE557_WT_VS_I_AB_KO_DC_UP	46	14	9	5
GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN	30	8	3	2
GSE3982_BASOPHIL_VS_NKCELL_UP	46	15	6	4
GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_DN	27	7	2	2
NFY_01	51	13	5	2
KONDO_EZH2_TARGETS	46	16	7	4
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	42	15	9	4
GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	39	10	4	3
GSE29618_MONOCYTE_VS_PDC_DN	48	12	5	2
GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_DN	30	10	5	3
GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_UP	52	14	8	3
GSE2706_2H_VS_8H_LPS_STIM_DC_DN	37	13	8	5
GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP	37	16	8	3
BCAT.100_UP.V1_DN	29	6	2	2
WESTON_VEGFA_TARGETS_12HR	27	7	4	2
FIGUEROA_AML_METHYLATION_CLUSTER_2_UP	31	8	4	2
MIKKELSEN_DEDIFFERENTIATED_STATE_DN	12	6	3	1
FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION	22	6	3	2
WONG_ENDOMETRIAL_CANCER_LATE	7	2	1	2
GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	34	11	5	2
GSE23568_ID3_KO_VS_WT_CD8_TCELL_UP	32	12	7	3
GSE20727_CTRL_VS_H2O2_TREATED_DC_UP	35	11	5	4
GSE12366_GC_BCELL_VS_PLASMA_CELL_UP	41	11	6	3
GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_UP	53	12	6	2
LIU_COMMON_CANCER_GENES	32	8	4	2
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES	43	9	4	4
GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN	33	8	4	2
GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP	45	15	9	4
GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_DN	42	10	6	2
GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP	44	11	4	3
GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP	31	10	4	2
GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP	49	15	5	2
GSE17721_POLYIC_VS_CPG_8H_BMDC_UP	40	10	5	3
GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_DN	49	15	9	5
GSE17721_POLYIC_VS_CPG_24H_BMDC_DN	36	11	4	4
REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION	31	8	3	2
GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN	37	14	7	2
GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_DN	35	9	4	2
GSE2585_CTEC_VS_MTEC_THYMUS_DN	31	13	4	3
SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES	30	8	2	2
GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_DN	49	13	8	3
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN	47	12	6	4
GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_UP	42	14	6	3
GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	32	9	4	2
GSE7460_CD8_TCELL_VS_TREG_ACT_UP	49	15	7	3
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	39	12	5	3
GSE17721_CTRL_VS_CPG_24H_BMDC_UP	44	13	5	2
GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN	36	10	4	3
GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_DN	47	13	5	2
GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP	45	13	6	4
GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP	30	10	3	2
KRAS.600.LUNG.BREAST_UP.V1_UP	44	18	7	3
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP	36	9	4	2
KRAS.PROSTATE_UP.V1_UP	33	8	3	2
GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_UP	45	14	7	2
REACTOME_DIABETES_PATHWAYS	34	10	5	3
GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_DN	44	15	7	3
BASSO_B_LYMPHOCYTE_NETWORK	47	12	5	4
GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_UP	30	11	3	2
GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	37	14	6	3
GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN	34	11	6	4
GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_UP	36	11	5	2
GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP	32	8	3	2
GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_UP	48	14	5	3
GSE27786_CD4_TCELL_VS_NKCELL_DN	35	10	5	3
GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	38	11	6	2
GSE3982_EOSINOPHIL_VS_MAC_DN	44	17	8	3
GSE27786_LIN_NEG_VS_NKCELL_UP	37	10	3	2
GSE30083_SP2_VS_SP4_THYMOCYTE_UP	28	11	4	2
GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_DN	47	16	10	4
GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_DN	45	15	6	2
GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_DN	42	12	5	2
CRX_NRL_DN.V1_UP	46	12	5	3
PETRETTO_CARDIAC_HYPERTROPHY	35	9	3	2
PID_P38_ALPHA_BETA_PATHWAY	27	6	2	2
LOPEZ_TRANSLATION_VIA_FN1_SIGNALING	29	8	4	2
MORI_PRE_BI_LYMPHOCYTE_DN	36	12	6	2
BIOCARTA_BCR_PATHWAY	28	6	3	2
LANDIS_BREAST_CANCER_PROGRESSION_DN	25	7	3	3
CAIRO_HEPATOBLASTOMA_DN	47	19	9	3
GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_DN	42	14	8	4
GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_DN	43	15	5	4
GSE17721_POLYIC_VS_CPG_8H_BMDC_DN	42	9	6	2
GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_UP	37	10	6	2
GSE27786_NKTCELL_VS_NEUTROPHIL_DN	51	15	6	5
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP	36	12	7	2
GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_UP	47	17	9	4
GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_UP	27	7	2	2
GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP	47	8	4	3
GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_UP	52	16	8	4
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES	42	12	6	2
GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_UP	51	12	5	2
ROSS_AML_WITH_PML_RARA_FUSION	35	9	3	2
GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_DN	32	9	4	2
GSE45365_NK_CELL_VS_CD11B_DC_DN	42	11	5	2
GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_UP	52	12	6	5
WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53	7	5	2	0
GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP	49	16	9	3
GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_UP	43	9	3	2
BENPORATH_ES_CORE_NINE	27	7	3	2
GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP	48	15	9	5
GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_DN	36	12	5	3
GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN	50	20	9	4
GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP	41	10	4	3
GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_DN	34	11	5	3
FUNG_IL2_SIGNALING_1	26	5	2	2
SASAKI_TARGETS_OF_TP73_AND_TP63	6	5	2	1
GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_DN	34	10	4	2
GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP	56	16	8	3
GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP	34	10	5	4
WELCSH_BRCA1_TARGETS_DN	34	8	4	2
GSE40443_INDUCED_VS_TOTAL_TREG_DN	46	17	8	3
GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN	31	13	7	4
AR_02	40	9	5	3
SCHOEN_NFKB_SIGNALING	30	9	3	3
LANDIS_ERBB2_BREAST_TUMORS_65_DN	19	7	3	3
REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S	32	7	3	2
PAX8_01	40	9	5	3
REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6	31	7	6	3
GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP	41	11	6	4
GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_DN	50	18	9	2
KAECH_NAIVE_VS_MEMORY_CD8_TCELL_DN	43	13	6	3
GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_UP	40	15	7	3
TTCNRGNNNNTTC_HSF_Q6	29	11	5	2
GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_UP	31	10	6	3
GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_UP	40	11	5	2
GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN	31	9	4	2
GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_UP	32	8	4	2
GSE17580_TREG_VS_TEFF_S_MANSONI_INF_DN	46	17	9	3
GSE17721_CTRL_VS_LPS_2H_BMDC_DN	34	11	3	2
GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_DN	39	10	4	3
GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN	39	12	4	2
KRAS.600_UP.V1_DN	40	14	6	3
GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	45	14	5	2
GSE27786_LSK_VS_NKTCELL_DN	42	13	5	2
GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_DN	38	12	6	2
GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN	46	15	5	2
GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_UP	36	9	4	3
GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_DN	44	12	7	3
GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN	39	11	5	3
GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_DN	47	15	7	3
chr5q33	7	7	1	0
LIN_MELANOMA_COPY_NUMBER_DN	25	8	2	2
SIMBULAN_UV_RESPONSE_NORMAL_DN	28	8	4	2
REACTOME_TRNA_AMINOACYLATION	27	5	3	1
KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS	50	13	6	3
QI_HYPOXIA	34	9	4	2
GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_DN	49	16	8	3
GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_UP	47	13	5	2
GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP	52	15	5	3
GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_UP	50	16	8	3
GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN	35	11	6	4
BRUINS_UVC_RESPONSE_MIDDLE	32	6	3	2
GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_DN	40	12	8	4
CAIRO_LIVER_DEVELOPMENT_DN	53	18	10	7
GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN	51	17	8	5
GSE17721_CTRL_VS_POLYIC_24H_BMDC_DN	34	12	6	2
GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	45	17	5	4
GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_DN	30	11	5	2
GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_UP	45	11	4	2
SIG_CHEMOTAXIS	19	9	4	1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP	46	12	5	2
GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP	48	14	7	3
COUP_DR1_Q6	54	17	11	3
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN	19	5	2	2
LIU_IL13_PRIMING_MODEL	29	8	4	2
MCBRYAN_TERMINAL_END_BUD_UP	8	5	1	0
STEGMEIER_PREMITOTIC_CELL_CYCLE_REGULATORS	20	5	2	2
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	37	14	8	3
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP	41	16	6	4
GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP	55	15	8	4
GSE22886_NAIVE_TCELL_VS_NKCELL_DN	53	18	7	4
GSE40273_XBP1_KO_VS_WT_TREG_UP	39	12	4	3
GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP	27	10	2	2
GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN	37	10	5	2
PTEN_DN.V2_UP	29	14	4	2
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	38	10	6	3
APPIERTO_RESPONSE_TO_FENRETINIDE_DN	23	7	3	2
RASHI_RESPONSE_TO_IONIZING_RADIATION_1	28	7	2	2
GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN	46	12	6	4
REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC	34	6	4	2
REACTOME_NUCLEAR_SIGNALING_BY_ERBB4	35	9	4	2
GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP	54	18	8	4
JIANG_AGING_HYPOTHALAMUS_UP	7	5	1	0
MEDINA_SMARCA4_TARGETS	30	6	2	2
CUI_TCF21_TARGETS_UP	24	6	3	2
GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_DN	35	10	5	2
GGAANCGGAANY_UNKNOWN	15	6	3	2
REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS	40	12	6	4
DARWICHE_PAPILLOMA_RISK_LOW_UP	36	12	6	3
GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_DN	52	17	7	5
NRL_DN.V1_UP	44	10	4	2
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS	39	9	3	2
GSE6674_UNSTIM_VS_CPG_STIM_BCELL_DN	35	11	6	3
REACTOME_L1CAM_INTERACTIONS	40	11	3	2
PID_RAC1_REG_PATHWAY	20	9	4	3
PARK_HSC_MARKERS	34	8	3	2
WANG_BARRETTS_ESOPHAGUS_UP	22	5	2	2
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP	21	7	3	2
GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	45	13	5	3
GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_UP	55	19	9	3
GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_UP	32	9	4	3
GSE21670_STAT3_KO_VS_WT_CD4_TCELL_DN	47	21	11	5
CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP	27	6	3	2
GHANDHI_BYSTANDER_IRRADIATION_DN	17	10	3	3
GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN	49	15	7	4
RIZ_ERYTHROID_DIFFERENTIATION_HBZ	14	7	3	2
CHANGOLKAR_H2AFY_TARGETS_UP	17	8	3	1
ZHAN_MULTIPLE_MYELOMA_HP_UP	17	9	5	2
JIANG_TIP30_TARGETS_UP	13	7	2	0
GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_UP	34	7	3	2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	44	9	4	2
MCLACHLAN_DENTAL_CARIES_DN	34	11	4	2
chr20q13	31	11	5	3
GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN	36	13	8	2
GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP	31	9	4	2
SWEET_KRAS_TARGETS_UP	26	8	4	2
HUMMEL_BURKITTS_LYMPHOMA_UP	25	7	3	0
PID_ECADHERIN_STABILIZATION_PATHWAY	43	9	3	2
REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21	33	7	6	3
HUPER_BREAST_BASAL_VS_LUMINAL_UP	15	8	3	1
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_DN	32	11	4	2
GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_DN	54	18	7	4
GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	25	8	4	2
ZHAN_MULTIPLE_MYELOMA_CD2_DN	10	5	1	2
HALLMARK_APICAL_SURFACE	33	8	4	2
PID_ILK_PATHWAY	25	7	4	3
REACTOME_INFLUENZA_LIFE_CYCLE	27	5	3	2
REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE	34	7	5	3
REACTOME_PROLACTIN_RECEPTOR_SIGNALING	30	7	3	2
VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN	15	8	2	2
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP	56	21	7	5
TAKAO_RESPONSE_TO_UVB_RADIATION_DN	33	9	4	3
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN	34	8	5	3
HALLMARK_PROTEIN_SECRETION	23	10	4	2
GSE24142_DN2_VS_DN3_THYMOCYTE_DN	34	12	5	3
GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP	36	10	4	3
GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP	44	15	6	3
LEE_TARGETS_OF_PTCH1_AND_SUFU_UP	29	7	4	2
IKEDA_MIR133_TARGETS_UP	26	8	3	1
CAGTCAC_MIR134	34	11	6	2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	39	12	5	2
REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS	37	13	5	3
GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_UP	49	10	4	3
GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP	39	12	5	2
GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_UP	37	9	4	2
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP	30	11	5	4
LY_AGING_OLD_DN	17	10	4	2
BROWNE_HCMV_INFECTION_30MIN_UP	14	6	2	2
GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_UP	41	9	3	2
HASINA_NOL7_TARGETS_DN	7	5	1	0
YIH_RESPONSE_TO_ARSENITE_C4	25	7	3	2
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP	22	5	2	0
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP	31	5	3	2
TGASTMAGC_NFE2_01	35	8	5	2
GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_DN	38	11	6	3
chr9q22	39	13	4	2
NAGASHIMA_NRG1_SIGNALING_DN	28	10	3	2
BROWNE_HCMV_INFECTION_4HR_UP	41	13	3	2
HOLLERN_SQUAMOUS_BREAST_TUMOR	19	13	6	3
GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN	33	7	3	2
CSR_EARLY_UP.V1_UP	33	9	4	2
GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN	35	9	4	2
GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP	30	10	5	2
GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN	41	15	7	3
DURAND_STROMA_NS_UP	43	13	7	3
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP	31	6	3	2
GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	35	11	4	3
GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP	31	9	3	2
GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_UP	34	8	3	2
REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS	23	8	4	2
HENDRICKS_SMARCA4_TARGETS_UP	26	12	6	3
ATGAAGG_MIR205	54	18	8	3
GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP	39	10	3	2
GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	37	11	5	3
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	32	8	4	2
DELYS_THYROID_CANCER_DN	61	23	6	3
CASTELLANO_NRAS_TARGETS_DN	15	7	3	3
REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE	40	9	5	3
HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR	26	7	3	2
NIELSEN_LEIOMYOSARCOMA_UP	14	6	2	2
LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK	29	8	3	2
REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS	32	9	5	3
TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN	26	6	3	2
REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION	27	4	2	2
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN	32	9	4	3
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN	38	7	4	2
MISSIAGLIA_REGULATED_BY_METHYLATION_DN	34	8	3	2
GAVIN_FOXP3_TARGETS_CLUSTER_T4	40	16	8	3
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_DN	46	13	7	3
GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	30	9	5	3
GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP	29	8	3	2
GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_DN	37	7	4	2
GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_DN	33	10	4	2
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_UP	35	10	4	3
GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN	43	11	6	3
GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_DN	39	13	6	3
CREB_02	50	17	7	3
WHITEFORD_PEDIATRIC_CANCER_MARKERS	32	8	4	2
GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN	33	10	5	3
GSE27786_LSK_VS_CD4_TCELL_UP	41	9	4	3
GSE11864_UNTREATED_VS_CSF1_IN_MAC_DN	45	12	7	2
GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN	29	9	2	2
GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_UP	34	8	3	2
GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_DN	31	9	5	3
GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN	46	15	7	3
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN	48	15	6	4
GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP	35	11	4	2
GSE14415_INDUCED_VS_NATURAL_TREG_DN	40	7	4	3
GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN	43	12	4	2
GSE37532_WT_VS_PPARG_KO_LN_TREG_UP	57	16	7	3
MILI_PSEUDOPODIA_HAPTOTAXIS_UP	40	14	6	3
REACTOME_PHOSPHORYLATION_OF_THE_APC_C	37	8	5	3
REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B	37	8	5	3
GEORGANTAS_HSC_MARKERS	22	12	5	2
KRIEG_HYPOXIA_VIA_KDM3A	14	7	2	1
PID_HES_HEY_PATHWAY	34	9	4	3
REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_	36	7	4	2
GSE28408_LY6G_POS_VS_NEG_DC_DN	44	16	8	4
GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN	36	13	4	2
GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_DN	32	13	5	3
GSE27786_LIN_NEG_VS_NKTCELL_UP	48	12	6	2
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	41	15	8	4
GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_DN	38	9	4	2
GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	30	11	5	3
GSE27896_HDAC6_KO_VS_WT_TREG_DN	36	10	5	3
GSE40493_BCL6_KO_VS_WT_TREG_UP	38	12	8	2
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP	30	7	4	2
GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN	42	13	5	4
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN	48	17	8	2
GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN	40	12	5	2
GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_DN	43	11	5	4
GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP	35	13	6	2
GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP	37	12	7	4
GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_UP	43	12	6	2
GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_DN	49	17	8	3
PRC1_BMI_UP.V1_UP	35	12	5	3
YANG_BREAST_CANCER_ESR1_LASER_DN	16	6	2	0
FURUKAWA_DUSP6_TARGETS_PCI35_UP	16	6	3	1
GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP	42	9	3	2
GSE25087_FETAL_VS_ADULT_TREG_UP	48	16	9	5
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_UP	33	10	6	2
GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_UP	34	8	3	2
GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_UP	41	14	7	2
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	39	7	4	3
GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_DN	31	8	3	2
GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP	38	8	4	2
GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_UP	32	9	4	2
GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_UP	36	9	5	2
GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_UP	32	9	5	2
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN	30	7	3	3
GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_DN	34	11	6	3
GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_DN	35	12	6	5
GSE27786_CD8_TCELL_VS_NKCELL_UP	46	9	6	2
GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP	42	12	6	3
GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_UP	40	11	6	5
GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN	35	10	4	2
BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	8	4	1	0
REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS	33	9	5	2
REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY	31	10	4	2
REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION	20	5	3	1
WANG_CISPLATIN_RESPONSE_AND_XPC_UP	40	13	8	2
MA_PITUITARY_FETAL_VS_ADULT_DN	10	6	2	1
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	18	9	4	1
KARLSSON_TGFB1_TARGETS_UP	36	12	5	3
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN	18	10	3	2
KANG_AR_TARGETS_DN	29	8	5	1
GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_UP	45	8	3	2
GSE27786_LIN_NEG_VS_NEUTROPHIL_UP	37	10	4	2
GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_DN	39	9	4	2
GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_UP	40	11	7	3
GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_DN	33	12	6	4
GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_DN	45	14	7	3
GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP	35	12	5	2
GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN	52	19	9	5
GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_UP	39	12	5	3
GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN	42	15	7	3
GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN	48	18	10	4
GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_DN	39	8	4	2
GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_DN	39	14	8	5
GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN	40	14	7	2
GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_UP	36	9	6	3
GSE3982_BASOPHIL_VS_TH2_DN	47	15	9	6
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	45	12	4	2
GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_UP	40	11	6	3
GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP	31	9	5	3
GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_UP	36	11	5	4
REACTOME_ORC1_REMOVAL_FROM_CHROMATIN	29	6	4	2
GSE9037_WT_VS_IRAK4_KO_BMDM_DN	36	16	9	3
GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP	41	13	5	2
GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN	34	10	4	2
GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_DN	48	10	5	2
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	19	7	2	2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	49	13	5	3
GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP	41	13	5	2
GSE360_L_MAJOR_VS_T_GONDII_DC_UP	39	14	6	3
ISSAEVA_MLL2_TARGETS	31	8	3	3
DOANE_BREAST_CANCER_ESR1_UP	40	13	7	2
GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN	23	12	6	3
GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_UP	39	19	10	4
GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN	34	11	4	2
GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_UP	39	8	4	2
GSE10325_BCELL_VS_LUPUS_BCELL_DN	32	11	6	2
GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_UP	51	14	8	5
GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_DN	38	12	5	2
ESC_V6.5_UP_EARLY.V1_DN	35	11	4	3
GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN	39	10	4	3
GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	43	11	5	3
GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN	40	8	4	2
GSE17186_MEMORY_VS_NAIVE_BCELL_UP	46	12	8	4
GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN	39	10	5	3
IRF2_01	48	15	6	5
GRABARCZYK_BCL11B_TARGETS_DN	29	8	3	2
chr2q37	23	8	3	0
GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_UP	29	10	4	2
PHONG_TNF_TARGETS_UP	27	6	3	3
GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_UP	48	16	5	3
GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_DN	45	16	6	2
GSE14000_UNSTIM_VS_16H_LPS_DC_DN	32	9	4	2
GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	38	12	5	2
WESTON_VEGFA_TARGETS_6HR	30	7	4	2
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	40	13	7	4
GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_DN	44	11	4	2
NAGASHIMA_EGF_SIGNALING_UP	31	7	3	2
VIETOR_IFRD1_TARGETS	7	5	2	1
REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A	25	9	5	2
MOREIRA_RESPONSE_TO_TSA_DN	37	12	7	2
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	18	6	2	2
SCHURINGA_STAT5A_TARGETS_UP	23	7	2	1
GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP	52	15	7	3
GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN	32	12	5	2
GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_UP	50	15	8	5
GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_DN	51	15	6	4
GSE9650_NAIVE_VS_EFF_CD8_TCELL_DN	48	15	8	3
GSE21063_WT_VS_NFATC1_KO_BCELL_UP	56	16	8	4
GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_UP	21	8	3	2
GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN	39	13	6	3
GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_UP	34	11	6	4
GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_DN	38	8	3	2
GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_UP	32	9	4	2
GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	44	12	5	3
GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	38	11	6	3
GSE3982_DC_VS_BASOPHIL_DN	45	17	8	3
GSE43955_1H_VS_42H_ACT_CD4_TCELL_UP	47	13	6	2
ETF_Q6	33	10	4	0
GSE31622_WT_VS_KLF3_KO_BCELL_UP	46	14	6	3
GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_UP	45	13	7	2
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP	33	12	4	2
GSE14000_4H_VS_16H_LPS_DC_UP	41	13	7	3
REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES	36	8	3	2
REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS	37	13	5	3
GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_DN	23	10	4	3
GSE4142_GC_BCELL_VS_MEMORY_BCELL_DN	43	12	4	2
GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_DN	46	13	6	2
GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN	39	12	5	3
GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP	40	14	7	5
GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_UP	45	15	9	3
GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP	38	10	4	2
GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN	34	13	7	3
GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_UP	50	10	4	3
GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_DN	45	17	7	2
REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY	30	11	7	3
GSE20366_CD103_KLRG1_DP_VS_DN_TREG_UP	41	13	5	4
GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_DN	34	15	6	4
CTIP_DN.V1_UP	31	9	4	3
GSE42724_NAIVE_VS_MEMORY_BCELL_UP	41	16	7	4
WCTCNATGGY_UNKNOWN	37	9	4	2
GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN	40	15	6	4
GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	47	13	4	3
GSE8835_HEALTHY_VS_CLL_CD4_TCELL_UP	48	12	5	4
GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_DN	34	12	7	3
GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN	36	14	5	3
GSE17721_CTRL_VS_CPG_6H_BMDC_DN	40	13	5	3
GENTILE_RESPONSE_CLUSTER_D3	26	7	2	2
GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_DN	50	18	10	6
GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP	33	11	4	2
CATGTAA_MIR496	61	27	7	2
CCTGTGA_MIR513	47	12	4	3
GTCAACC_MIR3805P	12	6	1	1
CHEN_ETV5_TARGETS_TESTIS	13	10	5	2
LA_MEN1_TARGETS	6	4	1	0
GAJATE_RESPONSE_TO_TRABECTEDIN_DN	14	6	2	0
GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	22	9	4	2
GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN	42	17	8	4
GSE22589_HEALTHY_VS_SIV_INFECTED_DC_DN	45	14	6	2
GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_UP	43	14	5	5
GSE3982_MAST_CELL_VS_NEUTROPHIL_UP	42	11	6	3
GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_DN	46	16	8	4
GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_DN	38	11	5	3
GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_DN	35	10	4	2
GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN	49	15	8	3
GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP	39	7	3	2
GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN	36	11	3	2
GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP	39	13	6	3
GSE14026_TH1_VS_TH17_DN	30	8	3	2
YAGI_AML_WITH_T_8_21_TRANSLOCATION	59	16	6	5
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN	62	18	6	6
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_UP	47	10	4	2
GSE2826_WT_VS_BTK_KO_BCELL_UP	42	12	6	3
AGTCAGC_MIR345	33	11	6	2
GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN	36	10	6	2
RAMALHO_STEMNESS_UP	44	11	6	3
GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN	36	11	5	2
GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_UP	45	18	8	3
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	40	13	5	4
GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_UP	43	19	10	5
GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP	47	12	5	2
GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP	36	13	6	4
GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_UP	38	17	8	4
HOXA9_DN.V1_UP	35	13	8	3
GSE3982_MAC_VS_NKCELL_UP	42	14	7	3
GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_DN	42	17	9	3
GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_UP	42	16	9	6
HALLMARK_KRAS_SIGNALING_DN	47	12	6	2
GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP	52	16	8	3
GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP	48	14	5	2
GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_DN	40	9	4	2
GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN	39	12	4	2
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_UP	37	10	5	2
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE	25	6	3	2
GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN	29	13	5	3
GSE17721_CTRL_VS_CPG_2H_BMDC_UP	44	13	6	2
GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN	43	13	6	3
GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN	40	14	6	3
GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_UP	42	15	8	3
LY_AGING_PREMATURE_DN	28	6	3	1
HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	13	7	2	2
REACTOME_RECYCLING_PATHWAY_OF_L1	17	5	2	1
TAXCREB_02	25	10	6	3
KYNG_WERNER_SYNDROM_UP	8	4	1	0
MATZUK_EMBRYONIC_GERM_CELL	32	11	4	2
WANG_TUMOR_INVASIVENESS_DN	47	16	11	5
GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP	53	16	5	4
GSE2826_XID_VS_BTK_KO_BCELL_UP	39	12	5	3
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP	44	18	8	4
GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	35	11	5	3
MARKEY_RB1_CHRONIC_LOF_DN	31	9	5	3
GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_UP	21	10	3	2
GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_UP	40	14	8	3
GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN	32	11	4	2
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR	40	11	4	2
GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN	26	8	3	3
GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_UP	46	14	6	3
GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP	37	15	4	2
GSE12366_GC_VS_MEMORY_BCELL_UP	44	13	6	3
GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP	41	15	8	4
GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP	46	15	6	4
GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_DN	42	14	5	4
LU_AGING_BRAIN_UP	46	21	12	5
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	48	15	9	4
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1	46	10	4	3
CORRE_MULTIPLE_MYELOMA_DN	37	11	5	3
MORI_PRE_BI_LYMPHOCYTE_UP	25	8	3	2
HOWLIN_PUBERTAL_MAMMARY_GLAND	35	10	5	4
COATES_MACROPHAGE_M1_VS_M2_DN	39	11	4	2
KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION	33	13	8	5
REACTOME_SPHINGOLIPID_METABOLISM	27	8	3	2
GSE3982_EOSINOPHIL_VS_TH1_UP	43	14	5	2
GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_DN	47	14	6	5
GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP	35	13	3	2
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	44	20	11	5
GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP	42	13	7	4
GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN	56	16	6	4
GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_UP	37	12	6	3
GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN	46	14	6	4
GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_DN	51	20	12	5
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	28	5	2	3
ALK_DN.V1_DN	33	12	6	4
AAAGGAT_MIR501	33	11	4	2
KIM_WT1_TARGETS_8HR_DN	33	9	3	2
GSE15767_MED_VS_SCS_MAC_LN_UP	29	12	6	2
GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_DN	40	12	6	3
GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN	50	12	5	2
GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_DN	41	11	5	3
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_DN	37	14	4	3
GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP	46	13	7	2
GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_DN	38	15	7	3
GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_DN	57	19	10	3
GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_UP	45	12	4	2
JOHNSTONE_PARVB_TARGETS_1_DN	36	13	6	2
KYNG_DNA_DAMAGE_DN	38	14	8	4
GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN	50	18	7	4
IK3_01	55	19	8	3
GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_UP	45	17	10	4
GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_UP	38	14	7	3
GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN	37	13	5	2
GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_UP	45	15	8	3
HALLMARK_INFLAMMATORY_RESPONSE	40	19	7	5
SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES	3	3	1	0
ABBUD_LIF_SIGNALING_1_DN	23	7	2	2
chr5q21	25	11	5	1
REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS	29	7	3	2
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	12	5	2	1
GOLUB_ALL_VS_AML_DN	22	3	2	2
GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP	56	16	8	4
PIGF_UP.V1_UP	32	9	4	2
GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP	36	7	3	2
GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_DN	45	14	5	2
GSE3039_CD4_TCELL_VS_NKT_CELL_UP	48	13	8	4
AMIT_SERUM_RESPONSE_120_MCF10A	18	7	3	2
BILD_SRC_ONCOGENIC_SIGNATURE	23	7	3	2
GSE43955_1H_VS_60H_ACT_CD4_TCELL_DN	54	15	9	4
GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_DN	38	12	5	3
GSE14699_NAIVE_VS_ACT_CD8_TCELL_UP	43	13	7	3
TCF11MAFG_01	50	18	6	3
GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_DN	41	13	7	3
GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN	32	11	3	2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	46	15	8	4
GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP	57	21	10	4
GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_UP	33	9	4	2
GSE13229_IMM_VS_MATURE_NKCELL_UP	35	11	5	3
GSE11057_CD4_CENT_MEM_VS_PBMC_UP	42	13	7	3
KRAS.300_UP.V1_UP	43	16	7	3
CRX_DN.V1_UP	36	10	4	4
DAZARD_RESPONSE_TO_UV_SCC_DN	39	14	8	2
KRAS.300_UP.V1_DN	29	10	2	1
ATAAGCT_MIR21	51	14	7	5
GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_UP	48	15	8	4
GSE39864_WT_VS_GATA3_KO_TREG_UP	37	14	7	2
GAGCCAG_MIR149	43	12	5	3
KRAS.LUNG_UP.V1_DN	34	10	4	2
REACTOME_M_G1_TRANSITION	33	6	4	2
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	34	9	4	2
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP	38	15	4	3
GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN	41	17	9	3
GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP	40	17	7	3
HWANG_PROSTATE_CANCER_MARKERS	24	6	3	2
BIOCARTA_PTDINS_PATHWAY	20	5	3	2
OSADA_ASCL1_TARGETS_DN	11	8	3	1
GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_UP	46	11	5	3
GSE14000_TRANSLATED_RNA_VS_MRNA_DC_DN	46	9	4	3
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	33	11	5	1
RRCCGTTA_UNKNOWN	29	9	4	2
BAE_BRCA1_TARGETS_UP	38	11	5	3
HALLMARK_TNFA_SIGNALING_VIA_NFKB	52	18	8	5
GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	44	11	4	2
GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_DN	36	11	5	3
GSE26669_CD4_VS_CD8_TCELL_IN_MLR_UP	47	17	9	3
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	54	21	10	4
HMEF2_Q6	42	17	6	4
WATANABE_COLON_CANCER_MSI_VS_MSS_DN	34	8	4	3
ATAACCT_MIR154	36	13	6	3
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	37	10	5	2
GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_UP	39	14	7	4
FRIDMAN_SENESCENCE_UP	32	9	4	4
CROMER_METASTASIS_DN	38	7	4	3
KEGG_P53_SIGNALING_PATHWAY	42	9	3	3
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	25	8	3	0
GAVIN_FOXP3_TARGETS_CLUSTER_P2	32	13	5	2
OXFORD_RALA_OR_RALB_TARGETS_DN	9	6	2	2
TERAMOTO_OPN_TARGETS_CLUSTER_6	10	5	2	2
chr12p11	15	12	3	2
SA_B_CELL_RECEPTOR_COMPLEXES	26	6	3	2
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE	6	6	1	0
BIOCARTA_STRESS_PATHWAY	28	9	5	3
FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP	24	5	2	0
REACTOME_APOPTOSIS	45	9	4	3
GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_UP	33	13	5	3
GSE14350_IL2RB_KO_VS_WT_TREG_DN	46	19	9	5
GSE17721_0.5H_VS_8H_LPS_BMDC_DN	33	10	5	3
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON	29	11	5	3
GAANYNYGACNY_UNKNOWN	30	7	2	2
GSE20715_WT_VS_TLR4_KO_LUNG_UP	41	16	9	2
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON	41	12	4	2
LEIN_PONS_MARKERS	41	9	3	2
PID_P53_DOWNSTREAM_PATHWAY	44	12	7	4
SHIN_B_CELL_LYMPHOMA_CLUSTER_7	31	9	4	3
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	31	7	3	1
chr4q25	13	11	5	0
PID_CDC42_REG_PATHWAY	21	9	3	3
XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR	19	6	2	2
CAFFAREL_RESPONSE_TO_THC_24HR_5_UP	25	6	3	2
LI_CISPLATIN_RESISTANCE_UP	10	8	2	0
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN	21	6	3	2
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD	20	8	5	2
chr5q32	4	4	1	0
CHYLA_CBFA2T3_TARGETS_DN	49	16	9	3
chr4p16	32	13	4	1
chr4q22	11	9	3	0
GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN	37	16	8	5
REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT	38	17	10	4
REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS	34	15	7	2
REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT	32	15	10	3
BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN	9	6	2	0
GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP	56	19	8	3
GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN	32	12	4	2
LASTOWSKA_COAMPLIFIED_WITH_MYCN	29	11	3	0
AKT_UP.V1_DN	42	12	6	3
GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP	39	14	8	5
GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN	43	18	8	5
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN	37	10	4	3
chr14q11	31	11	5	2
chr6q22	18	10	5	3
GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_UP	33	13	7	2
VERRECCHIA_RESPONSE_TO_TGFB1_C6	5	5	1	1
BRUNEAU_SEPTATION_ATRIAL	7	7	2	0
CROMER_METASTASIS_UP	27	8	4	2
GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP	42	10	6	5
GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP	31	13	5	2
COLINA_TARGETS_OF_4EBP1_AND_4EBP2	42	17	9	3
GSE10325_MYELOID_VS_LUPUS_MYELOID_UP	44	17	10	3
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP	6	6	2	1
GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_UP	40	13	6	3
CHANG_CORE_SERUM_RESPONSE_DN	35	11	7	2
KEGG_TIGHT_JUNCTION	46	19	9	5
chr2q31	31	9	4	0
MEL18_DN.V1_DN	48	16	6	3
NABA_ECM_AFFILIATED	25	12	4	2
BRUNEAU_SEPTATION_VENTRICULAR	31	12	6	2
KORKOLA_YOLK_SAC_TUMOR	30	11	5	2
KEGG_CARDIAC_MUSCLE_CONTRACTION	30	12	7	2
REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR	12	7	3	1
GSE360_DC_VS_MAC_L_MAJOR_DN	41	12	6	2
GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_DN	27	10	4	2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6	28	11	5	1
GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_DN	37	13	5	2
REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA	10	6	2	1
REACTOME_ADP_SIGNALLING_THROUGH_P2RY12	12	6	2	0
GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN	38	10	4	2
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP	34	13	5	3
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_UP	43	14	8	4
GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN	44	10	7	2
GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_UP	44	12	7	3
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_UP	42	12	6	2
GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP	42	8	3	2
GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_DN	49	15	8	2
GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_UP	32	10	6	2
REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS	33	6	3	2
REACTOME_PI3K_CASCADE	37	9	5	4
REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS	33	7	3	2
GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_DN	47	12	6	3
REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR	33	8	4	3
GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_UP	46	12	3	2
GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_DN	35	8	4	2
chr11p14	32	10	4	1
GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN	45	15	9	4
REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS	29	7	3	2
GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_UP	43	11	5	2
GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_UP	46	10	5	3
GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	43	14	9	4
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN	44	10	4	2
GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_UP	45	13	5	3
GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_DN	46	12	6	4
chr16q22	45	14	4	2
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP	39	10	3	2
GUO_HEX_TARGETS_UP	42	11	6	3
HOEBEKE_LYMPHOID_STEM_CELL_UP	49	15	7	3
LEE_DIFFERENTIATING_T_LYMPHOCYTE	46	15	7	3
GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_UP	37	13	5	3
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_UP	38	14	7	3
GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_DN	43	14	9	5
GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP	48	12	4	3
GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_DN	38	9	5	3
GSE30083_SP1_VS_SP3_THYMOCYTE_DN	36	10	6	4
SCHEIDEREIT_IKK_TARGETS	36	10	5	3
GSE5960_TH1_VS_ANERGIC_TH1_DN	41	9	5	2
COUP_01	53	15	7	4
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	31	6	4	3
REACTOME_PKB_MEDIATED_EVENTS	26	6	3	2
GSE24210_IL35_TREATED_VS_RESTING_TREG_DN	41	10	5	2
GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_UP	31	13	6	3
GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP	49	11	5	3
GOLDRATH_HOMEOSTATIC_PROLIFERATION	35	8	4	2
GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP	41	9	4	2
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN	36	12	5	3
GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_DN	41	12	6	3
GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP	45	13	7	2
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	33	9	3	2
ATCATGA_MIR433	38	10	4	2
GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN	45	12	7	4
GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_DN	44	15	7	4
GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_DN	37	13	6	4
GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN	43	13	6	3
GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN	38	10	4	2
GSE17721_4H_VS_24H_POLYIC_BMDC_DN	39	11	6	3
GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_UP	51	16	9	3
HOSHIDA_LIVER_CANCER_SURVIVAL_DN	41	14	6	2
DR3_Q4	49	16	7	3
GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_UP	44	12	6	2
GSE6674_CPG_VS_PL2_3_STIM_BCELL_UP	39	10	5	2
GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN	46	18	10	3
NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	27	7	4	3
GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_UP	46	11	6	2
GSE40443_INDUCED_VS_TOTAL_TREG_UP	48	18	9	2
GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP	40	10	4	2
GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_UP	31	9	4	2
GSE36095_WT_VS_HDAC9_KO_TREG_DN	33	13	8	3
REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING	35	9	4	3
GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_UP	46	11	6	3
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN	16	7	3	1
GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	33	9	4	2
GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP	51	15	7	2
GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_UP	34	11	6	2
GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN	44	12	6	4
GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	48	14	7	5
GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_UP	44	13	7	4
JNK_DN.V1_DN	36	12	6	4
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN	42	17	8	3
GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN	48	16	6	5
GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_UP	36	12	5	3
GSE13547_WT_VS_ZFX_KO_BCELL_DN	34	9	3	2
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_DN	32	9	4	2
GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP	41	11	4	2
GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_DN	27	7	3	2
GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_DN	41	14	7	5
AMIT_SERUM_RESPONSE_60_MCF10A	32	10	4	3
GSE17721_CTRL_VS_POLYIC_6H_BMDC_DN	38	15	5	2
REACTOME_FRS2_MEDIATED_CASCADE	36	8	4	2
GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_UP	33	7	4	2
GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN	44	15	7	3
GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	34	14	9	3
ATAGGAA_MIR202	41	17	8	2
PID_ATF2_PATHWAY	31	8	4	2
YTCCCRNNAGGY_UNKNOWN	45	12	6	3
GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_UP	47	15	7	4
GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP	44	9	4	2
GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_UP	51	15	8	4
GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_UP	34	12	5	2
GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN	41	14	6	3
GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_UP	31	11	6	3
GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_DN	34	8	3	2
GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP	51	15	9	5
GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_UP	43	13	6	6
BMI1_DN_MEL18_DN.V1_DN	39	12	3	2
GSE17721_CTRL_VS_CPG_0.5H_BMDC_DN	38	8	3	2
GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_DN	47	15	8	2
GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP	47	17	10	2
GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_UP	47	13	6	2
GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_UP	53	18	7	2
BAKER_HEMATOPOIESIS_STAT3_TARGETS	25	6	4	2
JAEGER_METASTASIS_DN	44	19	8	4
GSE45365_WT_VS_IFNAR_KO_BCELL_UP	44	12	6	4
GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_DN	45	15	6	3
GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN	43	10	5	2
GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_UP	43	14	6	2
GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_UP	33	9	5	2
BRIDEAU_IMPRINTED_GENES	39	16	8	3
GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP	53	15	6	5
GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_DN	38	12	6	3
GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_DN	41	9	4	2
WONG_MITOCHONDRIA_GENE_MODULE	34	10	5	2
GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	46	14	6	3
GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_DN	51	17	10	5
GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP	50	13	7	4
GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_UP	35	8	3	2
YAGI_AML_SURVIVAL	32	9	4	1
GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_UP	47	13	7	5
GSE17721_12H_VS_24H_PAM3CSK4_BMDC_DN	41	11	4	2
REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	36	11	7	3
DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN	23	7	3	2
chr5q14	33	8	3	0
GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_DN	49	12	5	3
GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_DN	35	12	6	3
GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_UP	41	16	9	4
GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DN	40	15	8	3
GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN	28	12	5	3
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP	51	16	9	4
AGGGCCA_MIR328	45	12	4	2
GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN	44	14	5	2
GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN	42	13	7	4
GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_UP	40	12	8	3
REACTOME_PHASE_II_CONJUGATION	24	7	4	2
GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_DN	47	11	5	3
GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_DN	43	11	5	3
GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_DN	25	11	3	2
GSE14415_INDUCED_TREG_VS_TCONV_UP	34	9	4	3
GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_DN	38	13	7	4
PID_IL2_STAT5_PATHWAY	32	11	6	3
GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN	39	13	4	3
GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_DN	42	15	9	5
GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	37	11	6	2
GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	39	10	5	2
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	27	9	4	2
GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP	36	13	7	4
GSE17721_0.5H_VS_24H_LPS_BMDC_UP	44	11	6	2
GSE27786_LSK_VS_ERYTHROBLAST_UP	35	10	5	2
GSE29618_BCELL_VS_PDC_UP	41	16	9	3
GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN	42	11	5	3
GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_UP	41	10	4	2
GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN	40	12	5	4
REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS	29	11	5	3
STK33_SKM_UP	39	16	7	4
GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN	52	14	8	5
GSE11924_TH1_VS_TH17_CD4_TCELL_DN	43	14	7	4
GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_DN	38	10	5	3
GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_DN	49	15	8	4
HOWLIN_CITED1_TARGETS_1_UP	39	10	6	3
ST_GA13_PATHWAY	23	10	5	1
GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_DN	31	11	4	2
GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN	44	9	4	3
GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_UP	26	9	3	2
GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	42	12	7	2
GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_DN	33	15	9	3
GSE2706_R848_VS_LPS_2H_STIM_DC_UP	46	11	6	3
GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_UP	39	9	3	2
PTEN_DN.V1_DN	48	14	6	3
GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN	38	11	5	3
WINTER_HYPOXIA_UP	36	7	3	3
GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN	42	12	5	3
GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_UP	39	13	5	2
DARWICHE_SKIN_TUMOR_PROMOTER_UP	30	8	4	2
REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS	28	8	4	2
GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_DN	41	13	5	2
GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_UP	42	13	4	2
GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN	44	12	6	3
SHIN_B_CELL_LYMPHOMA_CLUSTER_8	47	14	7	3
GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_UP	39	9	4	2
GSE18281_CORTEX_VS_MEDULLA_THYMUS_DN	33	13	7	3
GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN	48	15	8	4
GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP	43	9	4	3
GSE24726_WT_VS_E2_2_KO_PDC_DN	42	11	3	2
DE_YY1_TARGETS_DN	39	15	6	2
GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN	36	9	3	2
GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP	40	11	5	4
KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	33	6	3	2
GSE17721_LPS_VS_POLYIC_2H_BMDC_UP	37	16	8	4
GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN	37	9	4	3
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP	43	14	7	3
GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_UP	36	9	4	2
GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_UP	40	8	3	2
GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_UP	31	9	4	3
GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_UP	50	16	7	2
BENPORATH_MYC_TARGETS_WITH_EBOX	55	18	10	5
GSE18893_TCONV_VS_TREG_2H_CULTURE_DN	46	18	9	5
ATGGYGGA_UNKNOWN	37	8	4	2
GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN	34	9	4	2
CDPCR3_01	34	8	3	1
GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_UP	35	11	7	3
GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN	50	14	6	3
GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_UP	49	14	7	2
HILLION_HMGA1B_TARGETS	26	8	4	2
GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP	36	11	4	2
GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_UP	40	10	4	3
PENG_LEUCINE_DEPRIVATION_DN	43	11	6	2
GENTILE_UV_RESPONSE_CLUSTER_D1	6	6	3	1
GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP	42	16	7	2
NIELSEN_LEIOMYOSARCOMA_CNN1_DN	34	9	4	2
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	31	9	5	2
JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP	45	12	5	4
GSE27786_LSK_VS_ERYTHROBLAST_DN	38	10	6	2
GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_DN	42	12	4	3
GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_UP	37	9	5	3
GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP	40	11	4	3
BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS	35	11	5	4
BAKER_HEMATOPOESIS_STAT5_TARGETS	29	7	4	2
HE_PTEN_TARGETS_DN	24	7	3	1
ZHU_SKIL_TARGETS_DN	22	5	3	0
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP	32	9	5	2
GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_UP	44	9	3	2
GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN	40	10	5	3
GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN	47	13	8	5
GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	43	10	4	2
GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_DN	46	9	5	4
SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP	27	11	4	2
NOUZOVA_METHYLATED_IN_APL	33	11	5	2
ST_FAS_SIGNALING_PATHWAY	41	8	4	2
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN	32	9	5	3
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C	42	13	6	4
GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_UP	38	14	6	5
AP1_C	56	19	10	5
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN	43	11	6	2
GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_DN	40	8	4	2
GSE22886_CD8_VS_CD4_NAIVE_TCELL_UP	39	11	4	3
GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN	47	13	7	3
GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_DN	43	11	7	3
GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_DN	45	11	6	3
MARTIN_INTERACT_WITH_HDAC	43	11	5	3
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2	32	10	5	2
GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_UP	35	9	4	2
GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_DN	51	12	6	4
GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP	41	12	5	3
GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_DN	27	8	3	2
GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP	42	11	7	4
PID_AR_PATHWAY	35	6	3	2
GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP	48	16	8	5
GSE17721_LPS_VS_CPG_16H_BMDC_UP	42	14	7	2
USF2_Q6	49	17	8	4
GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_UP	32	7	4	2
GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP	42	16	7	3
GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_DN	32	9	4	2
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN	23	6	3	2
REACTOME_PI_3K_CASCADE	30	9	5	3
LAU_APOPTOSIS_CDKN2A_UP	24	8	4	2
HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC	32	10	6	3
REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0	27	6	4	2
GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_DN	43	17	10	4
GSE3982_DC_VS_NKCELL_DN	46	10	3	2
GSE14308_TH1_VS_NAIVE_CD4_TCELL_UP	39	12	6	3
GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN	33	11	6	3
GSE7460_TREG_VS_TCONV_ACT_DN	37	15	8	2
GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP	25	7	2	2
GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_UP	40	16	6	3
GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_DN	44	17	6	2
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	34	9	5	2
GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP	40	11	5	2
GSE13229_MATURE_VS_INTMATURE_NKCELL_DN	48	12	6	4
GSE14308_TH2_VS_INDUCED_TREG_UP	40	12	6	3
QI_PLASMACYTOMA_UP	34	15	7	3
BIOCARTA_NTHI_PATHWAY	26	11	7	3
BIOCARTA_CHEMICAL_PATHWAY	16	5	3	1
ROSS_AML_WITH_MLL_FUSIONS	35	8	4	2
GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_UP	27	7	3	2
MARKS_HDAC_TARGETS_UP	29	8	3	1
GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN	32	10	4	2
GSE13887_RESTING_VS_ACT_CD4_TCELL_DN	33	13	7	3
REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING	35	9	3	2
HORIUCHI_WTAP_TARGETS_UP	51	21	9	4
GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_UP	38	8	4	3
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER	33	9	4	2
GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN	44	15	6	4
GSE2706_UNSTIM_VS_2H_LPS_DC_DN	40	15	7	4
LEONARD_HYPOXIA	32	9	3	2
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	25	8	4	2
GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP	34	8	4	3
GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_UP	32	9	5	2
GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_DN	35	9	4	2
GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_UP	35	11	7	3
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	61	20	8	6
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE	50	19	10	4
GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP	41	10	6	2
KRAS.AMP.LUNG_UP.V1_DN	35	11	6	2
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_UP	48	16	9	4
GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_DN	46	18	9	3
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN	40	11	6	3
GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	44	15	7	2
GSE17721_12H_VS_24H_CPG_BMDC_DN	34	13	8	3
GSE14308_TH2_VS_TH1_UP	44	12	5	3
GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP	29	9	4	2
DAIRKEE_CANCER_PRONE_RESPONSE_E2	21	7	3	1
REACTOME_G0_AND_EARLY_G1	25	8	4	2
MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3	33	12	4	2
ONO_FOXP3_TARGETS_DN	31	11	7	3
GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP	36	10	5	4
GSE2706_2H_VS_8H_R848_STIM_DC_DN	38	16	8	2
GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP	29	14	7	3
GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_DN	41	16	7	3
GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_UP	40	14	7	2
GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP	44	14	7	3
GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN	37	16	7	4
LINDSTEDT_DENDRITIC_CELL_MATURATION_C	36	14	7	5
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	31	6	3	1
GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_DN	41	9	3	2
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_UP	34	13	6	3
GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_UP	40	13	7	4
PID_HNF3B_PATHWAY	26	9	5	2
GSE3982_DC_VS_BCELL_UP	39	14	4	2
GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_UP	36	12	3	2
GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_DN	54	18	8	5
GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_DN	39	15	8	4
PID_VEGFR1_PATHWAY	33	9	5	3
REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING	33	8	3	2
SCIBETTA_KDM5B_TARGETS_DN	26	7	3	2
GUO_TARGETS_OF_IRS1_AND_IRS2	44	19	8	4
GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN	44	13	5	2
GCNP_SHH_UP_LATE.V1_DN	44	12	6	2
KENNY_CTNNB1_TARGETS_UP	22	6	3	1
GALLUZZI_PERMEABILIZE_MITOCHONDRIA	35	9	3	2
ZHOU_TNF_SIGNALING_30MIN	29	6	4	2
KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_UP	49	15	8	4
GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN	38	14	5	4
GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_UP	34	11	5	3
GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN	39	16	8	4
PR_02	42	16	6	3
DCA_UP.V1_UP	38	12	5	3
GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_UP	45	13	8	2
BAKKER_FOXO3_TARGETS_DN	41	15	7	4
GSE7852_LN_VS_THYMUS_TREG_DN	46	17	9	4
GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_DN	40	11	5	2
GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_UP	43	16	5	2
GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN	43	14	6	2
GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP	45	16	8	3
GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	45	15	8	3
GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP	34	12	6	3
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP	16	7	3	1
RAMALHO_STEMNESS_DN	26	8	4	2
GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	51	17	9	4
MARKS_HDAC_TARGETS_DN	20	5	4	1
REACTOME_MTORC1_MEDIATED_SIGNALLING	24	6	3	1
REACTOME_ENDOGENOUS_STEROLS	18	7	5	3
SA_PROGRAMMED_CELL_DEATH	8	2	1	1
REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP	21	6	3	2
REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS	25	8	3	1
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP	40	12	7	3
GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_DN	44	14	7	5
GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN	27	10	6	2
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_DN	39	13	7	3
GROSS_HYPOXIA_VIA_ELK3_DN	37	12	5	3
GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_DN	54	16	8	4
GSE17580_TREG_VS_TEFF_DN	38	13	8	3
GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP	28	6	3	2
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	28	7	2	0
GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_UP	37	10	6	2
GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_UP	40	11	4	2
GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_UP	43	16	6	4
PID_INSULIN_GLUCOSE_PATHWAY	32	6	3	2
DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	38	11	4	3
REACTOME_STEROID_HORMONES	9	8	4	2
REACTOME_PIP3_ACTIVATES_AKT_SIGNALING	25	7	4	3
VALK_AML_CLUSTER_7	28	6	3	1
GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN	44	13	8	4
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_UP	34	13	6	3
GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_UP	46	11	5	2
GSE27786_LSK_VS_BCELL_UP	30	7	4	2
GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_DN	38	15	6	2
GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_DN	41	9	5	3
SWEET_KRAS_ONCOGENIC_SIGNATURE	38	9	5	2
GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_UP	42	13	6	2
GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN	43	12	6	2
GSE2706_UNSTIM_VS_2H_LPS_DC_UP	37	7	3	2
GSE6259_33D1_POS_DC_VS_BCELL_UP	40	11	5	3
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN	36	12	5	3
URS_ADIPOCYTE_DIFFERENTIATION_UP	42	12	5	3
GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP	33	11	7	2
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	29	5	3	1
SIG_IL4RECEPTOR_IN_B_LYPHOCYTES	29	11	6	4
chr6p12	42	11	4	1
GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_DN	44	14	5	3
GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP	49	18	9	3
GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_DN	40	14	9	3
GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_DN	38	11	5	2
HALLMARK_PI3K_AKT_MTOR_SIGNALING	42	17	10	4
ENGELMANN_CANCER_PROGENITORS_UP	32	8	3	2
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	44	12	5	4
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	23	8	5	1
PID_LKB1_PATHWAY	38	8	5	2
AMIT_EGF_RESPONSE_60_HELA	24	7	4	2
LEE_AGING_CEREBELLUM_UP	47	11	6	5
KONDO_COLON_CANCER_HCP_WITH_H3K27ME3	26	8	3	0
GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_DN	30	9	4	2
GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN	41	10	4	2
GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_UP	32	9	4	2
GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN	60	17	9	6
GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	38	9	4	2
GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP	31	10	6	2
GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_UP	28	7	4	3
SASAKI_ADULT_T_CELL_LEUKEMIA	39	15	6	4
GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_UP	35	16	9	4
GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP	34	12	6	3
MULLIGHAN_MLL_SIGNATURE_2_DN	48	20	10	2
GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN	40	16	8	4
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_	35	9	5	4
GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_UP	42	11	5	3
HOEBEKE_LYMPHOID_STEM_CELL_DN	45	11	5	2
KEGG_LEISHMANIA_INFECTION	28	11	5	2
chr7q11	28	6	3	1
LIM_MAMMARY_LUMINAL_MATURE_DN	31	15	5	2
VALK_AML_CLUSTER_10	21	8	3	1
KEGG_GLUTATHIONE_METABOLISM	25	6	3	3
GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN	30	10	5	2
GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_DN	47	18	12	6
GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_UP	31	8	3	2
GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN	44	13	6	3
GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_UP	31	9	3	2
GTGCCAT_MIR183	45	16	8	5
GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_DN	33	7	3	2
GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP	31	11	5	2
AR_01	47	13	6	4
WONG_EMBRYONIC_STEM_CELL_CORE	38	11	5	3
GSE14308_TH1_VS_NATURAL_TREG_UP	46	14	7	3
GSE22886_CD4_TCELL_VS_BCELL_NAIVE_DN	47	15	7	3
GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN	37	11	6	3
MEF2_01	48	21	7	3
ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR	26	8	3	1
REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION	8	6	3	1
REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP	24	7	3	2
REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1	24	7	3	2
REACTOME_GLUTATHIONE_CONJUGATION	23	7	5	3
GSE3982_MAST_CELL_VS_MAC_UP	34	11	4	3
GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_UP	36	13	7	3
GSE32986_UNSTIM_VS_GMCSF_STIM_DC_DN	47	17	9	4
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP	30	10	4	2
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN	36	8	4	3
chr3q27	33	11	4	1
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR	29	8	3	2
GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_DN	46	13	6	2
GSE27786_NKCELL_VS_NEUTROPHIL_DN	50	14	6	3
GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_UP	46	14	7	3
GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP	35	11	3	3
BROWNE_HCMV_INFECTION_1HR_UP	33	10	3	2
REACTOME_SIGNALING_BY_WNT	29	8	6	3
BRUECKNER_TARGETS_OF_MIRLET7A3_UP	32	10	3	3
GSE11924_TH1_VS_TH17_CD4_TCELL_UP	44	14	7	3
GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN	36	14	6	4
GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP	35	12	6	2
GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP	37	14	9	2
GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_DN	45	11	4	2
ODONNELL_TFRC_TARGETS_UP	46	19	10	3
GSE557_CIITA_KO_VS_I_AB_KO_DC_DN	34	11	6	2
GSE17721_CTRL_VS_CPG_6H_BMDC_UP	42	13	7	3
GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_UP	37	15	8	3
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP	44	13	7	3
GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN	37	11	7	5
GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP	34	11	8	3
GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_UP	41	13	9	4
GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_UP	38	12	5	2
GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN	41	17	7	5
GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_UP	37	11	6	3
GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN	34	13	5	3
GSE6259_33D1_POS_DC_VS_CD4_TCELL_DN	45	14	6	4
GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_DN	32	14	8	2
REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX	28	6	3	2
REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D	14	8	4	2
GSE27786_NEUTROPHIL_VS_MONO_MAC_UP	33	9	4	2
GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN	29	10	4	2
GSE27786_NKTCELL_VS_MONO_MAC_DN	41	11	4	3
GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN	49	14	5	2
GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN	30	12	6	2
GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_UP	35	12	8	4
GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN	34	10	5	2
GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP	47	14	5	4
GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_DN	46	16	9	5
GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP	36	13	5	2
GSE3982_NEUTROPHIL_VS_TH2_DN	38	14	7	3
GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN	49	18	10	4
GSE360_CTRL_VS_T_GONDII_DC_UP	41	13	6	2
GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_DN	32	12	6	3
BIOCARTA_P53_PATHWAY	31	8	4	2
SA_REG_CASCADE_OF_CYCLIN_EXPR	26	5	3	2
REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN	28	6	3	2
DELASERNA_MYOD_TARGETS_DN	30	8	3	2
LIU_NASOPHARYNGEAL_CARCINOMA	28	6	3	2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	35	9	4	2
GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN	35	9	5	2
GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN	63	20	11	8
GSE369_SOCS3_KO_VS_WT_LIVER_UP	42	10	4	2
GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP	31	10	4	3
GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_DN	34	14	7	3
GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_UP	50	20	8	4
GSE24292_WT_VS_PPARG_KO_MACROPHAGE_UP	45	16	8	3
GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_DN	45	16	8	4
GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP	33	14	6	5
GSE17721_POLYIC_VS_CPG_12H_BMDC_DN	38	11	4	5
GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP	33	10	5	3
LEE_LIVER_CANCER_SURVIVAL_DN	31	9	3	2
HOFMANN_CELL_LYMPHOMA_DN	41	14	7	4
YAGI_AML_RELAPSE_PROGNOSIS	28	8	4	1
KASLER_HDAC7_TARGETS_2_DN	23	6	3	2
BROWNE_HCMV_INFECTION_16HR_DN	39	10	4	2
GGCCAGT_MIR193A_MIR193B	35	11	4	3
MEK_UP.V1_DN	48	17	7	4
GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_UP	39	10	4	3
GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN	37	9	4	2
GSE13306_TREG_RA_VS_TCONV_RA_UP	38	12	5	4
GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_UP	35	14	7	4
YGCANTGCR_UNKNOWN	42	11	5	2
GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP	37	11	4	2
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP	53	17	9	4
GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN	32	16	7	4
GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_UP	36	11	5	2
BHAT_ESR1_TARGETS_VIA_AKT1_DN	43	11	5	3
WHITFIELD_CELL_CYCLE_G2	33	8	4	2
GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP	38	14	6	2
GSE20366_TREG_VS_NAIVE_CD4_TCELL_DN	45	20	10	5
GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP	44	17	7	4
GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_DN	46	16	8	6
KANG_GLIS3_TARGETS	21	9	4	2
KEGG_PROTEASOME	26	4	3	2
PID_IL2_PI3K_PATHWAY	37	16	8	3
CERVERA_SDHB_TARGETS_1_DN	17	8	4	1
REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE	24	8	4	3
PID_EPO_PATHWAY	36	16	8	4
DELPUECH_FOXO3_TARGETS_DN	10	6	2	1
GTCGATC_MIR3695P	23	7	3	0
REACTOME_ETHANOL_OXIDATION	24	8	3	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30	19	5	3	1
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP	33	12	6	3
GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_UP	44	10	4	2
BARIS_THYROID_CANCER_UP	22	6	3	2
GRANDVAUX_IRF3_TARGETS_DN	24	7	3	1
GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_DN	43	14	7	5
LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES	29	7	3	2
DAWSON_METHYLATED_IN_LYMPHOMA_TCL1	47	22	6	2
chr3q21	11	7	3	0
IVANOVSKA_MIR106B_TARGETS	30	7	3	2
GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP	32	12	4	2
GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_UP	43	14	7	4
GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_UP	30	7	3	3
GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_DN	43	16	8	4
GSE13522_WT_VS_IFNAR_KO_SKIN_UP	32	11	4	2
GSE45365_BCELL_VS_CD8_TCELL_UP	37	10	4	3
GCNP_SHH_UP_EARLY.V1_UP	42	12	6	3
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN	49	12	5	2
GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_UP	34	13	7	3
GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN	41	14	7	3
PID_PI3KCI_AKT_PATHWAY	30	7	3	2
ST_P38_MAPK_PATHWAY	23	9	3	3
GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_DN	37	16	7	3
GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN	41	15	8	4
DCA_UP.V1_DN	41	13	7	3
GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP	34	11	5	2
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_DN	42	16	8	3
GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_UP	39	10	5	2
GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN	38	7	4	2
P53_DN.V2_UP	39	17	10	4
LIM_MAMMARY_LUMINAL_PROGENITOR_UP	13	7	3	1
GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_DN	38	9	4	2
GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_DN	36	11	7	4
GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_DN	36	12	6	2
KEGG_HUNTINGTONS_DISEASE	48	12	6	3
GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP	31	8	3	2
GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_DN	42	14	9	3
GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN	33	7	3	2
GSE21033_3H_VS_12H_POLYIC_STIM_DC_UP	44	13	5	2
ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE	24	7	3	2
GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_UP	37	9	4	3
REACTOME_ER_PHAGOSOME_PATHWAY	29	7	6	2
LEE_LIVER_CANCER	37	14	7	4
REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1	29	5	4	2
REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES	28	6	4	2
GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN	34	10	6	2
GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN	31	8	4	2
GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN	47	16	7	4
CAGGTCC_MIR492	38	10	6	2
CCAGGTT_MIR490	37	10	5	2
GSE17721_LPS_VS_POLYIC_6H_BMDC_UP	37	12	6	2
GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN	51	20	7	5
GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_DN	44	15	6	3
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP	35	10	5	2
GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_DN	34	13	6	3
GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_DN	48	12	4	2
CRX_NRL_DN.V1_DN	33	13	8	3
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	29	10	5	2
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_UP	38	13	9	3
GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN	38	9	4	2
GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_UP	35	10	5	2
CHENG_RESPONSE_TO_NICKEL_ACETATE	26	6	3	2
REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT	26	5	4	2
REACTOME_GAB1_SIGNALOSOME	25	8	5	3
BIOCARTA_IL2RB_PATHWAY	28	10	6	4
GGCAGAC_MIR346	32	9	5	3
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN	30	13	8	3
REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1	26	5	4	2
PID_FOXM1_PATHWAY	40	10	6	2
REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G	26	5	4	2
MALONEY_RESPONSE_TO_17AAG_DN	33	6	3	1
MODY_HIPPOCAMPUS_POSTNATAL	43	10	5	2
LIU_SMARCA4_TARGETS	21	7	3	2
HOLLERN_EMT_BREAST_TUMOR_UP	43	14	7	3
GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_DN	40	16	7	4
PENG_GLUCOSE_DEPRIVATION_DN	37	9	5	3
GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_DN	36	14	6	3
HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2	30	9	4	4
PHESSE_TARGETS_OF_APC_AND_MBD2_UP	8	6	3	1
GTCTACC_MIR379	25	5	3	2
ZHENG_RESPONSE_TO_ARSENITE_DN	12	6	3	1
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP	8	5	2	2
GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION	21	6	3	2
REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK	26	5	3	2
GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN	48	12	6	2
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	47	17	7	4
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	29	7	3	1
RNCTGNYNRNCTGNY_UNKNOWN	37	11	6	2
MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED	20	8	3	1
GSE40666_WT_VS_STAT4_KO_CD8_TCELL_UP	40	16	9	2
GSE3982_MAC_VS_BCELL_DN	41	11	5	3
GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN	35	11	4	3
GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_UP	35	14	8	4
HSIAO_LIVER_SPECIFIC_GENES	62	24	13	6
GSE369_SOCS3_KO_VS_WT_LIVER_DN	46	11	7	5
GSE3982_MAC_VS_TH2_UP	34	12	6	2
PARENT_MTOR_SIGNALING_DN	31	6	3	2
chr6q23	21	9	5	3
KEGG_BLADDER_CANCER	32	7	3	2
TCTAGAG_MIR517	31	10	5	2
KEGG_LYSINE_DEGRADATION	34	7	4	2
KRASNOSELSKAYA_ILF3_TARGETS_DN	34	9	4	2
COURTOIS_SENESCENCE_TRIGGERS	24	7	3	2
REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS	18	5	2	1
GALIE_TUMOR_STEMNESS_GENES	15	9	4	1
GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP	19	9	5	2
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_DN	37	14	7	4
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	33	10	6	2
NRL_DN.V1_DN	31	12	6	3
GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	36	14	8	2
JAIN_NFKB_SIGNALING	27	10	6	2
HOSHIDA_LIVER_CANCER_SUBCLASS_S3	43	18	9	6
GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_DN	50	16	9	4
GSE25087_FETAL_VS_ADULT_TREG_DN	36	14	7	2
GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_DN	36	14	7	4
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN	35	8	3	2
KAMMINGA_EZH2_TARGETS	21	6	4	3
GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP	39	7	4	2
BIOCARTA_ETS_PATHWAY	24	7	3	2
GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_DN	36	11	5	2
GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN	28	8	4	2
GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN	51	16	9	4
PENG_GLUCOSE_DEPRIVATION_UP	26	5	3	2
chr1p33	21	9	3	0
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	21	7	4	2
CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN	22	7	3	1
GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_UP	42	12	6	3
GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_DN	40	9	3	3
GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_UP	32	11	5	3
GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP	33	8	4	3
GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_DN	34	12	7	3
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_DN	40	14	6	3
GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_UP	39	9	4	2
GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN	38	9	3	2
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	27	11	6	3
GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_DN	43	14	7	3
HALLMARK_FATTY_ACID_METABOLISM	29	10	6	3
DELPUECH_FOXO3_TARGETS_UP	45	11	7	4
REACTOME_MITOTIC_G2_G2_M_PHASES	39	8	4	2
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	36	9	4	3
GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN	50	16	5	3
GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	38	13	7	3
GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_DN	32	12	4	3
GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_UP	40	9	4	3
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_DN	32	12	7	2
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	30	12	5	2
GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_UP	39	12	6	4
XU_GH1_AUTOCRINE_TARGETS_DN	36	13	4	1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	26	9	2	1
BIOCARTA_INSULIN_PATHWAY	32	10	5	4
GCGCTTT_MIR518B_MIR518C_MIR518D	25	7	4	2
GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_UP	35	13	7	3
GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP	47	14	5	4
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP	44	18	7	4
BIOCARTA_P38MAPK_PATHWAY	27	9	5	3
REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS	18	8	4	1
REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX	25	5	3	2
GAVIN_FOXP3_TARGETS_CLUSTER_P4	40	14	6	4
GSE22886_CTRL_VS_LPS_24H_DC_DN	32	11	4	3
GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_UP	38	16	8	3
BENPORATH_NOS_TARGETS	53	18	9	3
GCAAGGA_MIR502	30	10	3	2
PID_TELOMERASE_PATHWAY	47	14	10	5
GSE17721_POLYIC_VS_CPG_16H_BMDC_DN	38	11	5	3
GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_UP	40	9	4	2
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_UP	43	11	6	2
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_DN	39	10	3	2
GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_DN	33	12	5	2
GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN	45	16	8	3
ROZANOV_MMP14_TARGETS_UP	39	11	4	3
RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN	5	5	1	0
IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM	23	6	3	1
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN	10	5	2	0
FUJIWARA_PARK2_IN_LIVER_CANCER_UP	16	5	2	1
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	33	13	7	2
KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY	26	10	5	2
GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_DN	36	9	6	4
GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_DN	35	14	7	5
GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP	44	16	8	3
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP	37	8	4	2
KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_DN	37	13	8	3
GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_UP	45	14	6	2
LEIN_MEDULLA_MARKERS	35	9	3	2
LEE_AGING_NEOCORTEX_DN	32	7	3	2
VANLOO_SP3_TARGETS_DN	31	7	4	2
BRACHAT_RESPONSE_TO_METHOTREXATE_DN	5	5	2	0
LUI_TARGETS_OF_PAX8_PPARG_FUSION	31	9	5	2
LANDIS_ERBB2_BREAST_TUMORS_65_UP	8	5	2	2
BIOCARTA_AKT_PATHWAY	29	9	6	4
REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS	20	6	3	1
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	20	6	3	1
ZIRN_TRETINOIN_RESPONSE_WT1_UP	33	11	4	3
BIOCARTA_PROTEASOME_PATHWAY	19	4	2	2
SHI_SPARC_TARGETS_UP	26	9	4	2
WINZEN_DEGRADED_VIA_KHSRP	41	14	8	3
GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_UP	15	7	3	2
GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN	35	13	6	3
GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP	34	11	4	2
GSE43955_1H_VS_60H_ACT_CD4_TCELL_UP	35	11	6	4
GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_DN	35	12	4	2
GSE7460_TCONV_VS_TREG_LN_DN	45	15	7	2
GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP	47	16	8	4
GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_DN	42	14	7	4
GSE36078_WT_VS_IL1R_KO_LUNG_DC_UP	35	16	7	4
GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP	35	11	5	3
GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP	25	8	3	2
GSE17721_LPS_VS_POLYIC_1H_BMDC_DN	45	12	6	2
GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_DN	46	16	8	3
GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_DN	25	8	4	2
GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_UP	34	10	5	2
VILIMAS_NOTCH1_TARGETS_UP	26	10	4	2
GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP	33	10	5	2
GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_DN	36	13	8	2
GSE4142_NAIVE_VS_MEMORY_BCELL_DN	28	7	4	3
GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP	16	10	4	2
GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_UP	32	10	3	2
GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN	41	12	4	2
TSAI_RESPONSE_TO_IONIZING_RADIATION	44	16	9	4
GSE25677_MPL_VS_R848_STIM_BCELL_UP	38	15	7	3
GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP	55	17	10	5
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	41	15	5	1
LEIN_CEREBELLUM_MARKERS	19	7	2	2
MCCLUNG_COCAIN_REWARD_4WK	23	8	4	3
REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING	26	10	6	2
KEGG_HOMOLOGOUS_RECOMBINATION	25	8	6	3
KAMIKUBO_MYELOID_CEBPA_NETWORK	15	9	5	1
PID_ALK1_PATHWAY	29	9	4	1
BIOCARTA_CERAMIDE_PATHWAY	11	8	4	1
REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	23	17	6	1
MATZUK_CENTRAL_FOR_FEMALE_FERTILITY	25	9	3	2
GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_DN	41	13	7	5
GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP	39	14	7	2
GSE13306_RA_VS_UNTREATED_TREG_DN	32	10	5	3
GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_UP	47	15	7	5
KEGG_ALZHEIMERS_DISEASE	38	10	5	4
GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_UP	36	9	6	3
GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN	28	10	5	4
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN	23	8	3	2
REACTOME_REGULATION_OF_APOPTOSIS	25	5	2	2
RB_P107_DN.V1_DN	43	10	4	3
GSE17721_LPS_VS_POLYIC_0.5H_BMDC_DN	47	12	6	3
GSE17721_CTRL_VS_CPG_12H_BMDC_UP	41	9	5	2
GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_DN	47	14	7	3
GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_DN	38	15	8	3
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	28	9	3	3
GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP	43	12	5	3
GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN	34	12	6	4
GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_DN	43	17	8	2
GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_UP	44	11	5	4
GSE22886_NAIVE_VS_MEMORY_TCELL_DN	37	16	7	4
GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_DN	34	10	6	2
CHUNG_BLISTER_CYTOTOXICITY_UP	31	10	4	3
HALLMARK_DNA_REPAIR	25	7	3	2
KOHOUTEK_CCNT2_TARGETS	23	6	2	2
GSE36009_UNSTIM_VS_LPS_STIM_DC_DN	41	15	8	6
GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_UP	24	16	6	3
REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING	37	10	6	4
GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_DN	31	14	8	4
GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_UP	44	13	4	2
GSE27786_CD4_VS_CD8_TCELL_UP	42	14	6	2
GSE20366_TREG_VS_TCONV_DN	48	17	9	3
GSE19825_CD24LOW_VS_IL2RA_HIGH_DAY3_EFF_CD8_TCELL_DN	35	11	6	3
chr3q22	17	8	4	0
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN	11	9	3	0
JOHNSTONE_PARVB_TARGETS_2_UP	30	9	4	3
KEGG_LYSOSOME	39	7	4	2
GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_DN	46	12	7	5
TESAR_JAK_TARGETS_MOUSE_ES_D3_UP	7	6	3	1
REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE	7	3	2	2
MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	22	5	3	2
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	32	9	4	3
GSE22432_CDC_VS_COMMON_DC_PROGENITOR_DN	37	10	5	2
RIGGINS_TAMOXIFEN_RESISTANCE_DN	46	20	6	3
GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_DN	35	13	7	4
GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_DN	31	11	5	3
GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_DN	45	12	7	2
GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN	41	13	6	2
GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_UP	39	12	6	2
LEE_CALORIE_RESTRICTION_NEOCORTEX_DN	25	10	4	3
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	27	6	2	2
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_DN	38	12	6	2
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_UP	40	14	7	2
CSR_LATE_UP.V1_UP	38	10	5	3
VERHAAK_GLIOBLASTOMA_NEURAL	35	12	3	2
MARKEY_RB1_ACUTE_LOF_DN	39	14	6	3
GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN	29	10	4	2
GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_DN	35	12	5	3
GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_DN	38	15	7	3
KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_DN	38	15	8	3
GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_DN	39	11	3	2
PID_HEDGEHOG_GLI_PATHWAY	30	8	4	2
GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP	44	16	6	2
HILLION_HMGA1_TARGETS	31	8	3	3
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER	39	15	7	3
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	18	9	5	2
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN	8	4	2	1
BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER	44	14	9	4
BIOCARTA_HER2_PATHWAY	38	8	5	4
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP	20	4	1	1
PID_RAS_PATHWAY	26	9	5	3
RAPA_EARLY_UP.V1_UP	40	11	5	3
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN	42	15	8	3
GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_UP	38	14	7	5
GSE3982_BCELL_VS_BASOPHIL_DN	40	16	6	3
GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_UP	46	12	3	2
RAMASWAMY_METASTASIS_UP	26	6	3	2
chr18q21	30	8	4	3
HUANG_FOXA2_TARGETS_UP	26	9	3	2
chr7q21	30	13	5	2
WAKASUGI_HAVE_ZNF143_BINDING_SITES	32	6	3	2
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	31	13	8	4
GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP	38	12	7	4
GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN	31	10	5	2
GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_UP	34	13	4	2
KRAS.KIDNEY_UP.V1_UP	48	17	4	2
AKT_UP_MTOR_DN.V1_UP	43	12	5	4
KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_UP	28	7	3	2
GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_UP	33	11	2	2
GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP	27	8	3	2
GSE10325_CD4_TCELL_VS_MYELOID_UP	43	15	7	4
GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_UP	44	14	8	3
GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_UP	35	13	6	4
GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_DN	32	10	6	2
GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN	35	12	5	4
REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS	31	10	5	2
GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN	45	11	5	4
BEIER_GLIOMA_STEM_CELL_DN	32	9	5	3
GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_UP	24	10	4	3
BOYLAN_MULTIPLE_MYELOMA_C_D_DN	47	22	9	2
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	30	8	5	2
MORI_MATURE_B_LYMPHOCYTE_UP	34	12	5	2
STANELLE_E2F1_TARGETS	29	5	3	1
GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	48	19	10	7
KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	22	7	4	1
GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_DN	38	12	6	2
GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	32	6	3	2
MIKKELSEN_PLURIPOTENT_STATE_DN	24	8	4	2
CHUANG_OXIDATIVE_STRESS_RESPONSE_DN	17	5	3	2
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN	12	5	2	0
GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS	17	6	3	2
MATZUK_PREOVULATORY_FOLLICLE	20	8	5	2
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP	40	16	3	2
GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	41	11	6	3
GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_DN	30	9	4	3
CCATCCA_MIR432	33	11	4	3
GSE6259_33D1_POS_DC_VS_CD8_TCELL_UP	31	9	4	2
GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN	37	12	5	2
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	27	9	4	2
WNT_UP.V1_DN	41	15	7	3
GSE7219_WT_VS_NIK_NFKB2_KO_DC_DN	42	15	6	4
GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_UP	43	13	6	2
GSE45365_NK_CELL_VS_BCELL_UP	34	10	4	3
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	30	10	4	1
GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_DN	30	9	4	2
GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_UP	42	16	7	3
GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_UP	36	8	3	2
GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_UP	37	12	7	3
OHM_METHYLATED_IN_ADULT_CANCERS	39	10	5	4
GENTLES_LEUKEMIC_STEM_CELL_UP	23	9	3	2
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	24	8	3	2
JAZAG_TGFB1_SIGNALING_DN	28	7	3	4
BURTON_ADIPOGENESIS_11	32	13	5	2
GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_UP	41	11	4	3
GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_UP	33	10	6	3
GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN	36	11	7	3
GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN	40	16	8	3
KRAS.PROSTATE_UP.V1_DN	37	11	4	2
CDPCR1_01	53	20	7	4
GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP	32	11	4	2
REACTOME_DNA_REPAIR	30	7	3	2
GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN	23	7	3	2
GSE42724_MEMORY_VS_B1_BCELL_DN	39	14	5	3
GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	35	10	4	3
chr11p15	35	14	6	3
REACTOME_INTERFERON_SIGNALING	40	12	4	2
GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	34	10	5	4
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	30	8	3	2
GENTILE_UV_RESPONSE_CLUSTER_D4	20	10	4	3
SMIRNOV_RESPONSE_TO_IR_2HR_DN	30	11	4	1
GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_DN	36	12	5	3
IL15_UP.V1_DN	37	12	6	3
GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_UP	38	10	3	2
GSE19198_1H_VS_6H_IL21_TREATED_TCELL_UP	50	16	7	3
HOWLIN_CITED1_TARGETS_1_DN	12	8	3	1
TRACEY_RESISTANCE_TO_IFNA2_DN	8	6	2	2
PID_CD40_PATHWAY	24	9	5	2
JIANG_HYPOXIA_VIA_VHL	10	5	2	1
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN	11	8	3	1
VALK_AML_CLUSTER_6	27	8	3	0
RUIZ_TNC_TARGETS_UP	50	16	6	3
REACTOME_DSCAM_INTERACTIONS	24	7	3	2
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP	28	6	3	2
BIOCARTA_RNA_PATHWAY	34	11	6	4
XU_AKT1_TARGETS_48HR	28	7	3	1
REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY	14	5	2	1
GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_DN	41	14	8	3
XU_RESPONSE_TO_TRETINOIN_DN	23	8	3	2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN	15	6	3	2
GSE27434_WT_VS_DNMT1_KO_TREG_UP	29	10	5	2
WAESCH_ANAPHASE_PROMOTING_COMPLEX	33	8	6	3
BIOCARTA_EIF_PATHWAY	25	6	3	2
GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN	12	9	3	1
GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP	30	10	3	2
FOURNIER_ACINAR_DEVELOPMENT_LATE_UP	9	7	3	1
LEI_HOXC8_TARGETS_UP	10	7	3	2
HOOI_ST7_TARGETS_UP	31	10	3	2
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN	25	9	3	2
RAGHAVACHARI_PLATELET_SPECIFIC_GENES	14	6	2	2
GUO_HEX_TARGETS_DN	29	7	3	2
ALK_DN.V1_UP	41	16	7	3
GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN	44	13	7	4
SMID_BREAST_CANCER_LUMINAL_B_UP	51	19	8	2
GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_UP	32	12	6	2
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	46	14	5	3
GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP	36	10	5	2
GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_DN	36	11	6	6
DARWICHE_PAPILLOMA_RISK_HIGH_UP	32	11	6	3
GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_DN	28	8	4	2
HEIDENBLAD_AMPLICON_12P11_12_UP	29	6	3	2
GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN	35	13	6	2
GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP	33	12	3	2
GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	33	10	5	3
GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_DN	38	10	5	2
WHITEHURST_PACLITAXEL_SENSITIVITY	15	7	3	2
REACTOME_SIGNAL_TRANSDUCTION_BY_L1	38	8	3	2
VANASSE_BCL2_TARGETS_UP	11	8	3	1
WIERENGA_STAT5A_TARGETS_GROUP2	32	12	7	4
PID_ERA_GENOMIC_PATHWAY	26	9	5	2
GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_DN	49	14	8	3
GSE27786_CD8_TCELL_VS_MONO_MAC_DN	30	9	5	2
GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP	38	8	4	2
QI_PLASMACYTOMA_DN	33	11	4	2
GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_DN	42	14	6	4
GSE14308_TH1_VS_INDUCED_TREG_DN	39	16	8	3
GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN	33	8	3	2
GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_UP	26	10	4	2
GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_DN	42	16	9	3
DARWICHE_PAPILLOMA_PROGRESSION_RISK	24	8	3	2
FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	16	7	4	2
GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN	30	8	3	2
BIOCARTA_ERK_PATHWAY	40	8	4	2
KEGG_PROPANOATE_METABOLISM	10	7	3	0
BIOCARTA_NO1_PATHWAY	27	9	4	2
BURTON_ADIPOGENESIS_1	27	7	4	1
DASU_IL6_SIGNALING_SCAR_UP	27	7	3	2
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP	35	8	4	1
LI_PROSTATE_CANCER_EPIGENETIC	31	9	4	2
GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_UP	31	10	4	3
GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_UP	39	14	6	2
GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_UP	23	8	3	2
GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_UP	30	9	5	3
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN	32	9	5	2
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN	44	14	9	3
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	49	17	9	5
CHANG_CYCLING_GENES	37	9	4	2
PID_P38_GAMMA_DELTA_PATHWAY	28	7	4	2
ELLWOOD_MYC_TARGETS_UP	28	9	5	0
REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL	16	3	2	2
REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1	27	6	3	1
REACTOME_SIGNALING_BY_FGFR3_MUTANTS	25	8	4	2
MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP	20	11	3	1
BIOCARTA_SKP2E2F_PATHWAY	25	6	3	2
chr4p12	9	6	3	0
KRAS.600_UP.V1_UP	50	22	8	3
GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP	40	13	8	3
GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_UP	32	10	5	2
GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_UP	53	18	6	3
GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_UP	44	15	8	4
GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_DN	33	11	5	2
GSE11057_CD4_EFF_MEM_VS_PBMC_UP	46	14	8	4
GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN	30	14	7	3
GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP	37	14	9	2
PID_FGF_PATHWAY	35	10	6	4
SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	40	13	7	1
LAIHO_COLORECTAL_CANCER_SERRATED_DN	32	9	7	2
TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA	31	13	6	4
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11	26	8	3	2
CAHOY_ASTROCYTIC	15	7	2	2
SWEET_KRAS_TARGETS_DN	34	7	4	2
RUIZ_TNC_TARGETS_DN	30	10	3	1
BOQUEST_STEM_CELL_DN	30	14	5	0
GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN	32	9	4	2
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_UP	40	15	9	3
NOTCH_DN.V1_DN	39	13	7	2
GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP	31	11	7	1
GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_DN	37	16	7	3
CAMPS_COLON_CANCER_COPY_NUMBER_DN	30	10	5	3
TAGAACC_MIR182	33	8	4	2
NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON	24	8	4	2
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	16	5	2	2
RICKMAN_HEAD_AND_NECK_CANCER_B	27	10	4	2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	19	5	3	1
KIM_ALL_DISORDERS_CALB1_CORR_DN	15	6	3	2
PPARG_01	18	7	2	1
KEGG_FATTY_ACID_METABOLISM	26	9	3	2
chr3p24	27	10	3	0
LIU_CDX2_TARGETS_UP	35	11	6	4
REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	8	6	2	1
KEGG_TRYPTOPHAN_METABOLISM	13	8	4	2
BRUNO_HEMATOPOIESIS	28	10	4	3
ENGELMANN_CANCER_PROGENITORS_DN	26	7	4	3
REACTOME_CELL_JUNCTION_ORGANIZATION	38	14	5	2
BAKKER_FOXO3_TARGETS_UP	28	9	4	2
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	28	8	3	2
GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_UP	31	10	4	2
GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN	34	12	5	3
GSE27786_LIN_NEG_VS_MONO_MAC_UP	31	8	3	2
GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN	35	12	3	2
GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN	34	11	4	3
GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_DN	39	16	10	5
GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP	38	12	5	2
GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_DN	32	10	5	2
GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP	35	14	7	3
GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_UP	31	9	5	2
GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	32	14	6	3
GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_DN	28	8	3	2
GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_UP	36	10	5	3
GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_UP	49	17	10	4
VANASSE_BCL2_TARGETS_DN	33	11	4	3
CAAGGAT_MIR362	34	10	5	2
SESTO_RESPONSE_TO_UV_C7	21	5	2	2
REACTOME_UNFOLDED_PROTEIN_RESPONSE	19	8	4	2
MILI_PSEUDOPODIA_CHEMOTAXIS_UP	25	8	4	2
TACAATC_MIR508	32	9	4	2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	28	9	4	2
chr3p25	33	8	3	0
REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT	24	8	3	1
RODRIGUES_NTN1_AND_DCC_TARGETS	31	6	3	2
CHANGOLKAR_H2AFY_TARGETS_DN	29	7	4	1
GSE27786_BCELL_VS_NKCELL_UP	33	11	4	2
GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_UP	38	11	6	3
GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_DN	32	9	6	5
REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER	29	8	4	2
KEGG_PYRUVATE_METABOLISM	29	7	3	2
GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_DN	31	10	4	3
GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_DN	41	9	4	2
GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP	32	8	4	3
AMUNDSON_GAMMA_RADIATION_RESPONSE	22	7	3	1
GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP	43	14	7	4
ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY	25	9	4	2
GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_DN	49	15	7	4
REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION	14	8	5	2
REACTOME_ACTIVATION_OF_RAC	30	9	3	1
SANDERSON_PPARA_TARGETS	6	5	2	0
BIOCARTA_P27_PATHWAY	24	5	3	2
BIOCARTA_EGFR_SMRTE_PATHWAY	27	8	4	3
KINNEY_DNMT1_METHYLATION_TARGETS	10	4	2	1
DEMAGALHAES_AGING_DN	23	7	4	2
REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS	2	2	1	0
REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION	28	11	4	3
REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION	26	6	3	1
SESTO_RESPONSE_TO_UV_C3	18	6	3	2
WIKMAN_ASBESTOS_LUNG_CANCER_UP	19	5	3	1
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP	30	10	6	3
GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_DN	48	16	8	3
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	29	11	5	3
GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN	48	15	4	2
GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP	34	10	4	2
WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP	35	9	4	3
KEGG_CELL_ADHESION_MOLECULES_CAMS	41	17	6	1
GSE12839_CTRL_VS_IL12_TREATED_PBMC_DN	27	10	5	2
GSE21033_3H_VS_24H_POLYIC_STIM_DC_DN	25	7	4	2
GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_UP	48	14	7	4
GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_UP	50	14	6	4
GSE27786_BCELL_VS_NEUTROPHIL_DN	36	13	6	3
GSE17721_LPS_VS_CPG_12H_BMDC_UP	37	11	5	2
GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN	37	9	5	3
GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN	35	8	3	2
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	27	7	3	2
FRASOR_RESPONSE_TO_ESTRADIOL_UP	34	11	5	2
KEGG_AMINOACYL_TRNA_BIOSYNTHESIS	20	6	3	1
chr6q24	19	8	3	2
GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP	34	14	8	4
GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN	40	12	6	2
GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP	29	10	3	2
GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_DN	32	11	3	3
GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_DN	39	12	5	3
GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP	50	15	7	4
GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_UP	39	13	6	2
GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_DN	41	11	3	2
BROWNE_HCMV_INFECTION_8HR_UP	34	9	4	2
SNACANNNYSYAGA_UNKNOWN	33	8	4	2
RYCACNNRNNRNCAG_UNKNOWN	37	10	5	3
OUILLETTE_CLL_13Q14_DELETION_UP	32	11	4	2
GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN	39	10	5	2
GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	32	11	7	3
GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_DN	46	15	7	3
GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_DN	35	12	5	4
GSE40273_GATA1_KO_VS_WT_TREG_UP	30	6	3	2
GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_UP	33	10	4	2
AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G	42	12	5	3
GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN	46	15	7	3
ATF2_UP.V1_DN	45	23	9	2
GSE3039_CD4_TCELL_VS_B1_BCELL_UP	40	15	7	3
PID_AP1_PATHWAY	40	15	10	5
HAHTOLA_SEZARY_SYNDROM_DN	30	12	7	4
MADAN_DPPA4_TARGETS	11	6	3	0
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN	18	11	4	2
PID_HIV_NEF_PATHWAY	19	9	6	3
chr17q23	26	7	3	2
ST_G_ALPHA_I_PATHWAY	10	9	3	1
REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY	23	6	3	2
chr7p11	12	7	3	2
REACTOME_OTHER_SEMAPHORIN_INTERACTIONS	13	5	2	1
ALX4_01	12	6	3	2
REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS	20	6	3	1
NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN	27	9	5	3
SHIN_B_CELL_LYMPHOMA_CLUSTER_9	26	9	6	2
RB_DN.V1_DN	31	9	4	3
GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_DN	36	8	3	2
GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN	49	19	8	5
GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_UP	43	16	9	6
GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP	32	14	6	3
GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_UP	52	19	6	4
GOLDRATH_IMMUNE_MEMORY	23	9	5	3
chr17p13	34	9	5	2
GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_DN	43	19	8	4
GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP	38	14	8	3
GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_UP	44	14	5	2
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	35	12	6	3
GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_UP	36	14	5	3
GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP	39	18	7	2
GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_UP	50	16	8	2
GSE14308_TH2_VS_TH1_DN	47	12	6	4
PID_INTEGRIN3_PATHWAY	15	11	5	1
SAGIV_CD24_TARGETS_DN	23	9	5	2
KLEIN_TARGETS_OF_BCR_ABL1_FUSION	33	12	7	4
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN	39	13	6	1
PID_ATR_PATHWAY	24	8	4	1
GENTILE_UV_RESPONSE_CLUSTER_D6	22	9	4	2
GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_DN	51	16	7	5
GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN	45	13	6	2
GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP	31	11	6	3
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_DN	35	15	6	3
GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_DN	40	13	6	4
SCHUHMACHER_MYC_TARGETS_UP	24	7	3	2
MEIS1AHOXA9_01	39	16	7	2
RASHI_RESPONSE_TO_IONIZING_RADIATION_6	28	8	4	2
REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	31	7	4	3
GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	36	11	5	2
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	30	9	4	2
GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_DN	41	12	8	5
RIGGI_EWING_SARCOMA_PROGENITOR_DN	43	18	6	3
GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_DN	43	14	5	3
GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN	31	8	4	2
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP	34	12	7	3
GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_DN	34	14	8	3
chr1p35	29	7	3	0
REACTOME_G1_S_SPECIFIC_TRANSCRIPTION	23	7	3	2
REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER	23	7	3	2
REACTOME_INFLAMMASOMES	8	6	4	1
BIOCARTA_CD40_PATHWAY	25	7	4	2
chr14q12	34	7	3	2
WOO_LIVER_CANCER_RECURRENCE_DN	25	6	3	2
BIOCARTA_HIF_PATHWAY	25	7	3	1
REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1	29	6	3	2
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN	25	8	4	2
ZUCCHI_METASTASIS_UP	22	5	3	2
REACTOME_ACTIVATION_OF_GENES_BY_ATF4	19	6	3	2
LE_NEURONAL_DIFFERENTIATION_DN	32	7	3	2
REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING	28	6	3	2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	22	5	2	2
TIAN_BHLHA15_TARGETS	33	8	5	3
chr12q	25	6	3	2
chr6p24	15	9	4	3
DAZARD_UV_RESPONSE_CLUSTER_G28	33	6	3	1
ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE	20	6	2	2
WONG_PROTEASOME_GENE_MODULE	28	5	3	2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3	24	8	3	3
NIELSEN_LIPOSARCOMA_DN	30	8	3	2
WALLACE_PROSTATE_CANCER_UP	25	5	3	2
GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_DN	33	9	5	3
GSE17721_CTRL_VS_LPS_8H_BMDC_DN	48	16	7	5
GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP	35	13	7	4
GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_UP	34	10	4	2
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	24	9	3	2
ZHAN_MULTIPLE_MYELOMA_MF_DN	26	10	5	2
REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS	28	9	3	2
LUI_THYROID_CANCER_PAX8_PPARG_UP	21	8	4	2
MYC_Q2	36	12	5	3
WANG_TARGETS_OF_MLL_CBP_FUSION_DN	25	5	2	2
CHUNG_BLISTER_CYTOTOXICITY_DN	22	9	3	2
KEGG_STEROID_HORMONE_BIOSYNTHESIS	25	10	5	3
GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN	30	11	4	3
GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_UP	38	14	8	2
GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_DN	50	19	8	3
GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN	40	16	9	5
GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP	30	11	5	3
GSE18893_TCONV_VS_TREG_24H_TNF_STIM_UP	40	10	4	2
GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_DN	25	6	2	2
GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP	34	13	6	3
GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_DN	36	17	8	3
LENAOUR_DENDRITIC_CELL_MATURATION_DN	24	8	4	3
DORMOY_ELAVL1_TARGETS	26	9	6	2
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3	8	5	2	0
SUZUKI_AMPLIFIED_IN_ORAL_CANCER	22	6	3	2
BIOCARTA_CTLA4_PATHWAY	32	15	8	1
ST_GA12_PATHWAY	23	6	2	2
SA_PTEN_PATHWAY	24	6	3	2
KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION	23	6	3	0
BIOCARTA_IGF1MTOR_PATHWAY	30	8	4	2
REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER	9	5	2	2
ABDELMOHSEN_ELAVL4_TARGETS	27	10	4	2
BIOCARTA_CDMAC_PATHWAY	24	10	6	3
PID_ERBB_NETWORK_PATHWAY	33	13	6	1
KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS	23	5	3	1
LE_SKI_TARGETS_UP	29	8	3	2
GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN	42	16	5	3
GSE2585_THYMIC_MACROPHAGE_VS_MTEC_UP	41	11	7	2
GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP	45	13	6	4
GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_DN	33	11	6	3
GSE37301_PRO_BCELL_VS_CD4_TCELL_DN	33	15	8	3
STREICHER_LSM1_TARGETS_UP	17	8	3	1
KUNINGER_IGF1_VS_PDGFB_TARGETS_DN	17	8	5	3
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION	15	7	3	1
REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	33	13	5	1
MARZEC_IL2_SIGNALING_DN	22	7	2	2
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6	23	7	3	1
GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_DN	38	8	3	3
HOOI_ST7_TARGETS_DN	30	13	6	2
BURTON_ADIPOGENESIS_8	37	8	4	1
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	23	11	4	2
GSE30083_SP2_VS_SP4_THYMOCYTE_DN	36	15	8	3
GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_DN	37	11	5	2
GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN	34	13	7	1
GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_DN	41	15	7	4
GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_UP	38	15	4	2
KRAS.BREAST_UP.V1_UP	38	13	7	4
GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP	32	13	4	3
TTCCGTT_MIR191	23	6	3	2
chr5q31	30	13	6	1
GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN	35	13	8	4
GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_DN	27	9	4	2
GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_UP	53	21	9	3
GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	36	13	6	4
GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_UP	36	13	8	5
GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	42	17	9	4
NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON	27	9	4	1
GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP	26	7	4	2
WINTER_HYPOXIA_METAGENE	46	15	7	4
ROSS_LEUKEMIA_WITH_MLL_FUSIONS	27	8	3	2
GSE17721_0.5H_VS_24H_CPG_BMDC_UP	26	7	3	2
GSE3982_BCELL_VS_BASOPHIL_UP	32	10	5	3
REACTOME_POTASSIUM_CHANNELS	36	14	3	2
FUJII_YBX1_TARGETS_DN	32	11	4	4
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	33	10	4	2
GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_DN	29	9	5	2
GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_UP	38	14	8	3
GSE27786_CD8_TCELL_VS_NEUTROPHIL_UP	31	11	6	2
TTGGGAG_MIR150	42	12	6	3
GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_UP	33	10	5	2
PID_CDC42_PATHWAY	33	8	3	2
GSE27786_BCELL_VS_NKTCELL_UP	40	10	4	3
AHR_01	32	11	6	2
GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_UP	32	9	5	4
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	29	10	5	2
GSE17721_CTRL_VS_LPS_12H_BMDC_UP	35	11	5	3
GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	42	18	10	4
GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_DN	34	11	5	3
GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_UP	34	10	6	3
GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP	39	9	4	2
GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_UP	38	15	6	2
GSE17721_CTRL_VS_POLYIC_6H_BMDC_UP	27	8	3	2
GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_UP	33	11	4	2
GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_DN	38	9	4	2
GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_UP	44	13	8	4
REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT	19	6	3	2
GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_UP	33	11	5	2
GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP	37	14	7	4
KEGG_ARGININE_AND_PROLINE_METABOLISM	27	9	3	2
chr5p13	27	11	5	2
GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN	29	10	3	2
NAKAMURA_ADIPOGENESIS_EARLY_UP	33	10	6	4
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	23	7	3	2
chr8p23	53	21	8	5
DURCHDEWALD_SKIN_CARCINOGENESIS_UP	29	7	3	2
GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP	43	10	4	3
GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_DN	35	13	8	4
GSE45365_WT_VS_IFNAR_KO_BCELL_DN	39	13	6	5
KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	35	10	6	3
GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_DN	34	9	4	2
GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_UP	38	14	8	5
SA_G1_AND_S_PHASES	27	5	3	3
GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_DN	39	17	9	3
REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK	38	17	5	2
GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_UP	40	19	8	3
GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_DN	34	12	5	3
GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_DN	41	14	8	3
REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS	22	5	3	2
GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN	34	11	4	2
GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP	38	15	7	3
GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_UP	46	17	9	5
MOREIRA_RESPONSE_TO_TSA_UP	32	8	5	3
GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN	48	15	7	4
GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_DN	31	9	3	2
BOYAULT_LIVER_CANCER_SUBCLASS_G2	22	5	2	2
GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_UP	39	14	6	3
PARK_HSC_AND_MULTIPOTENT_PROGENITORS	25	8	4	3
GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN	32	12	7	3
GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_DN	36	10	4	2
GSE17721_0.5H_VS_12H_CPG_BMDC_DN	40	16	7	3
GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_DN	41	11	4	3
GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP	36	12	6	4
GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_DN	29	12	4	2
DORN_ADENOVIRUS_INFECTION_24HR_DN	28	8	4	2
GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP	45	13	7	2
GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP	34	12	7	3
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	28	8	3	2
GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN	37	15	8	3
GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	23	8	4	3
GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN	31	10	4	3
GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_DN	40	11	5	3
GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_UP	29	9	5	3
KYNG_RESPONSE_TO_H2O2	34	10	5	2
GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN	45	15	7	3
GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN	29	10	4	2
GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_DN	28	11	5	2
GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_UP	32	10	5	3
BIOCARTA_GH_PATHWAY	29	9	4	2
GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN	36	11	5	4
GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_UP	28	7	3	3
GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_UP	39	13	7	5
GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_DN	39	12	7	3
GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_UP	34	11	4	2
WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	27	8	3	2
HALLMARK_INTERFERON_ALPHA_RESPONSE	28	8	3	2
GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_DN	37	9	4	3
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS	34	15	5	2
REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM	27	10	7	4
GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	30	11	3	2
WOOD_EBV_EBNA1_TARGETS_UP	35	12	6	2
GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP	41	16	9	5
ZHU_CMV_24_HR_UP	28	7	4	3
TCCCCAC_MIR491	36	14	6	2
GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_UP	40	16	6	4
GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_DN	33	11	6	2
DANG_MYC_TARGETS_UP	35	12	6	2
GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP	31	13	6	2
REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS	29	14	7	1
GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP	29	10	5	2
PROVENZANI_METASTASIS_UP	33	14	6	2
GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN	37	9	4	3
GSE27786_CD4_TCELL_VS_NKCELL_UP	42	15	10	4
GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_UP	42	10	4	3
GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_DN	38	14	7	3
ZHAN_MULTIPLE_MYELOMA_HP_DN	23	6	3	1
GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_UP	33	12	6	2
IWANAGA_CARCINOGENESIS_BY_KRAS_UP	32	12	7	2
GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_UP	36	12	8	5
GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	39	15	8	5
CHICAS_RB1_TARGETS_LOW_SERUM	29	7	3	2
GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_DN	50	14	7	3
GSE360_L_MAJOR_VS_T_GONDII_DC_DN	37	15	9	4
CCAWWNAAGG_SRF_Q4	35	13	7	4
GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN	31	12	6	2
SNF5_DN.V1_DN	38	14	7	3
GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP	47	14	7	6
BARIS_THYROID_CANCER_DN	32	9	7	4
GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP	32	9	3	2
AMIT_EGF_RESPONSE_60_MCF10A	30	8	4	3
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	31	10	5	2
GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_UP	38	11	6	2
LIN_NPAS4_TARGETS_UP	31	10	3	2
HOLLEMAN_DAUNORUBICIN_B_ALL_DN	22	5	3	3
GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_UP	37	13	6	2
GTGCAAA_MIR507	45	23	9	3
GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP	26	10	5	3
SCHRAMM_INHBA_TARGETS_DN	24	7	3	3
GSE27786_LIN_NEG_VS_BCELL_UP	35	11	4	2
DORN_ADENOVIRUS_INFECTION_48HR_DN	24	6	3	1
SMITH_LIVER_CANCER	30	8	4	3
LIEN_BREAST_CARCINOMA_METAPLASTIC	29	9	4	2
DORN_ADENOVIRUS_INFECTION_32HR_DN	24	6	3	1
FIGUEROA_AML_METHYLATION_CLUSTER_6_UP	33	12	7	3
GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	37	14	7	5
GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_UP	31	11	4	2
GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	40	10	6	4
GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_DN	40	14	6	2
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	32	8	3	2
GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_DN	26	6	2	2
GSE42724_NAIVE_BCELL_VS_PLASMABLAST_DN	34	15	7	3
REACTOME_RNA_POL_II_TRANSCRIPTION	20	6	3	2
GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_UP	30	9	4	2
GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN	29	10	4	2
BIOCARTA_RB_PATHWAY	24	4	3	2
GSE6259_DEC205_POS_DC_VS_BCELL_UP	40	12	5	3
GSE3982_MAST_CELL_VS_BASOPHIL_DN	36	15	8	4
GSE3982_MAST_CELL_VS_NKCELL_UP	29	10	3	2
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	25	6	3	2
GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_UP	40	10	5	2
GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_UP	35	12	5	4
REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE	21	5	2	2
GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	38	12	5	2
MA_PITUITARY_FETAL_VS_ADULT_UP	24	7	3	0
DELACROIX_RAR_TARGETS_DN	26	9	3	2
REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE	29	9	5	4
GSE17186_MEMORY_VS_NAIVE_BCELL_DN	34	13	6	4
YAATNANRNNNCAG_UNKNOWN	29	8	3	3
GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP	39	13	6	3
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE	28	9	3	2
GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_DN	27	8	4	1
GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	33	12	4	3
AHRARNT_02	24	6	3	2
BIOCARTA_ERYTH_PATHWAY	26	9	6	2
GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP	31	11	6	2
GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_UP	31	11	3	2
WARTERS_RESPONSE_TO_IR_SKIN	28	7	3	2
GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_UP	38	13	5	2
GSE33425_CD161_INT_VS_NEG_CD8_TCELL_UP	38	16	10	3
PAL_PRMT5_TARGETS_DN	23	5	3	2
ST_JNK_MAPK_PATHWAY	27	6	2	3
WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN	17	3	2	1
HOLLEMAN_DAUNORUBICIN_ALL_DN	16	5	2	2
NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON	18	4	2	2
chr5q35	23	6	2	0
GSE360_CTRL_VS_L_DONOVANI_DC_UP	36	13	7	5
chr10q24	28	13	6	2
ULE_SPLICING_VIA_NOVA2	31	14	5	3
GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION	22	9	4	2
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP	42	22	6	2
chr8q24	25	9	3	2
LEIN_OLIGODENDROCYTE_MARKERS	24	6	3	1
MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN	30	10	6	3
GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN	41	16	9	4
KARLSSON_TGFB1_TARGETS_DN	40	13	5	2
JEON_SMAD6_TARGETS_DN	27	8	4	3
GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN	34	9	4	2
PID_HIF1A_PATHWAY	29	7	3	3
GSE3982_NEUTROPHIL_VS_BCELL_UP	35	14	7	4
GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	33	11	5	4
GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_DN	30	13	6	3
PID_BETA_CATENIN_NUC_PATHWAY	30	11	6	3
RGTTAMWNATT_HNF1_01	34	13	7	4
GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN	27	9	6	2
GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_UP	25	9	3	2
GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN	40	17	8	3
BILD_CTNNB1_ONCOGENIC_SIGNATURE	33	10	4	3
DORN_ADENOVIRUS_INFECTION_12HR_DN	25	6	3	3
GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN	28	11	7	2
AMIT_EGF_RESPONSE_240_HELA	30	9	5	4
GACAGGG_MIR339	35	13	4	3
GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN	34	13	6	3
GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP	43	17	9	4
GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP	36	9	4	2
GSE27786_BCELL_VS_NKCELL_DN	31	13	6	2
BYSTROEM_CORRELATED_WITH_IL5_UP	25	7	3	3
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	24	6	3	2
LUI_THYROID_CANCER_CLUSTER_3	25	7	4	2
PID_HDAC_CLASSIII_PATHWAY	30	8	4	2
NELSON_RESPONSE_TO_ANDROGEN_DN	30	10	3	1
GSE42021_TREG_VS_TCONV_PLN_UP	34	12	4	2
GSE3982_EOSINOPHIL_VS_DC_UP	34	11	4	2
GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP	36	16	9	2
GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP	36	11	6	3
NGUYEN_NOTCH1_TARGETS_DN	34	13	7	3
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	24	10	5	1
KEGG_TASTE_TRANSDUCTION	25	7	3	2
PID_EPHRINB_REV_PATHWAY	28	9	3	1
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR	21	6	4	2
MATZUK_LUTEAL_GENES	21	5	2	2
GAUTSCHI_SRC_SIGNALING	21	5	3	2
YEMELYANOV_GR_TARGETS_DN	30	9	4	3
CAFFAREL_RESPONSE_TO_THC_24HR_3_DN	20	6	4	1
GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_DN	38	16	7	4
KTGGYRSGAA_UNKNOWN	30	10	6	4
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3	28	7	4	3
AGGCACT_MIR5153P	40	10	4	2
GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP	41	12	7	3
GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN	30	8	4	2
GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_UP	40	16	10	5
GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN	28	12	5	2
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	27	6	2	2
WHITFIELD_CELL_CYCLE_G1_S	28	7	3	2
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	20	6	2	2
GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_UP	25	8	4	2
GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP	42	12	4	2
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	27	11	3	2
ZHU_CMV_ALL_UP	30	7	4	3
ST_WNT_BETA_CATENIN_PATHWAY	28	8	4	2
GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_DN	33	13	6	3
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_UP	39	13	8	4
DOANE_BREAST_CANCER_CLASSES_UP	29	8	4	2
AAGTCCA_MIR422B_MIR422A	38	12	7	2
BIOCARTA_MTOR_PATHWAY	21	7	4	0
BIOCARTA_TEL_PATHWAY	34	11	6	3
WELCSH_BRCA1_TARGETS_UP	34	14	8	4
KIM_MYCN_AMPLIFICATION_TARGETS_UP	39	14	8	3
GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP	46	19	9	3
BURTON_ADIPOGENESIS_3	30	9	3	3
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP	23	7	3	2
FRASOR_TAMOXIFEN_RESPONSE_UP	30	7	2	3
GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN	31	9	4	3
GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_DN	33	10	4	3
GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_UP	32	10	4	4
GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN	30	9	4	4
GSE27786_LSK_VS_BCELL_DN	42	10	5	3
GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_UP	47	16	7	5
MATZUK_MEIOTIC_AND_DNA_REPAIR	26	7	4	2
MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3	27	9	2	2
HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN	34	12	6	2
GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_UP	31	9	5	3
GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_UP	26	7	3	2
GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN	40	12	7	4
GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP	27	7	4	2
GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP	39	17	9	4
GSE27786_LIN_NEG_VS_CD4_TCELL_UP	39	10	4	3
BIOCARTA_ATRBRCA_PATHWAY	22	5	2	2
REACTOME_CGMP_EFFECTS	19	6	2	2
REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN	18	6	3	1
WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	26	8	2	2
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27	24	6	3	0
WHITESIDE_CISPLATIN_RESISTANCE_UP	25	5	3	1
TCGA_GLIOBLASTOMA_MUTATED	23	8	4	2
MACAEVA_PBMC_RESPONSE_TO_IR	27	8	4	2
WHITFIELD_CELL_CYCLE_G2_M	38	13	8	4
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN	28	9	3	2
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN	37	11	5	2
GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_DN	34	11	4	2
GEISS_RESPONSE_TO_DSRNA_UP	28	10	5	4
GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_UP	34	11	3	2
GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN	40	12	7	6
SU_LIVER	37	16	8	5
BROWNE_HCMV_INFECTION_10HR_DN	31	9	4	2
AGTTCTC_MIR146A_MIR146B	29	9	4	2
GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	32	10	6	2
AKT_UP.V1_UP	26	7	2	2
GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_DN	32	10	4	2
RICKMAN_HEAD_AND_NECK_CANCER_A	24	9	3	1
GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_UP	33	11	8	3
PROVENZANI_METASTASIS_DN	33	14	5	2
GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_DN	28	9	5	2
GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_UP	32	12	7	2
GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_DN	34	12	7	2
GGCACAT_MIR455	27	8	3	3
CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	27	10	4	2
JACKSON_DNMT1_TARGETS_DN	22	7	4	2
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP	20	6	3	2
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN	17	6	2	0
DING_LUNG_CANCER_BY_MUTATION_RATE	24	10	3	0
GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_DN	39	16	7	3
KRAS.AMP.LUNG_UP.V1_UP	32	10	5	2
GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_UP	28	10	5	2
GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN	37	11	7	4
GSE3982_MAST_CELL_VS_DC_UP	31	9	4	2
KEGG_RNA_DEGRADATION	24	8	5	2
GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP	41	11	4	3
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN	29	11	4	3
RAO_BOUND_BY_SALL4	36	11	5	3
RICKMAN_HEAD_AND_NECK_CANCER_E	31	12	7	4
GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_DN	40	14	7	5
GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN	37	8	4	3
LIAO_HAVE_SOX4_BINDING_SITES	32	11	7	2
IRITANI_MAD1_TARGETS_DN	22	6	3	2
REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS	20	4	2	2
BIOCARTA_PTC1_PATHWAY	25	6	3	2
GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN	35	13	7	3
GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_DN	35	8	5	3
HALLMARK_INTERFERON_GAMMA_RESPONSE	36	16	7	3
KRAS.LUNG.BREAST_UP.V1_UP	34	14	5	3
GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	32	10	4	2
GOLUB_ALL_VS_AML_UP	22	7	4	2
KIM_LIVER_CANCER_POOR_SURVIVAL_UP	31	9	4	3
GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP	30	10	5	4
GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_DN	37	9	5	3
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	29	9	4	3
KEGG_PYRIMIDINE_METABOLISM	25	7	3	2
BROWNE_HCMV_INFECTION_12HR_DN	29	10	4	2
KAMMINGA_SENESCENCE	28	9	4	3
GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_UP	30	9	4	1
YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN	26	9	4	2
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP	26	7	4	3
SANSOM_WNT_PATHWAY_REQUIRE_MYC	28	10	4	2
KEGG_INOSITOL_PHOSPHATE_METABOLISM	30	10	6	3
REACTOME_MEIOSIS	30	7	3	2
GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_DN	38	15	5	3
GSE3982_NEUTROPHIL_VS_BASOPHIL_UP	35	13	7	2
GSE3982_DC_VS_BCELL_DN	34	13	5	2
GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_DN	40	13	5	3
CCANNAGRKGGC_UNKNOWN	34	13	7	3
SMIRNOV_RESPONSE_TO_IR_6HR_DN	27	16	7	3
GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_UP	32	13	5	3
GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	32	12	5	4
GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP	37	15	8	4
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN	23	6	2	2
HINATA_NFKB_TARGETS_FIBROBLAST_UP	29	11	4	2
BOYLAN_MULTIPLE_MYELOMA_D_UP	28	10	4	2
GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_UP	41	15	7	2
BIDUS_METASTASIS_DN	36	11	4	3
FOSTER_KDM1A_TARGETS_UP	40	17	7	3
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	38	10	6	1
KENNY_CTNNB1_TARGETS_DN	29	8	3	2
GERHOLD_ADIPOGENESIS_DN	28	8	4	2
GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_UP	34	12	8	3
GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_DN	33	14	7	4
LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN	22	6	3	2
TERAMOTO_OPN_TARGETS_CLUSTER_1	29	6	3	2
LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP	26	7	3	2
REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION	20	5	3	0
EHRLICH_ICF_SYNDROM_UP	26	10	5	2
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA	16	5	3	1
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	26	5	2	1
KRAS.LUNG_UP.V1_UP	40	11	6	3
GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_UP	28	9	3	2
BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	20	9	2	2
ZHANG_RESPONSE_TO_CANTHARIDIN_DN	31	7	3	2
CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	26	7	3	2
GEORGES_CELL_CYCLE_MIR192_TARGETS	25	6	3	2
GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP	41	12	5	3
GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP	36	11	7	2
GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_DN	35	12	6	5
chr12p12	23	10	2	2
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	40	12	5	2
DITTMER_PTHLH_TARGETS_UP	29	8	4	3
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	32	13	6	4
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	29	9	4	2
REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION	23	6	2	2
ALONSO_METASTASIS_DN	28	10	5	2
AZARE_STAT3_TARGETS	24	6	2	1
PID_INTEGRIN_A9B1_PATHWAY	22	6	3	1
REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_	17	4	2	2
GSE9988_LPS_VS_LOW_LPS_MONOCYTE_UP	30	12	6	3
GSE24210_TCONV_VS_TREG_UP	30	10	5	2
GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_UP	44	12	7	4
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	27	8	3	2
GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN	33	10	5	2
GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_DN	30	8	4	3
GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_UP	32	8	3	2
GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_DN	31	11	6	3
BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	24	7	4	1
RADAEVA_RESPONSE_TO_IFNA1_UP	23	8	5	3
GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN	31	11	4	2
GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_DN	36	11	4	2
GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP	35	13	7	2
KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY	31	13	6	2
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_DN	35	12	5	2
SIMBULAN_PARP1_TARGETS_UP	21	5	2	2
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	20	5	2	2
PID_IL3_PATHWAY	23	6	3	1
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	27	5	3	2
REACTOME_RNA_POL_I_TRANSCRIPTION	27	5	3	1
GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN	28	10	4	2
GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN	35	12	6	3
GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_DN	27	9	4	1
GSE339_CD4POS_VS_CD8POS_DC_DN	25	6	2	2
MATZUK_EARLY_ANTRAL_FOLLICLE	21	7	3	2
REACTOME_SEROTONIN_RECEPTORS	25	7	3	0
GSE3982_DC_VS_NKCELL_UP	46	14	7	2
GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN	25	8	4	2
GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN	35	12	5	3
HINATA_NFKB_TARGETS_KERATINOCYTE_UP	29	9	4	2
GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN	40	14	9	4
XU_GH1_AUTOCRINE_TARGETS_UP	36	12	4	2
HALMOS_CEBPA_TARGETS_DN	28	9	6	3
PID_AURORA_A_PATHWAY	18	5	3	2
BIOCARTA_GSK3_PATHWAY	26	10	6	3
WOOD_EBV_EBNA1_TARGETS_DN	22	8	3	3
CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	31	11	4	2
REACTOME_SIGNALING_BY_ROBO_RECEPTOR	20	7	2	1
chr1q25	24	8	3	0
REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING	21	5	2	2
LOPES_METHYLATED_IN_COLON_CANCER_UP	25	9	4	2
REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	24	9	5	2
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	25	6	3	1
GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_UP	38	16	8	4
GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP	48	15	9	3
GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN	42	10	5	3
GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP	43	14	10	3
GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN	43	11	5	3
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP	26	10	3	2
GSE45365_WT_VS_IFNAR_KO_CD11B_DC_DN	28	9	3	2
GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP	32	13	7	2
KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS	21	4	2	1
ZHENG_RESPONSE_TO_ARSENITE_UP	12	5	3	1
REACTOME_REGULATORY_RNA_PATHWAYS	28	6	3	2
HOLLERN_PAPILLARY_BREAST_TUMOR	23	6	3	1
CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL	22	4	3	1
HASLINGER_B_CLL_WITH_17P13_DELETION	28	8	5	2
REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS	26	8	5	3
VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP	28	6	3	2
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP	24	5	3	1
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	20	6	3	1
REACTOME_SIGNALING_BY_FGFR_MUTANTS	26	8	4	3
LEE_EARLY_T_LYMPHOCYTE_DN	27	11	5	3
TAVOR_CEBPA_TARGETS_UP	20	7	3	2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	22	8	2	2
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST	38	10	5	3
CHIN_BREAST_CANCER_COPY_NUMBER_UP	29	9	6	3
BIOCARTA_WNT_PATHWAY	29	9	5	3
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN	20	4	2	1
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM	23	6	3	2
DORSAM_HOXA9_TARGETS_DN	25	9	5	2
GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP	27	10	4	3
GSE22045_TREG_VS_TCONV_UP	28	7	2	2
GSE557_WT_VS_CIITA_KO_DC_UP	33	10	4	2
KHETCHOUMIAN_TRIM24_TARGETS_UP	27	10	6	2
ASTON_MAJOR_DEPRESSIVE_DISORDER_UP	31	11	5	3
GERHOLD_RESPONSE_TO_TZD_UP	16	4	2	2
PID_NFAT_TFPATHWAY	32	12	6	3
TERAMOTO_OPN_TARGETS_CLUSTER_5	24	5	2	0
GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	32	10	4	2
KAUFFMANN_DNA_REPLICATION_GENES	29	11	6	3
GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN	27	8	4	2
ATGCAGT_MIR217	33	13	6	4
GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_DN	50	18	9	2
GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_DN	30	12	5	3
GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_UP	30	9	4	2
chr1q32	22	9	4	0
FURUKAWA_DUSP6_TARGETS_PCI35_DN	30	10	4	2
MA_MYELOID_DIFFERENTIATION_UP	25	8	3	1
PID_NECTIN_PATHWAY	26	10	4	3
GREENBAUM_E2A_TARGETS_UP	21	6	3	2
BIOCARTA_IL1R_PATHWAY	21	9	5	3
WANG_RESPONSE_TO_BEXAROTENE_DN	21	8	2	2
STONER_ESOPHAGEAL_CARCINOGENESIS_UP	20	6	2	2
GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_UP	34	13	7	3
GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_UP	32	12	7	2
SHEPARD_CRUSH_AND_BURN_MUTANT_UP	33	9	4	2
GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_DN	33	9	3	2
GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP	37	15	8	3
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN	32	12	6	3
LEE_LIVER_CANCER_MYC_DN	25	8	3	1
INGA_TP53_TARGETS	28	9	3	2
WU_HBX_TARGETS_2_DN	25	6	3	2
REACTOME_CHOLESTEROL_BIOSYNTHESIS	20	3	1	1
chr7q35	27	9	5	2
PID_IL5_PATHWAY	27	8	5	2
VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN	23	6	3	2
GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP	36	12	5	2
GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_UP	25	6	3	2
GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_UP	32	12	6	2
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	27	7	4	2
GSE19198_6H_VS_24H_IL21_TREATED_TCELL_UP	30	13	8	2
GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_DN	26	10	4	2
GSE27786_LSK_VS_NKCELL_UP	24	8	4	2
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_UP	22	9	3	2
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP	27	7	2	2
chr1p32	21	10	5	0
VILLANUEVA_LIVER_CANCER_KRT19_DN	29	9	5	2
BCAT_BILD_ET_AL_DN	23	8	3	1
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN	23	8	3	3
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP	20	6	3	2
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	33	10	3	2
BURTON_ADIPOGENESIS_12	22	8	2	2
GRADE_COLON_CANCER_DN	22	6	3	1
VARELA_ZMPSTE24_TARGETS_DN	21	6	2	2
HALLMARK_NOTCH_SIGNALING	27	9	5	3
PID_IL1_PATHWAY	18	7	4	3
REACTOME_MEIOTIC_RECOMBINATION	28	9	6	3
REACTOME_SHC_MEDIATED_CASCADE	22	5	2	1
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	28	7	3	2
PTEN_DN.V1_UP	43	15	8	4
GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN	32	14	6	4
GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_DN	35	12	4	3
GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN	39	17	9	3
GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_DN	29	9	3	2
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	28	9	4	2
SESTO_RESPONSE_TO_UV_C0	31	11	8	2
GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP	25	6	2	2
GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_UP	30	10	4	3
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	34	17	9	5
chr5p14	21	7	2	0
NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	22	9	5	3
PID_HIF2PATHWAY	24	7	2	2
LI_CISPLATIN_RESISTANCE_DN	24	7	2	2
BIOCARTA_DEATH_PATHWAY	27	8	5	3
chr2p21	29	12	4	0
ZHENG_IL22_SIGNALING_DN	34	14	9	3
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN	18	8	3	1
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN	26	9	6	3
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	33	11	5	3
GSE7852_LN_VS_THYMUS_TCONV_UP	28	9	4	3
GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_UP	35	10	5	2
REACTOME_CHROMOSOME_MAINTENANCE	34	6	2	2
REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES	31	11	7	3
DAZARD_RESPONSE_TO_UV_SCC_UP	26	8	3	3
GSE21033_3H_VS_12H_POLYIC_STIM_DC_DN	28	8	3	2
CHANG_IMMORTALIZED_BY_HPV31_DN	22	8	4	2
HALMOS_CEBPA_TARGETS_UP	24	7	4	3
PID_RAC1_PATHWAY	24	7	3	1
GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP	30	11	5	3
GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_UP	28	8	2	2
GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN	29	10	4	2
GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_DN	29	12	3	2
GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_UP	40	11	4	2
ODONNELL_METASTASIS_UP	27	9	4	2
GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_UP	34	13	7	3
GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_DN	49	18	9	3
GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	33	10	4	2
GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN	25	8	3	2
GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_DN	33	10	5	4
FIGUEROA_AML_METHYLATION_CLUSTER_5_UP	22	6	3	2
YAMASHITA_SILENCED_BY_METHYLATION	7	5	2	0
BUSA_SAM68_TARGETS_DN	19	5	2	2
LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP	6	4	2	1
PYEON_HPV_POSITIVE_TUMORS_DN	18	6	3	2
DIERICK_SEROTONIN_FUNCTION_GENES	9	5	2	2
ZHAN_MULTIPLE_MYELOMA_MS_DN	16	7	3	2
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP	26	9	4	2
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	20	4	3	2
WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER	32	11	3	2
GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP	39	14	5	4
GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_DN	27	8	3	4
GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_DN	37	9	4	4
GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN	29	10	4	2
GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_DN	37	16	8	2
GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_DN	37	13	7	3
STAMBOLSKY_BOUND_BY_MUTATED_TP53	26	8	3	1
PID_WNT_CANONICAL_PATHWAY	23	9	6	1
REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS	24	8	5	2
chr8q11	22	7	3	1
REACTOME_PERK_REGULATED_GENE_EXPRESSION	17	5	3	1
OUYANG_PROSTATE_CANCER_MARKERS	29	10	5	2
TOMLINS_METASTASIS_DN	15	5	2	0
REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING	16	11	7	1
REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX	18	5	3	1
FIGUEROA_AML_METHYLATION_CLUSTER_4_UP	24	8	3	1
AACYNNNNTTCCS_UNKNOWN	33	10	5	3
GSE27786_LIN_NEG_VS_ERYTHROBLAST_DN	30	10	4	2
GSE11057_PBMC_VS_MEM_CD4_TCELL_DN	35	15	7	3
GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN	36	14	7	3
SABATES_COLORECTAL_ADENOMA_UP	34	11	6	4
GSE3982_NEUTROPHIL_VS_TH2_UP	40	16	9	5
GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN	28	10	5	2
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	20	6	3	2
ELLWOOD_MYC_TARGETS_DN	24	8	4	2
SEMENZA_HIF1_TARGETS	30	11	5	2
PID_ATM_PATHWAY	25	9	6	2
REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER	14	5	3	2
BURTON_ADIPOGENESIS_PEAK_AT_8HR	27	9	5	3
FUJII_YBX1_TARGETS_UP	28	7	3	1
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	29	8	3	2
GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	41	15	6	2
GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_UP	29	11	5	3
GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_UP	26	10	4	2
GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN	35	15	6	3
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN	25	8	2	2
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	24	8	3	2
GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_UP	37	10	5	3
GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	35	15	9	3
LABBE_WNT3A_TARGETS_UP	35	6	3	2
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	20	7	5	2
GSE37532_WT_VS_PPARG_KO_LN_TREG_DN	21	11	4	3
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_UP	30	10	5	3
WONG_ENDMETRIUM_CANCER_DN	35	14	4	2
HECKER_IFNB1_TARGETS	21	6	2	2
SHEPARD_BMYB_TARGETS	32	8	4	2
BIOCARTA_GCR_PATHWAY	29	11	5	3
BIOCARTA_ATM_PATHWAY	19	10	6	4
REACTOME_ELONGATION_ARREST_AND_RECOVERY	10	4	2	1
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	21	5	3	1
BIOCARTA_TNFR2_PATHWAY	13	7	4	2
REACTOME_MRNA_CAPPING	11	4	2	1
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN	24	8	3	2
SHIPP_DLBCL_CURED_VS_FATAL_UP	19	6	2	2
YIH_RESPONSE_TO_ARSENITE_C3	26	8	4	2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP	21	8	4	2
MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	23	9	3	2
chr2p25	27	8	3	0
VALK_AML_CLUSTER_11	25	7	4	2
GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_UP	44	18	11	4
GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP	38	12	6	4
KEGG_APOPTOSIS	32	13	8	4
TTTNNANAGCYR_UNKNOWN	33	11	2	2
chr12q13	36	16	8	3
GSE6681_DELETED_FOXP3_VS_WT_TREG_UP	36	14	7	5
REN_BOUND_BY_E2F	29	6	3	2
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	22	7	3	2
CROONQUIST_STROMAL_STIMULATION_UP	27	6	2	2
REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE	24	9	5	2
GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_UP	32	9	3	2
GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	42	12	6	4
GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN	32	11	6	4
SIRNA_EIF4GI_UP	32	8	3	2
BEIER_GLIOMA_STEM_CELL_UP	26	10	4	2
BURTON_ADIPOGENESIS_PEAK_AT_24HR	18	5	3	3
YU_MYC_TARGETS_UP	16	5	2	1
CHANDRAN_METASTASIS_TOP50_UP	22	7	3	2
GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN	29	12	4	2
OKUMURA_INFLAMMATORY_RESPONSE_LPS	41	17	9	6
DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP	16	4	2	1
GOUYER_TUMOR_INVASIVENESS	18	5	2	2
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3	11	3	1	1
REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION	18	5	3	2
WORSCHECH_TUMOR_REJECTION_DN	18	5	2	1
LIN_APC_TARGETS	35	7	3	2
BOYLAN_MULTIPLE_MYELOMA_C_DN	31	13	6	3
GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_DN	41	23	8	5
GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN	42	17	7	4
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5	13	8	3	1
CHEN_PDGF_TARGETS	26	8	3	1
chr8q23	22	9	3	1
NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER	30	12	4	1
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	27	10	6	1
REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS	22	5	3	1
PID_BETA_CATENIN_DEG_PATHWAY	24	7	4	3
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP	19	6	3	1
JIANG_TIP30_TARGETS_DN	27	7	5	3
NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN	8	6	2	1
MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN	19	7	3	0
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS	13	9	6	1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5	24	8	4	2
JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN	26	6	3	2
MTOR_UP.N4.V1_DN	29	9	3	2
OLSSON_E2F3_TARGETS_DN	20	6	3	0
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	24	6	3	2
GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_DN	38	14	7	4
GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_UP	40	15	8	3
GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN	36	15	6	3
GSE6259_CD4_TCELL_VS_CD8_TCELL_DN	29	10	4	2
KAUFFMANN_MELANOMA_RELAPSE_UP	16	6	2	1
LEE_AGING_CEREBELLUM_DN	31	12	4	2
GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_DN	32	9	4	2
GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_UP	48	15	8	3
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS	26	11	4	3
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN	25	7	3	1
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP	21	6	2	1
COLLER_MYC_TARGETS_UP	22	6	2	2
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	12	6	2	0
ZIRN_TRETINOIN_RESPONSE_UP	21	7	3	1
TIEN_INTESTINE_PROBIOTICS_2HR_UP	24	6	3	2
WONG_ENDMETRIUM_CANCER_UP	20	4	2	1
REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX	11	4	2	1
ZHAN_MULTIPLE_MYELOMA_SPIKED	24	6	3	2
REACTOME_NUCLEOTIDE_EXCISION_REPAIR	14	6	3	2
TAGGTCA_MIR192_MIR215	33	13	6	3
BIOCARTA_FCER1_PATHWAY	26	6	3	2
REACTOME_AMINE_LIGAND_BINDING_RECEPTORS	10	7	2	0
GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_DN	31	10	4	3
BRCA1_DN.V1_UP	21	7	3	3
GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_UP	29	9	4	2
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	29	10	4	3
GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_DN	23	13	6	0
GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_UP	33	10	3	3
GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_DN	31	10	5	2
ABRAMSON_INTERACT_WITH_AIRE	17	4	2	2
KEGG_GLYCEROLIPID_METABOLISM	24	9	3	1
YAP1_UP	20	7	3	2
TRAYNOR_RETT_SYNDROM_UP	22	6	2	2
PID_HNF3A_PATHWAY	20	7	4	2
CAHOY_ASTROGLIAL	28	8	3	2
FIGUEROA_AML_METHYLATION_CLUSTER_1_UP	28	10	4	2
chr1q12	20	5	3	0
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_DN	16	4	2	0
KRISHNAN_FURIN_TARGETS_UP	17	4	2	0
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP	8	5	2	0
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP	20	5	2	1
SANCHEZ_MDM2_TARGETS	22	6	3	2
MUNSHI_MULTIPLE_MYELOMA_DN	11	4	2	0
TURJANSKI_MAPK14_TARGETS	23	7	3	0
MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN	18	6	2	2
MURAKAMI_UV_RESPONSE_1HR_DN	16	3	1	0
chr5p12	22	5	2	0
ACAACTT_MIR382	39	14	7	4
KEGG_GLYCEROPHOSPHOLIPID_METABOLISM	28	10	4	2
SESTO_RESPONSE_TO_UV_C1	13	8	3	1
LI_WILMS_TUMOR_ANAPLASTIC_UP	17	7	3	1
VERNELL_RETINOBLASTOMA_PATHWAY_DN	22	7	4	2
YANG_BREAST_CANCER_ESR1_BULK_UP	19	6	3	0
NEWMAN_ERCC6_TARGETS_UP	24	9	4	3
VALK_AML_CLUSTER_16	22	6	3	2
chr14q13	11	6	2	1
RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2	15	7	3	2
REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION	20	6	3	2
EGUCHI_CELL_CYCLE_RB1_TARGETS	19	6	3	0
KIM_HYPOXIA	20	6	2	2
MEISSNER_BRAIN_ICP_WITH_H3K4ME3	24	4	2	2
GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_DN	32	9	5	3
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	38	14	6	5
GTAAACC_MIR2995P	22	10	5	2
LIU_TARGETS_OF_VMYB_VS_CMYB_DN	28	9	5	3
VANHARANTA_UTERINE_FIBROID_UP	26	9	4	2
GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_DN	33	12	5	2
chr3p21	55	18	9	2
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN	30	13	6	4
HUANG_GATA2_TARGETS_DN	35	13	5	2
GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP	36	13	6	2
KEGG_ETHER_LIPID_METABOLISM	15	6	2	1
TERAO_AOX4_TARGETS_SKIN_DN	20	5	2	2
DEN_INTERACT_WITH_LCA5	20	5	2	1
NAKAYAMA_FGF2_TARGETS	17	5	2	1
chr18q11	19	6	3	2
REACTOME_INWARDLY_RECTIFYING_K_CHANNELS	27	8	2	2
KEGG_PROTEIN_EXPORT	22	7	3	1
KONDO_COLON_CANCER_HCP_WITH_H3K27ME1	17	7	2	1
CAFFAREL_RESPONSE_TO_THC_DN	16	4	2	2
GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_UP	31	13	7	5
HOFMANN_CELL_LYMPHOMA_UP	25	9	6	4
LIANG_SILENCED_BY_METHYLATION_2	23	8	3	2
AMIT_EGF_RESPONSE_40_HELA	13	7	3	1
MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	19	7	3	2
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN	12	5	2	2
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN	15	5	2	2
GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_UP	33	11	5	2
BIOCARTA_EPONFKB_PATHWAY	15	8	3	0
KOINUMA_COLON_CANCER_MSI_DN	19	6	3	2
KORKOLA_SEMINOMA_DN	17	5	2	1
HOLLEMAN_DAUNORUBICIN_B_ALL_UP	18	5	1	2
KOMMAGANI_TP63_GAMMA_TARGETS	23	5	2	2
ZHAN_MULTIPLE_MYELOMA_PR_DN	31	13	4	2
ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF	18	5	2	2
MANTOVANI_NFKB_TARGETS_DN	17	4	2	2
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN	14	3	2	0
MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP	18	6	3	0
DORN_ADENOVIRUS_INFECTION_32HR_UP	9	7	3	1
PRAMOONJAGO_SOX4_TARGETS_DN	23	5	2	2
GYORFFY_MITOXANTRONE_RESISTANCE	28	11	6	3
GGATCCG_MIR127	18	5	2	2
BIOCARTA_LECTIN_PATHWAY	14	5	3	0
KORKOLA_CHORIOCARCINOMA_DN	18	6	2	1
IIZUKA_LIVER_CANCER_EARLY_RECURRENCE	18	5	2	0
POS_RESPONSE_TO_HISTAMINE_DN	7	3	2	2
CHEN_HOXA5_TARGETS_6HR_UP	5	2	1	0
STOSSI_RESPONSE_TO_ESTRADIOL	22	10	4	1
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR	21	6	2	1
REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS	11	3	2	1
REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION	23	6	3	2
KEGG_SULFUR_METABOLISM	22	7	3	2
chr4q27	21	6	2	0
APRELIKOVA_BRCA1_TARGETS	23	7	3	2
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	22	8	3	2
MOSERLE_IFNA_RESPONSE	19	7	2	0
WU_HBX_TARGETS_1_DN	20	4	2	1
LIANG_SILENCED_BY_METHYLATION_UP	19	5	2	2
BIOCARTA_G2_PATHWAY	23	6	3	0
AIGNER_ZEB1_TARGETS	23	7	2	1
SHIN_B_CELL_LYMPHOMA_CLUSTER_2	22	11	4	2
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN	16	8	3	2
GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_UP	27	11	4	2
BIOCARTA_RAC1_PATHWAY	19	7	3	1
DER_IFN_BETA_RESPONSE_UP	28	10	5	3
DUAN_PRDM5_TARGETS	41	15	8	5
GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_UP	28	9	3	2
GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_DN	33	12	7	4
GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN	36	10	6	2
GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_DN	31	9	2	2
GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP	37	9	5	3
LABBE_TGFB1_TARGETS_DN	18	8	3	1
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	22	8	3	1
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP	20	6	3	2
TSUNODA_CISPLATIN_RESISTANCE_DN	21	8	4	2
DAUER_STAT3_TARGETS_DN	20	7	2	1
GSE339_CD8POS_VS_CD4CD8DN_DC_UP	26	9	4	2
GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_UP	38	10	5	2
GSE3982_DC_VS_MAC_DN	29	11	4	2
GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP	36	15	5	3
BASSO_CD40_SIGNALING_UP	27	12	6	2
GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP	30	8	4	3
GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_UP	33	11	3	2
GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP	26	9	2	2
GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	37	17	9	7
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP	15	7	3	1
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR	21	7	4	0
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	25	5	2	2
REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS	21	7	4	1
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP	24	8	4	2
ZHAN_LATE_DIFFERENTIATION_GENES_UP	19	7	3	2
DORN_ADENOVIRUS_INFECTION_12HR_UP	11	5	2	1
KEGG_SELENOAMINO_ACID_METABOLISM	22	6	3	2
POS_HISTAMINE_RESPONSE_NETWORK	19	7	2	3
chr6q14	26	12	2	2
GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN	33	7	3	2
GGARNTKYCCA_UNKNOWN	24	9	3	1
WINTER_HYPOXIA_DN	25	11	5	2
SMIRNOV_RESPONSE_TO_IR_2HR_UP	34	12	5	2
HENDRICKS_SMARCA4_TARGETS_DN	23	8	3	2
REACTOME_PI_METABOLISM	25	8	4	2
GSE40493_BCL6_KO_VS_WT_TREG_DN	27	10	5	3
GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP	37	14	6	3
REACTOME_GAP_JUNCTION_DEGRADATION	17	6	2	2
BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN	21	7	3	0
REACTOME_P75NTR_SIGNALS_VIA_NFKB	14	8	5	1
REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES	13	4	2	0
KORKOLA_EMBRYONAL_CARCINOMA_DN	18	6	2	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8	22	6	2	2
TSUDA_ALVEOLAR_SOFT_PART_SARCOMA	24	6	2	2
LEE_METASTASIS_AND_RNA_PROCESSING_UP	23	6	3	1
BAKER_HEMATOPOESIS_STAT1_TARGETS	11	4	2	0
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24	25	8	4	0
AMIT_EGF_RESPONSE_20_MCF10A	21	7	4	2
KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM	9	5	2	1
GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	5	4	1	1
INAMURA_LUNG_CANCER_SCC_UP	17	5	2	1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	30	7	3	3
BOSCO_TH1_CYTOTOXIC_MODULE	32	13	6	3
HELLER_SILENCED_BY_METHYLATION_DN	22	10	3	2
ONDER_CDH1_TARGETS_3_DN	20	10	5	3
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	22	7	3	2
GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP	31	13	8	3
HALLMARK_MYC_TARGETS_V2	26	6	3	2
PID_ARF6_TRAFFICKING_PATHWAY	22	9	3	1
VALK_AML_CLUSTER_4	15	9	5	1
ANDERSEN_LIVER_CANCER_KRT19_UP	21	7	4	0
LU_TUMOR_VASCULATURE_UP	24	5	2	2
DANG_MYC_TARGETS_DN	21	9	6	4
REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX	15	4	2	2
FIGUEROA_AML_METHYLATION_CLUSTER_6_DN	23	8	3	1
GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP	34	14	6	4
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	37	14	5	4
GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_UP	18	6	2	2
JAK2_DN.V1_DN	27	7	2	2
SANA_TNF_SIGNALING_UP	22	8	4	3
BRUECKNER_TARGETS_OF_MIRLET7A3_DN	27	9	3	2
CHESLER_BRAIN_QTL_CIS	20	6	2	2
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP	34	10	4	2
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	19	5	2	1
BECKER_TAMOXIFEN_RESISTANCE_UP	28	9	5	2
YAMASHITA_LIVER_CANCER_STEM_CELL_UP	32	7	4	2
REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS	24	6	3	1
SERVITJA_LIVER_HNF1A_TARGETS_UP	30	11	4	2
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_11	21	5	3	2
KANG_IMMORTALIZED_BY_TERT_DN	26	9	2	2
KIM_GLIS2_TARGETS_UP	24	6	3	2
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	23	9	3	2
CTGYNNCTYTAA_UNKNOWN	35	10	4	2
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	14	8	5	2
chr8q13	17	6	2	1
FARMER_BREAST_CANCER_CLUSTER_2	21	6	3	1
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	25	6	3	3
OLSSON_E2F3_TARGETS_UP	27	7	2	2
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	17	6	2	0
BIOCARTA_FAS_PATHWAY	22	7	2	0
HUNSBERGER_EXERCISE_REGULATED_GENES	21	5	2	2
GROSS_ELK3_TARGETS_UP	25	7	3	2
GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN	22	9	4	2
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP	32	12	6	4
PID_CASPASE_PATHWAY	17	8	4	2
SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION	27	8	5	3
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	33	10	5	3
MAHAJAN_RESPONSE_TO_IL1A_DN	29	9	5	1
KRAS.LUNG.BREAST_UP.V1_DN	29	10	3	2
SHIN_B_CELL_LYMPHOMA_CLUSTER_1	22	5	2	1
chr2p15	11	8	3	0
FINETTI_BREAST_CANCER_KINOME_GREEN	20	6	2	0
PARK_APL_PATHOGENESIS_UP	21	6	3	0
WANG_METASTASIS_OF_BREAST_CANCER	19	5	2	0
ZHOU_PANCREATIC_BETA_CELL	11	6	3	1
REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT	12	4	2	1
EHRLICH_ICF_SYNDROM_DN	16	5	1	0
LOPEZ_MESOTHELIOMA_SURVIVAL_UP	10	3	1	1
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION	22	8	5	2
REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1	20	6	3	3
REACTOME_MICRORNA_MIRNA_BIOGENESIS	14	4	2	1
INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP	19	6	3	1
CAIRO_PML_TARGETS_BOUND_BY_MYC_DN	25	6	3	3
ONDER_CDH1_TARGETS_3_UP	18	6	3	1
BIOCARTA_SALMONELLA_PATHWAY	19	4	2	1
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6	12	3	1	1
PIEPOLI_LGI1_TARGETS_UP	5	5	1	0
GSE40655_FOXO1_KO_VS_WT_NTREG_DN	26	9	5	2
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN	24	8	4	3
GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_UP	28	8	2	2
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	18	9	6	3
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE	23	8	3	2
PID_ALPHA_SYNUCLEIN_PATHWAY	26	5	2	2
DUTTA_APOPTOSIS_VIA_NFKB	16	7	3	3
TERAO_AOX4_TARGETS_SKIN_UP	26	7	4	2
GHANDHI_BYSTANDER_IRRADIATION_UP	30	10	4	3
REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS	24	8	2	2
HUANG_FOXA2_TARGETS_DN	26	8	4	1
FRIDMAN_IMMORTALIZATION_DN	26	6	2	2
SESTO_RESPONSE_TO_UV_C8	25	11	6	1
BIOCARTA_MYOSIN_PATHWAY	19	5	2	2
MORI_SMALL_PRE_BII_LYMPHOCYTE_UP	24	10	2	2
SHIN_B_CELL_LYMPHOMA_CLUSTER_3	29	10	6	3
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP	23	6	3	2
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	12	6	2	2
AMIT_SERUM_RESPONSE_240_MCF10A	26	10	5	1
MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED	23	6	2	1
CHIBA_RESPONSE_TO_TSA_UP	18	5	2	1
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	26	8	2	1
RICKMAN_HEAD_AND_NECK_CANCER_F	21	7	1	0
RAMASWAMY_METASTASIS_DN	32	9	5	2
BORLAK_LIVER_CANCER_EGF_UP	18	7	3	1
ZHENG_GLIOBLASTOMA_PLASTICITY_DN	13	6	2	2
GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_DN	27	9	3	2
REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_	20	6	3	1
AMIT_SERUM_RESPONSE_40_MCF10A	20	4	1	0
RIZ_ERYTHROID_DIFFERENTIATION_CCNE1	25	8	4	2
PID_AURORA_B_PATHWAY	24	7	3	1
PID_SYNDECAN_2_PATHWAY	24	6	3	2
GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP	30	13	6	3
LY_AGING_MIDDLE_DN	16	4	3	0
TSUNODA_CISPLATIN_RESISTANCE_UP	26	9	4	1
CAFFAREL_RESPONSE_TO_THC_8HR_5_UP	21	4	2	2
KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION	16	5	2	0
chr4q26	20	8	5	1
BIOCARTA_RARRXR_PATHWAY	27	9	5	2
MIZUKAMI_HYPOXIA_UP	23	4	2	1
MALIK_REPRESSED_BY_ESTROGEN	23	6	2	0
DORN_ADENOVIRUS_INFECTION_48HR_UP	15	7	3	2
PHESSE_TARGETS_OF_APC_AND_MBD2_DN	24	8	4	4
VERRECCHIA_RESPONSE_TO_TGFB1_C4	18	7	3	1
BIOCARTA_COMP_PATHWAY	13	4	3	0
REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA	17	5	3	0
HOWLIN_CITED1_TARGETS_2_DN	18	5	2	0
REACTOME_CD28_DEPENDENT_VAV1_PATHWAY	14	6	3	1
BIOCARTA_HIVNEF_PATHWAY	24	9	5	2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	22	8	3	2
GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_DN	26	11	5	2
LEE_AGING_NEOCORTEX_UP	26	9	5	3
HAN_JNK_SINGALING_DN	21	7	3	1
CAFFAREL_RESPONSE_TO_THC_UP	21	5	2	2
REACTOME_GLYCOSPHINGOLIPID_METABOLISM	17	5	2	0
REACTOME_TELOMERE_MAINTENANCE	17	3	2	2
REACTOME_MEIOTIC_SYNAPSIS	20	5	2	1
PID_SYNDECAN_4_PATHWAY	29	10	5	3
REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION	22	7	4	3
YANAGIHARA_ESX1_TARGETS	19	7	3	1
BIOCARTA_TOLL_PATHWAY	19	9	4	3
chr10p12	18	7	3	3
chr9q31	21	8	2	1
REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE	24	6	3	1
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	22	8	3	2
ANDERSEN_CHOLANGIOCARCINOMA_CLASS1	24	7	2	1
MARSON_FOXP3_TARGETS_UP	23	8	3	2
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP	32	11	3	2
GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN	24	9	3	2
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	31	10	5	3
GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP	24	8	4	2
GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_UP	35	10	5	2
MANTOVANI_VIRAL_GPCR_SIGNALING_UP	35	13	6	3
KEGG_PPAR_SIGNALING_PATHWAY	19	7	3	2
BIOCARTA_VDR_PATHWAY	21	6	2	2
PID_FRA_PATHWAY	27	8	4	2
KEGG_PHENYLALANINE_METABOLISM	23	6	3	2
KEGG_CYSTEINE_AND_METHIONINE_METABOLISM	21	7	3	2
BIOCARTA_PS1_PATHWAY	27	7	4	3
chr4q11	20	7	4	0
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP	20	7	2	2
LEE_NAIVE_T_LYMPHOCYTE	28	7	3	2
REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE	17	4	2	2
VALK_AML_WITH_FLT3_ITD	28	9	4	2
HUMMERICH_MALIGNANT_SKIN_TUMOR_DN	17	7	4	1
BROWNE_HCMV_INFECTION_2HR_UP	22	6	3	2
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN	18	5	2	1
ONGUSAHA_BRCA1_TARGETS_DN	12	4	2	0
NIELSEN_SYNOVIAL_SARCOMA_DN	16	4	2	0
WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	13	7	3	2
NAGY_TFTC_COMPONENTS_HUMAN	21	6	2	1
SIMBULAN_PARP1_TARGETS_DN	20	5	3	3
NIELSEN_LEIOMYOSARCOMA_DN	25	7	4	1
REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION	27	5	3	1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS	8	5	2	1
LIU_TOPBP1_TARGETS	26	6	2	2
REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI	14	7	3	1
WACKER_HYPOXIA_TARGETS_OF_VHL	27	6	2	2
WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC	25	6	2	2
REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT	26	7	4	2
WEBER_METHYLATED_HCP_IN_SPERM_UP	21	5	2	1
ACCAATC_MIR509	20	8	2	2
REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND	16	3	2	2
GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_UP	31	10	3	2
KRAS.KIDNEY_UP.V1_DN	32	12	5	4
BROWN_MYELOID_CELL_DEVELOPMENT_DN	24	10	4	2
GSE45365_NK_CELL_VS_CD11B_DC_UP	30	8	3	2
chr10q26	19	9	3	2
chr10q23	26	10	4	3
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7	27	8	3	2
SANA_RESPONSE_TO_IFNG_UP	19	5	2	1
GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP	33	13	7	3
GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	33	10	4	3
DURCHDEWALD_SKIN_CARCINOGENESIS_DN	34	9	4	2
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	24	11	6	4
chr10q21	25	13	5	3
EPPERT_LSC_R	26	8	5	2
BIOCARTA_GPCR_PATHWAY	25	7	3	2
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN	15	6	3	0
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP	20	8	3	1
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	40	16	10	4
QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2	29	9	3	2
PID_WNT_NONCANONICAL_PATHWAY	29	6	3	2
ZHAN_MULTIPLE_MYELOMA_LB_DN	18	5	2	1
chr17q11	31	12	7	3
GSE14415_INDUCED_VS_NATURAL_TREG_UP	30	10	4	2
XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN	36	8	3	2
RICKMAN_HEAD_AND_NECK_CANCER_C	32	13	7	3
BIOCARTA_IL3_PATHWAY	18	4	2	2
WU_ALZHEIMER_DISEASE_DN	24	6	2	2
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP	25	8	3	2
REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING	23	6	2	1
REACTOME_BETA_DEFENSINS	19	8	3	2
MURAKAMI_UV_RESPONSE_24HR	25	10	7	3
MACLACHLAN_BRCA1_TARGETS_UP	29	9	5	3
BIOCARTA_PITX2_PATHWAY	28	10	4	2
REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION	27	5	3	1
REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS	26	6	3	2
HINATA_NFKB_IMMU_INF	19	6	3	2
MILI_PSEUDOPODIA	23	6	2	2
HEIDENBLAD_AMPLICON_8Q24_UP	23	8	3	2
KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT	22	6	3	1
KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY	17	7	4	2
REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS	10	6	2	0
REACTOME_TRIGLYCERIDE_BIOSYNTHESIS	23	9	4	2
ONO_AML1_TARGETS_DN	28	12	7	3
GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_DN	38	18	8	4
GSE7764_NKCELL_VS_SPLENOCYTE_DN	14	8	2	2
BAELDE_DIABETIC_NEPHROPATHY_UP	21	7	3	2
RIZKI_TUMOR_INVASIVENESS_2D_UP	26	10	6	2
CTAGGAA_MIR384	26	11	4	2
BOYLAN_MULTIPLE_MYELOMA_D_DN	21	8	4	2
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP	10	7	3	1
LAU_APOPTOSIS_CDKN2A_DN	19	3	2	0
REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY	18	3	2	0
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP	19	7	2	2
AIYAR_COBRA1_TARGETS_UP	18	7	3	1
BIOCARTA_MPR_PATHWAY	25	5	2	2
GSE3982_BASOPHIL_VS_TH2_UP	31	15	6	3
chr2q34	17	6	2	0
DE_YY1_TARGETS_UP	20	7	3	3
DASU_IL6_SIGNALING_SCAR_DN	21	6	3	0
AMUNDSON_GAMMA_RADIATION_RESISTANCE	23	8	3	2
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23	20	7	2	2
ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE	21	6	3	2
BIOCARTA_CELL2CELL_PATHWAY	24	8	3	1
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN	19	7	2	0
FARMER_BREAST_CANCER_CLUSTER_7	25	7	3	2
ROY_WOUND_BLOOD_VESSEL_DN	31	10	7	3
REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS	19	5	2	1
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP	19	5	2	1
REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE	26	10	7	2
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN	9	4	2	2
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	28	9	5	3
BROWNE_INTERFERON_RESPONSIVE_GENES	21	8	3	2
ZHANG_GATA6_TARGETS_DN	27	6	2	2
GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_DN	22	8	3	3
WEINMANN_ADAPTATION_TO_HYPOXIA_DN	21	8	3	1
PID_PLK1_PATHWAY	26	7	4	1
REACTOME_IL1_SIGNALING	18	8	4	2
ABBUD_LIF_SIGNALING_1_UP	21	10	5	4
NAKAMURA_ADIPOGENESIS_LATE_DN	21	7	3	3
BCAT_BILD_ET_AL_UP	31	5	2	2
ZHANG_TLX_TARGETS_UP	21	10	5	2
GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_DN	26	9	4	2
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN	33	11	4	2
JI_RESPONSE_TO_FSH_DN	18	6	2	1
LEIN_NEURON_MARKERS	25	9	2	1
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP	35	10	6	2
CHENG_IMPRINTED_BY_ESTRADIOL	16	10	6	1
LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN	27	9	4	3
GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_DN	23	13	4	2
OHM_EMBRYONIC_CARCINOMA_DN	8	6	3	1
GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_DN	27	15	8	3
chr9p21	10	8	1	1
TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN	16	13	4	1
REACTOME_LIPOPROTEIN_METABOLISM	21	15	8	3
chr6q25	18	14	5	2
REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT	20	13	7	3
PID_IL12_2PATHWAY	27	16	7	4
TIAN_TNF_SIGNALING_VIA_NFKB	13	8	4	2
PID_IL12_STAT4_PATHWAY	28	12	6	3
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN	30	13	6	4
BIOCARTA_NFKB_PATHWAY	9	7	3	2
PID_IL23_PATHWAY	17	13	6	2
KEGG_HEMATOPOIETIC_CELL_LINEAGE	19	13	5	2
HALLMARK_IL6_JAK_STAT3_SIGNALING	19	14	6	4
WANG_TNF_TARGETS	10	8	5	2
GSE30971_WBP7_HET_VS_KO_MACROPHAGE_DN	25	12	6	3
chr9p24	15	11	5	2
chr10p15	14	13	4	2
BIOCARTA_RANKL_PATHWAY	4	4	2	0
chr5q22	13	9	3	2
BIOCARTA_41BB_PATHWAY	10	9	5	2
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	25	16	7	3
WORSCHECH_TUMOR_REJECTION_UP	13	10	4	4
PID_TNF_PATHWAY	15	7	3	3
BAFNA_MUC4_TARGETS_UP	6	5	4	1
GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	29	10	5	3
BIOCARTA_INFLAM_PATHWAY	20	7	6	3
SHANK_TAL1_TARGETS_DN	4	4	1	1
MARSHALL_VIRAL_INFECTION_RESPONSE_DN	12	8	4	1
PID_TCR_CALCIUM_PATHWAY	11	8	4	1
BIOCARTA_VIP_PATHWAY	10	9	4	0
FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1	8	7	4	2
TURJANSKI_MAPK7_TARGETS	6	6	2	0
GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_DN	36	16	9	5
GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN	28	11	5	3
GILMORE_CORE_NFKB_PATHWAY	6	6	2	2
KEGG_ASTHMA	6	5	4	2
GSE2706_UNSTIM_VS_8H_R848_DC_DN	22	14	4	2
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS	18	10	6	1
KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	16	13	6	2
BIOCARTA_STEM_PATHWAY	20	8	5	3
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN	9	8	5	2
P53_DN.V1_DN	36	17	10	5
GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_UP	26	16	6	3
SCHURINGA_STAT5A_TARGETS_DN	6	5	1	1
FUNG_IL2_SIGNALING_2	9	7	4	3
GAURNIER_PSMD4_TARGETS	12	10	5	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	16	12	5	3
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP	15	8	5	1
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP	8	6	3	2
BIOCARTA_CYTOKINE_PATHWAY	8	7	5	2
BIOCARTA_RELA_PATHWAY	7	7	3	0
ZHOU_TNF_SIGNALING_4HR	10	8	3	2
RASHI_NFKB1_TARGETS	10	7	3	2
BIOCARTA_TID_PATHWAY	11	10	6	1
GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN	29	9	5	3
chr4p14	6	5	2	1
YAN_ESCAPE_FROM_ANOIKIS	7	6	1	1
BIOCARTA_DC_PATHWAY	8	7	5	2
BIOCARTA_TH1TH2_PATHWAY	12	10	4	1
ST_GAQ_PATHWAY	9	8	2	2
REACTOME_GLYCOLYSIS	12	7	4	1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN	11	8	5	1
GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN	32	8	3	4
BIOCARTA_CARDIACEGF_PATHWAY	16	11	6	3
GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_UP	33	12	5	4
ST_TUMOR_NECROSIS_FACTOR_PATHWAY	7	6	2	2
DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS	17	7	5	3
LINDSTEDT_DENDRITIC_CELL_MATURATION_A	12	8	2	2
REACTOME_IL_RECEPTOR_SHC_SIGNALING	22	10	5	2
DAZARD_UV_RESPONSE_CLUSTER_G24	16	8	5	2
OHGUCHI_LIVER_HNF4A_TARGETS_DN	23	12	8	3
PID_HIF1_TFPATHWAY	32	11	5	3
BIERIE_INFLAMMATORY_RESPONSE_TGFB1	5	4	1	0
ACAACCT_MIR453	23	8	4	1
FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	21	9	4	3
COLDREN_GEFITINIB_RESISTANCE_UP	22	9	3	2
REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES	9	8	3	1
SEKI_INFLAMMATORY_RESPONSE_LPS_UP	15	8	3	2
MARSON_FOXP3_TARGETS_STIMULATED_UP	8	7	3	1
chr2q12	16	11	4	2
MAHAJAN_RESPONSE_TO_IL1A_UP	10	8	2	1
GSE12839_CTRL_VS_IL12_TREATED_PBMC_UP	30	10	4	3
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1	13	9	5	3
ZHAN_V2_LATE_DIFFERENTIATION_GENES	20	8	5	3
GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN	40	15	7	1
REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL	7	6	3	1
BIOCARTA_FREE_PATHWAY	5	5	4	2
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7	10	7	2	1
GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_DN	25	9	4	2
NAKAMURA_LUNG_CANCER	8	5	2	0
IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS	15	7	3	3
TAVAZOIE_METASTASIS	18	11	5	3
BURTON_ADIPOGENESIS_4	12	9	4	3
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	19	6	3	2
GHANDHI_DIRECT_IRRADIATION_UP	23	7	4	3
PID_DELTA_NP63_PATHWAY	17	8	3	3
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5	4	3	1	1
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN	8	5	3	3
BIOCARTA_IL17_PATHWAY	6	5	3	1
BIOCARTA_GRANULOCYTES_PATHWAY	15	8	6	2
chr11q23	15	10	4	4
SABATES_COLORECTAL_ADENOMA_SIZE_UP	26	8	4	2
KEGG_OTHER_GLYCAN_DEGRADATION	6	4	3	1
DIRMEIER_LMP1_RESPONSE_LATE_UP	20	9	5	2
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	16	13	5	1
BOYLAN_MULTIPLE_MYELOMA_PCA3_DN	20	7	3	3
FIGUEROA_AML_METHYLATION_CLUSTER_4_DN	12	9	5	2
HUMMEL_BURKITTS_LYMPHOMA_DN	4	4	2	1
MARSON_FOXP3_CORE_DIRECT_TARGETS	6	5	1	0
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD	9	6	3	1
CADWELL_ATG16L1_TARGETS_DN	18	6	3	2
CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP	9	5	2	0
ATM_DN.V1_DN	15	12	5	2
BROWNE_HCMV_INFECTION_30MIN_DN	19	12	5	3
KEGG_ALLOGRAFT_REJECTION	9	8	4	1
REACTOME_PLATELET_SENSITIZATION_BY_LDL	7	6	3	1
FERRANDO_TAL1_NEIGHBORS	5	5	3	0
REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION	7	7	4	1
REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX	8	7	4	1
REACTOME_REGULATION_OF_KIT_SIGNALING	16	5	3	3
AKL_HTLV1_INFECTION_UP	8	7	4	2
STREICHER_LSM1_TARGETS_DN	18	7	3	1
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	7	6	4	2
BIOCARTA_STATHMIN_PATHWAY	9	8	3	1
FERRARI_RESPONSE_TO_FENRETINIDE_UP	17	7	3	3
LANDEMAINE_LUNG_METASTASIS	19	8	4	4
YIH_RESPONSE_TO_ARSENITE_C1	11	7	3	1
GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN	14	9	4	5
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	24	8	3	2
HINATA_NFKB_TARGETS_KERATINOCYTE_DN	16	9	5	2
BIOCARTA_IL6_PATHWAY	14	6	3	0
BIOCARTA_IL2_PATHWAY	9	7	5	1
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	8	7	2	0
GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_UP	21	12	6	2
MTOR_UP.V1_UP	31	12	6	3
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP	5	4	1	1
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A	9	8	3	3
UROSEVIC_RESPONSE_TO_IMIQUIMOD	6	6	1	0
LEE_DOUBLE_POLAR_THYMOCYTE	9	7	3	2
GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_DN	23	9	4	2
HEIDENBLAD_AMPLICON_12P11_12_DN	10	8	5	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5	17	9	3	3
FINAK_BREAST_CANCER_SDPP_SIGNATURE	10	6	3	3
KEGG_AUTOIMMUNE_THYROID_DISEASE	11	10	5	1
KEGG_TYPE_I_DIABETES_MELLITUS	8	7	2	0
FARMER_BREAST_CANCER_CLUSTER_8	7	6	3	2
REACTOME_CTLA4_INHIBITORY_SIGNALING	10	7	3	2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	5	5	2	0
REACTOME_DARPP_32_EVENTS	12	8	5	1
GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP	24	12	6	3
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	6	5	3	1
REICHERT_MITOSIS_LIN9_TARGETS	16	6	3	3
HANSON_HRAS_SIGNALING_VIA_NFKB	17	10	5	1
PID_MYC_PATHWAY	25	7	4	2
ST_INTERLEUKIN_4_PATHWAY	16	8	5	1
LIU_LIVER_CANCER	8	6	3	2
MUELLER_METHYLATED_IN_GLIOBLASTOMA	5	4	1	2
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN	11	9	4	2
MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	30	12	5	3
GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	29	11	4	3
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN	18	8	5	3
HUMMERICH_SKIN_CANCER_PROGRESSION_UP	26	9	6	2
BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	6	5	1	1
MORI_PLASMA_CELL_DN	11	8	4	2
CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	9	7	2	1
GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN	27	12	4	2
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP	18	8	3	3
GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN	26	9	4	3
GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_DN	22	9	5	3
GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_DN	25	11	4	2
GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP	21	12	6	3
VALK_AML_CLUSTER_2	10	8	4	3
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP	15	9	5	2
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN	20	8	3	2
GSE22886_TH1_VS_TH2_48H_ACT_UP	30	13	7	5
TOMLINS_PROSTATE_CANCER_UP	20	10	6	4
GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_UP	34	16	6	2
KEGG_PARKINSONS_DISEASE	16	7	3	2
MCBRYAN_PUBERTAL_BREAST_3_4WK_DN	24	9	3	3
ZHAN_MULTIPLE_MYELOMA_DN	11	9	3	2
GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_DN	29	12	4	4
ONGUSAHA_TP53_TARGETS	18	7	3	3
PIONTEK_PKD1_TARGETS_UP	6	5	2	2
KAAB_FAILED_HEART_VENTRICLE_DN	7	6	3	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_14	5	4	1	0
ZHAN_MULTIPLE_MYELOMA_PR_UP	17	6	3	3
WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN	20	9	5	2
VARELA_ZMPSTE24_TARGETS_UP	15	8	3	1
REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	4	3	1	1
SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS	27	12	5	3
WINNEPENNINCKX_MELANOMA_METASTASIS_DN	7	6	2	1
BARRIER_COLON_CANCER_RECURRENCE_UP	10	7	3	3
CONRAD_STEM_CELL	12	9	5	1
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	7	7	4	1
CHANDRAN_METASTASIS_TOP50_DN	12	9	6	3
GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN	24	14	5	3
MCDOWELL_ACUTE_LUNG_INJURY_UP	12	6	3	0
REACTOME_INTERFERON_ALPHA_BETA_SIGNALING	13	10	6	3
chr9q33	22	9	5	4
KERLEY_RESPONSE_TO_CISPLATIN_UP	13	8	4	2
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	11	7	3	2
XU_CREBBP_TARGETS_DN	8	6	3	1
TESAR_ALK_TARGETS_HUMAN_ES_4D_DN	4	4	2	0
SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP	3	3	1	0
WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_DN	4	4	1	0
RAFFEL_VEGFA_TARGETS_DN	3	3	1	0
TESAR_ALK_TARGETS_HUMAN_ES_5D_DN	4	4	2	0
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	33	8	4	3
REACTOME_INTERFERON_GAMMA_SIGNALING	13	9	5	3
KRAS.50_UP.V1_UP	12	8	3	3
chr2q35	18	9	3	1
GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_UP	36	10	7	3
GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_UP	32	11	6	4
chr15q26	15	7	2	2
GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP	19	8	2	3
CAIRO_PML_TARGETS_BOUND_BY_MYC_UP	20	8	4	3
ANDERSEN_CHOLANGIOCARCINOMA_CLASS2	26	9	5	2
chr12q14	17	7	2	2
MENSSEN_MYC_TARGETS	22	5	2	2
GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN	35	12	6	4
BENPORATH_ES_2	18	8	4	2
WANG_CLIM2_TARGETS_DN	20	12	5	2
CAMPS_COLON_CANCER_COPY_NUMBER_UP	19	10	3	2
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	19	8	4	2
GSE11818_WT_VS_DICER_KO_TREG_UP	16	11	3	1
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN	13	5	2	1
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	20	8	3	3
REACTOME_COLLAGEN_FORMATION	12	6	2	2
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN	18	12	5	4
GSE13229_IMM_VS_INTMATURE_NKCELL_UP	36	16	9	5
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	32	12	6	3
SU_TESTIS	22	8	2	2
GALE_APL_WITH_FLT3_MUTATED_UP	10	5	2	2
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	14	9	4	1
chr2p12	17	7	2	0
PID_INTEGRIN1_PATHWAY	13	8	3	2
MOOTHA_VOXPHOS	9	5	2	2
BURTON_ADIPOGENESIS_PEAK_AT_0HR	22	6	2	2
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	21	11	3	2
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	21	7	2	2
KAYO_CALORIE_RESTRICTION_MUSCLE_DN	10	9	4	3
ATCTTGC_MIR31	23	11	6	3
TOOKER_GEMCITABINE_RESISTANCE_DN	22	7	3	2
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	13	6	2	2
TACGGGT_MIR99A_MIR100_MIR99B	13	6	2	0
BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	22	7	4	2
ZHAN_MULTIPLE_MYELOMA_MS_UP	30	12	4	2
KEGG_OXIDATIVE_PHOSPHORYLATION	15	5	2	2
GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_DN	17	11	3	3
GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP	17	7	2	2
HALLMARK_OXIDATIVE_PHOSPHORYLATION	19	8	4	2
SUZUKI_RESPONSE_TO_TSA	5	4	1	2
DAIRKEE_TERT_TARGETS_DN	27	10	4	2
chr7p14	12	8	3	2
GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP	19	8	2	2
chr8p21	17	8	3	2
GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_DN	22	12	4	2
VALK_AML_CLUSTER_13	9	6	2	1
chr3p14	17	12	3	0
chr6q13	17	7	2	2
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	9	6	3	2
BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	17	6	2	0
IGARASHI_ATF4_TARGETS_DN	12	7	2	2
KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM	24	8	4	3
GSE6259_33D1_POS_DC_VS_CD8_TCELL_DN	13	8	4	1
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM	21	9	3	2
REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT	11	8	4	2
CHEN_HOXA5_TARGETS_9HR_DN	11	6	2	2
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21	8	3	2	2
REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	11	6	3	2
CADWELL_ATG16L1_TARGETS_UP	28	11	6	4
SMITH_TERT_TARGETS_DN	16	8	2	2
REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM	14	8	2	2
GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP	27	11	4	2
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	32	12	6	3
PID_SYNDECAN_1_PATHWAY	12	5	2	2
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	19	8	4	1
KANG_CISPLATIN_RESISTANCE_UP	13	6	2	2
KANG_AR_TARGETS_UP	9	5	2	2
GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_DN	22	12	5	2
GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_DN	24	10	3	2
ZHANG_PROLIFERATING_VS_QUIESCENT	24	10	5	3
KANG_GIST_WITH_PDGFRA_UP	10	8	3	3
RADMACHER_AML_PROGNOSIS	21	11	6	2
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	22	10	5	1
HALLMARK_ANGIOGENESIS	21	7	3	2
GILDEA_METASTASIS	9	5	2	1
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_	14	4	2	2
GYORFFY_DOXORUBICIN_RESISTANCE	19	7	2	2
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_UP	22	8	2	2
LEE_LIVER_CANCER_E2F1_DN	11	7	3	2
NABA_COLLAGENS	11	6	2	2
JIANG_HYPOXIA_CANCER	8	6	2	2
ESC_V6.5_UP_LATE.V1_DN	13	9	3	3
REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS	11	5	3	2
HARRIS_HYPOXIA	20	6	2	2
SUNG_METASTASIS_STROMA_UP	28	9	2	2
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP	17	6	3	1
GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_UP	18	12	4	4
GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_DN	28	10	4	3
MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED	6	4	1	1
ST_GRANULE_CELL_SURVIVAL_PATHWAY	17	6	3	1
GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP	33	9	3	2
GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_UP	21	11	4	2
GENTILE_UV_RESPONSE_CLUSTER_D7	10	6	2	2
GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_DN	16	7	2	2
RAY_ALZHEIMERS_DISEASE	15	4	2	2
chr1p22	11	8	3	0
SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	16	8	2	2
ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE	9	6	2	1
REACTOME_METAL_ION_SLC_TRANSPORTERS	15	7	2	0
GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN	16	10	4	2
CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	22	6	2	2
GSE29618_BCELL_VS_PDC_DN	31	13	7	4
MAYBURD_RESPONSE_TO_L663536_UP	18	6	2	2
YRTCANNRCGC_UNKNOWN	23	8	3	2
RHODES_CANCER_META_SIGNATURE	14	4	2	2
LEE_LIVER_CANCER_DENA_UP	11	8	2	0
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP	12	9	2	2
JEON_SMAD6_TARGETS_UP	6	4	1	1
PID_INTEGRIN4_PATHWAY	10	5	2	2
MIKKELSEN_NPC_ICP_WITH_H3K27ME3	10	5	2	2
MURAKAMI_UV_RESPONSE_1HR_UP	7	5	2	1
GGGGCCC_MIR296	18	7	2	2
BROWNE_HCMV_INFECTION_12HR_UP	24	12	5	2
STEARMAN_TUMOR_FIELD_EFFECT_UP	23	9	4	2
GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_UP	22	9	3	2
DEMAGALHAES_AGING_UP	14	5	2	1
BURTON_ADIPOGENESIS_7	24	6	3	2
chr9q21	11	8	2	2
chr12q15	7	5	1	1
KEGG_PENTOSE_PHOSPHATE_PATHWAY	13	6	2	2
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2	17	5	2	2
ROETH_TERT_TARGETS_DN	7	5	2	0
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2	18	6	2	2
MARCHINI_TRABECTEDIN_RESISTANCE_DN	15	7	3	2
HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	24	9	4	2
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	11	9	4	2
AKL_HTLV1_INFECTION_DN	18	9	2	2
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17	7	3	2
GEISS_RESPONSE_TO_DSRNA_DN	25	5	3	2
GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_DN	35	10	6	4
GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP	24	12	5	2
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_UP	17	7	2	2
chr9q34	16	9	5	3
JIANG_AGING_CEREBRAL_CORTEX_UP	18	8	3	2
SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN	18	7	3	2
MOOTHA_GLUCONEOGENESIS	15	7	2	2
GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_DN	19	9	3	2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	20	11	7	4
GSE11924_TFH_VS_TH1_CD4_TCELL_DN	29	13	6	3
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	19	5	2	2
PID_RHOA_PATHWAY	19	7	2	2
ROY_WOUND_BLOOD_VESSEL_UP	21	5	2	1
MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	26	12	3	1
GRADE_METASTASIS_DN	10	5	2	2
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	15	7	3	0
LOPEZ_EPITHELIOID_MESOTHELIOMA	11	6	3	1
REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS	6	4	2	1
PATTERSON_DOCETAXEL_RESISTANCE	18	5	2	2
ODONNELL_METASTASIS_DN	13	4	2	2
YE_METASTATIC_LIVER_CANCER	12	7	3	0
REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN	9	5	2	2
EPPERT_PROGENITOR	13	7	2	2
CHANG_IMMORTALIZED_BY_HPV31_UP	30	10	4	2
SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN	6	4	1	0
MATZUK_STEROIDOGENESIS	8	6	3	3
NADELLA_PRKAR1A_TARGETS_UP	6	4	1	1
LEE_LIVER_CANCER_MYC_E2F1_UP	20	6	2	2
KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	21	7	3	2
chr12p13	16	6	3	2
WEINMANN_ADAPTATION_TO_HYPOXIA_UP	10	7	2	1
chr20p11	13	8	3	1
KEGG_HISTIDINE_METABOLISM	15	3	2	2
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	10	6	4	2
HOEGERKORP_CD44_TARGETS_DIRECT_UP	16	7	2	1
LIAN_LIPA_TARGETS_6M	17	9	3	2
REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1	15	9	3	2
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP	18	5	2	0
chr7q33	8	7	2	1
REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE	19	8	3	2
GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN	28	12	4	2
BASSO_CD40_SIGNALING_DN	20	8	2	1
YGTCCTTGR_UNKNOWN	29	9	2	2
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	18	9	4	3
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18	11	3	2
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP	19	6	3	1
ROZANOV_MMP14_TARGETS_DN	7	5	1	1
chr16q23	19	9	4	2
LIU_BREAST_CANCER	7	5	2	1
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP	10	8	2	2
GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN	18	8	3	2
GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP	18	9	2	2
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP	25	5	2	2
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE	10	5	2	2
NAKAMURA_METASTASIS	14	6	2	2
MMS_MOUSE_LYMPH_HIGH_4HRS_UP	8	5	2	2
TSENG_ADIPOGENIC_POTENTIAL_UP	10	7	1	2
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN	3	3	1	1
YU_BAP1_TARGETS	16	7	2	2
chr14q23	16	5	2	2
REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING	3	2	1	2
CHOW_RASSF1_TARGETS_DN	9	6	3	1
VERNELL_RETINOBLASTOMA_PATHWAY_UP	21	7	3	2
GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN	27	12	5	3
REACTOME_NCAM1_INTERACTIONS	11	6	3	2
GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN	24	13	5	2
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP	8	6	2	2
REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS	6	4	1	1
BECKER_TAMOXIFEN_RESISTANCE_DN	28	11	5	2
TSENG_IRS1_TARGETS_UP	29	11	6	3
NIELSEN_SCHWANNOMA_DN	23	10	4	3
WENG_POR_TARGETS_LIVER_DN	11	5	2	1
NIELSEN_SYNOVIAL_SARCOMA_UP	8	4	1	0
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN	18	8	3	1
FARMER_BREAST_CANCER_CLUSTER_6	18	8	4	0
BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	13	5	2	1
GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_DN	27	9	4	2
NABA_BASEMENT_MEMBRANES	10	7	2	0
LEE_LIVER_CANCER_CIPROFIBRATE_UP	11	7	2	2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9	13	8	4	3
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	21	9	3	1
KYNG_NORMAL_AGING_DN	11	6	2	1
GGTAACC_MIR4095P	21	10	5	2
STAEGE_EWING_FAMILY_TUMOR	25	6	3	2
BAE_BRCA1_TARGETS_DN	13	6	2	0
WIERENGA_PML_INTERACTOME	17	7	3	2
DOANE_BREAST_CANCER_ESR1_DN	13	6	2	2
MYOGNF1_01	27	7	3	2
RASHI_RESPONSE_TO_IONIZING_RADIATION_3	22	6	3	1
JAEGER_METASTASIS_UP	17	9	4	1
MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP	18	5	3	1
SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP	6	5	2	1
WEBER_METHYLATED_LCP_IN_SPERM_UP	8	4	2	0
TSUTSUMI_FBXW8_TARGETS	16	7	3	2
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP	17	8	2	2
WEBER_METHYLATED_IN_COLON_CANCER	8	7	3	1
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	13	7	3	3
KANG_FLUOROURACIL_RESISTANCE_UP	18	10	5	4
MAINA_VHL_TARGETS_DN	9	5	2	1
MURATA_VIRULENCE_OF_H_PILORI	16	5	2	2
KAMIKUBO_MYELOID_MN1_NETWORK	7	6	3	0
chr20p12	12	8	3	3
TANG_SENESCENCE_TP53_TARGETS_UP	16	6	2	2
MALONEY_RESPONSE_TO_17AAG_UP	12	5	2	2
NADERI_BREAST_CANCER_PROGNOSIS_UP	10	6	2	0
XU_GH1_EXOGENOUS_TARGETS_UP	13	6	2	2
GSE27786_CD8_TCELL_VS_ERYTHROBLAST_DN	17	8	3	3
KEGG_GLYCOLYSIS_GLUCONEOGENESIS	19	7	3	2
REACTOME_APOPTOTIC_EXECUTION_PHASE	19	8	3	1
ZHAN_MULTIPLE_MYELOMA_LB_UP	23	7	3	1
chr2q33	24	11	4	0
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP	7	5	2	1
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN	8	6	2	0
REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS	20	7	2	2
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE	8	6	2	1
REACTOME_LYSOSOME_VESICLE_BIOGENESIS	15	5	2	2
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP	12	5	2	2
REACTOME_INSULIN_RECEPTOR_RECYCLING	9	6	3	2
YUAN_ZNF143_PARTNERS	6	5	3	1
VALK_AML_CLUSTER_9	15	10	5	0
SCHRAETS_MLL_TARGETS_DN	9	7	3	1
HARRIS_BRAIN_CANCER_PROGENITORS	11	9	3	1
HUANG_DASATINIB_RESISTANCE_UP	17	9	2	1
REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS	5	4	1	1
MARTINELLI_IMMATURE_NEUTROPHIL_DN	5	3	1	0
REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS	7	6	2	2
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP	15	6	2	2
REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT	4	3	1	0
CHAN_INTERFERON_PRODUCING_DENDRITIC_CELL	7	5	2	1
OXFORD_RALA_TARGETS_DN	7	5	2	1
REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE	20	9	3	2
SCHLESINGER_METHYLATED_IN_COLON_CANCER	14	8	4	0
SU_PANCREAS	24	12	4	2
GSE13522_WT_VS_IFNG_KO_SKIN_UP	11	8	3	2
KEGG_TYROSINE_METABOLISM	20	7	2	2
REACTOME_PROTEIN_FOLDING	10	6	2	1
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN	26	11	4	2
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN	10	6	3	2
STAT3_01	14	5	2	1
REACTOME_GAP_JUNCTION_TRAFFICKING	16	5	2	1
SUMI_HNF4A_TARGETS	8	4	1	1
SAGIV_CD24_TARGETS_UP	8	6	1	2
GTAAGAT_MIR200A	22	12	3	2
LIAN_LIPA_TARGETS_3M	16	9	3	2
GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN	9	5	2	2
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	18	6	3	3
EHLERS_ANEUPLOIDY_UP	11	6	2	1
CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN	21	13	8	2
REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE	24	9	3	2
chr12q12	28	11	6	2
REACTOME_GLUCOSE_TRANSPORT	12	6	3	2
REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE	8	6	3	1
LINDVALL_IMMORTALIZED_BY_TERT_DN	23	8	2	2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8	21	8	4	1
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT	12	4	2	2
REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES	31	8	4	2
BIOCARTA_SRCRPTP_PATHWAY	20	7	4	2
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12	5	3	1	1
REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS	6	4	1	0
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN	15	5	2	2
GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_UP	25	11	5	2
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP	7	5	2	2
MEISSNER_ES_ICP_WITH_H3K4ME3	11	4	2	2
WU_HBX_TARGETS_2_UP	8	4	2	1
ONO_AML1_TARGETS_UP	13	5	2	0
SINGH_KRAS_DEPENDENCY_SIGNATURE_	20	7	2	1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP	5	5	1	1
REACTOME_MRNA_3_END_PROCESSING	7	6	3	1
KEGG_NUCLEOTIDE_EXCISION_REPAIR	9	7	2	1
PPARA_01	21	5	2	1
GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP	10	7	2	1
DAZARD_UV_RESPONSE_CLUSTER_G1	8	6	2	2
HALLMARK_BILE_ACID_METABOLISM	6	5	1	1
NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON	5	4	1	1
WENG_POR_TARGETS_GLOBAL_DN	21	8	5	1
REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY	6	4	2	1
REACTOME_KERATAN_SULFATE_BIOSYNTHESIS	12	7	3	1
GLI1_UP.V1_UP	6	5	2	2
chr14q22	8	6	2	2
GENTILE_UV_RESPONSE_CLUSTER_D5	23	8	4	2
LEIN_ASTROCYTE_MARKERS	14	7	2	2
GTTNYYNNGGTNA_UNKNOWN	7	5	2	2
WU_HBX_TARGETS_1_UP	12	6	3	3
CHANG_POU5F1_TARGETS_UP	11	5	2	1
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP	14	5	2	1
PIONTEK_PKD1_TARGETS_DN	19	5	2	2
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP	16	7	4	4
GHO_ATF5_TARGETS_UP	13	7	2	0
HAHTOLA_CTCL_PATHOGENESIS	7	6	2	2
HOEGERKORP_CD44_TARGETS_DIRECT_DN	11	5	2	1
REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY	6	4	2	2
KANG_FLUOROURACIL_RESISTANCE_DN	13	8	3	1
DAZARD_UV_RESPONSE_CLUSTER_G4	12	4	2	1
chr22q12	9	6	2	2
chr1q42	15	7	2	0
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	23	8	4	2
KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN	8	5	2	2
PASTURAL_RIZ1_TARGETS_DN	20	7	3	2
KORKOLA_CHORIOCARCINOMA	4	4	1	0
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3	5	3	1	2
PHONG_TNF_TARGETS_DN	2	2	1	0
RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP	5	4	1	1
DANG_REGULATED_BY_MYC_UP	9	6	3	1
PETRETTO_HEART_MASS_QTL_CIS_UP	6	4	1	1
REACTOME_RNA_POL_III_TRANSCRIPTION	6	5	2	2
REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES	29	8	4	2
GSE8835_CD4_VS_CD8_TCELL_DN	24	10	5	2
REACTOME_METABOLISM_OF_NON_CODING_RNA	5	4	2	1
WARTERS_IR_RESPONSE_5GY	13	5	2	2
NAKAMURA_ADIPOGENESIS_EARLY_DN	18	8	3	2
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	18	10	4	1
SHIN_B_CELL_LYMPHOMA_CLUSTER_5	7	4	3	1
KIM_LRRC3B_TARGETS	9	4	2	1
REACTOME_BASE_EXCISION_REPAIR	6	4	2	2
MOOTHA_GLYCOLYSIS	12	3	2	2
WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP	11	7	3	3
KEGG_CITRATE_CYCLE_TCA_CYCLE	10	6	3	1
KYNG_WERNER_SYNDROM_DN	6	5	1	1
YANG_BREAST_CANCER_ESR1_DN	6	5	1	0
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	4	2	1	1
REACTOME_GLOBAL_GENOMIC_NER_GG_NER	7	6	2	2
MCCLUNG_DELTA_FOSB_TARGETS_8WK	27	8	3	2
chr3p22	10	7	2	0
CROMER_TUMORIGENESIS_UP	10	5	2	1
MIKKELSEN_MEF_LCP_WITH_H3K27ME3	18	3	2	1
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	19	10	3	3
GUILLAUMOND_KLF10_TARGETS_DN	7	6	3	0
REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM	12	7	3	2
REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT	7	5	2	1
BIOCARTA_RHO_PATHWAY	19	6	3	2
PID_IL8_CXCR1_PATHWAY	9	5	2	1
REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS	16	5	2	3
LEE_LIVER_CANCER_ACOX1_DN	12	5	2	1
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP	19	7	3	2
LUI_THYROID_CANCER_CLUSTER_2	7	6	2	1
MA_MYELOID_DIFFERENTIATION_DN	15	10	5	1
KARAKAS_TGFB1_SIGNALING	17	6	2	0
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN	7	6	1	1
MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN	8	5	2	3
BIOCARTA_AGPCR_PATHWAY	13	7	3	1
CROONQUIST_IL6_DEPRIVATION_UP	19	5	2	2
BIOCARTA_ARAP_PATHWAY	14	5	2	2
ABBUD_LIF_SIGNALING_2_UP	12	6	2	1
TRAYNOR_RETT_SYNDROM_DN	16	10	6	2
GAVIN_FOXP3_TARGETS_CLUSTER_T7	11	8	3	0
TIEN_INTESTINE_PROBIOTICS_2HR_DN	21	8	3	2
REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY	2	2	1	0
ZHENG_FOXP3_TARGETS_DN	5	5	1	1
TCGATGG_MIR213	10	5	2	1
REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY	5	4	2	1
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN	4	4	1	0
MAINA_VHL_TARGETS_UP	4	2	1	0
CASTELLANO_HRAS_AND_NRAS_TARGETS_DN	5	4	2	0
MARSHALL_VIRAL_INFECTION_RESPONSE_UP	5	3	1	0
KIM_PTEN_TARGETS_DN	13	6	3	2
chr2q	9	4	2	0
MIZUKAMI_HYPOXIA_DN	6	4	2	0
PID_ERBB1_INTERNALIZATION_PATHWAY	14	6	2	0
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6	14	5	2	2
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	15	6	2	2
ZHU_CMV_8_HR_UP	14	6	2	0
BIOCARTA_TNFR1_PATHWAY	10	6	2	2
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	8	6	3	1
BIOCARTA_EGF_PATHWAY	15	7	2	1
CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY	6	5	1	0
ST_INTEGRIN_SIGNALING_PATHWAY	18	8	4	3
LEE_LIVER_CANCER_DENA_DN	6	5	2	0
ZHAN_MULTIPLE_MYELOMA_MF_UP	6	5	1	0
PID_ARF_3PATHWAY	11	4	2	1
LE_NEURONAL_DIFFERENTIATION_UP	19	6	2	2
GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP	16	7	3	0
BIOCARTA_SHH_PATHWAY	18	6	3	1
WANG_THOC1_TARGETS_DN	18	6	4	3
chr7p12	12	7	2	1
SCIBETTA_KDM5B_TARGETS_UP	8	6	2	1
chr7q34	6	5	1	2
BIOCARTA_PDGF_PATHWAY	18	8	3	1
HU_GENOTOXIC_DAMAGE_4HR	25	9	3	1
GSE22886_NEUTROPHIL_VS_DC_UP	21	8	2	1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN	23	10	4	4
KEEN_RESPONSE_TO_ROSIGLITAZONE_DN	21	10	6	0
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	10	7	2	2
REACTOME_AMYLOIDS	7	5	2	1
TING_SILENCED_BY_DICER	7	6	2	1
REACTOME_IRON_UPTAKE_AND_TRANSPORT	7	5	2	0
HEIDENBLAD_AMPLICON_8Q24_DN	11	7	3	2
LEE_CALORIE_RESTRICTION_MUSCLE_DN	11	6	3	2
BIOCARTA_CALCINEURIN_PATHWAY	7	5	2	1
REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE	8	6	3	0
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	16	6	3	1
KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	21	9	5	1
SESTO_RESPONSE_TO_UV_C4	17	6	3	1
YIH_RESPONSE_TO_ARSENITE_C2	6	5	1	0
LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS	8	5	2	0
BIOCARTA_PML_PATHWAY	12	5	2	2
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP	12	4	2	1
MARCHINI_TRABECTEDIN_RESISTANCE_UP	11	5	2	1
MAHADEVAN_IMATINIB_RESISTANCE_UP	8	5	1	0
REACTOME_AMINE_DERIVED_HORMONES	5	5	2	1
FINETTI_BREAST_CANCERS_KINOME_GRAY	19	6	2	0
REACTOME_XENOBIOTICS	16	8	5	4
SHIRAISHI_PLZF_TARGETS_DN	5	4	1	0
HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER	13	4	2	2
HOLLEMAN_DAUNORUBICIN_ALL_UP	12	4	2	1
MIKI_COEXPRESSED_WITH_CYP19A1	3	2	1	2
TSAI_DNAJB4_TARGETS_DN	7	5	2	2
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP	9	7	3	0
OHM_EMBRYONIC_CARCINOMA_UP	6	4	1	1
REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY	5	4	2	1
REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK	5	4	1	1
ABBUD_LIF_SIGNALING_2_DN	4	4	1	1
MATZUK_MATERNAL_EFFECT	6	4	2	2
CHESLER_BRAIN_QTL_TRANS	5	3	1	0
BOYLAN_MULTIPLE_MYELOMA_PCA1_DN	4	4	1	1
WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP	7	4	2	0
REACTOME_COPI_MEDIATED_TRANSPORT	8	5	2	1
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	21	7	2	2
LEE_LIVER_CANCER_MYC_UP	12	7	3	0
LEE_LIVER_CANCER_MYC_E2F1_DN	4	4	1	1
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN	18	7	4	2
YAP1_DN	12	8	5	1
GUTIERREZ_MULTIPLE_MYELOMA_UP	13	6	2	0
ZEMBUTSU_SENSITIVITY_TO_CISPLATIN	9	5	2	2
DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	6	5	2	1
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP	9	5	2	1
KEGG_RNA_POLYMERASE	6	3	2	1
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP	6	5	2	0
SEKI_INFLAMMATORY_RESPONSE_LPS_DN	6	2	1	1
WU_HBX_TARGETS_3_UP	5	4	2	1
SA_CASPASE_CASCADE	6	5	1	1
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7	23	4	2	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP	17	8	4	1
BCAT_GDS748_UP	7	6	1	1
chr1q23	13	10	5	1
chr14q31	6	5	1	1
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	7	3	1	2
chr6q27	6	5	1	1
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP	8	6	2	0
REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS	9	6	2	1
REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	16	9	2	1
HU_ANGIOGENESIS_UP	5	4	1	0
MCCABE_HOXC6_TARGETS_CANCER_DN	12	6	2	2
GRADE_COLON_VS_RECTAL_CANCER_UP	12	5	2	0
PID_IL8_CXCR2_PATHWAY	9	5	2	1
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	18	6	2	2
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP	18	7	3	2
XU_GH1_EXOGENOUS_TARGETS_DN	32	7	4	2
MAYBURD_RESPONSE_TO_L663536_DN	20	7	2	2
SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN	8	6	1	0
ZAMORA_NOS2_TARGETS_DN	26	11	4	2
CORRE_MULTIPLE_MYELOMA_UP	26	11	2	2
KYNG_DNA_DAMAGE_BY_4NQO	12	6	2	1
CHOI_ATL_STAGE_PREDICTOR	7	5	2	0
KIM_MYCL1_AMPLIFICATION_TARGETS_DN	6	4	2	2
VERRECCHIA_RESPONSE_TO_TGFB1_C2	22	10	5	3
BUDHU_LIVER_CANCER_METASTASIS_UP	9	8	4	1
REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION	6	4	2	1
MIKKELSEN_IPS_LCP_WITH_H3K27ME3	5	3	1	0
WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1	7	5	1	1
OXFORD_RALB_TARGETS_UP	5	4	1	0
KANG_CISPLATIN_RESISTANCE_DN	4	3	1	1
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP	16	8	4	1
KEGG_FOLATE_BIOSYNTHESIS	6	4	2	0
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN	4	3	1	1
NADELLA_PRKAR1A_TARGETS_DN	9	7	1	1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	6	5	2	1
FIGUEROA_AML_METHYLATION_CLUSTER_2_DN	15	8	4	1
MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY	8	7	4	2
REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION	4	3	1	0
CHOI_ATL_CHRONIC_VS_ACUTE_DN	8	6	2	0
REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR	10	6	3	0
LIANG_SILENCED_BY_METHYLATION_DN	15	5	2	1
ZHU_SKIL_TARGETS_UP	9	7	2	1
OXFORD_RALA_AND_RALB_TARGETS_DN	9	6	2	0
chr1p	9	5	3	0
REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA	11	8	4	0
LUCAS_HNF4A_TARGETS_DN	5	4	1	1
LUCAS_HNF4A_TARGETS_UP	16	8	2	0
SHIPP_DLBCL_CURED_VS_FATAL_DN	6	5	1	1
MCDOWELL_ACUTE_LUNG_INJURY_DN	21	9	3	2
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP	14	6	2	1
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP	12	7	3	2
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS	25	8	3	1
SESTO_RESPONSE_TO_UV_C6	26	7	4	2
KUMAR_AUTOPHAGY_NETWORK	20	6	2	2
GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_UP	30	10	4	3
GLI1_UP.V1_DN	12	7	4	3
CHOW_RASSF1_TARGETS_UP	10	5	2	1
CHIBA_RESPONSE_TO_TSA_DN	11	7	2	1
GAVIN_PDE3B_TARGETS	12	9	2	0
chr3q23	8	7	2	0
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4	11	7	3	2
REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE	13	4	2	2
REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING	14	5	2	1
REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS	10	7	2	1
chr4q12	8	6	2	0
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	14	7	2	2
chr1q24	11	9	4	0
BIOCARTA_EIF2_PATHWAY	16	6	2	1
BIOCARTA_ETC_PATHWAY	4	3	1	0
NOUSHMEHR_GBM_SOMATIC_MUTATED	8	5	2	0
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN	6	3	2	2
BIOCARTA_ACE2_PATHWAY	8	7	3	2
MEISSNER_NPC_ICP_WITH_H3K4ME3	8	3	2	2
PID_ALK2_PATHWAY	8	7	2	0
REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS	5	4	1	0
AACGGTT_MIR451	6	5	1	0
REACTOME_GLYCOPROTEIN_HORMONES	6	6	1	1
LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP	4	4	1	0
BIOCARTA_SARS_PATHWAY	12	6	2	0
REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND	4	2	1	2
RAFFEL_VEGFA_TARGETS_UP	17	5	2	0
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN	7	6	2	1
OSAWA_TNF_TARGETS	7	4	2	0
CGTCTTA_MIR208	6	5	1	0
NADLER_OBESITY_UP	10	5	2	2
NIKOLSKY_BREAST_CANCER_19P13_AMPLICON	12	6	4	3
HEDENFALK_BREAST_CANCER_BRACX_DN	7	4	1	0
KIM_GERMINAL_CENTER_T_HELPER_DN	13	7	3	2
chr2q32	15	9	2	0
COWLING_MYCN_TARGETS	10	6	2	1
NEWMAN_ERCC6_TARGETS_DN	18	11	3	0
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	13	6	2	0
CHIBA_RESPONSE_TO_TSA	15	7	3	0
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN	7	6	2	1
REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING	10	7	3	1
VALK_AML_CLUSTER_8	7	5	1	0
chr20q12	6	5	1	2
chr2p22	13	11	2	0
HOEGERKORP_CD44_TARGETS_TEMPORAL_DN	7	6	2	2
GAJATE_RESPONSE_TO_TRABECTEDIN_UP	7	5	2	2
FRIDMAN_SENESCENCE_DN	6	5	2	0
HEDENFALK_BREAST_CANCER_BRACX_UP	6	5	1	1
REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE	9	7	2	1
IGLESIAS_E2F_TARGETS_DN	10	5	2	0
REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS	8	6	2	2
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES	7	6	1	2
KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP	9	7	2	1
BIOCARTA_RANMS_PATHWAY	6	3	2	1
HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER	16	8	2	2
KEGG_STEROID_BIOSYNTHESIS	6	4	2	1
SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN	5	4	1	0
KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP	5	4	2	0
REACTOME_CS_DS_DEGRADATION	20	5	2	2
REACTOME_G2_M_CHECKPOINTS	7	6	3	0
NAKAMURA_METASTASIS_MODEL_DN	9	6	2	2
REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S	10	6	3	1
chr7q36	17	6	2	2
EINAV_INTERFERON_SIGNATURE_IN_CANCER	6	5	1	0
BIOCARTA_CCR3_PATHWAY	23	6	3	2
WANG_NFKB_TARGETS	7	3	2	1
chr2p11	5	4	1	0
MATZUK_SPERMATOGONIA	13	5	2	0
NOJIMA_SFRP2_TARGETS_DN	6	5	2	1
GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_DN	18	9	3	2
LEIN_CHOROID_PLEXUS_MARKERS	16	7	2	2
NAKAMURA_CANCER_MICROENVIRONMENT_DN	11	7	2	1
ROESSLER_LIVER_CANCER_METASTASIS_DN	7	5	1	0
KEGG_BASE_EXCISION_REPAIR	6	4	2	2
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN	15	9	5	2
KRIGE_AMINO_ACID_DEPRIVATION	12	7	2	1
KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM	5	4	2	1
chr2p16	14	10	3	1
chr17q24	9	5	2	2
NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS	4	3	1	0
TERAMOTO_OPN_TARGETS_CLUSTER_4	5	3	1	1
TAGHAVI_NEOPLASTIC_TRANSFORMATION	13	5	2	2
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE	10	8	3	1
LI_CYTIDINE_ANALOGS_CYCTOTOXICITY	11	6	3	2
REACTOME_PECAM1_INTERACTIONS	17	6	3	2
REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM	5	4	1	1
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN	10	5	2	1
ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS	21	7	3	2
ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN	7	4	2	0
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4	7	5	2	0
BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP	12	5	2	2
BIOCARTA_BARRESTIN_PATHWAY	12	5	3	2
REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS	6	5	2	0
XU_RESPONSE_TO_TRETINOIN_UP	9	7	3	0
REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI	10	4	2	1
REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION	7	5	2	1
GSE40666_WT_VS_STAT4_KO_CD8_TCELL_DN	21	8	4	2
LAIHO_COLORECTAL_CANCER_SERRATED_UP	21	10	6	1
BROWNE_HCMV_INFECTION_6HR_UP	11	6	2	2
TSENG_ADIPOGENIC_POTENTIAL_DN	8	6	2	2
NAKAYAMA_FRA2_TARGETS	9	7	3	0
GRADE_COLON_VS_RECTAL_CANCER_DN	14	6	2	1
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN	6	4	1	1
PID_REELIN_PATHWAY	22	6	2	2
SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER	8	7	3	0
BROWNE_HCMV_INFECTION_10HR_UP	11	7	2	1
ROVERSI_GLIOMA_COPY_NUMBER_DN	9	9	3	1
DITTMER_PTHLH_TARGETS_DN	22	7	4	1
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	21	12	6	2
REACTOME_ZINC_TRANSPORTERS	12	6	2	1
BIOCARTA_CFTR_PATHWAY	4	3	1	0
chr11p12	12	9	4	3
BIOCARTA_TRKA_PATHWAY	8	6	2	1
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP	4	3	2	1
LEE_SP4_THYMOCYTE	11	6	3	0
MOOTHA_TCA	8	5	3	1
GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3	5	3	1	1
REACTOME_HYALURONAN_METABOLISM	9	5	2	2
KEGG_RENIN_ANGIOTENSIN_SYSTEM	10	8	3	2
OZANNE_AP1_TARGETS_UP	15	11	5	2
GSE2706_2H_VS_8H_LPS_STIM_DC_UP	30	11	3	2
IKEDA_MIR30_TARGETS_DN	14	9	2	2
chr11q14	9	7	2	1
HONMA_DOCETAXEL_RESISTANCE	23	8	5	2
KEEN_RESPONSE_TO_ROSIGLITAZONE_UP	7	3	2	1
MODY_HIPPOCAMPUS_NEONATAL	14	9	3	1
PLASARI_NFIC_TARGETS_BASAL_UP	9	7	2	2
KORKOLA_CORRELATED_WITH_POU5F1	9	3	2	1
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	8	6	2	0
BALDWIN_PRKCI_TARGETS_UP	8	6	2	1
NOJIMA_SFRP2_TARGETS_UP	8	5	2	0
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	6	5	1	0
chr6p	5	4	1	0
OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_DN	4	3	1	1
HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3	20	6	3	0
LEE_LIVER_CANCER_MYC_TGFA_DN	6	6	2	1
MIKKELSEN_IPS_ICP_WITH_H3K27ME3	8	7	1	2
ZWANG_EGF_PERSISTENTLY_DN	12	7	2	1
REACTOME_MRNA_SPLICING_MINOR_PATHWAY	18	5	3	2
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN	7	6	1	1
REACTOME_SIGNALING_BY_FGFR1_MUTANTS	19	9	4	2
chr2p13	14	9	2	0
GENTILE_UV_RESPONSE_CLUSTER_D9	18	6	2	1
GHANDHI_DIRECT_IRRADIATION_DN	13	8	3	1
NGUYEN_NOTCH1_TARGETS_UP	17	5	2	2
LIU_IL13_MEMORY_MODEL_UP	16	5	2	2
MATZUK_OVULATION	18	10	5	3
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP	12	6	3	0
VILIMAS_NOTCH1_TARGETS_DN	6	4	2	1
ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN	6	5	2	1
chr3p23	5	4	1	0
REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS	7	5	2	3
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8	14	8	4	2
KORKOLA_TERATOMA_UP	17	4	2	2
REACTOME_METABOLISM_OF_POLYAMINES	7	5	1	0
REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT	16	12	6	2
REACTOME_PYRUVATE_METABOLISM	5	4	1	1
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS	7	5	1	1
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP	13	6	3	2
PID_UPA_UPAR_PATHWAY	19	7	2	2
GROSS_ELK3_TARGETS_DN	9	8	4	1
ZWANG_EGF_PERSISTENTLY_UP	10	8	3	2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	5	5	1	0
CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE	20	6	2	1
CHEN_LIVER_METABOLISM_QTL_CIS	9	7	2	0
REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1	15	7	3	1
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN	7	5	1	1
THUM_MIR21_TARGETS_HEART_DISEASE_UP	11	5	2	2
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	10	6	3	1
REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER	5	4	2	2
LIM_MAMMARY_LUMINAL_PROGENITOR_DN	27	8	3	2
chr3q24	6	5	1	0
SA_MMP_CYTOKINE_CONNECTION	7	4	2	1
VICENT_METASTASIS_UP	8	7	3	1
FINETTI_BREAST_CANCER_KINOME_RED	11	6	2	2
WANG_RECURRENT_LIVER_CANCER_DN	6	4	1	0
BIOCARTA_CARM1_PATHWAY	7	5	2	0
GHO_ATF5_TARGETS_DN	6	5	1	0
LUND_SILENCED_BY_METHYLATION	10	4	2	2
LY_AGING_MIDDLE_UP	8	4	1	1
SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP	5	3	1	0
BIOCARTA_CCR5_PATHWAY	6	5	1	1
NIELSEN_LIPOSARCOMA_UP	16	6	2	2
KEGG_NON_HOMOLOGOUS_END_JOINING	9	6	4	0
DORSAM_HOXA9_TARGETS_UP	9	6	2	0
KAAB_FAILED_HEART_ATRIUM_UP	14	6	3	2
BIOCARTA_PLATELETAPP_PATHWAY	13	10	6	3
BIOCARTA_AMI_PATHWAY	14	10	6	3
chr7q31	12	9	2	2
HAN_JNK_SINGALING_UP	9	9	5	1
chr4q13	4	4	0	0
chr7p21	7	7	1	2
CTCTAGA_MIR526C_MIR518F_MIR526A	11	7	2	1
KEGG_O_GLYCAN_BIOSYNTHESIS	14	6	1	1
LU_TUMOR_VASCULATURE_DN	6	6	1	0
chr8q22	8	8	1	0
ROETH_TERT_TARGETS_UP	5	5	0	0
PLASARI_TGFB1_TARGETS_1HR_DN	5	5	1	0
WOTTON_RUNX_TARGETS_DN	15	7	2	1
YU_MYC_TARGETS_DN	12	10	5	1
TAKAYAMA_BOUND_BY_AR	8	6	1	1
REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS	3	3	0	0
REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING	8	8	4	0
chr1p13	23	14	5	2
HOFFMAN_CLOCK_TARGETS_UP	5	5	1	0
chr14q21	9	9	2	1
KEGG_STARCH_AND_SUCROSE_METABOLISM	5	5	1	0
chr4q32	6	6	0	0
YANG_BREAST_CANCER_ESR1_LASER_UP	13	7	3	2
ZHENG_FOXP3_TARGETS_UP	14	10	2	0
chr2q22	10	10	4	0
HATADA_METHYLATED_IN_LUNG_CANCER_DN	10	6	2	1
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN	4	4	0	0
ZHAN_MULTIPLE_MYELOMA_CD1_DN	6	6	1	0
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	9	9	2	0
REACTOME_HS_GAG_BIOSYNTHESIS	10	10	1	0
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN	6	6	0	0
WEBER_METHYLATED_ICP_IN_SPERM_UP	4	4	0	0
WAGNER_APO2_SENSITIVITY	5	5	0	0
ROVERSI_GLIOMA_LOH_REGIONS	14	14	3	0
BROWNE_HCMV_INFECTION_2HR_DN	7	7	1	0
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP	7	7	1	0
THILLAINADESAN_ZNF217_TARGETS_DN	5	5	0	0
IKEDA_MIR1_TARGETS_DN	5	5	0	0
chr3q25	11	9	4	0
REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	8	8	1	0
WOTTON_RUNX_TARGETS_UP	12	6	1	0
chr7q22	9	8	1	1
chr2q21	7	7	0	0
WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN	7	6	2	1
chr2q24	12	11	3	0
chr3p26	7	7	0	0
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN	12	9	3	3
SU_THYMUS	8	7	3	0
KRASNOSELSKAYA_ILF3_TARGETS_UP	6	6	0	0
LINDSTEDT_DENDRITIC_CELL_MATURATION_D	10	7	3	1
GTTGNYNNRGNAAC_UNKNOWN	17	8	3	2
WATANABE_COLON_CANCER_MSI_VS_MSS_UP	16	7	3	2
chr2q14	5	5	0	0
CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY	5	5	0	0
chr3q12	6	6	0	0
chr6q12	6	6	0	0
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP	4	4	0	0
HASEGAWA_TUMORIGENESIS_BY_RET_C634R	4	4	0	0
REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS	12	6	2	1
chr10p13	6	5	1	1
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP	10	5	1	1
KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM	6	6	1	1
REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1	21	9	4	3
PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP	6	6	1	0
BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX	6	5	1	1
chr13q12	8	7	2	1
KANG_GIST_WITH_PDGFRA_DN	6	6	1	0
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_3	5	5	1	0
chr19p12	5	5	0	1
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP	20	8	3	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	17	8	3	0
chr1p21	9	7	1	0
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	4	4	0	0
BOWIE_RESPONSE_TO_TAMOXIFEN	3	3	0	0
chr13q33	6	6	0	0
KYNG_DNA_DAMAGE_BY_UV	11	10	2	1
KEGG_DORSO_VENTRAL_AXIS_FORMATION	10	7	2	2
chr17p11	5	4	1	2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	10	6	3	2
REACTOME_PACKAGING_OF_TELOMERE_ENDS	5	3	2	1
chr2q11	11	9	5	0
HOWLIN_CITED1_TARGETS_2_UP	9	8	4	2
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	9	5	2	2
REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS	21	6	2	2
SUNG_METASTASIS_STROMA_DN	7	5	2	2
KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM	12	6	2	1
BIOCARTA_SPRY_PATHWAY	5	4	1	1
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES	9	8	2	0
REACTOME_LAGGING_STRAND_SYNTHESIS	12	3	2	2
BIOCARTA_TPO_PATHWAY	8	6	3	1
REACTOME_EXTENSION_OF_TELOMERES	13	4	2	2
BIOCARTA_GLEEVEC_PATHWAY	7	6	2	0
KALMA_E2F1_TARGETS	14	4	2	2
MIKKELSEN_MCV6_LCP_WITH_H3K27ME3	7	6	2	2
REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING	18	5	2	2
REACTOME_POL_SWITCHING	14	5	2	2
OHASHI_AURKA_TARGETS	3	2	1	0
REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI	15	11	6	2
chr14q32	31	9	4	2
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN	7	6	4	0
REACTOME_RAP1_SIGNALLING	14	7	3	2
PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN	7	4	1	0
SEIDEN_MET_SIGNALING	12	6	3	0
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	13	7	3	0
REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS	8	6	2	1
BIOCARTA_EPO_PATHWAY	5	4	2	0
BARRIER_COLON_CANCER_RECURRENCE_DN	5	4	1	1
PID_INTEGRIN5_PATHWAY	9	8	4	0
KEGG_DNA_REPLICATION	13	4	2	2
HALLMARK_PEROXISOME	8	7	2	2
TURJANSKI_MAPK8_AND_MAPK9_TARGETS	10	5	2	2
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP	11	8	4	3
MCBRYAN_TERMINAL_END_BUD_DN	7	5	2	1
DAZARD_UV_RESPONSE_CLUSTER_G5	9	6	3	2
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP	18	7	2	1
FOURNIER_ACINAR_DEVELOPMENT_LATE_DN	6	4	1	1
KEGG_BETA_ALANINE_METABOLISM	6	5	1	0
ONO_FOXP3_TARGETS_UP	11	9	5	0
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM	10	6	3	2
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	15	7	4	4
REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS	10	5	2	1
PID_S1P_META_PATHWAY	6	5	2	0
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP	6	4	2	0
REACTOME_ADP_SIGNALLING_THROUGH_P2RY1	17	7	2	1
VANLOO_SP3_TARGETS_UP	4	4	1	0
YAGUE_PRETUMOR_DRUG_RESISTANCE_UP	6	5	1	1
CAFFAREL_RESPONSE_TO_THC_8HR_3_DN	15	6	3	2
PID_ARF6_PATHWAY	15	6	2	1
BILANGES_SERUM_RESPONSE_TRANSLATION	24	10	4	4
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	7	6	3	1
VANDESLUIS_NORMAL_EMBRYOS_DN	10	6	3	1
CROMER_TUMORIGENESIS_DN	9	5	2	0
WILLIAMS_ESR1_TARGETS_UP	8	6	2	1
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP	7	4	2	2
REACTOME_KERATAN_SULFATE_DEGRADATION	8	4	2	2
GALIE_TUMOR_ANGIOGENESIS	6	5	2	1
MCCABE_HOXC6_TARGETS_DN	18	7	2	2
BIOCARTA_SPPA_PATHWAY	17	5	2	2
MANTOVANI_NFKB_TARGETS_UP	5	5	1	1
REACTOME_SIGNAL_AMPLIFICATION	21	7	2	1
POS_RESPONSE_TO_HISTAMINE_UP	4	3	1	0
SU_KIDNEY	5	4	1	2
BIOCARTA_EPHA4_PATHWAY	8	7	3	1
MANN_RESPONSE_TO_AMIFOSTINE_DN	13	5	2	1
CHESLER_BRAIN_D6MIT150_QTL_TRANS	6	5	2	1
chr4p11	5	4	1	0
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN	5	4	1	0
LE_EGR2_TARGETS_DN	18	8	3	1
MACLACHLAN_BRCA1_TARGETS_DN	10	5	2	0
PID_ERB_GENOMIC_PATHWAY	7	5	2	2
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES	6	5	1	1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN	5	5	2	1
REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS	5	4	1	1
LOPES_METHYLATED_IN_COLON_CANCER_DN	23	10	5	0
MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED	5	4	1	1
GNATENKO_PLATELET_SIGNATURE	12	7	3	1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15	11	5	2	2
HOLLERN_MICROACINAR_BREAST_TUMOR_UP	7	5	2	2
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	11	7	3	1
chr1p12	6	5	2	0
ZHAN_LATE_DIFFERENTIATION_GENES_DN	5	4	2	0
PAX5_02	13	6	2	2
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP	20	5	2	2
MEISSNER_BRAIN_HCP_WITH_H3K4ME2	7	6	2	2
LEE_LIVER_CANCER_HEPATOBLAST	12	5	2	2
REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS	14	5	2	1
KORKOLA_TERATOMA	13	8	4	0
SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	15	6	2	1
PODAR_RESPONSE_TO_ADAPHOSTIN_DN	14	8	4	1
BIOCARTA_CBL_PATHWAY	5	4	1	1
PID_TCR_RAS_PATHWAY	9	5	2	1
FUKUSHIMA_TNFSF11_TARGETS	15	8	3	3
MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	4	3	1	0
KEGG_RIBOFLAVIN_METABOLISM	7	5	2	0
REACTOME_DEADENYLATION_OF_MRNA	4	4	1	0
APPIERTO_RESPONSE_TO_FENRETINIDE_UP	15	6	2	1
DOANE_BREAST_CANCER_CLASSES_DN	9	7	3	0
CASTELLANO_NRAS_TARGETS_UP	15	9	4	2
GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_DN	21	10	3	1
REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR	6	5	2	0
REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_	7	6	2	2
AMUNDSON_DNA_DAMAGE_RESPONSE_TP53	7	5	2	2
REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS	15	6	3	1
ST_G_ALPHA_S_PATHWAY	16	6	3	3
MIKKELSEN_ES_ICP_WITH_H3K27ME3	6	5	1	1
NUTT_GBM_VS_AO_GLIOMA_UP	8	7	1	0
ALONSO_METASTASIS_NEURAL_UP	13	6	3	1
VISALA_AGING_LYMPHOCYTE_DN	12	7	4	1
LIU_TARGETS_OF_VMYB_VS_CMYB_UP	10	6	3	1
REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM	9	6	2	1
BRACHAT_RESPONSE_TO_CISPLATIN	19	6	3	2
VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP	14	6	3	0
ABE_INNER_EAR	12	6	2	2
KEGG_ABC_TRANSPORTERS	12	9	3	3
BIOCARTA_MTA3_PATHWAY	11	5	3	2
KRCTCNNNNMANAGC_UNKNOWN	8	6	2	0
TERAMOTO_OPN_TARGETS_CLUSTER_7	7	6	2	0
REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA	10	6	3	0
REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS	14	5	3	1
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	12	6	2	0
REACTOME_PEROXISOMAL_LIPID_METABOLISM	8	5	1	0
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN	14	8	4	1
BIOCARTA_ACTINY_PATHWAY	7	6	2	1
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION	9	6	2	0
NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP	5	4	1	0
DALESSIO_TSA_RESPONSE	8	6	3	1
NAM_FXYD5_TARGETS_DN	7	5	2	0
SPIRA_SMOKERS_LUNG_CANCER_DN	8	7	2	0
BURTON_ADIPOGENESIS_9	13	8	3	3
MOOTHA_ROS	5	4	1	1
NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF	8	5	2	2
SESTO_RESPONSE_TO_UV_C2	9	7	3	2
PID_THROMBIN_PAR4_PATHWAY	13	5	3	1
PID_CONE_PATHWAY	5	4	1	1
KASLER_HDAC7_TARGETS_1_DN	9	7	2	1
GREENBAUM_E2A_TARGETS_DN	9	7	4	2
PID_RHODOPSIN_PATHWAY	6	5	2	1
chr13q21	12	8	2	1
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP	4	4	0	0
NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON	7	7	0	0
chr8p11	6	6	0	0
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	5	5	1	0
RUAN_RESPONSE_TO_TROGLITAZONE_UP	8	6	1	1
BIOCARTA_IL4_PATHWAY	7	6	5	1
ST_IL_13_PATHWAY	5	5	3	0
BIOCARTA_IL5_PATHWAY	5	5	3	0
REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS	2	2	1	0
BIOCARTA_TCYTOTOXIC_PATHWAY	4	4	1	0
BIOCARTA_TCRA_PATHWAY	2	2	1	0
BIOCARTA_THELPER_PATHWAY	3	3	1	0
REACTOME_PD1_SIGNALING	4	4	3	0
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP	6	6	3	1
BIOCARTA_ASBCELL_PATHWAY	5	5	3	0
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL	7	7	3	1
chr13q32	7	7	3	1
BIOCARTA_CSK_PATHWAY	4	4	3	0
HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	7	7	3	0
PID_IL27_PATHWAY	11	11	5	2
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN	7	7	5	0
KIM_TIAL1_TARGETS	6	6	3	0
NEMETH_INFLAMMATORY_RESPONSE_LPS_DN	7	7	3	0
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP	6	6	3	0
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	6	6	3	0
REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS	12	8	4	1
REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	11	7	3	1
REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	12	8	4	1
MIKKELSEN_ES_HCP_WITH_H3K27ME3	19	7	3	1
YAMASHITA_METHYLATED_IN_PROSTATE_CANCER	7	7	3	0
BUSA_SAM68_TARGETS_UP	5	5	2	0
ZHAN_EARLY_DIFFERENTIATION_GENES_UP	5	5	2	0
LANDIS_BREAST_CANCER_PROGRESSION_UP	9	7	3	2
TBK1.DN.48HRS_DN	4	4	1	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17	13	7	3	0
SU_PLACENTA	7	6	2	0
REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION	7	7	1	1
CHESLER_BRAIN_HIGHEST_EXPRESSION	22	9	4	0
chr18q22	12	8	2	1
chr2p14	14	6	2	0
IKEDA_MIR133_TARGETS_DN	24	6	3	0
KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	22	7	2	2
KEGG_DRUG_METABOLISM_CYTOCHROME_P450	14	9	4	2
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	9	8	3	1
REACTOME_HDL_MEDIATED_LIPID_TRANSPORT	22	9	4	2
MOOTHA_GLYCOGEN_METABOLISM	24	9	4	0
REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2	22	9	4	3
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP	14	4	1	0
THUM_MIR21_TARGETS_HEART_DISEASE_DN	13	5	2	0
RAHMAN_TP53_TARGETS_PHOSPHORYLATED	9	4	2	0
BILANGES_SERUM_SENSITIVE_VIA_TSC1	17	4	1	0
REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE	13	7	3	1
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	15	6	2	0
WILLIAMS_ESR2_TARGETS_DN	10	5	1	1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP	17	6	2	0
PID_INTEGRIN2_PATHWAY	13	5	2	1
BRACHAT_RESPONSE_TO_METHOTREXATE_UP	16	6	2	1
HORTON_SREBF_TARGETS	21	9	3	4
REACTOME_SULFUR_AMINO_ACID_METABOLISM	15	7	2	0
LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN	11	6	3	1
LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN	10	5	2	1
KREPPEL_CD99_TARGETS_DN	14	5	2	0
ST_MYOCYTE_AD_PATHWAY	19	9	2	2
chr10p11	6	5	1	1
ST_STAT3_PATHWAY	15	4	2	0
VALK_AML_CLUSTER_5	18	7	3	1
NICK_RESPONSE_TO_PROC_TREATMENT_DN	14	5	2	0
VALK_AML_CLUSTER_12	17	8	4	3
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	15	5	2	0
TCCGTCC_MIR184	15	5	2	1
NAGY_STAGA_COMPONENTS_HUMAN	17	5	2	0
BIOCARTA_MONOCYTE_PATHWAY	13	7	4	1
NGO_MALIGNANT_GLIOMA_1P_LOH	11	5	2	1
REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS	14	5	2	1
KIM_MYCL1_AMPLIFICATION_TARGETS_UP	6	4	1	1
RICKMAN_HEAD_AND_NECK_CANCER_D	6	5	2	0
SEMBA_FHIT_TARGETS_UP	9	3	1	0
YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP	18	6	2	0
REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION	21	5	2	1
DORSEY_GAB2_TARGETS	12	9	3	2
ALONSO_METASTASIS_EMT_UP	18	6	2	0
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN	12	7	3	1
REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS	13	3	1	1
REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION	22	8	4	3
MIKKELSEN_ES_LCP_WITH_H3K27ME3	9	5	2	1
KEGG_SPHINGOLIPID_METABOLISM	13	5	2	0
THILLAINADESAN_ZNF217_TARGETS_UP	22	7	2	1
MCGOWAN_RSP6_TARGETS_UP	10	6	3	1
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP	23	8	3	0
chr17p12	11	7	2	1
MOOTHA_FFA_OXYDATION	9	5	3	1
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP	13	5	2	1
AMIT_EGF_RESPONSE_40_MCF10A	10	4	1	0
REACTOME_BOTULINUM_NEUROTOXICITY	10	4	1	1
REACTOME_TIGHT_JUNCTION_INTERACTIONS	9	5	2	0
KEGG_LONG_TERM_POTENTIATION	19	7	2	2
chr21q22	5	5	1	0
KEGG_OLFACTORY_TRANSDUCTION	14	10	4	1
chr5p15	6	6	1	0
chr11q24	7	7	1	2
chr17q25	5	5	1	1
chr18p11	5	5	1	2
chr11q12	11	8	4	3
REACTOME_OLFACTORY_SIGNALING_PATHWAY	8	7	3	1
chr22q11	4	4	1	2
chr7q32	3	3	0	0
chr18q12	8	6	2	1
chr16q13	3	3	0	0
chr22q13	6	5	2	2
chr11q22	6	6	1	0
chr11p13	5	5	0	0
chr6q16	13	12	4	1
REACTOME_ION_CHANNEL_TRANSPORT	5	5	0	0
chr3q13	4	4	0	0
REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT	4	4	0	0
chr11q21	10	9	3	1
chr4q35	9	8	4	1
chr8p12	3	3	0	1
chr9q32	5	5	1	1
NIKOLSKY_BREAST_CANCER_5P15_AMPLICON	4	4	1	0
chr15q14	5	5	1	0
chr1q44	4	4	0	0
NOUSHMEHR_GBM_SILENCED_BY_METHYLATION	9	8	2	1
chr14q24	13	9	2	2
REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES	7	6	2	1
PID_INTEGRIN_CS_PATHWAY	5	5	2	1
chr18q23	5	5	0	0
REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM	12	9	3	1
chr15q15	5	5	1	1
OHGUCHI_LIVER_HNF4A_TARGETS_UP	4	4	0	0
chr13q34	3	3	0	0
chr8p22	12	8	2	1
REACTOME_GABA_A_RECEPTOR_ACTIVATION	6	6	1	0
chr6q15	6	5	2	1
BURTON_ADIPOGENESIS_10	6	5	2	1
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN	12	7	2	2
COLLIS_PRKDC_SUBSTRATES	8	4	1	1
chr13q13	5	5	1	0
chr3q28	4	4	0	0
MAHADEVAN_IMATINIB_RESISTANCE_DN	4	4	0	0
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP	4	4	0	0
CUI_TCF21_TARGETS_DN	16	9	4	1
REACTOME_TRANSPORT_OF_ORGANIC_ANIONS	4	4	0	1
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP	4	4	0	0
chr2p	5	5	1	0
MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH	6	6	1	0
chr6p23	4	4	0	0
chr20p13	3	3	0	0
chr10q11	4	4	0	1
KEGG_NITROGEN_METABOLISM	7	6	2	0
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	7	7	2	0
chr2q13	3	3	0	0
SCHRAETS_MLL_TARGETS_UP	6	5	2	1
LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES	8	6	3	1
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B	7	7	1	0
REACTOME_SIGNALING_BY_HIPPO	5	5	1	1
ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	4	4	0	0
REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION	6	6	2	1
NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON	6	6	1	1
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	9	6	2	0
chr1q41	6	6	1	0
REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM	3	3	0	0
chr2q23	6	6	1	0
chr15q13	4	4	0	1
chr12q22	8	7	3	1
XU_AKT1_TARGETS_6HR	4	4	1	1
REACTOME_COMPLEMENT_CASCADE	9	6	2	0
KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	16	9	5	2
TOMLINS_PROSTATE_CANCER_DN	7	7	2	1
WANG_METHYLATED_IN_BREAST_CANCER	18	7	4	0
PIEPOLI_LGI1_TARGETS_DN	4	4	1	0
NAKAJIMA_MAST_CELL	9	5	1	1
chr4p13	4	4	0	0
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP	5	5	2	1
YANG_BREAST_CANCER_ESR1_BULK_DN	9	6	2	2
chr11q	3	3	0	1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16	3	3	0	0
chr8q	3	3	0	0
BIOCARTA_NOS1_PATHWAY	7	7	3	0
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN	9	6	2	1
HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	7	7	1	0
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP	5	5	1	0
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	3	3	2	0
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION	13	7	2	1
OKAWA_NEUROBLASTOMA_1P36_31_DELETION	8	7	1	0
NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON	3	3	0	1
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	4	4	1	0
NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON	3	3	0	0
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1	4	4	0	0
SA_FAS_SIGNALING	10	6	3	1
WU_ALZHEIMER_DISEASE_UP	5	5	1	0
ANDERSEN_LIVER_CANCER_KRT19_DN	10	7	2	1
TOOKER_GEMCITABINE_RESISTANCE_UP	11	5	2	2
GROSS_HIF1A_TARGETS_DN	8	8	2	0
SABATES_COLORECTAL_ADENOMA_SIZE_DN	4	4	1	0
GRANDVAUX_IRF3_TARGETS_UP	7	6	2	1
chr13q11	4	4	1	2
chr10p14	5	5	1	0
PARK_TRETINOIN_RESPONSE	3	3	0	0
KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM	5	5	2	1
MAHADEVAN_RESPONSE_TO_MP470_UP	4	4	1	0
NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP	8	5	2	1
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN	4	4	1	0
OSADA_ASCL1_TARGETS_UP	7	6	2	1
ZHENG_IL22_SIGNALING_UP	6	6	2	0
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	11	8	2	0
DONATO_CELL_CYCLE_TRETINOIN	3	3	0	0
ALONSO_METASTASIS_EMT_DN	5	5	1	0
chr9p11	4	4	0	0
CHENG_TAF7L_TARGETS	4	4	0	0
chr5q	6	5	2	0
chr3q	3	3	0	0
FIGUEROA_AML_METHYLATION_CLUSTER_5_DN	9	6	2	1
HU_GENOTOXIC_DAMAGE_24HR	5	5	1	2
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN	4	4	1	1
LEE_LIVER_CANCER_CIPROFIBRATE_DN	4	4	1	0
BIOCARTA_PGC1A_PATHWAY	7	6	1	0
STEGER_ADIPOGENESIS_DN	8	6	1	1
REACTOME_KINESINS	4	4	1	1
WIKMAN_ASBESTOS_LUNG_CANCER_DN	3	3	0	0
VALK_AML_WITH_EVI1	7	5	1	0
TESAR_JAK_TARGETS_MOUSE_ES_D3_DN	5	5	1	0
XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP	3	3	0	0
TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP	6	6	1	0
WAGSCHAL_EHMT2_TARGETS_UP	3	3	0	0
REACTOME_REGULATION_OF_COMPLEMENT_CASCADE	4	4	0	0
REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX	2	2	0	0
REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS	7	6	1	0
STARK_HYPPOCAMPUS_22Q11_DELETION_DN	3	3	0	0
KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS	7	6	2	1
OUYANG_PROSTATE_CANCER_PROGRESSION_UP	11	5	2	0
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP	4	4	1	0
KANNAN_TP53_TARGETS_DN	4	4	0	0
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP	4	4	1	1
HOLLERN_MICROACINAR_BREAST_TUMOR_DN	9	8	2	1
chr4q34	7	7	1	0
OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP	3	3	1	0
REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION	6	6	2	0
REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS	10	9	3	1
CROONQUIST_NRAS_SIGNALING_UP	5	5	0	0
chr21q11	4	4	0	0
MATZUK_POSTIMPLANTATION_AND_POSTPARTUM	5	5	0	0
CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	10	6	3	2
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN	7	5	2	1
NIELSEN_LEIOMYOSARCOMA_CNN1_UP	4	4	0	0
PID_PDGFRA_PATHWAY	4	4	1	0
REACTOME_DOUBLE_STRAND_BREAK_REPAIR	7	5	2	1
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN	5	5	1	0
NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON	3	3	1	0
chr15q	2	2	0	0
REACTOME_PROSTANOID_LIGAND_RECEPTORS	5	5	1	0
YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN	2	2	0	0
PALOMERO_GSI_SENSITIVITY_DN	2	2	0	0
FIGUEROA_AML_METHYLATION_CLUSTER_7_DN	7	6	2	0
WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN	3	3	0	0
VISALA_AGING_LYMPHOCYTE_UP	1	1	0	0
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS	3	3	0	0
REACTOME_HS_GAG_DEGRADATION	6	6	1	1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN	3	3	1	0
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI	3	3	0	0
LANG_MYB_FAMILY_TARGETS	7	6	2	1
REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING	9	9	2	2
WEBER_METHYLATED_HCP_IN_SPERM_DN	4	4	1	1
WONG_IFNA2_RESISTANCE_DN	8	8	4	1
BIOCARTA_LAIR_PATHWAY	8	5	2	0
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN	6	5	1	0
COLLIS_PRKDC_REGULATORS	11	8	4	1
chr1q43	5	5	1	0
REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION	14	12	5	4
REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT	10	9	3	0
KEGG_N_GLYCAN_BIOSYNTHESIS	11	6	1	1
BIOCARTA_IL10_PATHWAY	8	7	3	1
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN	7	6	3	2
chr13q22	6	4	1	1
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION	3	3	0	0
chr3q29	3	3	0	0
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN	10	7	2	0
MOOTHA_PYR	3	3	0	0
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN	4	4	0	0
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN	3	3	0	0
GALI_TP53_TARGETS_APOPTOTIC_UP	3	3	0	0
REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS	5	5	1	0
TSAI_DNAJB4_TARGETS_UP	3	3	0	0
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1	3	3	1	0
REACTOME_GAP_JUNCTION_ASSEMBLY	4	4	1	1
REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE	3	3	0	0
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22	6	5	2	0
BIOCARTA_LYM_PATHWAY	3	3	0	0
REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING	8	4	1	1
HO_LIVER_CANCER_VASCULAR_INVASION	4	4	1	0
EHLERS_ANEUPLOIDY_DN	5	4	1	0
REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS	8	7	1	1
WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION	6	5	1	0
chr3p13	2	2	0	0
BIOCARTA_GABA_PATHWAY	3	3	0	0
DER_IFN_GAMMA_RESPONSE_DN	4	4	1	0
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN	5	3	2	0
REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS	3	3	0	0
REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING	7	7	3	0
YANG_MUC2_TARGETS_DUODENUM_6MO_UP	3	3	0	0
chr16q21	4	4	0	0
PID_VEGF_VEGFR_PATHWAY	6	5	1	1
REACTOME_THE_NLRP3_INFLAMMASOME	4	4	1	1
REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS	6	6	1	0
REACTOME_TRYPTOPHAN_CATABOLISM	3	3	0	0
HASLINGER_B_CLL_WITH_11Q23_DELETION	6	6	2	2
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP	5	4	2	1
ZHANG_INTERFERON_RESPONSE	3	3	0	0
REACTOME_EGFR_DOWNREGULATION	4	4	1	0
KRAS.50_UP.V1_DN	5	5	1	0
HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY	9	7	3	1
REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS	7	7	2	0
PID_DNA_PK_PATHWAY	6	4	1	0
REACTOME_DEFENSINS	17	8	3	2
MIZUSHIMA_AUTOPHAGOSOME_FORMATION	6	5	2	1
chr5q15	5	5	1	0
BIOCARTA_CK1_PATHWAY	4	4	1	0
KYNG_NORMAL_AGING_UP	4	4	0	0
BIOCARTA_MEF2D_PATHWAY	5	5	1	0
REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES	6	4	2	0
ZHAN_MULTIPLE_MYELOMA_CD1_UP	5	5	1	0
HOUSTIS_ROS	4	4	1	1
REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING	7	7	2	0
KEGG_GRAFT_VERSUS_HOST_DISEASE	4	4	0	0
WANG_RESPONSE_TO_BEXAROTENE_UP	5	5	1	0
KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS	4	4	1	1
chr21q21	4	4	0	0
LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	3	3	0	0
REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS	8	8	2	1
KEGG_RETINOL_METABOLISM	15	9	4	1
REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII	5	5	2	1
BIOCARTA_D4GDI_PATHWAY	3	3	0	0
CLAUS_PGR_POSITIVE_MENINGIOMA_DN	5	5	1	0
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	5	5	1	0
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN	11	6	2	1
DAZARD_UV_RESPONSE_CLUSTER_G2	7	5	2	1
REACTOME_SYNTHESIS_OF_PA	5	5	0	0
chr9p13	5	5	1	0
KORKOLA_SEMINOMA_UP	3	3	1	2
REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	4	4	0	1
NIKOLSKY_BREAST_CANCER_20P13_AMPLICON	2	2	0	0
DER_IFN_ALPHA_RESPONSE_DN	4	4	1	0
CHOI_ATL_ACUTE_STAGE	3	3	0	0
ZERBINI_RESPONSE_TO_SULINDAC_DN	1	1	0	0
NIKOLSKY_BREAST_CANCER_17P11_AMPLICON	4	4	0	0
BIOCARTA_CTL_PATHWAY	4	4	1	1
BIOCARTA_RAB_PATHWAY	3	3	0	0
SHIN_B_CELL_LYMPHOMA_CLUSTER_6	1	1	0	0
REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK	1	1	0	1
ZHENG_FOXP3_TARGETS_IN_THYMUS_DN	4	4	0	0
FAELT_B_CLL_WITH_VH3_21_DN	6	5	2	2
TGCACGA_MIR517A_MIR517C	6	6	2	0
CHEN_LUNG_CANCER_SURVIVAL	11	4	2	2
MANN_RESPONSE_TO_AMIFOSTINE_UP	3	3	2	0
MATTHEWS_AP1_TARGETS	2	2	0	0
KEGG_GLYCOSAMINOGLYCAN_DEGRADATION	4	4	1	1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN	4	4	0	0
AGARWAL_AKT_PATHWAY_TARGETS	4	4	1	0
REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS	2	2	0	0
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN	2	2	0	0
LIU_CMYB_TARGETS_DN	2	2	0	0
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS	3	3	0	0
MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN	6	6	1	0
REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE	1	1	0	0
REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES	4	3	1	1
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL	2	2	0	1
BIOCARTA_CLASSIC_PATHWAY	6	3	2	0
REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	10	7	3	2
VANTVEER_BREAST_CANCER_BRCA1_UP	10	5	2	1
FARMER_BREAST_CANCER_CLUSTER_1	6	5	3	0
VALK_AML_CLUSTER_3	5	5	0	0
JONES_TCOF1_TARGETS	4	4	0	0
MATZUK_CUMULUS_EXPANSION	3	3	0	0
KHETCHOUMIAN_TRIM24_TARGETS_DN	3	3	0	0
MOTAMED_RESPONSE_TO_ANDROGEN_DN	3	3	0	0
TOMIDA_LUNG_CANCER_POOR_SURVIVAL	3	3	0	0
REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS	2	2	0	0
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18	3	3	0	1
WALLACE_PROSTATE_CANCER_DN	3	3	0	0
PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN	3	3	0	0
CAFFAREL_RESPONSE_TO_THC_8HR_5_DN	3	3	0	0
KASLER_HDAC7_TARGETS_2_UP	2	2	0	0
WILLIAMS_ESR1_TARGETS_DN	4	4	0	0
HOFFMAN_CLOCK_TARGETS_DN	5	4	1	1
JU_AGING_TERC_TARGETS_DN	3	3	0	0
SRF_01	11	5	2	2
REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS	8	8	3	0
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN	8	5	2	1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	6	4	2	1
MELLMAN_TUT1_TARGETS_UP	8	5	2	0
BILANGES_RAPAMYCIN_SENSITIVE_GENES	5	5	0	0
KORKOLA_EMBRYONAL_CARCINOMA_UP	4	4	1	1
chr15q11	3	3	0	0
BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	4	4	1	0
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN	3	3	1	0
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	5	5	1	1
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL	4	4	1	1
FARMER_BREAST_CANCER_CLUSTER_3	6	4	1	0
REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING	4	4	1	0
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN	4	4	1	2
ZHOU_PANCREATIC_EXOCRINE_PROGENITOR	4	4	1	0
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS	4	4	1	0
BIOCARTA_IL22BP_PATHWAY	7	6	2	1
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP	4	4	1	1
REACTOME_ACYL_CHAIN_REMODELLING_OF_PG	3	3	0	0
PID_RANBP2_PATHWAY	5	5	1	0
REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER	3	3	1	1
REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN	6	5	2	1
SU_SALIVARY_GLAND	6	6	0	0
BIOCARTA_LEPTIN_PATHWAY	8	5	2	1
chr9q13	4	4	0	0
KEGG_BUTANOATE_METABOLISM	7	6	2	0
MAEKAWA_ATF2_TARGETS	5	5	2	1
AIYAR_COBRA1_TARGETS_DN	4	4	1	1
KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	2	2	0	0
AGCGCTT_MIR518F_MIR518E_MIR518A	8	6	1	0
CHEOK_RESPONSE_TO_HD_MTX_UP	5	5	1	0
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	2	2	1	1
YANG_BCL3_TARGETS_DN	3	3	0	0
FREDERICK_PRKCI_TARGETS	3	3	1	0
chr19q12	4	4	0	0
REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS	6	6	0	1
LOPEZ_MESOTHELIOMA_SURVIVAL_DN	10	5	1	0
REACTOME_IRAK1_RECRUITS_IKK_COMPLEX	4	4	1	0
OXFORD_RALA_AND_RALB_TARGETS_UP	6	4	2	0
ZHANG_GATA6_TARGETS_UP	5	5	1	1
HOLLERN_SOLID_NODULAR_BREAST_TUMOR_UP	5	5	1	0
REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON	5	5	0	0
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE	5	5	2	2
NEBEN_AML_WITH_FLT3_OR_NRAS_DN	4	4	1	0
REACTOME_RNA_POL_III_CHAIN_ELONGATION	4	4	2	1
REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	2	2	0	0
KEGG_MISMATCH_REPAIR	4	4	1	0
VALK_AML_WITH_11Q23_REARRANGED	8	5	2	1
KIM_PTEN_TARGETS_UP	13	4	1	1
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN	6	5	2	0
REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR	8	5	2	1
INGRAM_SHH_TARGETS	3	3	1	0
chr6p11	4	4	1	0
SA_G2_AND_M_PHASES	2	2	0	0
DASU_IL6_SIGNALING_DN	2	2	0	0
MIKKELSEN_DEDIFFERENTIATED_STATE_UP	7	5	1	1
PALOMERO_GSI_SENSITIVITY_UP	9	6	2	1
SCHRAMM_INHBA_TARGETS_UP	2	2	0	0
BAUS_TFF2_TARGETS_DN	4	4	1	0
REACTOME_PURINE_CATABOLISM	5	5	2	2
AUJLA_IL22_AND_IL17A_SIGNALING	2	2	0	0
MCCABE_HOXC6_TARGETS_UP	4	4	1	0
RADAEVA_RESPONSE_TO_IFNA1_DN	4	4	0	0
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9	6	4	1	1
GROSS_HIF1A_TARGETS_UP	3	3	0	0
GOUYER_TATI_TARGETS_UP	2	2	0	0
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25	4	4	1	0
WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP	4	4	1	0
chr1p11	3	3	0	0
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP	3	3	0	0
YIH_RESPONSE_TO_ARSENITE_C5	3	3	0	0
ST_JAK_STAT_PATHWAY	10	5	2	0
REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS	7	5	2	1
KEGG_BASAL_TRANSCRIPTION_FACTORS	4	4	2	1
NADERI_BREAST_CANCER_PROGNOSIS_DN	4	4	1	0
REACTOME_SYNTHESIS_OF_PC	6	6	1	0
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN	8	4	2	0
TURJANSKI_MAPK11_TARGETS	3	3	0	0
NAKAMURA_ALVEOLAR_EPITHELIUM	2	2	1	0
KREPPEL_CD99_TARGETS_UP	3	3	1	0
ZIRN_TRETINOIN_RESPONSE_WT1_DN	2	2	1	0
REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC	5	5	2	0
STONER_ESOPHAGEAL_CARCINOGENESIS_DN	4	4	0	0
GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN	4	4	0	0
KAPOSI_LIVER_CANCER_MET_DN	3	3	1	0
CASTELLANO_HRAS_AND_NRAS_TARGETS_UP	3	3	0	0
chr9q12	3	3	1	0
PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP	4	4	1	0
KIM_GLIS2_TARGETS_DN	4	4	1	0
MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN	1	1	0	0
NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON	4	4	1	0
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN	1	1	0	0
SIMBULAN_UV_RESPONSE_NORMAL_UP	2	2	0	0
BIOCARTA_PARKIN_PATHWAY	4	4	0	0
VANDESLUIS_NORMAL_EMBRYOS_UP	4	4	1	0
TERAO_AOX4_TARGETS_HG_DN	3	3	1	0
REACTOME_INTRINSIC_PATHWAY	9	6	4	2
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN	5	5	2	0
chrxp11	1	1	0	0
chr10q	3	3	0	0
HU_ANGIOGENESIS_DN	7	6	3	0
BIOCARTA_CASPASE_PATHWAY	4	4	1	0
WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP	11	7	3	0
REACTOME_IL_6_SIGNALING	4	4	1	0
REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1	5	5	1	0
REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10	4	4	1	0
REACTOME_SYNTHESIS_OF_PE	6	6	2	0
IVANOV_MUTATED_IN_COLON_CANCER	3	3	0	1
BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	3	3	0	0
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE	6	6	2	2
SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP	4	4	1	1
BIOCARTA_CACAM_PATHWAY	3	3	0	0
DORN_ADENOVIRUS_INFECTION_24HR_UP	3	3	0	0
KEGG_DRUG_METABOLISM_OTHER_ENZYMES	9	8	4	0
JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	8	5	2	0
REACTOME_SMOOTH_MUSCLE_CONTRACTION	10	7	2	0
TIAN_TNF_SIGNALING_NOT_VIA_NFKB	4	4	2	1
MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP	4	4	1	0
ABE_VEGFA_TARGETS	9	8	4	2
REACTOME_REGULATION_OF_IFNG_SIGNALING	6	6	2	0
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	3	3	0	0
DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP	4	4	1	0
CHASSOT_SKIN_WOUND	5	4	1	0
REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES	3	3	0	0
KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN	2	2	0	0
BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN	4	4	1	0
WHITESIDE_CISPLATIN_RESISTANCE_DN	3	3	0	0
chr7q	2	2	0	0
CLIMENT_BREAST_CANCER_COPY_NUMBER_DN	7	6	2	1
CONRAD_GERMLINE_STEM_CELL	2	2	0	0
BIOCARTA_TCAPOPTOSIS_PATHWAY	3	3	0	0
NOUSHMEHR_GBM_GERMLINE_MUTATED	3	3	0	1
HEDVAT_ELF4_TARGETS_UP	4	4	1	0
COLLER_MYC_TARGETS_DN	3	3	0	0
KUWANO_RNA_STABILIZED_BY_NO	3	3	0	0
SEIKE_LUNG_CANCER_POOR_SURVIVAL	4	4	1	0
WEBER_METHYLATED_ICP_IN_FIBROBLAST	5	5	1	1
REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR	6	5	1	0
CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	3	3	0	1
FERRANDO_LYL1_NEIGHBORS	10	7	3	3
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP	5	4	1	1
KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	3	3	0	0
BIOCARTA_NDKDYNAMIN_PATHWAY	4	4	1	0
REACTOME_BASIGIN_INTERACTIONS	5	5	2	2
KEGG_PRIMARY_IMMUNODEFICIENCY	6	6	3	0
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP	5	5	1	1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS	5	5	1	0
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX	7	7	1	0
REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS	4	4	1	0
REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS	3	3	0	1
REACTOME_ACYL_CHAIN_REMODELLING_OF_PS	3	3	0	0
chr9p12	3	3	0	0
REACTOME_ACYL_CHAIN_REMODELLING_OF_PI	3	3	0	0
HOEGERKORP_CD44_TARGETS_TEMPORAL_UP	11	6	3	1
ROZANOV_MMP14_CORRELATED	4	4	1	1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP	7	5	1	1
MATZUK_FERTILIZATION	3	3	0	0
ACGCACA_MIR210	2	2	0	0
DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN	2	2	0	0
REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN	11	5	2	0
REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA	2	2	1	0
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN	3	3	0	0
ACCGAGC_MIR423	8	7	3	1
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP	4	4	1	0
GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN	4	4	1	0
LI_WILMS_TUMOR_ANAPLASTIC_DN	3	3	0	0
CHANG_POU5F1_TARGETS_DN	3	3	0	0
RODRIGUES_DCC_TARGETS_UP	3	3	0	0
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5	5	5	1	0
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP	2	2	0	0
BUDHU_LIVER_CANCER_METASTASIS_DN	1	1	0	0
ELVIDGE_HIF2A_TARGETS_UP	3	3	0	0
BASSO_HAIRY_CELL_LEUKEMIA_DN	4	4	1	0
REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE	2	2	0	0
CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_DN	3	3	0	0
WANG_THOC1_TARGETS_UP	3	3	1	0
KEGG_GALACTOSE_METABOLISM	4	4	1	0
KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	3	3	0	0
REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	11	7	2	1
BIOCARTA_NO2IL12_PATHWAY	6	6	1	0
KORKOLA_YOLK_SAC_TUMOR_UP	2	2	0	1
KEGG_ONE_CARBON_POOL_BY_FOLATE	4	4	1	1
BIOCARTA_HSP27_PATHWAY	5	5	3	0
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN	9	5	2	1
PETRETTO_HEART_MASS_QTL_CIS_DN	6	6	2	0
PAX3_01	7	7	2	0
BIOCARTA_MITOCHONDRIA_PATHWAY	5	5	1	1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD	3	3	0	0
REACTOME_PYRIMIDINE_METABOLISM	6	5	2	0
REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES	3	3	0	1
WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN	3	3	0	0
REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY	5	5	1	0
HINATA_NFKB_MATRIX	8	6	2	1
ITO_PTTG1_TARGETS_UP	3	3	0	1
SHIRAISHI_PLZF_TARGETS_UP	6	3	1	1
KEGG_LIMONENE_AND_PINENE_DEGRADATION	6	4	2	1
KEGG_REGULATION_OF_AUTOPHAGY	2	2	0	0
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN	9	7	4	1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	4	4	1	1
SCHUHMACHER_MYC_TARGETS_DN	2	2	0	0
CASTELLANO_HRAS_TARGETS_DN	4	4	1	0
chr3p	4	4	1	0
CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP	1	1	0	0
ZEILSTRA_CD44_TARGETS_DN	4	4	1	0
YOKOE_CANCER_TESTIS_ANTIGENS	10	5	2	0
DIRMEIER_LMP1_RESPONSE_LATE_DN	3	3	0	0
BIOCARTA_AKAP95_PATHWAY	3	3	1	0
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP	5	3	1	1
HUMMERICH_BENIGN_SKIN_TUMOR_DN	7	6	3	1
REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE	4	4	2	1
AGCGCAG_MIR191	9	4	1	1
HAHTOLA_MYCOSIS_FUNGOIDES_DN	8	4	1	1
TOMIDA_METASTASIS_DN	3	3	1	0
XU_CREBBP_TARGETS_UP	4	4	1	0
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP	6	6	0	0
AMIT_SERUM_RESPONSE_480_MCF10A	3	3	0	0
FLORIO_HUMAN_NEOCORTEX	3	3	0	0
CORRADETTI_MTOR_PATHWAY_REGULATORS_DN	2	2	0	0
KONDO_HYPOXIA	3	3	0	0
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN	1	1	0	1
REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS	3	3	0	0
WEBER_METHYLATED_LCP_IN_SPERM_DN	3	3	0	0
chr14q	4	4	0	0
WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP	2	2	0	0
NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON	4	4	1	0
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN	2	2	0	0
REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6_ALPHA	3	3	1	0
WANG_ESOPHAGUS_CANCER_PROGRESSION_UP	2	2	0	0
PETRETTO_BLOOD_PRESSURE_UP	5	5	1	0
SOUCEK_MYC_TARGETS	3	3	0	0
FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN	4	4	1	0
KAUFFMANN_MELANOMA_RELAPSE_DN	4	4	1	0
FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN	3	3	0	0
LUI_THYROID_CANCER_CLUSTER_5	3	3	1	0
BIOCARTA_DNAFRAGMENT_PATHWAY	4	4	1	1
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2	2	2	0	0
SUZUKI_CTCFL_TARGETS_UP	4	4	1	0
MIKKELSEN_PLURIPOTENT_STATE_UP	4	4	1	0
CLAUS_PGR_POSITIVE_MENINGIOMA_UP	3	3	0	0
REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM	3	3	0	0
FRASOR_TAMOXIFEN_RESPONSE_DN	3	3	0	0
GENTLES_LEUKEMIC_STEM_CELL_DN	3	3	0	0
CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB	6	6	2	0
VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP	10	8	2	2
STEINER_ERYTHROCYTE_MEMBRANE_GENES	3	3	0	0
chr16p	4	4	0	0
YANAGISAWA_LUNG_CANCER_RECURRENCE	3	3	0	0
SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM	4	4	1	0
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN	8	6	2	2
REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE	10	7	2	1
PETROVA_PROX1_TARGETS_UP	4	4	1	1
REACTOME_PURINE_METABOLISM	7	5	3	2
VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN	3	3	0	0
BAFNA_MUC4_TARGETS_DN	4	4	1	0
LIU_IL13_MEMORY_MODEL_DN	2	2	0	0
CAFFAREL_RESPONSE_TO_THC_8HR_3_UP	3	3	0	0
NEBEN_AML_WITH_FLT3_OR_NRAS_UP	2	2	1	0
TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP	3	3	0	0
GGCGGCA_MIR371	4	4	1	0
chr19p	4	4	1	0
JIANG_CORE_DUPLICON_GENES	2	2	1	0
CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP	3	3	0	0
chr12q11	1	1	0	0
TESAR_ALK_TARGETS_HUMAN_ES_5D_UP	2	2	0	0
OZANNE_AP1_TARGETS_DN	6	6	2	0
INAMURA_LUNG_CANCER_SCC_SUBTYPES_DN	3	3	0	0
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN	4	4	1	0
chr4q33	4	4	1	0
MIKKELSEN_NPC_WITH_LCP_H3K27ME3	4	4	0	0
VALK_AML_WITH_T_8_21_TRANSLOCATION	4	4	1	0
BIOCARTA_BLYMPHOCYTE_PATHWAY	4	4	0	0
SASSON_FSH_RESPONSE	2	2	0	0
MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP	3	3	0	0
AMIT_EGF_RESPONSE_20_HELA	2	2	0	0
MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	3	3	0	0
KOBAYASHI_EGFR_SIGNALING_6HR_UP	3	3	0	0
REACTOME_METABOLISM_OF_PORPHYRINS	2	2	0	0
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN	2	2	0	0
HASLINGER_B_CLL_WITH_6Q21_DELETION	5	5	1	0
REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	4	4	1	1
REACTOME_CALNEXIN_CALRETICULIN_CYCLE	4	4	2	1
REACTOME_GLUCURONIDATION	1	1	0	0
NAKAJIMA_EOSINOPHIL	3	3	0	0
WILENSKY_RESPONSE_TO_DARAPLADIB	4	4	2	0
KEGG_NOTCH_SIGNALING_PATHWAY	8	6	2	1
CHEN_ETV5_TARGETS_SERTOLI	3	3	0	0
HAHTOLA_MYCOSIS_FUNGOIDES_UP	5	5	1	0
HUMMERICH_BENIGN_SKIN_TUMOR_UP	3	3	0	0
REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY	7	6	2	0
NIELSEN_SCHWANNOMA_UP	22	5	2	1
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN	4	3	1	1
WONG_IFNA2_RESISTANCE_UP	5	5	0	0
REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC	5	5	2	0
REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR	2	2	0	0
REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS	3	3	1	0
RUAN_RESPONSE_TO_TNF_UP	4	4	0	0
REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES	4	4	1	0
HAEGERSTRAND_RESPONSE_TO_IMATINIB	4	4	1	0
BIOCARTA_SODD_PATHWAY	4	4	1	0
CGCAAAA_MIR450	3	3	0	0
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6	5	4	3	1
KORKOLA_EMBRYONAL_CARCINOMA	1	1	0	0
KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN	2	2	0	0
TRACEY_RESISTANCE_TO_IFNA2_UP	3	3	1	0
chr22q	3	3	0	0
CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN	2	2	0	0
IGARASHI_ATF4_TARGETS_UP	3	3	0	0
FU_INTERACT_WITH_ALKBH8	2	2	0	1
chr4q	3	3	0	0
OHASHI_AURKB_TARGETS	4	4	0	0
FUJIWARA_PARK2_IN_LIVER_CANCER_DN	5	4	2	0
PETRETTO_BLOOD_PRESSURE_DN	4	3	1	0
REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE	1	1	0	0
IM_SREBF1A_TARGETS	2	2	0	1
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP	4	4	1	0
SEF1_C	3	3	0	0
NICK_RESPONSE_TO_PROC_TREATMENT_UP	3	3	0	0
KERLEY_RESPONSE_TO_CISPLATIN_DN	2	2	0	0
NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA	2	2	0	0
TESAR_ALK_TARGETS_EPISC_4D_UP	3	3	0	0
BIOCARTA_AHSP_PATHWAY	3	3	1	1
REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION	8	5	2	0
STANHILL_HRAS_TRANSFROMATION_UP	2	2	0	0
REACTOME_MUSCLE_CONTRACTION	11	8	2	0
CHEOK_RESPONSE_TO_HD_MTX_DN	7	5	2	1
MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3	5	5	1	1
BERGER_MBD2_TARGETS	3	3	0	0
TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN	3	3	1	0
MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP	2	2	0	1
GOUYER_TATI_TARGETS_DN	5	5	2	1
BAUS_TFF2_TARGETS_UP	10	8	4	1
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP	4	4	1	0
BIOCARTA_EXTRINSIC_PATHWAY	11	8	4	2
KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION	3	3	0	0
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN	6	6	3	1
KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN	5	5	1	1
SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN	11	7	3	2
REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION	3	3	1	0
ST_INTERFERON_GAMMA_PATHWAY	9	4	2	0
DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4	13	6	2	1
WEBER_METHYLATED_ICP_IN_SPERM_DN	3	3	1	0
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	4	4	1	0
WALLACE_JAK2_TARGETS_UP	5	4	2	0
BIOCARTA_INTRINSIC_PATHWAY	11	8	4	2
CAFFAREL_RESPONSE_TO_THC_24HR_3_UP	6	5	2	0
GALI_TP53_TARGETS_APOPTOTIC_DN	4	4	0	0
GROSS_HYPOXIA_VIA_HIF1A_ONLY	3	3	0	0
YANG_MUC2_TARGETS_COLON_3MO_DN	2	2	0	0
ITO_PTTG1_TARGETS_DN	3	3	2	0
NAGY_PCAF_COMPONENTS_HUMAN	3	3	0	0
GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP	3	3	0	0
ST_PAC1_RECEPTOR_PATHWAY	6	6	2	0
chr16q11	3	3	0	0
GLINSKY_CANCER_DEATH_UP	2	2	0	0
FARDIN_HYPOXIA_9	2	2	0	0
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	6	3	1	1
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN	3	3	0	0
REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS	2	2	0	0
REACTOME_SIGNALING_BY_NOTCH3	3	3	1	0
HUMMERICH_MALIGNANT_SKIN_TUMOR_UP	8	5	2	1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD	3	3	0	0
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	5	5	2	1
LIU_CDX2_TARGETS_DN	1	1	0	0
KORKOLA_CHORIOCARCINOMA_UP	3	3	1	0
REN_MIF_TARGETS_DN	3	3	1	0
FERRARI_RESPONSE_TO_FENRETINIDE_DN	3	3	1	0
MAINA_HYPOXIA_VHL_TARGETS_UP	3	3	1	0
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN	2	2	0	0
chr9p	3	3	0	0
chr11p	4	4	1	0
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2	3	3	1	0
SMID_BREAST_CANCER_NORMAL_LIKE_DN	4	4	1	0
LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED	3	3	1	0
REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION	6	5	2	1
LUI_THYROID_CANCER_CLUSTER_4	5	3	1	1
LY_AGING_OLD_UP	5	4	1	1
REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR	3	3	0	0
PASTURAL_RIZ1_TARGETS_UP	3	3	0	0
SCHMAHL_PDGF_SIGNALING	10	6	2	1
MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN	2	2	1	0
FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP	3	3	0	0
YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN	7	3	1	1
WELCH_GATA1_TARGETS	7	4	2	1
REACTOME_COMMON_PATHWAY	10	7	4	2
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN	5	4	1	0
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP	10	6	3	2
BIOCARTA_FIBRINOLYSIS_PATHWAY	9	7	4	3
REACTOME_PURINE_SALVAGE	3	3	1	0
BIOCARTA_KREB_PATHWAY	5	5	3	1
CROONQUIST_STROMAL_STIMULATION_DN	5	4	1	1
JU_AGING_TERC_TARGETS_UP	3	3	0	0
chr3q11	3	3	0	0
ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS	16	3	1	1
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING	4	4	1	0
LU_TUMOR_ENDOTHELIAL_MARKERS_DN	2	2	1	0
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP	4	4	1	0
ABDULRAHMAN_KIDNEY_CANCER_VHL_UP	3	3	0	0
CROSBY_E2F4_TARGETS	1	1	0	0
REACTOME_BINDING_AND_ENTRY_OF_HIV_VIRION	3	3	0	0
MCGOWAN_RSP6_TARGETS_DN	2	2	1	0
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN	5	4	2	1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN	4	4	1	0
TESAR_ALK_TARGETS_EPISC_3D_UP	3	3	0	0
chr9p23	4	4	1	0
REACTOME_REGULATION_OF_IFNA_SIGNALING	4	4	1	1
TERAMOTO_OPN_TARGETS_CLUSTER_3	2	2	1	0
ZIRN_TRETINOIN_RESPONSE_DN	2	2	0	0
ONGUSAHA_BRCA1_TARGETS_UP	3	3	0	1
BIOCARTA_VITCB_PATHWAY	4	4	0	0
BIOCARTA_P35ALZHEIMERS_PATHWAY	10	4	2	1
REACTOME_PYRIMIDINE_CATABOLISM	4	4	0	0
REACTOME_SIGNALING_BY_NOTCH2	3	3	1	0
BIOCARTA_SET_PATHWAY	3	3	1	0
REACTOME_SIGNALING_BY_NOTCH4	3	3	1	0
CHESLER_BRAIN_D6MIT150_QTL_CIS	3	3	0	0
REACTOME_P2Y_RECEPTORS	2	2	0	0
REACTOME_OPSINS	3	3	0	0
MOTAMED_RESPONSE_TO_ANDROGEN_UP	2	2	0	0
chr12p	2	2	0	0
BIOCARTA_GLYCOLYSIS_PATHWAY	3	3	0	0
ROAZ_01	3	3	0	0
DING_LUNG_CANCER_MUTATED_RECURRENTLY	4	4	1	0
BIOCARTA_NEUROTRANSMITTERS_PATHWAY	3	3	1	0
NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN	3	3	0	0
REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX	3	3	1	1
NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON	2	2	0	0
BIOCARTA_FEEDER_PATHWAY	2	2	0	0
ISHIKAWA_STING_SIGNALING	2	2	0	0
MARTINELLI_IMMATURE_NEUTROPHIL_UP	1	1	0	0
SHI_SPARC_TARGETS_DN	7	4	1	0
LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP	3	3	1	1
REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS	2	2	0	0
JOHNSTONE_PARVB_TARGETS_1_UP	4	3	2	0
YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP	3	3	1	0
ST_TYPE_I_INTERFERON_PATHWAY	4	4	1	0
SEMBA_FHIT_TARGETS_DN	3	3	0	0
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	5	5	1	0
REACTOME_STRIATED_MUSCLE_CONTRACTION	6	6	2	0
GALE_APL_WITH_FLT3_MUTATED_DN	2	2	1	1
REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX	3	3	1	1
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP	5	4	1	0
CHEN_HOXA5_TARGETS_6HR_DN	2	2	0	0
BYSTRYKH_SCP2_QTL	2	2	0	0
NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON	2	2	0	0
chr19q	2	2	0	0
MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3	2	2	1	0
DER_IFN_BETA_RESPONSE_DN	3	3	1	0
CASTELLANO_HRAS_TARGETS_UP	6	3	2	1
chr18p	3	3	0	0
LUDWICZEK_TREATING_IRON_OVERLOAD	2	2	0	0
chr1q	2	2	0	0
chr7p	1	1	0	0
chr6q	6	4	2	1
AGTGCGT_MIR521	4	3	2	1
